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Preface to ”The Multi-Dimensional Contributions
of Prefrontal Circuits to Emotion Regulation during
Adulthood and Critical Stages of Development”
The Multidimensional Contributions of Prefrontal Circuits to Emotion Regulation during
Adulthood and Critical Stages of Development.
The prefrontal cortex (PFC) and neighbouring anterior cingulate cortex play a pivotal role
in regulating our emotions, as shown by the marked alterations in activity within prefrontal and
cingulate circuits that accompany mood and anxiety disorders. These regions are functionally
diverse. Thus, a critical step towards better stratification of the symptoms of mood and
anxiety disorders and more effective individualised treatment strategies is to define their unique
contributions to the regulation of positive and negative emotions.
Since many disorders of emotion have their onset during childhood and adolescence, it is
also important to extend our understanding of these prefrontal circuits to the developing brain.
This Special Issue brings together the most recent research in humans and other animals that
addresses these important questions. Alterations in activity and structural morphology in specific
prefrontal circuits identified in adult and adolescent clinical populations are investigated in rodents
and monkeys to determine their causal contribution to emotion and cognitive dysregulation.
The importance of stress and altered neurodevelopmental trajectories, highlighted as important
factors leading to symptoms of anxiety and depression in clinical studies, is explored at the system,
cellular, and molecular levels of prefrontal circuits in animals. Together these papers illustrate the
importance of the cross-species translation of prefrontal function to inform our understanding of the
psychological and physiological mechanisms underlying affective disorders.
The first set of papers consider the adult prefrontal cortex. The functions of area 25 in
humans and monkeys and its putative homologue, the infralimbic cortex in rodents, are reviewed in
Alexander and colleagues along with their relevance to our understanding of anxiety and anhedonia.
One particular cognitive function, occasion setting, is explored in rats by Roughley and Killcross,
specifically focussing on the role of the infralimbic and prelimbic cortices. The role of stress in
inducing dysregulation within the prefrontal cortex is then discussed by Datta and Arnsten, drawing
upon data from humans, monkeys and rats to provide a description of the molecular mechanisms
that may mediate such effects and the ensuing loss of hierarchical control. To complete this section,
the prospects of using functional magnetic resonance imaging to discover biomarkers that will predict
an individual’s risk of developing a psychiatric disorder are considered by Nord and colleagues,
focussing on fronto-amygdala connectivity. Turning to adolescence, Ernst and colleagues discuss
the use of machine learning to test models of brain–behaviour interactions during development.
Three papers then describe altered prefrontal function, the first in relation to the neurodevelopmental
disorder Williams syndrome, involving reductions in grey matter within area 25 associated with the
symptoms of anxiety and hypersociability (Wilder and colleagues). A second reviews the altered
intrinsic and extrinsic connectivity of the prefrontal cortex in relation to positive and negative emotion
in adolescents suffering from depression (Kaya and McCabe). The ontogeny of strategies to effectively
regulate emotion is discussed by Young and colleagues from behavioural, psychophysiological and
neural perspectives considering how their dysregulation may underlie symptoms of anxiety and
ix
depression in adolescents. The final two papers by Zimmerman and Schipper and their colleagues
provide insights into the neurodevelopmental time-course underlying the regulation of threat in







A Focus on the Functions of Area 25
Laith Alexander 1,2, Hannah F. Clarke 1,2,* and Angela C. Roberts 1,2,*
1 Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge CB2 3DY,
UK; la326@cam.ac.uk
2 Behavioural and Clinical Neuroscience Institute, Department of Psychology, University of Cambridge,
Cambridge CB2 3EB, UK
* Correspondence: acr4@cam.ac.uk (A.C.R.); hfc23@cam.ac.uk (H.F.C.); Tel.: +44-1223-339015 (A.C.R.);
+44-1223-33758 (H.F.C.)
Received: 18 March 2019; Accepted: 29 May 2019; Published: 3 June 2019
Abstract: Subcallosal area 25 is one of the least understood regions of the anterior cingulate cortex, but
activity in this area is emerging as a crucial correlate of mood and affective disorder symptomatology.
The cortical and subcortical connectivity of area 25 suggests it may act as an interface between the
bioregulatory and emotional states that are aberrant in disorders such as depression. However,
evidence for such a role is limited because of uncertainty over the functional homologue of area 25 in
rodents, which hinders cross-species translation. This emphasizes the need for causal manipulations
in monkeys in which area 25, and the prefrontal and cingulate regions in which it is embedded,
resemble those of humans more than rodents. In this review, we consider physiological and behavioral
evidence from non-pathological and pathological studies in humans and from manipulations of area
25 in monkeys and its putative homologue, the infralimbic cortex (IL), in rodents. We highlight
the similarities between area 25 function in monkeys and IL function in rodents with respect to the
regulation of reward-driven responses, but also the apparent inconsistencies in the regulation of
threat responses, not only between the rodent and monkey literatures, but also within the rodent
literature. Overall, we provide evidence for a causal role of area 25 in both the enhanced negative
affect and decreased positive affect that is characteristic of affective disorders, and the cardiovascular
and endocrine perturbations that accompany these mood changes. We end with a brief consideration
of how future studies should be tailored to best translate these findings into the clinic.
Keywords: area 25; infralimbic; autonomic; emotion; anhedonia; negative affect; anticipatory arousal
1. Introduction
Area 25 is found within the subcallosal cortex and is one of the least understood regions of the
anterior cingulate cortex (ACC). It is variably included with adjacent regions of the subcallosal zone
(scACC), also referred to as subgenual, and more broadly, the ventromedial prefrontal cortex (vmPFC),
which includes medial PFC regions anterior to the genu of the corpus callosum. Although there is
variation in the precise extent of area 25 within current architectonic maps of this area, particularly in
the macaque [1,2], there is consensus with respect to its extreme caudal position within the subcallosal
region, lying adjacent to the lateral septum of the basal forebrain. Where maps in the macaque differ
is with respect to whether area 25 extends onto the orbital surface or not. Area 25 is characterized
as agranular cortex in humans, with no identified granular layer IV [3], and dysgranular cortex
in monkeys [1] with a very thin granular layer IV, anteriorly. The overall layering within area 25
is relatively undifferentiated, with fusion of layers II and III into a broad supragranular layer and
fusion of layers V and VI into a much narrower, but dense infragranular layer. Based on tracing
studies in rhesus macaques (Figure 1A), area 25 is densely connected with neighboring ventromedial
and posterior orbitofrontal cortex (OFC), involved in affective evaluation and a moderate pathway
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linking it to fronto-polar area 10 and cognition. Outside of the PFC, area 25 has strong connections
with the interoceptive regions of the anterior insula, the medial temporal lobe memory system,
the auditory association cortex in the superior temporal gyrus and the multimodal superior temporal
sulcus [1]. As described in [1], the propensity of area 25 projections to originate in deep layers and end
within superficial layers of eulaminate brain regions is a pattern normally associated with feedback
organization. However, its connectivity with agranular regions, including neighboring posterior OFC,
vmPFC, medial temporal lobe (MTL) and anterior insula, appears feedforward in nature, suggesting
that activity is initiated in area 25. Subcortically, area 25 has by far the strongest reciprocal connectivity
with the amygdala compared to all other prefrontal regions. It also has dense projections to the
ventral striatum, a number of nuclei within the hypothalamus (including the preoptic area, lateral
hypothalamus and dorsomedial hypothalamus), bed nucleus of the stria terminalis, medial septum,
diagonal band of Broca and substantia innominata. In the brainstem there are also projections to the
monoamine systems as well as the periaqueductal grey and parabrachial nucleus [1,2]. This connectivity
pattern positions area 25 at the intersection between emotion, visceromotor function and memory.
 
Figure 1. The connectivity of area 25 in macaques and the infralimbic cortex (IL) in rodents. In the
macaque (A) area 25 has widespread efferent and afferent connections with many cortical and subcortical
regions that are comparable to the efferent and afferent connections of IL in the rat (B). Afferents and
2
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efferents are depicted superimposed on orbital, medial and lateral views of the macaque and rat brains
based on anterograde and retrograde tracing studies. Macaque: [1,4–15]. Rat: [4,6,9]. Abbreviations:
AC, Anterior Cingulate; Acb, Accumbens; AIa/p, Agranular Insula anterior/posterior; Amyg, Amygdala
(AA, anterior amygdala; AB, Accessory Basal; BMA, basomedial; BLA, basolateral; Bpc/mc, Basal
parvicellular/magnocellular; CE, CM, centromedial; central; COA, cortical; LA, lateral; MEA, medial;
PA, posterior; TR, Amygdalo-piriform transition zone); AON, Anterior Olfactory Nucleus; BF, Basal
Forebrain (BNST, Bed Nucleus of the Stria Terminalis; DB, Diagonal Band of Broca; EN, endopiriform
nucleus; LS, Lateral Septum; MPO, Medial Preoptic Area MS, Medial Septum; SI, Substantia Innominata;
TTv/d, ventral/dorsal Taenia Tecta); cc, Corpus Callosum; Cdm, medial Caudate; CLA, Claustrum;
CLi, Central linear nucleus; CPu, CaudatePutamen; EC, Entorhinal Cortex; ECT, Ectorhinal Cortex;
FPm, Frontal Polar Cortex, medial; HF, Hippocampal Formation, Hyp, Hypothalamus (AH, anterior
nucleus; AHAvm, Anterior Hypothalamic area, ventromedial; DHA, Dorsal Hypothalamic area; DMH,
Dorsomedial, LHA, Lateral Hypothalamic area; LPOA, lateral Preoptic area; MB, Mammillary bodies;
MPOA, medial Preoptic area; Pef, Perifornical; PH, Posterior nucleus; PHA, Posterior Hypothalamic
area; PeriMam, Peri-mammillary; SupraMam, Supra-mammillary; TM, Tubero-mammillary; ParaMam,
Paramammillary); IL, Infralimbic;; IP, interpeduncular nucleus; OFC, Orbitofrontal cortex (LO, lateral
orbital; VLO, ventrolateral orbital; VO, ventral orbital; MO, medial orbital); Opro, Orbital proisocortex;
OPAI, Orbital periallocortex; Pons/Medulla (Barrington’s N, Barrington’s Nucleus; CN, Cuneiform
nucleus; dlPAG, dorsolateral Periaqueductal Grey; DMNvagus, Dorsal Motor Nucleus of Vagus;
DR, Dorsal Raphe; LC, Locus Coeruleus; LDT, Laterodorsal tegmental nucleus; MR, Median Raphe;
NI, Nucleus Incertus; NSTract, Nucleus of the Solitary Tract; PBl/m, Parabrachial lateral/medial;
RF, Reticular Formation); pg, perigenual; PL, Prelimbic; PRC, Perirhinal Cortex; RPO, Nucleus
pontis oralis; RSC, Retrosplenial Cortex; SNc, Substantia nigra pars compacta; Thalamus: (Am,
medial Anterior; CEs/m/dc, Central superior/medial/ densocellular; IAM, Interanteriomedial; IMD,
Intermediodorsal; LD, Lateral dorsal; LH, Lateral Habenula; Lim, Limitans; LP, Lateral posterior;
MDpc/mc, Mediodorsal parvocellular.magnocellular; PF, parafascicular; PM, medial Pulvinar; PT,
Parataenial; PV, Paraventricular, R, Reuniens; RH, Rhomboid; sc, subcallosal; SM, Submedial; Vamc,
Ventral Anterior magnocellular); STG, Superior Temporal Gyrus, STS, Superior Temporal Sulcus; TEI,
TF, TH, TP, Temporal pole; VTA, Ventral Tegmental Area; Brodmann’s Areas, 9, 10, 11, 12, 13, 14, 23, 24,
25, 28, 30, 32, 35, 36, 46, TE1, TF, TH. Nomenclature of prefrontal cortex parcellation in macaque based
on [15].
According to Vogt [16], area 25 can be identified across humans, monkeys, rats and mice which
should facilitate inter-species translation of findings across experimental studies. However, structural
homology does not necessarily equate to functional homology. In rodents, the area identified as
area 25 by Vogt, is commonly called infralimbic cortex (IL) and so will be referred to as IL in this
review. As would be expected if primate area 25 and rodent IL are homologous, IL projects to many
of the same cortical and subcortical projection areas linked to emotion, visceromotor control and
memory as area 25 in the macaque [4] (Figure 1B). Certainly, Haber and colleagues have confirmed the
similarity of the IL-25-striatal projection pattern across rats and macaques [5]. In contrast, Barbas and
colleagues [17] suggest that IL-amygdala projections of the rat more closely resemble the posterior
OFC-amygdala projections of a macaque because of the similarity of the projections onto the GABAergic
inhibitory intercalated masses of the amygdala. Notably absent in rats [4,6] are connections with
auditory association and polymodal sensory association cortices that have been described in macaques.
Conversely, in rats, IL projects to the accessory olfactory nucleus involved in olfactory processing and
the Nucleus of the Solitary Tract and other autonomic effector regions in the brainstem, which are not
innervated directly by the primate area 25 [1]. Moreover, as will be seen later in the descriptions of
functional effects of the rodent IL compared to the monkey area 25, potential differences do emerge,
suggesting that the assumption of functional homology between these regions may be premature.
Another issue hampering translation is that, often when describing activation foci within the subcallosal
zone, human neuroimaging studies do not differentiate between the distinct cytoarchitectonic regions
present within this zone [18]. Moreover, in some cases, the term vmPFC is used instead to refer to an
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even broader area that not only includes the subcallosal cortex, but extends rostrally into ventromedial
regions lying in front of the genu [19]. As a consequence, activation loci that truly include area 25
are less evident in the human neuroimaging literature [20], highlighting why current understanding
of the functions of this region is particularly dependent upon neurobiological studies targeting area
25 in monkeys. By careful comparison with studies of IL in rodents we can begin to piece together
the functions of this region, determine the extent of functional homology, and inform future studies
in humans.
2. Physiological Function and the Subcallosal Zone
A prominent function of area 25, and one that is perhaps key to our overall understanding of
this subcallosal region, is its involvement in visceral control and feedback mechanisms involving
cardiovascular, endocrine and immune systems. Area 25 has been implicated in the regulation of
autonomic (particularly cardiovascular) and endocrine functions in studies of non-human primates and
humans, and significant insight has also been gleaned from studies in rodents exploring the anatomical
connectivity and functional importance of its putative homologue, IL, as described in detail below.
When reviewing this literature two factors should be taken into account. First, whether the study has
employed an awake or anesthetized preparation, since anesthesia is known to alter cardiovascular
activity [21]. Second, how the cortex has been manipulated. Several early functional studies employed
electrical stimulation [22] and the frequency of stimulation, together with pulse duration, can result
in differing magnitudes of effects and activate adjacent fiber pathways [23]. Furthermore, whether
the impact of electrical stimulation is analogous to ‘activating’ or ‘inhibiting’ a brain region is not
always known.
2.1. Area 25 and Cardiovascular Function
In humans, despite the strong connections between area 25 and autonomic control centers,
neuroimaging studies investigating heart rate (HR) and blood pressure (BP) regulation have consistently
implicated more dorsal and perigenual (pg)ACC regions rather than more ventral area 25 [24–28].
However, investigations of the dynamic adjustment of HR, using measures of heart rate variability,
do implicate area 25 activity across cognitive, motor and affective manipulations [29]. In particular,
activity in the caudal regions of human vmPFC, that included area 25, correlated positively with
vagal tone whilst shifting between affective states [30]. This linked area 25 and vmPFC BOLD
activity patterns directly with high frequency band components of heart rate variability, thought to
reflect parasympathetic activity [31]. Thus, in particular, area 25 may modulate parasympathetic
output [32,33].
More rarely, modulation of cardiovascular function has also been observed following deep brain
stimulation of the human vmPFC, including area 25, in patients undergoing electrode implantation
as a prelude to surgery to relieve epilepsy [34]. In the four patients with electrodes within scACC,
stimulation produced consistent and striking hypotensive changes; specifically, a reduction in systolic
BP with more variable changes in diastolic BP. Hypotensive effects were substantially greater in those
patients with a more caudal placement in area 25 compared to a more rostral placement (within
area 14; Figure 2Ai). However this interpretation is confounded by differences in the laterality of
the hemisphere stimulated, and uncertainty over whether the neurophysiological consequence of
deep brain stimulation is excitation, inhibition, or a more generalized disruption [35]. Thus, although
scACC/25 is implicated in autonomic, particularly parasympathetic, regulation, the precise role area 25
plays in humans is still unclear.
4
Brain Sci. 2019, 9, 129
 
Figure 2. Examples of the relationship between cardiovascular and endocrine responsivity and area
25/infralimbic (IL) activity in emotional and non-emotional conditions in human, macaque, marmoset
and rat. (A) In humans, (i) stimulation of area 25 via deep brain stimulation (red circles indicate
stimulation loci) causes a brief hypertension followed by pronounced hypotension in anesthetized
humans [34] while (ii) the administration of peripheral cortisol decreases area 25 activation to sad
stimuli (brain region shaded blue) in the absence of any stressors [36]. (B) In macaques (i) stimulation of
area 25 in anesthetized animals caused a brief hypertension followed by pronounced hypotension [22],
similar to humans, and (ii) cortisol release correlates with ventromedial prefrontal cortex (vmPFC)
activity during neutral conditions (large demarcated area), and specifically with area 25 during both
stressful and neutral conditions (small demarcated area; [37]). (C) In marmosets, pharmacological
inactivation of area 25 with GABA A and B agonists (muscimol and baclofen; ‘musbac’) in a neutral
condition caused a reduction in heart rate (HR) and mean arterial blood pressure (MAP) that was
accompanied by an increase in heart rate variability (HRV). Subdivision of the cardiac vagal and cardiac
sympathetic indices (CVI and CSI) revealed that this HRV change was caused by a selective increase in
the parasympathetic CVI [38]. (D) In rats (i) inactivation of IL had no effect on HR and MAP [39], unlike
humans and non-human primates, but (ii) selective glucocorticoid receptor (GCR) silencing within
the IL reduced activity within the open field test indicating that cortisol can modulate IL’s impact
on emotional behavior [40]. Thus, whereas manipulation of area 25 in a neutral setting consistently
5
Brain Sci. 2019, 9, 129
modulates cardiovascular function in humans and non-human primates, such changes are not apparent
after IL manipulation in the rat. However, glucocorticoids appear to modulate negative emotion in
both area 25 and IL indicating similarities in some functional domains, but not others.
Consistent with humans, anatomical tracing of area 25 connectivity in macaque monkeys shows
dense projections to the hypothalamic autonomic nuclei which then project to the nucleus of the
solitary tract and spinal autonomic centers [41]. Regions of non-human primate vmPFC, including
area 25, also diffusely innervate multiple amygdala nuclei, meaning there is dual access to an
emotional-visceral motor system [42,43]. Consistent with these anatomical connections, selective
manipulations of non-human primate area 25 have shown the importance of this area in contributing
to autonomic regulation.
Early functional work, much of which was carried out in macaques, largely focused on determining
the contributions of the cingulate gyrus to cardiovascular regulation, rather than the involvement
of area 25 specifically [44]. Nevertheless, evidence for a role of ventral subregions came when
Kaada and colleagues applied electrical stimulation to regions of pgACC and scACC in anesthetized
macaques [22]. Stimulation throughout these regions induced cardiovascular changes, with the most
prominent cardiovascular change observed in ‘posterior subcallosal cortex,’ corresponding to area
25. In addition to having a respiratory effect, application of electrical current in this region produced
a BP response, characterized by a transient hypertension followed by a more prolonged—but still
short-lived—refractory hypotension (Figure 2Bi). These data support the findings in humans, in
which hypotension was observed following deep brain stimulation in caudal vmPFC regions [34].
However, apart from the observation that enhanced activity within scACC/25 is seen during vegetative
states such as sleeping (which potentially also reflects an influence on parasympathetic activity [45]),
there has been little further electrophysiological investigation of the role of the primate vmPFC in
autonomic regulation.
More recently, targeted pharmacological manipulations within the non-human primate vmPFC
have specifically dissected out area 25’s role in autonomic regulation [38]. Inactivation of area 25 (using
a cocktail of GABA A and B agonists) in marmosets, New World monkeys, whilst in an emotionally
neutral, quiet resting state, was found to have profound effects on cardiovascular activity, reducing HR
and BP and increasing heart rate variability. When effects on heart rate variability were fractionated
into vagal (parasympathetic) and sympathetic contributions, area 25 inactivation selectively increased
cardiac vagal tone. These effects should be contrasted with the very limited effects on baseline
cardiovascular activity, in the form of a modest increase in BP, which followed inactivation of area
32. Area 25 inactivation also reduced the learned HR increases associated with a stressful outcome,
while area 32 inactivation elevated them [38], and area 25, but not area 32, activity mediated the
normalization effects of hippocampal activation on the autonomic correlates of high-trait anxious
responses [46]. Together, these pharmacological studies suggest that non-human primate area 25 has a
critical causal role in modulating activity within a central autonomic network during both neutral and
emotional states.
These findings do have some apparent similarity to a large body of work in rodents that supports
a role for rodent vmPFC, including IL, in the regulation of cardiovascular function. Like in humans and
non-human primates, the anatomical connectivity of IL points to a role in autonomic regulation. The IL
projects to many autonomic control regions (the hypothalamus, amygdala, insula and periaqueductal
gray [4,23]) which in turn project to the autonomic effector regions in the brainstem (Figure 1B). The IL
and ventral aspects of the PL also project directly to these brainstem systems including the nucleus
of the solitary tract [47] and the spinal cord (intermediolateral nucleus) [48]. These direct projections
have led some researchers to coin the term ‘visceral motor cortex’ for these regions [23,47].
The anatomy is supported by functional studies of cardiovascular regulation which clearly
demonstrate that IL manipulations can alter cardiovascular function. Nevertheless, it is difficult to
compare these findings with those of non-human primates due to differences in the pharmacological
compounds used, and variations in behavioral paradigms and types of stressor. Furthermore,
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only a few studies have investigated the consequences of IL manipulation in baseline, emotionally
neutral conditions. Thus, inactivation of IL with a localized muscimol microinfusion had no effect
on cardiovascular control during baseline conditions [39], whilst IL disinhibition with bicuculline
increased respiratory and cardiac outflow [49]. In stressful situations the IL does appear to regulate
cardiovascular responses, but in a stressor-specific manner [50]. Cobalt chloride injection in the IL
(which silences inputs and outputs and ‘inactivates’ the brain region) reduces tachycardia associated
with restraint stress [51]. In contrast, IL inactivation with muscimol did not alter the cardiovascular
responses induced by air puff stress, indicating that there are either functional differences in the
mechanism of inactivation, or behavioral differences as a consequence of different stressors [39].
Different again, activation of IL with the excitatory amino acid, N-Methyl-d-Aspartate (NMDA) did
decrease the HR and BP responses induced by the same air puff [39]. Although both these stressors are
unconditioned, air puff is considered a milder stressor compared to restraint stress.
In studies that have investigated the involvement of the IL in regulating conditioned (learned)
cardiovascular responses it has been shown that excitotoxic lesions primarily targeting the IL (with
variable involvement of the more dorsal prelimbic [PL] subregion) decreased HR responses to a tone
predicting shock [52]. This is similar to the reduction in conditioned HR responses seen after area 25
inactivation in the marmoset [38].
In summary, non-human primate area 25 manipulations can clearly modulate cardiovascular
function during both neutral and stressful conditions, particularly within the parasympathetic domain.
IL manipulation in rodents also modulates cardiovascular function indicating some degree of functional
conservation across species, but the direction and consistency of these cardiovascular alterations differ,
depending upon the nature of the manipulation and the type of stressor, making it difficult to compare
directly with primates. Further investigations that control for these variables are required to fully
compare the autonomic influences of rodent IL function with that of primate area 25.
2.2. Area 25 and Endocrine Function
As well as the autonomic component of visceral control, there is strong evidence that area 25,
and associated prefrontal regions, also regulates the endocrine component via interactions with the
hypothalamic–pituitary–adrenal (HPA) axis, the body’s primary stress response system. Unfortunately,
as discussed below, surprisingly few studies have examined the neural correlates of HPA axis regulation
in humans. Those that have, identify area 25 as an important contributor because it not only shows
sensitivity to circulating cortisol levels but appears to be able to directly regulate HPA axis function.
Exogenous cortisol administration directly modulates the response of area 25 to sad picture stimuli,
blunting sadness-induced activation [36]. This indicates that area 25 is sensitive to circulating cortisol.
Furthermore, in young adolescents, salivary cortisol measurements during social stress positively
correlate with elevated functional connectivity between area 25 and the salience network, including
the dACC and bilateral anterior insula [53]. However, it is unclear whether this correlation specifically
reflects the actions of cortisol on activity within this network, or the effects of the stressor per se or
the effects of area 25 on HPA axis function. Stronger negative functional connectivity has also been
observed between a region of the vmPFC (encompassing area 25, subcallosal area 24 and perigenual
area 32) and the amygdala that was associated with higher cortisol levels [54]. It was proposed that
this negative functional connectivity reflects the top-down regulation of the amygdala during stress,
which subsequently modulates HPA axis activity. Conversely, however, the correlation could reflect
the impact of elevated cortisol on network activity. Nevertheless, together, these findings highlight
the complex interactions between prefrontal (including area 25) top-down regulation of the HPA axis,
and its regulation by cortisol.
This complex relationship between area 25, the HPA axis and sensitivity to cortisol is also seen in
non-human primates. High densities of glucocorticoid and mineralocorticoid receptors, which are
sensitive to cortisol and other stress hormones, have been found in the vmPFC (including area 25) and
lateral PFC of squirrel monkeys [55], indicating that these areas are sensitive to cortisol. The macaque
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also shows direct projections to central autonomic centers such as the hypothalamus, but also indirect
projections to the adrenal medulla itself, through which it can regulate HPA axis activity. Recent
anatomical tracing studies have used injections of rabies virus into the adrenal medulla and a survival
time series analysis method to identify the third and fourth order neurons from areas 24c, 25 and
32 as the densest projections to the adrenal medulla. These regions are broadly similar to regions
identified in human functional imaging studies related to autonomic modulation, negative affect
and cognitive control, indicating that this medial region may mediate the effects of chronic stress
on visceral function [56]. Consistent with this, metabolic activity within area 25 has been related to
individual differences in HPA axis regulation in macaque monkeys [37]. Having been exposed to four
situations of increasing stress for 30 minutes (home with cage-mate, home alone, human intruder
exposure or foreign cage alone), macaques then underwent femoral venipuncture for cortisol levels
together with - 2-deoxy-2-[18F]fluoro-Dglucose (18F-FDG) Positron Emission tomography (PET) scan.
Area 25 was the only brain region in which activity correlated with cortisol output across different
contexts. However, as already described for humans, the directionality of the relationship between
area 25 activity and circulating cortisol remains unclear. This is because a positive relationship could
reflect both stimulatory and inhibitory (negative feedback) processes co-occurring within the HPA
axis. For example, area 25 activity could be correlated with cortisol output if it were providing a direct
stimulatory input to the HPA axis, or if it were activated by increasing concentrations of circulating
cortisol to exert negative feedback.
As in non-human primates, high densities of glucocorticoid receptors are found in the rodent
vmPFC, and importantly, the directionality of the relationship between IL activity and cortisol levels
has been identified in rodents, as IL manipulations have been shown to alter stress hormone activity
in response to a stressor. Thus, after restraint stress, radiofrequency ablation of caudal IL increases
adrenocorticotropic hormone (ACTH/corticosterone) levels, while corticosterone implants into IL
reduce ACTH/corticosterone levels [57]. Neither manipulation had effects on baseline levels. Clearly
therefore, the IL is acting to regulate the HPA axis. It should be noted that combined manipulations of
IL and PL have also been shown to modulate corticosterone responses to some stressors, albeit in a
different manner to IL alone, but these results are difficult to interpret as the precise area responsible
for the effect is not known [58,59]. There is also evidence that glucocorticoids acting directly on
IL can regulate the behavioral correlates of acute and chronic stress. Thus, a selective knockdown
of glucocorticoid receptors within IL (not PL) increases immobility time in the forced swim test,
a commonly used assay of depression-like behavior [40] (Figure 2Dii). However, it remains to be seen
if administration of cortisol also directly alters IL activity, as seen in humans.
2.3. Area 25 and Immune Function
In addition to the role that area 25 plays in the release and regulation of physiological factors
such as stress hormones, emerging evidence also implicates area 25 as a key player in the orchestrated
responses to immune challenges. In humans, elevated activity within area 25 and subcallosal area
24 has been associated with increased levels of interleukin-1β during grief elicitation [60]. Injection
of the typhoid vaccine increases interleukin-6 levels and negative mood compared to placebo,
and inflammation-associated mood-deterioration directly correlates with elevated activity in area 25,
subcallosal area 24 and pgACC area 32 [61]. Depressed patients also show significantly increased
numbers of microglial cells in area 25, suggestive of increased inflammation within area 25 itself [62].
However, further work is necessary—particularly in preclinical rodent and non-human primate
models—to elucidate whether there is a clinically significant interplay between area 25 and the
immune system.
2.4. Summary
To conclude, area 25 clearly contributes to the regulation of the cardiovascular, endocrine and
immune components of a co-ordinated visceral response, and as such, holds a vital integrative role
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across humans, non-human primates and rodents. Despite this, this visceral integration appears to be
unconnected to the level of the intrinsic resting connectivity network related to internal processing
in the brain. Thus, in healthy subjects, area 25 and the caudal scACC are generally not included
within the default mode network; an intrinsic, distributed network of brain regions, including the
posterior cingulate and rostral vmPFC, which shows correlated activity at rest, together with correlated
task-dependent modulations [63–65] (but see [65–67] which do suggest area 25 involvement). However,
it should be noted that area 25 can be preferentially recruited into the default mode network in
depressed states. In these situations, the integrative visceral roles of area 25 could assume undue
prominence [68] manifesting as suppression of parasympathetic outflow, elevated baseline HR and
reduced baseline heart rate variability [29,69]. This is consistent with the preferential modulation of
cardiovascular parasympathetic regulation after area 25 manipulations in humans and non-human
primates, the evidence for autonomic dysregulation in depression, and the preferential effects of the
novel antidepressant ketamine on the scACC, including area 25 [38,65,70,71]. Area 25 may therefore be
a key node in the integration of negative mood and abnormal visceral regulation, a premise supported
by two recent meta-analyses of neuroimaging data that have associated area 25 activity with functions
attributed to the default mode network, including emotion processing, attribution of affective meaning
and autonomic function, as well as mentalization and autobiographical memory [19,72–74]. If so,
area 25 is in a unique position to subconsciously link bioregulatory states with their mnemonic and
emotional mood states.
3. Emotional Function and the Subcallosal Zone
3.1. Human Area 25 and Its Association with Negative Emotion and Anhedonia
3.1.1. Non-Pathological Mood States
The subcallosal region of the ACC, including area 25, has received significant attention in the
context of negative mood and depression. This is due to the high frequency at which functional and
morphological changes within this region have been identified in studies of negative affect, and the
function of this region as a point of integration between visceral, attentional and affective information
important for homeostasis and allostasis.
Suggestions that elevated area 25 activity may be relevant to disorders of enhanced negative
emotion, in part, derive from studies implicating subregions of the scACC in transient states of sadness
induced in healthy control subjects. In a comprehensive meta-analysis of earlier work that included
55 PET and fMRI emotion-induction studies across both positive and negative valence, induction
of sadness was significantly associated with activation/increases in rCBF of an scACC region which
partly encompassed area 25 [75]. Two important issues should be highlighted. First, only 46% of
studies using sadness induction paradigms reported increased activity within the subcallosal region.
This may be because of differences in the sadness provocation methods used. Earlier studies scanned
participants during active generation of the sad state and yielded variable subcallosal activation [76–78].
In contrast, studies which scanned participants once the sad state was attained reported more consistent
subcallosal activation [79,80]. Second, when subcallosal activation was reported to include area 25,
closer inspection revealed activity to be focused in a more rostral area encompassing subcallosal area
24 rather than area 25.
Nevertheless, studies subsequent to this meta-analysis have identified elevated activity associated
with negative affect in area 25. For example, increased activity within a region bordering areas 10 m,
32 m and 25 m positively correlated with an aggregate self-report score of individuals’ experience
of negative affect over the previous month [81]. Moreover, assessment of the neural responses to
sad pictures in healthy elderly individuals revealed elevated activity within the subcallosal region,
extending along the rostro-caudal extent to include area 25, subcallosal area 24 and area 14 [82].
Of particular interest, is a recent study [36] in which area 25 was not only selectively activated in
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participants viewing sad stimuli, but this activity was reduced by hydrocortisone, highlighting the
sensitivity of this region to circulating cortisol.
In addition to the use of pictorial or autobiographical stimuli to induce negative mood states,
several studies have explored regional metabolism in the context of affective verbal processing.
In these studies, regions of the medial PFC are robustly engaged by emotional words, irrespective
of valence. However, these regions are typically more rostral than area 25, corresponding to the area
25/24 border zone, subcallosal area 24 and area 32 [83,84]. Tryptophan depletion has also been used
to induce negative mood states in healthy controls [85]. Tryptophan is the precursor of serotonin
(5-hydroxytryptamine; 5-HT), and rapid depletion of tryptophan reduces brain 5-HT. The effects of
tryptophan depletion span cognitive and affective domains, although the magnitude of the affective
change is variable, with some studies showing that healthy controls—even if given selective serotonin
reuptake inhibitor (SSRI) medication—do not show any mood changes [86]. In one such study, acute
tryptophan depletion increased rCBF bilaterally in area 25 that correlated with reduced mood, and
simultaneously decreased rCBF in dACC/area 24 in a mood-independent manner [87].
An additional cluster of studies have implicated scACC in negative affect derived from social
exclusion and rejection in adolescents and young adults. In these studies, social exclusion is typically
induced using a virtual game termed Cyberball [88], in which participants are excluded from a
ball-tossing game by other pre-programmed virtual participants. However, a meta-analysis of
fMRI-measured brain activations during social exclusion, predominantly using the Cyberball task,
identified positive correlations between social exclusion and activity centered on subcallosal area 24,
rather than area 25 [89].
In summary, the location of activation within the scACC during negative mood states, including
sadness, is quite variable and only sometimes is area 25 included. Indeed, a recent study used
the cytoarchitectonic and chemoarchitectonic profile of ten human post-mortem brains to construct
continuous and maximum probability maps of the distinct subcallosal fields for areas 25, 24, 32 and
33. Using a forward inference approach, the functional connectivity profile of each area was assessed
and it was the subcallosal portion of area 24, rather than area 25, that showed consistent activation in
psychological processes encompassing ‘sadness’ [18].
3.1.2. Pathological Mood States
In one of the earliest studies to report a relationship between reduced volume of the scACC in both
unipolar and bipolar depressed subjects [90], the region of interest lay relatively rostral, at the border
between subcallosal area 24 and perigenual area 32. Indeed, in an extension of this initial study, the
region of interest still lay anterior to area 25 [91]. A subsequent study measured the volumes of both
an ‘anterior’ region corresponding to subcallosal area 24, and a ‘posterior’ region corresponding to
area 25 [92]. Here, the volume of left area 25 was smallest for patients with psychotic major depression
compared to schizophrenics and healthy controls, whereas volumes of the subcallosal area 24 did not
differ between groups. More recently, several studies have identified reductions in subcallosal volume
encompassing varying portions of area 24 [93], area 25 [94], or both [95–97].
Besides reports of volume change, there have also been reports of functional abnormalities. In early
studies, hypoperfusion in broad regions encompassing the scACC was consistently reported in Single
Photon Emission Computed Tomography (SPECT) and PET studies [98–102]. However, these studies
are in part confounded by the influence of volumetric changes within area 25 of patients suffering from
Major Depressive Disorder [92]. When corrected for regional atrophy, area 25 does not show reduced
activity—instead, rCBF measurements suggest activity is normal [80] or elevated [103]—although in the
latter study the subjects were treatment resistant and the elevated activity appeared more rostral than
area 25. However, more consistent are the reductions seen in area 25 activity in treatment responders
following deep brain stimulation [103], fluoxetine [80], and the placebo effect [104].
Primary increases within subregions of the scACC in depressed populations have also been
reported in functional studies. For example, when comparing patients with Major Depressive Disorder
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to non-depressed individuals, greater activity within area 25 was associated with the processing
of sad faces, whereas greater activity within subcallosal area 24 was associated with processing of
happy faces [105]. A subsequent meta-analysis of resting-state and emotion-activation studies found
increased activity within right area 25 of depressed patients when exposed to positive emotional
stimuli [106], and decreased activity following SSRI treatment. However, a more recent meta-analysis
found decreases in area 25 associated with emotional processing tasks in depressed patients, although
this study did not separate the positive and negative domains of emotion processing [107].
Besides negative mood, a key symptom of depression is anhedonia, the loss of interest and
pleasure in all or almost all activities. It is highly prevalent in depression [108] and is a negative
prognostic indicator [109,110], often associated with treatment resistant depression. However, area
25 is seldom identified in anhedonia-related neuroimaging studies. Functional activity changes
associated with anhedonia are typically more rostral than area 25, encompassing regions such as area
10/24 and perigenual area 32 [111]. A recent study did however investigate abnormal connectivity
patterns in a more posterior subcallosal region associated with altered activity in mood and anxiety
disorders based, on an activation-likelihood estimation meta-analysis. The connectivity of the ROI
with key reward-related regions (including the nucleus accumbens and ventral tegmental area [VTA])
was negatively correlated with anhedonia during pleasant music listening, but not anxiety levels,
whereas resting state activity changes within the ROI did not differentiate between the two symptom
clusters [112]. However, this ROI mainly included area 24 and was still rostral to area 25.
3.1.3. Neurobiological Models of Depression with a Focus on Human Area 25
There are several influential neurobiological models of depression that directly
implicate vmPFC dysfunction in its etiology and/or pathogenesis, namely the limbic-cortical,
cortico-striato-pallido-thalamic (CSPT) and default mode network models. These models are not
mutually exclusive and are overlapping in terms of the neurobiological substrates being implicated, and
the consequences that dysfunction within these structures has on behavior, physiology and cognition.
We will focus on the role of area 25 within these models.
The limbic-cortical model was formulated in order to link impairments in cognition to sustained
alterations in mood states characteristic of depression [113]. It focused on hypoactivity in a dorsal
compartment proposed to be principally involved with the attentional and cognitive features of
depression, including dm/dlPFC, area 24, parietal cortex and the dorsal striatum. Hyperactivity in a
ventral compartment, consisting of limbic and paralimbic structures including area 25, was proposed to
mediate the vegetative and somatic aspects of depression. Finally, the rostral cingulate, corresponding
to perigenual areas 24 and 32, [113] was proposed to regulate the interaction between the dorsal and
ventral compartments. Depression was then hypothesized to result from a failure of the coordinated
interactions within and between compartments.
One of the most promising treatment modalities developed from this model is deep brain
stimulation. In 2005, it was reported that deep brain stimulation targeting area 25 ameliorated
symptoms of depression in four out of six individuals with treatment refractory depression [103].
Although an industry-sponsored trial utilizing deep brain stimulation of area 25 has failed in recent
years [114], this has not stalled further investigation, with subsequent work refining neurosurgical
targeting techniques and identifying potential biomarkers which might predict treatment response.
Tractography imaging techniques to identify similarities in electrode contacts within deep brain
stimulation responders have also highlighted the importance of four white matter bundles underlying
area 25 [115]. This approach is proving valuable in identifying optimal deep brain stimulation targets
to achieve antidepressant responses [116].
The cortico-striato-pallido-thalamic model posits abnormal activity in the CSPT circuitry to explain,
at least in part, the clinical symptoms and cognitive deficits associated with depression. CSPT loops
connect regions of the PFC with the basal ganglia and thalamus in a parallel but overlapping manner
to support a multitude of behavioral and cognitive functions [117]. Evidence for the importance of
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CSPT circuitry in mood disorders includes: (i) structural and functional imaging studies that show
evidence of alterations in CSPT components associated with depression [118–120]; and (ii) a higher
prevalence of depression associated with neurodegenerative and vascular diseases that involve CSPT
circuitry [121–123]. The ventral caudate and nucleus accumbens (forming, together with the olfactory
tubercle, the ventral striatum) are arguably the most consistently implicated striatal subregions in
depression. Patients with remitted depression show hyperactivation of the caudate and accumbens
during negative picture viewing [124], and currently depressed patients show hypoactivation of
the accumbens and ventral caudate during rewards [125,126]. Aberrant ventral striatal functional
connectivity also predicts future risk for developing depression [127].
Given the anatomical evidence that area 25 and adjacent vmPFC projects strongly to the ventral
striatum [117], area 25-ventral striatal limbic circuitry has been explored in the context of CSPT
changes associated with depression. Meta-analytic approaches have consistently identified volumetric
abnormalities within these limbic CSPT circuits: reduced volume in the PFC—especially area 25
and OFC—together with reduced volume in the ventral caudate and putamen [128,129]. However,
a meta-analysis of functional resting-state network connectivity in depression identified reduced
connectivity between subcallosal activity rostral to area 25 and the ventral striatum [130].
Finally, in the default mode network model, increases in functional connectivity between the caudal
vmPFC, specifically area 25 and nodes (rostral vmPFC and posterior cingulate cortex) within the default
mode network, have been reported in people with depression [131]. Thalamic involvement is also
evident, with increased connectivity between area 25, the mediodorsal (MD) thalamus and the default
mode network, which has also been linked to higher levels of rumination [132–134]. These findings
have led to the proposal that increased functional connectivity between this network (involved in
biasing towards self-referential thinking processes) and area 25 (supporting negatively affectively-laden
behavioral withdrawal) result in pathological rumination: self-focused, negatively valenced and
withdrawn thinking processes [132]. However, since area 25 does not directly project to nodes of the
network [135], but does project to the MD thalamus (which itself projects to the network nodes) it is
suggested that the increased correlation of activity between area 25 and the default mode network is
mediated by projections through the MD thalamus.
Altogether, whilst there is considerable correlative evidence for a role of area 25 in negative
mood states in humans, direct evidence is limited. Whilst there have been a number of important
studies describing the behavioral effects of varying levels of damage to human vmPFC (for review
see [136], the selective contributions of area 25 could not be determined. Perhaps surprisingly, few
non-human primate studies have addressed the contributions of area 25 to emotion and its regulation
and thus, until recently, the majority of our understanding had come from studies of the IL in rodents.
The findings from monkeys and rodents will now be described and their translatability to one another,
and to human studies, will be discussed.
3.2. Monkey Area 25 and Its Association with Negative Emotion and Anhedonia
3.2.1. Neurophysiological Correlates of Reward and Punishment
One of the earliest studies in macaques to record in mid to caudal regions of area 25 found that
the neurons had very low spontaneous firing rates, and failed to respond to tastes and olfactory cues,
or to reward associated stimuli on a visual discrimination reversal task, including faces. Of the 93
recorded neurons, 11 showed an increase in responding from zero to approximately four spikes/sec
during slow wave sleep [45]. Consistent with the lack of responsiveness to appetitive cues, a more
recent study also showed that area 25 neurons displayed little response to appetitive conditioned
stimuli (CSs; i.e., visual cues paired with reward) and unconditioned stimuli (USs; i.e., reward) during
appetitive blocks of a Pavlovian task [137]. However, they did signal both aversive CSs and USs, in the
form of visual cues paired with an air puff to the face. In contrast, more ventrally located neurons [1,2]
were persistently more active in appetitive blocks. When recordings were made more rostrally in
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perigenual regions of area 25, neurons responded to a wide range of variables during a gambling task,
both positive and negative, although there was a bias towards encoding of negative outcomes [138].
An overlapping region of recordings in this perigenual zone identified neurons as being more sensitive
to internal factors, such as satiation, rather than external factors, such as visual cues [139]. Whether
these differences across studies reflect changes in function between rostral and caudal and dorsal and
ventral sectors of area 25 remain to be determined.
3.2.2. Area 25 Manipulations and Threat
Recently, pharmacological studies have been carried out in marmoset monkeys that temporarily
inactivate or activate area 25 (see Figure 3). Inactivation with GABA A and B agonists (muscimol
and baclofen) (i) reduced the expression of behavioral (orienting/scanning) and cardiovascular (blood
pressure and heart rate) conditioned threat responses during Pavlovian discriminative conditioning
when a previously neutral stimulus (i.e., an auditory cue) became associated with an aversive event
(i.e., a loud noise and (ii) accelerated extinction of conditioned cardiovascular and behavioral responses,
when the conditioned stimulus no longer predicted the aversive event (i.e., rubber snake) [38]. These
findings suggest that non-human primate area 25 normally acts to drive Pavlovian cardiovascular and
behavioral responses during threatening situations.
The directionality of the effects of area 25 manipulations were conserved in the instrumental
domain too. Using a touchscreen approach-avoidance decision-making task where marmosets
responded for rewards with the potential for punishment, inactivation of marmoset area 25 reduced
punishment avoidance. Conversely, enhancing pre-synaptic glutamate release within area 25 (using
a combination of mGlu2/3 and GABAB receptor antagonists) enhanced punishment avoidance [140].
The increased sensitivity to punishment seen when glutamate release in area 25 was enhanced, causally
relates elevated activity in area 25 to negative decision-making biases observed in individuals with
depression [142,143]. Consistent with these findings, increasing activity within marmoset area 25 using
an alternative method, namely inhibiting the excitatory amino acid transporter-2 (EAAT2) to reduce
glutamate reuptake (using dihydrokainic acid [DHK],) enhanced marmoset responsivity on the human
intruder test, a classic method of measuring anxiety-like behavior in a primate which assesses the
behavioral responses to an unfamiliar human that elicits uncertainty [141]. Taken together, these data
suggest that inhibiting activity within marmoset area 25 reduces the behavioral and cardiovascular
correlates of negative affect, whereas increasing activity has the opposite effect, and enhances these
correlates. These effects may reflect the behavioral and physiological output of the neural bias in
encoding negative outcomes described in electrophysiological studies.
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Figure 3. Over-activation and inactivation of area 25 in marmoset has largely opposing effects on
tests measuring the regulation of responsivity to rewarding and punishing stimuli. Top from left.
Over-activation via presynaptic glutamatergic disinhibition increased the bias away from punishment
in an approach-avoidance decision making paradigm [140], and over-activation via inhibition of
the excitatory glutamate amino acid transporter (EAAT2; with dihydrokainic acid [DHK]) increased
anxiety-like behavior in the human intruder paradigm, increased the break point in a progressive
ratio task, left sucrose consumption unaltered, and blunted the anticipation of food reward during
appetitive conditioning [141]. Bottom from left. In contrast, inactivation with GABA A and B agonists
(muscimol and baclofen) decreased the avoidance of punishment during approach-avoidance decision
making [140] and reversed the blunted cardiovascular responsivity to threat in high trait anxious
animals [46]. Inactivation also blunted the threat-induced anticipatory increases in heart rate and
vigilant scanning (not shown) during Pavlovian threat conditioning and enhanced the rate of threat
extinction [38], but had no effect on reward anticipation during appetitive conditioning [141]. *, p < 0.05,
†, p < 0.05, main effect of manipulation; error bars indicate SEM. Thus, in general, over-activation
blunted appetitive responses whilst enhancing threat-induced responses whilst inactivation primarily
dampened threat-induced responses.
3.2.3. Area 25 Manipulations and Reward
The only lesion study to target area 25 in a non-human primate implicated this region in the
maintenance of arousal in anticipation of positive rewarding outcomes. Ablation of area 25 in macaques
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impaired their ability to sustain autonomic (pupillary dilation) arousal during a trace interval between
an appetitive CS and US [144]. Disruption of this function could be relevant to the reduced reward
processing associated with depression, broadly referred to as anhedonia (involving a reduced ability
to experience pleasure, together with reduced anticipation and motivation). However, as discussed
above, reduced activity in this area is more consistently associated with recovery from depression.
Moreover, given that this study in macaques used ablations, it is possible that the effects reported
were a consequence of damage to fibers of passage, especially since this region is a major conduit for a
number of fiber bundles carrying fibers to and from the cortex [115].
More recently, temporary pharmacological manipulations in area 25 of marmoset monkeys
that selectively target neurons intrinsic to area 25, without affecting fibers of passage, has revealed
that over-activation of area 25 not only enhances negative reactivity but also blunts anticipatory
and motivational appetitive arousal (see Figure 3). The measurement of cardiovascular and
behavioral responses during the CS ‘anticipatory’ and US ‘consummatory’ period of a Pavlovian
appetitive conditioning task revealed selective blunting during the anticipatory period only following
DHK-induced increases in glutamate release in area 25. The same infusions also caused an earlier
breakpoint on an instrumental progressive ratio schedule of reinforcement [141] reflecting a reduction
in the willingness to work for reward. The finding that inactivation of area 25 (using the GABA A
and B agonists muscimol and baclofen) had no effect on anticipation suggests that area 25 activity is
not necessary for reward-related anticipatory arousal but, when activated, has an inhibitory effect.
An obvious question arising from these findings is what factor(s) naturally cause(s) activation of
area 25? Given the relationship between area 25 and the HPA axis, described above in ‘Area 25 and
endocrine function’, stress may be a key factor.
18F-FDG PET imaging has provided insight into the changes in downstream brain regions caused by
area 25 over-activation. These include increases in metabolic activity in the dorsomedial PFC and insula,
but decreases in activity within a region encompassing the nucleus of the solitary tract and brainstem
5-HT neurons [141], all regions implicated in the networks of depression [132]. Of particular relevance
to our understanding of current treatments of depression, peripheral ketamine, a recently discovered
glutamate based anti-depressant with particular efficacy in treating reward-related deficits [145–147],
ameliorated the anhedonia-like symptoms induced by area 25 over-activation. Not only did ketamine
restore cardiovascular and behavioral anticipatory arousal but it also reversed the changes in the
network. Thus, over-activation of area 25 produces both anxiety-like and anhedonia-like behavioral
symptoms in a monkey and, consistent with clinical reductions of area 25 activity in treatment
responders, ketamine ameliorates the anhedonia-like effects.
3.2.4. Area 25 and Its Interactions with the Anterior Hippocampus
Pharmacological intervention studies in marmosets have also probed the importance of area
25 in the wider network of structures important for regulating affective behavior. Initial studies
have focused on the anterior hippocampus (aHipp), given the importance of connectivity between
these regions in psychiatric disorders [148]. In one study, aHipp activations in high trait anxious
marmosets were shown to reduce the marmosets’ anxiety-like behavior to uncertain threat in the form
of a human intruder, as well as to normalize their blunted behavioral and cardiovascular response to
unpredictable aversive loud noise. Simultaneous inactivation of area 25, but not area 32, however,
blocked these anxiolytic effects, areas which, when inactivated independently, reduced or had no
effect on anxiety, respectively [46]. Simultaneous inactivations of area 25 have also been shown to
block the ability of aHipp activations to reduce punishment avoidance on an approach-avoidance
instrumental decision-making paradigm, despite area 25 reducing punishment avoidance when
inactivated independently [140]. In both examples, activation of aHipp and inactivation of area 25
independently reduced threat-induced responses, but when occurring simultaneously these anxiolytic
effects were abolished, thereby highlighting the importance of the interaction between these two
regions in the regulation of negative emotion. However, how their effects are orchestrated within
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the wider network of structures known to be involved in regulating responsivity to threat is a key
question for future studies. For example, the amygdala, striatum, OFC and ventrolateral prefrontal
cortex (vlPFC) have all been implicated in approach-avoidance decision making [149–152]. Indeed,
using the exact same paradigm, interactions between the OFC and amygdala in marmosets have been
shown to contribute to the long-lasting mnemonic effects of punishment on decision making, without
influencing decision making at the time of punishment per se [149]. Different again are the effects of
inactivation of the vlPFC, which acts to enhance avoidance of punishment on decision making at the
time of punishment. Since the aHipp projects to the vlPFC as well as area 25 [14] and there is weak
to moderate connectivity between area 25 and vlPFC [1], investigating the nature of the interactions
between these structures on approach-avoidance decision making and other threatening contexts is an
important next step.
3.3. Rodent Infralimbic Cortex and Its Association with Negative Emotion and Anhedonia
3.3.1. Conditioned Threat and Its Extinction
Experimental studies in rodents have implicated IL in a range of different behavioral functions,
but some of the most extensive investigations have focused upon its role in the extinction of conditioned
threat. Early experiments in rodents assessed the effects of broad lesions to mPFC (including PL,
IL, Medial OFC and ACC) on the extinction of threat memories, as measured by the low level of
conditioned freezing displayed to a CS that was no longer paired with foot shock, and found these
lesions severely impaired extinction, without an effect on the acquisition of conditioned freezing [153].
Subsequently, lesions restricted to the IL confirmed this region’s role in the successful recall of extinction
while, lesions that spared most of the IL did not have an effect, suggesting that the IL is the critical mPFC
sector necessary for recalling extinction memories [154]. Since this lesion work, electrophysiological,
microstimulation and pharmacological inactivation studies have also probed the specific contributions
of the IL and PL to threat regulation. In seminal work, reviewed in Milad and Quirk [155], recordings
from IL neurons during acquisition, extinction and extinction recall phases revealed that IL neurons
fired only when recalling a CS/noUS association on extinction recall days. The degree of firing
correlated with successful recall of this association: the more IL neurons fired, the less rodents froze.
Pharmacological inactivation studies have since extended this work by causally implicating IL in
extinction and extinction recall and indicate that IL is a key player in the inhibitory mechanisms
which may ‘gate’ information flow within downstream structures—such as the amygdala—during
CS-noUS learning and retention [156,157]. These effects are not just restricted to conditioned freezing,
as IL inactivation also disrupts extinction recall when avoidance is the conditioned response [158]
and conversely, IL activation during extinction using d-cycloserine can facilitate re-extinction of the
conditioned freezing response the next day [159].
Although neuroimaging studies in humans have been interpreted to support the role of this region
in recall of extinction of conditioned threat responses [160–162], as measured by skin conductance
responses, the regions of altered activity are far more rostral than area 25, in one case almost at the level
of the genu of the corpus callosum. Thus, although a region within vmPFC in humans shows correlated
activity with extinction recall, it does not correspond to area 25 (Figure 4A). Moreover, as described
above, inactivation of area 25 in marmosets facilitates extinction rather than impairs it, and in contrast
to the impaired extinction recall in rodents, has no apparent impact on its recall (compare Figures 4B
and 4C). Incidentally, area 32 inactivation in marmosets also produces opposite effects to those reported
following inactivation of the putative functionally homologous region in rats, namely, the PL, with area
32 inactivation retarding extinction in marmosets as opposed to the impaired threat recall after PL
inactivation in rats. There are at least two explanations for this discrepancy. The first is that the IL in
rodents is not functionally homologous to primate area 25. The second is that the task design used in
marmosets to study extinction of conditioned threat, although developed to match that of the rodents
as close as possible, was not identical and performance relied on different psychological processes to
16
Brain Sci. 2019, 9, 129
those of the rat, that were differentially sensitive to area 25 inactivation. If the latter, then at the very
least these results call into question the hypothesis that area 25 is essential for threat extinction and in
particular threat extinction recall. Instead, it suggests that the underlying function of this region, when
dysregulated, can have mixed effects on the extinction of conditioned threat responses, e.g., facilitative
or antagonistic, presumably depending upon the precise context in which the conditioned threat is
learned and modulated. Before considering, however, what the underlying function of IL might be,
the contribution of IL to additional behavioral domains will be discussed.
 
Figure 4. Re-thinking the role of area 25 in threat extinction in humans, marmosets and rats. (A) Human
neuroimaging of extinction recall has identified regions of the subcallosal zone (scACC) in which the
deactivation induced by the conditioned stimulus, CS+ is blocked following successful extinction
recall [160–162]. However, these regions of activity are generally more rostral than area 25. (B) In
marmosets, inactivation of area 25 with GABA A and B agonists (muscimol and baclofen; closed circles)
hastened the behavioral extinction of an aversive (rubber snake) Pavlovian conditioned association [38].
In contrast (C) IL inactivation in rats (muscimol; closed circles) impeded the behavioral extinction
and extinction recall of conditioned footshock. Redrawn from Sierra-Mercado et al., [157]. *, p < 0.05;
#, p < 0.05, manipulation×CS interaction; error bars indicate SEM. Arrow indicates point of inactivation.
3.3.2. Depression-Like and Anxiety-Like Symptoms
Besides extinction of conditioned threat, altered activity in rodent IL has been implicated in
putative depression-like (despair) and anxiety-like symptoms, as measured across a range of paradigms
including forced swim, tail suspension (despair-like tests) and novelty suppressed feeding, elevated
plus maze and open field (anxiety-like tests). Here, however, the findings have been contradictory.
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An early report [163] revealed anti-depressant effects of inactivation of IL induced by the GABA
agonist, muscimol, on the forced swim test in normal rats and those bred for high anxiety; activation of
this area by the GABA antagonist, bicuculline, had no effect. In contrast, more recently, activation of
IL induced by DHK [164] produced anti-depressant and anti-anxiety-like effects on the forced swim
test and novelty suppressed feeding tests, respectively. A similar effect is seen following an acute
optogenetically-induced activation of the pathway between IL and the amygdala [165], or following
sustained optogenetically-induced activation of area 25 globally [166]; in which case the anti-anxiety
effect is long lasting, being seen 24 h later and beyond. Different again, however, activation of
IL induced by a GABA-A antagonist, induced anxiety-like behaviors on elevated plus maze, open
field and novelty-suppressed feeding [167], as did an acute optogenetic activation of IL pyramidal
neurons [168]. Acute versus more sustained activation of IL may contribute to the variation in the
results, with acute effects tending to be anxiogenic whilst prolonged effects are more likely anxiolytic.
However, very recently, sustained activation induced by genetic knockdown of the astrocytic glutamate
transporter GLAST/GLT-1 expression, induced a depressive-like phenotype on the tail suspension and
forced swim tests [169]. Other contributory factors to the variation in findings may therefore include
whether the animal was tested in its subjective ‘night’ or ‘day’, with the former being likely to enhance
the level of stress experienced; however, this information is not always provided. Prior experience
with other stressors may also impact on overall subjective experience. Finally, whether IL was targeted
via cannulas passing through the PL or not has also been suggested to be an important consideration,
since there may be infusion spread up the tract which can only be ruled out by direct comparison with
infusions into the PL [170].
The contribution of IL to reward processing domains have also been investigated. Overall,
inactivation of the IL tends to increase, and activation of the IL reduce, reward driven behaviors
in a variety of contexts. These include the spontaneous recall and reinstatement of Pavlovian and
instrumental appetitive responses following extinction (reviewed in [171]) that are increased by
lesions/inactivation of IL, comparable to that seen following extinction of Pavlovian threat responses
reviewed above. Conversely, activation with d-cycloserine induces the opposite effect [172]. In addition,
activation with DHK increases the threshold for lever pressing for electrical brain stimulation and
increases the latency to begin consuming sucrose [173], all effects consistent with putative symptoms
of anhedonia and opposite to the anti-depressant effects on the forced swim test described above [164].
It should be noted however that in the latter [173], cannulas passed through the PL to reach the IL,
but infusions were not compared with equivalent manipulations of the PL. Nevertheless, additional
support of a pro-depressant effect of IL activation in the reward domain, sustained activation by
knockdown of GLAST/GLT-1 expression reduced sucrose consumption, an effect that was not due to PL
involvement [169]. Moreover, IL activation using the GABA antagonist bicuculline dampens the intense
eating behavior generated by glutamate disruptions in the nucleus accumbens shell [174]. In contrast,
acute inactivation of the IL does not affect the break point of a progressive ratio schedule [175]
and excitotoxic lesions of the IL have no effect on acquisition of appetitive Pavlovian conditioned
autoshaping [176]. Thus, in summary, as seen in marmosets, activation of IL very often has broader
effects on rewarded behaviors than effects of inactivation and in general, activation tends to dampen
reward driven responses.
Without direct comparisons across laboratories using identical paradigms and pharmacological
doses of drugs such as DHK and muscimol, or light stimulation parameters in the case of optogenetics,
it is difficult to reconcile these mixed pro-depressant and anti-depressant findings on tests of learned
helplessness and reward, and integrate them with the effects on conditioned threat extinction. Moreover,
it is problematic to interpret changes in apparently ‘normal’ behavioral responses on a given test
as anti-depressant, when there is no evidence that performance is ‘depressed-like’ in the first place.
There are many reasons why an animal may spend more time swimming in a forced swim test and
more time eating in the novelty suppressed feeding test other than they are displaying, respectively,
a less ‘depression-like’ and ‘anxiety-like’ phenotype [177]. Future studies should determine whether
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IL activation shows similar effects in a variety of other contexts designed to measure depression-like
and anxiety-like behaviors to determine the consistency of these effects e.g. anticipatory, motivational
and decision-making contexts related to reward processing and cognitive and affective negative biases
associated with anxiety. In addition, these studies should include the measurement of multiple indices
that extend beyond behavior to include physiological measures such as cardiovascular reactivity and
cortisol levels since, as described above, depressive and anxiety-like states have a marked impact on
physiology. Moreover, if testing for anti-depressant-like effects, it is more informative if a depressive-like
phenotype is induced first, such as that produced by learned helplessness models [178].
Given the marked variation between rodent studies with regards anti-depressant and anxiolytic
behavior, it is difficult to compare results with those described in marmosets. Comparisons are really
only informative when the same pharmacological manipulation is made across species. Thus, DHK
(overactivation)-induced anhedonia-like effects on responding to brain stimulation in rats [173] appear
consistent with the anhedonia-like effects of DHK infusion into area 25 on the instrumental progressive
ratio test in marmosets. Apparently different though is the deficit in sucrose consumption reported in
rats, but not in marmosets. However, it should be noted that sucrose consumption per se was intact in
rats and only a DHK-induced increase in the latency to begin drinking was observed. The latter could
be interpreted as an anticipatory effect, which would then be consistent with the DHK-induced effects
on anticipatory responding in marmosets. Nevertheless, it is still difficult to reconcile the hypothesized
anxiolytic/anti-depressant effects of rodent IL DHK in the novelty-suppressed feeding test [164], with
the DHK-induced increase in anxiety-like responses to an uncertain threat in the human intruder test
in marmosets [141]. Such discrepancies can only be resolved in future studies using more comparable
tests and with detailed comparison of the effects of DHK on network activity across species.
3.3.3. Stress and Its Controllability
Another emotion-related domain that involves both the IL and PL is the behavioral immunization
effect of learned control over a stressor. Those animals that learn to run in a wheel to escape tail shock
subsequently learn to avoid shock in other apparati (typically a shuttle box), in contrast to animals that
learn that their attempts to escape a shock are futile, and then go on to fail to avoid subsequent shuttle
box shocks [178]. This immunization effect produced by the experience of control over a stressor is
seen across a range of contexts including aggression, social dominance, immobility, neophobia, threat
conditioning and extinction [179]. PL appears most central to these effects since inactivation of PL
disrupts immunization effects on both social and shuttle box behavior, whereas IL inactivation only
blocks immunization effects on social behavior [180]. Enhanced release of serotonin in the dorsal raphe
nucleus (DRN) and forebrain terminal regions is implicated in the learned helplessness effect [179],
but only neurons in the PL (not IL) projecting to the DRN show selective activation to escapable
stress [181]. Thus, the role of the IL in the behavioral immunization effect remains less clear.
However, the sensitivity of the IL to stress per se does appear clear. Whilst chronic stress can induce
morphological changes within the PL and IL [182], the IL appears particularly sensitive, with even
acute stress causing apical dendritic retraction, reduced spine-induced learning and disrupted threat
extinction [183,184]. Moreover, intermittent stress in early adolescence increases the serotoninergic
innervation of IL, but not PL, and promotes the emergence of an anxious phenotype in adulthood,
although whether these two outputs were related was not investigated [183].
3.3.4. A More Complex Role for IL in Behavioral Control
Given the varied effects of experimental lesions or temporary inactivation of the IL and PL
across the appetitive/aversive and cognitive/emotion domains, recent critiques have attempted to
integrate these diverse findings [185,186] by taking into account the role of the IL in the ability of
well-trained responses to dominate behavior. As summarized by Sharpe and Killcross [186], lesions
of IL prevent appetitive instrumental responding becoming habit-like and insensitive to alterations
in the valuation of the goal, following over-training [187], and inactivation re-instates goal directed
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sensitivity of over-trained instrumental responses [188]. They also prevent over-trained responses from
disrupting the ability of contextual cues from an under-trained task to resolve response conflict in a rat
version of the Stroop task [189]. Accordingly, Sharpe and Killcross [186] propose that a parsimonious
explanation for IL function is that it acts to promote performance of well-trained responses that are
context independent and reflect the animal’s long term experience with the current contingencies.
This expands upon a previous synthesis that suggested that IL inhibited previously established goal
directed actions [185]. While they acknowledge some caveats with their current account, nevertheless
it makes the point that high-order cognitive functions within this region are likely to have variable
effects on tests of threat and reward driven behaviors depending upon the range of cues, responses
and contingencies that may be in operation. Certainly, a recent study inactivated, independently,
neuronal ensembles related to either food seeking or the extinction of food seeking within rat vmPFC,
(targeting the IL in particular) and revealed the opposing effects that such manipulations could have
on food seeking behavior [171]. It remains to be determined if similar effects can be seen with respect
to threat-driven behaviors in rodents.
4. Summary and Future Directions
Fundamental to our understanding of area 25 in disease states is gaining an insight into the
physiological, behavioral and cognitive functions requiring an ‘on-line’ area 25 (summarized in
Figure 5). Encouragingly, the finding that area 25 is an important cortical visceral motor center holds
across anatomical and functional studies in rodents, non-human primates and humans. This suggests
that there are aspects of area 25’s function in physiological domains that are conserved across species
and given the importance of autonomic activity in the generation of affect, it would not be unreasonable
to expect some degree of similarity in the effects of area 25 manipulations on affective behavior.
This may indeed be the case when comparing human, non-human primate and rodent findings with
respect to reward processing. Area 25 activation in marmosets blunts appetitive anticipatory and
motivational arousal, effects reversed by an acute dose of ketamine, thus mirroring the reduction in
area 25 activity following successful treatment in patients suffering from treatment-resistant depression.
IL activation in rats also tends to reduce rewarded responding. Nevertheless, caution is warranted
when drawing comparisons between behavioral and autonomic correlates of anticipatory affect in
non-human primates and rodents and subjective states in humans. Future studies in the clinic should
include the measurement of additional physiological and behavioral outputs to facilitate translation.
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Figure 5. A summary of the physiological and behavioral functions associated with human and
monkey area 25 and rodent infralimbic (IL). These representative studies illustrate, (i) the similarities
and differences in the functional effects of manipulations of area 25 in monkeys and IL in rodents; (ii)
how these map onto effects in humans; and (iii) where there are gaps in our knowledge. Blue bars
denote reductions in activity, red bars denote increases in activity whilst green bars denote either that
the direction of effects in area 25 are unclear, or that the effects may not be specific to area 25. Thus,
if red and blue bars are going in the same direction (as in rodent despair), or if the same colored bars
are going in opposite directions (as in rodent anxiety), the results are inconsistent. Headings above
the bars indicate physiological measure if in italics, and the behavioral paradigm if non-italic. Hatching
indicates correlations rather than manipulations. In terms of physiology, there is reasonable correspondence
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between monkey and rodent with respect to the reductions/increases in cardiovascular activity
following reductions/increases in area 25/IL activity, especially during stress; although there are
exceptions (see [39]). Any correspondence with the effects of stimulation in humans is unclear, however,
because the excitatory versus inhibitory effects of stimulation on area 25 activity are unknown; if indeed
the effects are due to changes in area 25 at all, since effects on fibers of passage cannot be ruled
out. In relation to cortisol, there is agreement between correlatory findings in humans and monkeys
that indicate positive correlations between cortisol levels and area 25 activity in monkeys and area
25 functional connectivity in humans. However, this similarity does not extend to rodents [57],
as radiofrequency ablation of the IL increases corticosteroids; although whether the ablation effects are
specific to the IL cannot be determined. Whilst immune function is related to area 25 activity in humans,
this hasn’t yet been addressed in monkeys or rodents. With respect to behavior, changes in activity
in area 25 in relation to depression can be variable, but successful treatment, especially in treatment
resistant patients following DBS, is very often associated with reductions in area 25 activity. In line with
this, the most consistent effects in both monkey area 25 and rodent IL are the overactivation-induced
anhedonia-like effects. In contrast, the effects in monkeys and rodents of area 25/IL manipulations on
conditioned threat responses and their extinction appear opposite, while in rodent studies the effects on
despair-like and anxiety-like behaviors are inconsistent. Abl, ablation manipulation; AP5, AP-5 (NMDA
antagonist); ACTH, adrenocorticotrophic hormone; Ant, Anticipatory arousal; Bic, Bicuculline (GABAA
antagonist); CoCl, Cobalt chloride (silences activity); CoT, conditioned threat; Cort, Corticosterone; CVI,
Cardiac vagal index of heart rate variability; CVS, Cardiovascular system; DBS, Deep brain stimulation;
dCS, d-Cycloserine (NMDA co-agonist); DHK, Dihydrokainic acid (EAAT2 inhibitor); DM, Decision
making (approach-avoidance); EPM, Elevated plus maze; Ext, Extinction; ExR, Extinction recall; Fdg,
Feeding behaviour; FST, Forced Swim Test; Gen, genetic manipulation; HInt, Human intruder test; HR,
Heart rate; HRV, heart rate variability; IL1β, Interleukin 1β; Les, lesion manipulation; LY/C, LY341495
(mGluR2/3 antagonist) and CGP52432 (GABAB antagonist); M, Muscimol (GABAA agonist); MAP,
mean arterial pressure; MB, Muscimol (GABAA agonist) and baclofen (GABAB agonist); Md, Mood;
Mot, Motivational arousal; NAff, Negative affect; NSF, Novelty suppressed feeding, OF, Open Field
test; Opto, Optogenetic manipulation; PAff, Positive affect; ReExt, Re-extinction; Sad, Response to
sad faces; SPT, Sucrose preference test; SSRI, Selective serotonin reuptake inhibitor; Stim, Stimulation
manipulation; TST, Tail suspension test; V, Veratrine (Sodium channel activator). Numbers indicate the
relevant reference.
Critical to overall progress in this field will be closer integration between studies across humans,
monkeys and rodents, with monkeys acting to bridge the gap between rodents and humans. Especially
important will be identifying under what circumstances area 25 is activated and determining the
interaction between cognitive, physiological and behavioral functions associated with this region.
From studies so far it can be seen that functional similarities between monkey area 25 and rodent
IL are far from clear and in some cases appear opposite. As discussed above, these may be due, in
part, to differences in the pharmacological tools used to induce activation and the duration of such
effects, along with variations in the psychological/cognitive mechanisms engaged to perform a given
task. However, it should also be borne in mind that whilst IL and area 25 are considered structurally
homologous, the anatomical framework in which they reside is not. Primate area 25 is operating in
concert with the highly developed dorsolateral (dlPFC), ventrolateral and frontopolar cortices, which
are likely to be contributing to many of the tasks in which area 25 manipulations have been investigated.
Thus, they may contribute to some of the differences observed between area 25 manipulations in
primates and rodents. Given the vast expansion of PFC in primates it is more than likely that there has
been an expansion and specialization of cognitive functions, in which the rudiments are instantiated in
more generic processing modules within the rodent PFC.
Future studies in non-human primates should focus on these higher-order regions and begin to
dissect out their interactions with area 25 to advance our understanding of the higher-order control
of reward and threat-driven behaviors. By employing novel chemogenetic and optogenetic tools,
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the investigation of these specific non-human primate pathways descending into area 25 is now
possible, alongside similar studies investigating selective efferents of area 25. This will be particularly
important in establishing the multitude of functions that area 25 likely contributes to, given its extensive
anatomical connectivity.
An additional consideration is how best to translate these findings into the clinic. So far,
most targeted area 25/IL manipulations in preclinical animal work involve transient activations or
inactivations, but see [169]. However, disease states are associated with chronic, long-term changes
in a distributed network of structures. For instance, it is a tonic elevation in area 25 that has been
associated with depression, compared to acute changes associated with sadness induction in healthy
controls [190]. At a cellular level, sustained changes in neural activity are more likely to cause receptor
desensitization and endocytosis, together with functional and structural plasticity. At a circuit level,
sustained alterations in activity of a single brain region are more likely to induce compensatory changes
in other brain networks, which may be relevant to the disease phenotype. Finally, at a cognitive level,
mental illnesses are associated with maladaptive learning over time, which further contributes to the
behavioral, subjective and executive sequelae of these disorders. Thus, future studies should also
determine the effects of chronic over-activity in area 25. These can be investigated using a variety
of techniques that would permit such chronicity without the need for chronic brain interventions.
These include the area 25-specific administration of siRNA targeting EAAT2 to inhibit glutamate
reuptake or the chronic administration of DREADD (designer receptors exclusively activated by
designer drugs) ligands using osmotic minipumps in animals with Gq-coupled DREADDs targeting
area 25 to increase neuronal excitability. Such studies should not only be undertaken in adulthood, but
also at different stages of development, because disorders such as anxiety and depression very often
have their onset during puberty and adolescence (for review see Young et al., this issue). Insight has
already been gained into the functional development of rodent vmPFC (including IL) in relation to
conditioned threat extinction (reviewed in Zimmermann et al, this Special issue), paving the way for
similar studies of primate area 25. Indeed, the unique growth trajectory of area 25 was revealed in
a recent study mapping marmoset structural growth trajectories of cortical and subcortical regions.
Compared to neighboring prefrontal and ACC areas, area 25 displayed an early onset of grey matter
decline (thought to reflect changes in synaptic plasticity, pruning and increased myelination) around
the start of puberty which then continued throughout adolescence, with the greatest rate of decline
not occurring until the end of adolescence [191]. This prolonged period of structural ‘change’ may
make area 25 particularly vulnerable to external stressors across extended periods of development
and may explain its prominent role in models of depression. As reviewed in Datta and Arnsten (this
Special issue) prefrontal cellular circuits, as revealed by studies of the cellular mechanisms underlying
working memory in dlPFC, appear particularly vulnerable to uncontrollable stress, effects that can be
exacerbated during adolescence, but whether similar or different interactions are played out in area 25
during development are as yet unknown.
5. Conclusions
Area 25 plays a key, causal role in physiological and behavioral changes that resemble symptoms
of enhanced negative affect and anhedonia, constituting key features of major psychiatric disorders
such as depression and anxiety. However, other regions within the vmPFC also play a role, and care
must be taken not to equate area 25 with the vmPFC. Further characterization of behavioral and
cognitive functions subserved specifically by area 25 in the non-diseased state will aid in delineating
the importance of dysfunction within area 25 to the phenotype of these conditions. Work in non-human
primates, whose vmPFC is more similar in its overall organization to humans than rodents, is critical to
this effort. Success is dependent on far closer integration of studies across species and more readiness
to acknowledge differences, as well as similarities, across those species.
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Abstract: Recent work suggests complementary roles of the prelimbic and infralimbic regions of
the rat medial prefrontal cortex in cognitive control processes, with the prelimbic cortex implicated
in top-down modulation of associations and the infralimbic cortex playing a role in the inhibition
of inappropriate responses. Following selective lesions made to prelimbic or infralimbic regions
(or control sham-surgery) rats received simultaneous training on Pavlovian feature negative (A+,
XA−) and feature positive (B−, YB+) discriminations designed to lead to hierarchical occasion-setting
control by the features (X, Y) over their respective targets (A, B). Evidence for hierarchical control
was assessed in a transfer test in which features and targets were swapped (YA, XB). All groups were
able to learn the feature negative and feature positive discriminations. Whilst sham-lesioned animals
showed no transfer of control by features to novel targets (a hallmark of hierarchical control), rats
with lesions of prelimbic or infralimbic regions showed evidence of transfer from the positive feature
(Y) to the negative target (A), and from the negative feature (X) to the positive target (B; although this
only achieved significance in infralimbic-lesioned animals). These data indicate that damage to either
of these regions disrupts hierarchical occasion-setting control, extending our knowledge of their role
in cognitive control to encompass flexible behaviours dictated by discrete cues.
Keywords: prelimbic; infralimbic; medial prefrontal cortex; cognitive control; hierarchical control;
occasion setting; extinction; Pavlovian
1. Introduction
In order to behave appropriately in environments that are complex and changing, operating
via simple associative contingencies is often insufficient. Instead, an organism must be able to use
task-relevant information to extract specific ‘rules’ for responding, as well as apply the top-down
control necessary to implement and adapt these strategies as required, including both the capacity
to promote relevant responses and the capacity to inhibit inappropriate responses. Previous research
has implicated the medial prefrontal cortex (mPFC) in this sort of hierarchical control of behavioural
responding, in recent years focusing specifically on prelimbic (PL) and infralimbic (IL) subregions.
These regions appear to serve separable but complementary functions that together may offer an
explanation as to how the mPFC might be organized to accommodate higher-order control processes.
The research detailed below provides direct evidence of the involvement of PL and IL regions in the
development of hierarchical control in the context of discrete cues controlling Pavlovian conditioning.
This expands our understanding of the role of these areas in the flexible control of behaviour,
complementing previous research examining contextual control of instrumental behaviours.
For example, in a rodent version of the Stroop task, work by Killcross, Haddon, and colleagues [1,2]
provided explicit evidence for differential involvement of PL and IL cortices in hierarchical control
of behaviour using contextual cues. Here, rats are trained on two biconditional discrimination tasks
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in separate contexts. These tasks involved presentations of two discriminable stimuli (auditory for
one context: A1 and A2, Visual for the other: V1 and V2), each of which dictated that responding on
a particular lever (L1 or L2) would be rewarded. At test, animals were presented with audio-visual
compounds of these stimuli in each context, where either both stimuli had stipulated the same response
in training (congruent) or had each stipulated an opposing response (incongruent). When presented
with incongruent trials, animals are required to use the experimental context in order to disambiguate
the conflicting response information and determine where to direct responding (i.e., the lever associated
with the stimulus element that had been trained in that context). Results demonstrated that temporary
inactivation of the PL cortex impaired the ability of these animals to perform context-appropriate
responses on the incongruent trials, suggesting that the PL cortex, in particular, is necessary for
using contextual information to guide appropriate responding in situations of cue and response
conflict [2]. In contrast, using a version of the task in which the amount of training on the two
discriminations was manipulated such that one discrimination received three times the training of
the other [1], rats are normally unable to use the undertrained contextual cues to allow expression of
the context-appropriate response when presented with an incongruent compound comprising both
undertrained and overtrained cues. However, following inactivation of the IL cortex prior to the test,
rats were able to overcome the impact of the overtrained discrimination in favour of the contextually
appropriate undertrained cue. This suggests that the IL cortex usually functions to promote basic
stimulus-response associations (which could be excitatory, inhibitory, or both), regardless of context,
and oppose top-down modulation by the contextual cues.
The PL cortex has also been shown to be important for contextual control of responding in aversive
Pavlovian conditioning [3]. In a contextual biconditional discrimination task, animals were trained
with two cues in two contexts. Both cues were presented in both contexts, but in the first context, one
cue was paired with a shock and the other with nothing, while in the second context this was reversed.
Thus, the context dictated which cue to fear and which cue was safe. Inactivation of the PL cortex was
found to interrupt both acquisition and performance of this discrimination, suggesting that the role of
the PL cortex in hierarchical control processes extends to both appetitive and aversive domains.
In both of the situations outlined above, each of the cues has a mixed associative history, sometimes
preceding an appetitive or aversive outcome and sometimes not, and the context is required to
determine which associative structure is operational at a given time. Another well-documented
phenomenon that may involve the same sort of contextual modulation of simple associative structures
is extinction. In extinction learning, an organism learns that a cue (CS) that previously predicted
an outcome (US) no longer does, resulting in a decrease in conditioned responding to that stimulus.
One prevalent model of extinction (Reference [4], but see also Reference [5]) stipulates that this learning
can be thought of in terms of a new inhibitory association forming, which exists alongside the original
excitatory one. This inhibitory association is context-dependent, such that it is only activated in
preference to the original learning in contexts similar to that in which extinction learning occurred [6].
In this way, the context is said to gate the inhibitory association, modulating behavioural performance
on the basis of which association is more likely to be valid in a particular environment.
There has been considerable research investigating the roles of PL and IL cortices in acquisition
and expression of extinction learning. For example, the IL cortex has been shown to be important for
the retrieval and expression of previously acquired extinction of fear learning [7], and lesions to the
IL cortex have also been shown to increase recovery, reinstatement, and renewal of an extinguished
Pavlovian response in an appetitive conditioning paradigm [8,9]. In contrast, lesions of the PL
cortex have been shown to impair renewal of an extinguished fear response, with extinction learning
appearing instead to generalize across contexts [10]. Taken together, these findings suggest that the
IL cortex is important for facilitating the expression of extinction learning, and the generalization
of inhibitory associations across contexts, while one possible function of the PL cortex is to gate the
inhibitory extinction association on the basis of contextual features, modulating the expression of
extinction based on contextual cues [11]. This is in line with evidence outlined above implicating the PL
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cortex in contextual modulation of behavior such that features of the organism’s current environment
are better able to retrieve appropriate associations that come to be expressed in behaviour. Conversely,
the IL cortex may be seen as again playing a complementary role by promoting the capacity of learning
to be generalized across contexts, independently of higher-order cues or rules.
Many of these studies examining the role of PL and IL in the development of behavioural
flexibility, or the implementation of rule-based strategies, have examined the ability of contextual cues
to come to control performance. However, recent work has indicated that the PL and IL may also both
play a role in the use of discrete cues to provide top-down control of response alternatives. On the
one hand, Meyer and Bucci [12] have demonstrated that pre-training lesions of the PL region of the
mPFC produce deficits in the acquisition of conditioned inhibition in a compound feature negative
discrimination (of the form A+, AX−, where A+ is a 10-s tone followed by pellet reward, and AX- is
presentation of a 10-s compound tone and light cue followed by no outcome). Rats with lesions of the
IL region produced a level of discrimination that did not differ significantly from either PL-lesioned
animals or sham-lesioned control animals. Prior to this, Rhodes and Killcross [13] examined the ability
of rats with IL-lesions to acquire conditioned inhibition using a similar simultaneous feature negative
design. As Meyer and Bucci also found, IL lesions were without effect in the acquisition of conditioned
inhibition in this design, coming, like sham-operated control animals, to respond reliably more to
A+ than AX− compounds. However, Rhodes and Killcross subsequently examined the status of the
conditioned inhibitor X in both summation and retardation tests. In a summation test in which inhibitor
X was paired with novel excitor B+, both lesioned and control animals showed an impact of the inhibitor
X on responding, confirming that inhibition had accrued to X during training. In the retardation test,
which examined the acquisition of conditioned responding to X (now X+) compared to a neutral cue
(Y+) to which animals had had equivalent exposure, only sham-operated control animals showed the
expected better acquisition to Y+ than to the inhibitory X+. For IL-lesioned animals, acquisition of
conditioned responding was equal to both X+ and Y+. Rhodes and Killcross [13] concluded that the
role of the IL cortex here was related specifically to the acquisition of both excitatory and inhibitory
associations with the same cue, echoing its role in the inhibitory learning thought to occur in extinction,
and more recent evidence suggesting a more general role in inhibitory associations [14].
However, these studies employing discrete-cue feature negative discriminations may not be
directly comparable to those examining top-down modulation of behaviour by contextual cues, where
the contextual cues are held to act as modulating factors. Whilst feature discriminations such as those
described above are laid out as occasion-setting preparations, whereby the feature X can come to
modulate the performance to the target A (much like the contextual cues may do in the studies outlined
previously), evidence suggests that this is unlikely when simultaneous presentations of the cues in
compound are used (as was the case in the above studies). Rather, simultaneous presentation of feature
and target cues in compound (AX−) encourages the development of direct (inhibitory) associations
between X and the target US or the behaviour engendered by presentation of A [4,15]. By contrast,
however, modulatory relationships are favored when the feature and target compounds are presented
sequentially or in series (that is, X followed by A). In these preparations, there is evidence that the
feature X comes to modulate the relationship between A and the US (see, e.g., Reference [16]).
If sequentially-arranged feature discriminations are underpinned by occasion-setting relationships,
the use of such procedures would seem a strong test-bed in which to further examine the role
of PL and IL function. In particular, it would permit examination of both the development and
execution of modulatory control over ambiguous relationships in discrete-cue Pavlovian conditioning
in a manner that can be compared and contrasted with evidence derived from studies examining
contextual modulation in both the Stroop analogue and extinction-based procedures. Such an
addition would provide a broader base of evidence from which to derive conclusions about PL and
IL function, specifically in the context of modulation of performance by top-down processes in which
behavioural control must be exerted to regulate responding to cues with an ambiguous or mixed history
of reinforcement.
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Of course, as the argument above makes clear, simply observing the acquisition of feature
discriminations does not, in itself, reveal the underlying associative structure; whilst we might arrange
serial feature-target compounds to promote the development of hierarchical occasion setting control,
this does not mean this is how the animals learn the tasks (they could, for example, nevertheless
produce direct associations between features and the US). Whilst the precise associative structure
underpinning occasion setting relationships are still somewhat in debate, in research that does evidence
a hierarchical account over a configural one, the failure of complete transfer between occasion-setting
cues plays a central role [4,16]. In general, features (X, Y) used in either sequential feature negative (A+,
XA−) or feature positive (B−, YB+) discriminations do not show transfer of control over separately
trained CSs (e.g., XC, or YD), and whilst there may be some (incomplete) transfer from one feature
positive discrimination to another similarly trained feature positive discrimination, transfer does not
occur between feature positive and feature negative discriminations under normal occasion setting
circumstances [17]. The reason for this is that the modulation of the relationship between CS and US
(whereby sometimes the CS predicts the occurrence of the US and sometimes it doesn’t) is found to be
substantially CS and US specific, emphasizing that the feature modulates the relationship between
CS and US, rather than the level of activation of associative representations of CS and/or US directly.
Another factor made plain by this account is that the relationship between CS and US must be
ambiguous (having a history of reinforcement and non-reinforcement) for occasion setting to play
a strong role. Accordingly, a test of transfer provides a clear method by which to explicitly assess the
associative structure underpinning feature discrimination.
The purpose of the current study is therefore two-fold. Firstly, we aimed to implement training
of serial feature-positive and feature-negative discriminations and assess whether, under normal
circumstances, animals acquire these discriminations via hierarchical occasion-setting mechanisms.
Secondly, we aimed to examine the role of PL and IL cortices in this process—whether lesions of the
PL or IL cortex impact acquisition of feature positive and feature negative discriminations, and/or the
manner in which these are acquired. To achieve this, we trained rats (following excitotoxic lesions of
PL, IL, or sham control surgery) simultaneously on both Pavlovian serial feature negative (A+ XA−)
and Pavlovian serial feature positive (B+, YB−) discrete cue discriminations. Following acquisition of
these discriminations, we examined the capacity of the features X and Y to transfer control to their
oppositely trained targets (probe tests XB and YA in extinction). It is specifically by the use of the
transfer task that one can reveal the specificity of the hierarchical control; if the training had brought
the relationships between A and B and the US under hierarchical occasion setting control by X and
Y respectively, then we would expect to see little or no transfer of control from X to B or Y to A.
In contrast, if the normal processes of occasion setting were disrupted, we might expect this to be
revealed in transfer of control from features X and Y to novel targets B and A.
If the PL cortex plays a general role in top-down control of both Pavlovian and instrumental tasks
(as we have suggested, see Reference [11]), and the IL cortex plays a role in promoting and acquiring
the basic associative relationships that are to be modulated, then the use of feature positive and feature
negative occasion setting and transfer tasks should be revealing. It was expected that sham-operated
control animals would demonstrate discriminative control of responding in both the feature positive
and feature negative tasks, and furthermore would not show transfer of this control in the probe
test. This would support the claim that discriminable responding to target cues in serially arranged
occasion-setting preparations typically falls under hierarchical control via the feature cues. Given prior
work indicating a role for the PL cortex in top-down modulation of performance towards ambiguous
cues, one may expect PL-lesioned animals to show an impairment in learning the discriminations (for
which there is some evidence in feature-negative preparations [18]). In addition, if they are able to
learn the discrimination, it was expected that the transfer test would reveal this not to be a function
of hierarchical control over responding (that is, these animals would show significant transfer). It is
more difficult to come up with specific predictions as to whether and how lesions of the IL cortex
may impact learning of the discriminations, since the main hypotheses regarding IL function are
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either firmly embedded in the context of extinction procedures [7] or relate to the development of
stimulus-response associations [11] which do not have a clear translation in the context of Pavlovian
conditioning. However, given the body of literature supporting dissociable functions of PL and IL
regions of the cortex, it would be interesting to determine if a similar dissociation is observed in
this paradigm.
2. Materials and Methods
2.1. Subjects
Subjects for this experiment comprised twenty-four (N = 24) experimentally naive, adult male
Long-Evans rats (Monash Animal Services, Gippsland, Victoria, Australia), weighing between
307–412 g at the start of experimentation. They were housed eight rats per cage, in a temperature- and
humidity-controlled environment (22 ◦C) operating on a 12-h light-dark cycle (lights on at 7:00 a.m.).
All experimental procedures took place during the light cycle. Following recovery from surgery,
animals were placed on a food restriction schedule on which it was ensured they maintained at least
85% of free-feeding weight. Water was available ad libitum. All procedures were carried out in
accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals
(NIH publications No. 80-123, revised 1996) and were approved by the University of New South Wales
Animal Care and Ethics Committee (ACE:09/39B).
2.2. Surgery
Prior to behavioral training, animals were randomly assigned to receive bilateral excitotoxic
lesions of the infralimbic cortex, prelimbic cortex, or sham surgery (n = 8). Surgery was performed
under isoflurane anesthesia in a standard stereotaxic frame (World Precision Instruments Inc.,
Sarasota, FL, USA), using a flat skull position. To produce lesions, 0.4 μL infusions of 10 μg/μL
N-methyl-D-aspartic acid (NMDA; Sigma-Aldrich, Buchs, Switzerland) were administered to either
the PL (coordinates from bregma; AP +3.2, L ± 0.7, and DV−4.0) or IL (coordinates from bregma;
AP +3.0, L ± 0.7, and DV-5.4) cortex using a 1-μl syringe (Hamilton, NV, USA). Infusions proceeded at
a rate of 0.1 μL/min, and once complete the syringe was left in place for a further four minutes to allow
the solution to diffuse into the tissue. Animals in the sham group underwent an identical procedure,
with the exception that no NMDA was administered. The syringe was entered at the PL site for four of
the sham animals and at the IL site for the other four. Post-surgery all animals were allowed to recover
over a minimum 10-day period, during which time they received daily post-operative observations,
and had ad libitum access to both food and water. Animals were subsequently placed on the food
restriction schedule, which was maintained for three days prior to the commencement of behavioural
training and was continued for the duration of testing.
2.3. Apparatus
Training was carried out using eight standard operant chambers measuring 25 × 25 × 22 cm and
housed in light- and sound-attenuating compartments (Paul Fray, Cambridge, UK). Each chamber was
composed of three aluminum walls with a clear Perspex front wall and ceiling. The floors consisted
of 18 stainless steel bars, 5 mm in diameter and spaced 1.5 cm apart. A magazine was located at the
bottom center of the left-hand wall, where grain pellets (45 mg; Bio-Serv, Flemington, NJ, USA) could
be delivered. Magazine entries were registered via the action of a Perspex flap that animals opened in
order to access the magazine. Auditory stimuli were provided by a speaker fitted into the back center
of the chamber’s ceiling, which was linked to an audio signal generator (Med Associates ANL-926,
Fairfax, VT, USA). Auditory stimuli consisted of a 2.8 kHz tone and white noise. Visual stimuli
consisted of a panel light located immediately above the magazine and an LED light located within
the magazine itself. Experimental operations were controlled and recorded by a desktop computer
equipped with MED-PC software (Med Associates Inc, Fairfax, VT, USA.).
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2.4. Procedures
2.4.1. Pretraining
Prior to discrimination training animals were given three 40-min sessions of magazine training, in
which they learned to retrieve food pellets that were delivered to the magazine. Pellets were delivered
approximately every 60 s according to a variable time schedule (VT60). For the first of these sessions
only, the magazine flaps were fixed open to facilitate access to the rewards.
2.4.2. Discrimination Training
All groups received 32 sessions of discrimination training in which animals were exposed to
concurrent serial feature positive and serial feature negative Pavlovian discrimination arrangements.
In the feature positive arrangement, a visual ‘target’ stimulus (Magazine Light or Panel Light;
designated cue B) was presented either alone with no reinforcement (B−) or was preceded by an
auditory ‘feature’ stimulus (Noise or Tone; designated cue Y) and was accompanied by the delivery of
a food reward (YB+). In the feature negative arrangement, the alternate target stimulus (Magazine
Light or Panel light; designated cue A) was either presented alone, in which case the presentation
was reinforced (A+), or was preceded by the alternate feature stimulus (noise or Tone; designated
cue X) and was not reinforced (XA−). A summary of this experimental design is shown in Table 1.
Combinations of auditory and visual stimuli were fully counterbalanced across animals.
Table 1. Summary of experimental design.
Target Alone Feature − Target Probe
Feature Positive B → No US Y − B → US Y − A → No US
X − B → No USFeature Negative A → US X − A → No US
Note. A and B represent target stimuli (magazine light and panel light), while X and Y represent feature stimuli
(tone and noise). US represents reinforcement via food pellet, and No US represents no reward. Animals are trained
and tested on all combinations.
Each session ran for approximately 64 min and consisted of 10 stimulus presentations of each
type (A+, XA−, B−, and YB+). In target-alone presentations, the target stimulus was presented for
10sec and was either followed by a reward or not, depending on trial type (A+ or B−). In feature-target
presentations (XA− and YB+), the feature stimulus was presented for 10 s and was immediately
followed by the 10 s target stimulus. For reinforced presentations, the termination of the target
stimulus coincided with the delivery of a reward. These trials were presented in random order with
the restriction of no more than two consecutive trials of the same type and were interspersed with
variable inter-trial intervals (ITI; M = 60 s).
2.4.3. Probe Test
Following discrimination training, all groups were given a test session incorporating probe trials
in which the original feature-target combinations were reversed. During this session groups received
the discrimination procedure in its entirety, immediately followed by an additional 15 min in which
animals were presented with six reverse feature-target presentations in the absence of reinforcement
(three each of YA− and XB−). This was to assess whether the capacity of features X and Y to control
responding would transfer to the opposing targets. These trials were interspersed with four more of
the usual target-alone presentations (two each of A+ and B−). Trials were presented in random order
and were separated by VT60 ITIs.
2.5. Histological Analysis
At the conclusion of behavioural testing, animals were given a lethal dose of sodium
pentobarbitone and were transcardially perfused via the ascending aorta with saline-based pre-wash
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followed by 4% paraformaldehyde solution. Brains were removed and post-fixed in paraformaldehyde
for a period of two days, before being transferred to sucrose solution (20% w/v) for a further 24 h. Forty
micrometer coronal sections of the brain were taken using a cryostat and mounted onto gelatine-coated
slides. Slides were air-dried overnight under a fume-hood and subsequently stained using cresyl violet.
Lesion placement was verified under a light microscope, with the extent and location of neuronal
damage for each animal recorded with reference to Paxinos and Watson’s atlas [19].
2.6. Statistics Analysis
Entry to the food magazine was the conditioned response measure of interest. Relative rates
(per 10 s) of conditioned responding were calculated by subtracting average baseline levels of magazine
entry from magazine entries performed during stimulus presentations. Baseline responding was
defined as the rate of magazine entry during the ITI period, averaged across all trials of the session.
Responding was measured over the full 10 s of feature presentations, and the final 5 s of target
presentations (to minimize interference from behavioral competition on trials on which the feature
preceded the target). Of primary interest were the rates of conditioned responding to target stimuli
(A and B) during acquisition and the probe test. Data were analyzed using mixed analysis of variance




All animals in the IL group showed substantial bilateral damage to the IL region, extending
throughout anterior and posterior regions, while neighboring cortical regions were left largely intact
(n = 8). Similarly, animals in the PL group showed acceptable levels of neuronal loss to the PL region,
which extended fully in the anterior direction but showed some sparing of the posterior region (n = 8).
Figure 1 illustrates the maximum (grey) and minimum (black) extent of lesion damage for both IL and
PL groups. Location and extent of lesions in this study are similar to those in previous work, in which
dissociable behavioural effects have been demonstrated [8–10,12,18,20].
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Figure 1. Schematic representation of location and extent of excitotoxic lesion damage to the prelimbic
(PL; a) and infralimbic (IL; b) cortices. Shaded regions indicate the minimum (black) and maximum




A preliminary analysis of baseline rates magazine entry was performed using a two-way mixed
ANOVA in which the between subjects factor was Group (Sham, PL, and IL) and the within subjects
factor was Session Block (1–8; blocks of four sessions). Results revealed no significant between-group
differences in rates of baseline responding (F < 1). Similar ANOVAs (with additional within-subjects
factor of Feature; present or absent) were also performed to analyze rates of acquisition of conditioned
magazine entry responding to target stimuli in the feature positive (B alone vs. B when preceded
by Y) and feature negative (A alone vs. A when preceded by X) discriminations. The data for these
analyses are displayed in Figure 2. As illustrated, acquisition of the feature positive association is
evidenced by increasing responding on reinforced YB+ trials compared to non-reinforced B- trials,
and rate of acquisition did not differ by group. There were significant main effects of Session Block
(F7,147 = 21.42; p < 0.001) and Feature (F1,21 = 27.74; p < 0.001) plus a significant Session Block by Feature
interaction (F7,147 = 12.19; p < 0.001), but no other effects or interactions were significant (all F < 1).
Acquisition of the feature negative association is evidenced by increasing responding on reinforced A+
trials, compared to non-reinforced XA− trials. Although it appears that animals in the PL lesion group
may have acquired this discrimination more slowly than either the IL lesion or Sham control group
(discriminated responding first appears in Block 3 or 4 for IL and Sham groups, but not until Block 6
for the PL lesion group), this was not statistically supported. As for the feature positive discrimination,
there were significant main effects of Session Block (F7,147 = 15.13; p < 0.001) and Feature (F1,21 = 9.68;
p = 0.005), as well as a Session Block by Feature interaction (F7,147 = 9.35; p < 0.001), but no other effects
or interactions were significant (notably no main effect of Group or interaction with Group; all F < 1).
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Figure 2. Acquisition of magazine entry responding (rate per 10 s) during target cue presentation
in the feature positive (panel A) and feature negative (panel B) discriminations. Solid line displays
responding to the reinforced target (i.e., on (Y)B+ trials for feature positive and A+ trials for feature
negative), while dotted line displays responding to the non-reinforced target (i.e., B− trials for the
feature positive and (X)A− trials for feature negative).
Responding to target stimuli during the final session of discrimination training is displayed
in Figure 3. Rats in all groups showed evidence of having acquired both the feature positive and
feature negative discriminations by the end of training, in that conditioned responding was greater on
reinforced trials (A+ and (Y)B+) than non-reinforced trials ((X)A− and B−).
Figure 3. Rate (per 10 s; relative to baseline) of magazine entry during presentation of the target cue on
feature-present and feature-absent trials of the feature negative ((X)A and A, respectively) and feature
positive ((Y)B and B, respectively) discriminations. Error bars represent +SEM.
Acquisition of conditioned responding to target stimuli in the feature positive (B− and (Y)B+)
and feature negative (A+ and (X)A−) discriminations was assessed via a three-way mixed ANOVA.
In this analysis, the between subjects factor was Group (Sham, PL, and IL), and within subjects factors
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were Discrimination (feature negative or feature positive) and Feature (present or absent). Results
revealed a significant Discrimination by Feature interaction (F1,21 = 29.88; p < 0.001). No other main
effects or interactions were significant (all F < 1).
Follow-up simple effects analysis of the interaction term indicate that averaging across groups,
conditioned responding during target presentation on the feature negative discrimination was greater
on the reinforced feature-absent trials (A+) than the non-reinforced feature-present trials ((X)A−;
F1,21 = 12.57; p = 0.002). For the feature positive discrimination, conditioned responding during
target presentation was greater on the reinforced feature-present trials ((Y)B+) than the non-reinforced
feature-absent trials (B−; F1,21 = 18.55; p < 0.001). In other words, animals were able to use the feature
cue to either inhibit (in the case of the feature negative discrimination) or elevate (in the case of the
feature positive discrimination) responding to the target cue, and this did not differ as a function of
lesion group.
Analysis of responding during feature presentation was also assessed, using a two-way mixed
ANOVA in which the between subjects factor was Group (Sham, PL, and IL) and the within subjects
factor was Feature (X or Y; negative and positive discriminations, respectively). Results revealed
a significant main effect of Feature (F1,21 = 24.86; p < 0.001), whereby conditioned responding during
the positive feature Y (which is followed by reinforced target B; M (±SD) for Sham = 3.58 (±2.03),
PL = 3.01 (±3.15), and IL = 2.86 (±2.64)) was greater than responding during the negative feature X
(which is followed by non-reinforced target A; M (±SD) for Sham = 0.51 (±0.62), PL = 0.64 (±0.26),
and IL = 0.54 (±0.49)). No other effect or interaction was significant (both F < 1), indicating that the
ability to discriminate between excitatory (Y) and inhibitory (X) features did not differ as a function of
lesion group.
3.2.2. Probe Test
Rates of responding to target stimuli during probe trials are displayed in Figure 4. As illustrated,
animals in both the PL and IL groups demonstrated differential responding to the target cues according
to whether the cues were presented alone (A+ or B−) vs. when they were preceded by the feature
opposite to that which they had been paired with in training ((Y)A or (X)B). Specifically, responding
to A was increased when preceded by Y, and responding to B was decreased when preceded by
X. In contrast, the presence of the reverse features did not appear to have a substantial effect on
responding to target stimuli for animals in the Sham group.
Figure 4. Rate (per 10 s; relative to baseline) of magazine entry during presentation of the target cue on
feature-present ((Y)A and (X)B) and feature-absent (A+ and B−) trials of the probe test. Note paired
features are the reverse of those in training. Error bars represent +SEM.
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These findings are supported by a three-way mixed ANOVA in which the between subjects
factor was Group (Sham, PL, and IL) and within subjects factors were Target (responding to A or
B) and Feature (present or absent; Y and X, respectively). Results revealed a main effect of Target
(F1,21 = 21.35; p < 0.001), whereby responding was greater during presentation of target cue A than
target cue B, irrespective of feature presence or absence, and averaged across lesion group. This reflects
the history of reinforcement for A and B alone (A+ and B-), and of X and Y as inhibitory and excitatory
modulators respectively. Main effects of Feature and Group were not significant (F1,21 = 2.61; p = 0.12
and F < 1, respectively).
More informative, however, is a significant three-way interaction between Group, Feature and
Target (F2,21 = 4.09; p = 0.03) and two-way interaction between Feature and Target (F1,21 = 16.75;
p = 0.001). Neither of the other interactions was significant (Group x Feature, F2,21 = 1.31; p = 0.29;
Group × Target, F2,21 = 1.97; p = 0.16). Simple effects analysis clarifies the interaction terms, revealing
that responding to target cue A was significantly greater when preceded by feature cue Y than when
presented alone for both the PL and IL groups (F1,21 = 9.60; p = 0.005 and F1,21 = 8.59; p = 0.008,
respectively), but not for the Sham group (F < 1). In addition, responding to target cue B was
significantly lower when preceded by cue X than when presented alone for the IL group (F1,21 = 12.05;
p = 0.002), though not for the PL or Sham groups (both F < 1). In the case of the PL group, however,
this is likely to be a floor effect given responding was already minimal to B when presented alone.
Together, these results indicate that both PL- and IL-lesioned animals demonstrate transfer
of feature properties to different targets to a greater extent than sham-operated control animals.
Specifically, in both these groups there is evidence of additive excitatory stimulus components to both
A and Y, and in the IL group there is evidence of additive inhibitory stimulus components to both B
and X. While this latter effect is not statistically supported in the PL group, it appears from that this
may be a floor effect, in that responding was already minimal to B when presented alone.
4. Discussion
Here we have described a single experiment designed to examine the role of PL and IL regions of
the mPFC in the development of hierarchical control in discrete cue Pavlovian feature negative and
feature positive discriminations. In sham-operated control animals, simultaneous acquisition of the
two discriminations proceeded uneventfully; although training was protracted, performance at the
end of training indicated good control of performance in both discriminations, with significantly more
responding to the rewarded cues (A+, and B+ following Y) than to non-rewarded cues (A− following
X, and B−). A very similar pattern was observed in animals that had received lesions of the PL and IL
prior to training, and no significant differences in acquisition were observed.
However, as indicated in the Introduction, performance during acquisition of these discriminations
does not necessarily reveal the underpinning associative structure. As such we examined transfer
of feature control over targets in separate probe tests. As expected (given the parameters used in
the study such as the serial presentations of features and targets [17]), sham-lesioned control animals
showed no transfer whatsoever across feature negative and feature positive discriminations. That
is, probe presentations of positive feature Y prior to previously rewarded A failed to produce any
significant enhancement of performance; similarly probe presentations of negative feature X prior
to previously non-rewarded B failed to produce any significant decrement in performance. As such,
we would conclude that in these sham-lesioned animals, the performance of the feature positive and
feature negative discriminations was very likely to be the product of an underpinning hierarchical
relationship in which the features came to modulate conditioned responding to targets with a mixed
history of reinforcement.
In contrast, discrete lesions of either the PL or IL resulted in probe test performance that was
markedly different. In the case of IL lesions, presentations of the positive feature Y enhanced
performance to novel target A, and presentations of the negative feature X attenuated conditioned
responding to novel target B. A very similar pattern of responding was observed following PL lesions,
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although the decrement in conditioned responding to cue B following presentations of negative
feature X failed to reach significance in post-hoc analyses. It is possible that this could simply reflect
a floor effect as baseline responding to target B (in the absence of X) was especially low in this group
of animals.
As such, one would have to argue that the control of performance in the feature positive and
feature negative discriminations in groups with lesions of the PL or IL regions, whilst superficially
similar to that of the sham-operated control group, was not controlled by the same underpinning
occasion setting structure. Rather, the evidence of both positive and negative transfer from features
to targets suggests that instead, the features have come to control performance by something other
than a hierarchical modulation of the association between targets and rewards. Based on alternative
findings from the occasion setting literature investigating the potential associative structures that may
control feature positive and feature negative discriminations (see, e.g., References [4,16]), it seems
likely that the features X and Y had developed their own associations with the US (inhibitory and
excitatory, respectively), and so came to control performance by a process of summation with separate
associations formed between targets A and B with the US (excitatory and inhibitory, respectively).
Accordingly, acquisition of the discriminations in lesioned groups may be understood in terms of
straight-forward error-correction models of associative learning (in particular the Rescorla-Wagner
model [21]), whereby excitatory and inhibitory associations of features and targets with the US sum
to control performance. Briefly the Rescorla-Wagner model posits that associative learning occurs
by a process of error correction whereby the outcome expected to occur following presentation of
a stimulus is compared to that which actually occurs and the difference—the prediction error—is then
used to adjust the expectancy when the stimulus is next encountered. A key tenet of this model is
that associative strength (or in other words, outcome expectancy) accrues separately to all stimuli
present on a trial, and is additive; hence the expectancy that is generated when a number of stimuli are
presented is equal to the sum of the expectancy for each stimulus (for example inhibition accruing to X
can offset excitation accruing to A, leading to lower expectancy on XA trials and hence to lower CRs).
Much previous work has implicated a role for the PL region of the mPFC in the top-down control
of behavior. Inactivation of the PL cortex impairs performance in a rodent analogue of the Stroop
task [2] and a contextual biconditional discrimination task [3], and PL lesions impair renewal of an
extinguished fear response [10] and acquisition of a compound feature negative discrimination [12].
In addition, of particular relevance to this study MacLeod and Bucci [18] found evidence for a modest
impairment in the rate of acquisition of a serial feature negative discrimination following lesions
targeting the PL region (but not following lesions of the IL region). Whilst there were no statistically
significant differences in acquisition between the three groups in the present study, there was some
indication that learning of the feature negative discrimination may have been slower in the PL-lesioned
group; rats with PL lesions failed to respond differentially to A+ and AX− until about the 6th block
of training, compared to about the 3rd or 4th in Sham and IL-lesioned rats. Combined with the data
showing transfer of occasion setting control, we would suggest that—as expected—lesions of the PL
mPFC lead to a disruption of the ability of feature cues within occasion setting procedures to act as
top-down modulators of associations formed between the target and US. Whilst rats with PL lesions
(as we have observed in other Pavlovian procedures [3]) appear to remain able to call upon learning
processes that conform to a Rescorla-Wagner model of associative learning [21], they cannot use cues or
contexts in a hierarchical manner to modulate performance towards ambiguous stimuli with a mixed
history of reinforcement. In this way, the data presented here confirm conclusions from previous work,
as well as extending those findings to encompass the role of the PL region in the use of discrete stimuli
as hierarchical modulators.
By contrast, the impact of lesions on the IL region on the acquisition and transfer tests are
somewhat more surprising. Whilst we found no evidence at all for any deficits in acquisition of the
two discriminations, both the positive and negative features were shown to be capable of transfer
of control to novel targets, closely aligning with the observations following lesions of the PL region.
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In previous work, the impact of manipulation of PL and IL regions has tended to produce clearly
dissociable results, often described as providing complementary functionality that collectively supports
the appropriate implementation of flexible, task-appropriate behaviour. As discussed previously, while
the PL cortex has been implicated in expression of Pavlovian conditioned associations, the IL cortex
is implicated in the expression of extinction learning [7,22]. Furthermore, while substantial evidence
exists to implicate the IL region in inhibitory control [23,24], the PL cortex does not appear to be
involved in this operation, being implicated in perseverative rather than premature responding [25].
Marquis et al. [2], Haddon and Killcross [1], and MacLeod and Bucci ([12]; see also Reference [18],
also provide explicit evidence of dissociations between PL and IL cortices in the contextual control
of instrumental actions, acquisition of occasion-setting modulation of Pavlovian responding, and
conditioned inhibition. In addition, similar effects have been found in studies using an optimal
set-shifting procedure [26] designed to assess the capacity to form attentional set (as opposed to
switching attentional set, cf. Reference [27]), which again found dissociations between PL and IL
regions. Other recent work has also highlighted dissociations between PL and IL function (albeit using
pharmacogenetic activation of local parvalbumin interneurons as a means to silence local neuronal
activity [28]), although these results stand at odds with many previous findings in suggesting deficits
in intra-dimensional set shifting following silencing of the PL, but not IL, region of the mPFC. Earlier
studies found no deficit in intradimensional set shifting following extensive mPFC lesions [27], and
clear evidence of set-formation deficits following IL lesions [26].
In seeking to explain the current findings, there are two possible alternatives. The first of these
is that the IL and PL cortices do not have separable roles, despite previous suggestions, and instead
subserve highly similar functions. However, extant literature such as that described above strongly
argues against this possibility. Thus, the present findings do not discount the weight of previous
evidence that, in the context of both Pavlovian and instrumental learning, PL and IL cortices subserve
differential functions (e.g., References [11,29]). As such, it remains to attempt to reconcile the current
results with the notion that IL and PL cortices do operate in different ways. With this in mind, a second
alternative explanation is that in the current studies, lesion groups show parallel deficits, but for
different reasons.
If we are to assume that the failure of PL-lesioned animals to acquire hierarchical occasion setting
control over behavioural responses [11], but that the function of the IL region is complementary (and
potentially opposing), then what are the options? The IL region has been implicated in the encoding
of inhibition irrespective of motivational value [14], extinction of Pavlovian fear conditioning [30] as
well as extinction in appetitive conditioning procedures [8,9], the development of opposing excitatory
and inhibitory associations linked to the same CS [13], the ability of training to influence choice
performance [1], habitual performance [20,31], and the promotion of well-learned responses over those
governed by top-down control [11]. Some researchers have also highlighted the notion that the IL cortex
supports behavioural flexibility in the context of extinction, but appears to oppose flexibility in the
context of its promotion of extensively trained, habitual responses [32], and have proposed a role for IL
in contingency tracking. In all cases, there is a link whereby the IL appears to have a central role in the
development of inhibitory relationships. In the broadest context, these might be inhibitory associations
between CS and US [33], encoding of CS-No US associations [34] or CS-No Event associations [35],
encoding of inhibitory S-R associations [4], or bidirectional encoding of reinforced and unreinforced
lever presses on an operant schedule [32]. In all cases, the IL appears to be responsible for the overlay
of inhibitory or ‘no event’ relationships to existing excitatory associations or positive contingencies
(see also Reference [36]). Recall also that rats lacking IL fail to show retardation in a test of inhibition
that requires excitatory associations to be overlaid on existing inhibitory associations [13], suggesting
this role in the encoding of opposing relationships may be bidirectional.
In the context of the current experiment, one of the requirements for the development of
a hierarchical occasion setting relationship is that the target cues have a mixed history of reinforcement.
It is precisely the representation of this ambiguous relationship that is modulated by the presence of the
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feature to afford top-down control over responding to the target. Following IL lesions, we propose that
animals are no longer able successfully to encode opposing relationships or contingencies around the
target cues, and therefore cannot form the type of relationship that attracts (or indeed may necessitate)
the development of occasion setting. This, in turn, leaves the animals to solve the task in a manner
that appears to make use of more basic associative structures, such that responding to XA− can be
reduced by offsetting excitation accruing to A (following A+ trials) with inhibition to X (acquired
on AX− trials); similarly inhibition accruing to B will offset excitation to Y, allowing solution of the
feature positive B− YB+ discrimination. Note also that previous work has found intact summation in
IL-lesioned animals, confirming that they are able to offset excitation and inhibition across separate
cues [13]. Further experiments where both excitatory and inhibitory relationships are arranged with
single cues would help to further elucidate this potential role of the IL.
5. Conclusions
Overall, the results of the current experiment then lead one to refine further the potential
complementary relationship between PL and IL regions of the mPFC. Once again we have
demonstrated that the PL region appears critical for the development of top-down control processes,
and now further hypothesize that the IL region may be needed to represent those ambiguous
relationships in the world that attract this top-down control. Of course, in many situations (and as
we have shown here) animals may make use of simpler associative structures to provide behavioural
solutions to non-linear discriminations, and indeed there are also configural associative structures
that can provide a solution in many cases [37]. However, in order to achieve the hierarchical control
that is the hallmark of truly flexible decision making, we would argue that the PL and IL must work
in concert to produce the necessary template from which genuine rule-based behaviour can emerge.
Understanding how rule-based behaviour is supported by these structures has the potential to open up
new avenues in the treatment or prevention of human mental disorders where normal decision-making
processes are disrupted, such as addiction and obsessive-compulsive disorder.
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Abstract: The newly evolved prefrontal cortex (PFC) generates goals for “top-down” control of
behavior, thought, and emotion. However, these circuits are especially vulnerable to uncontrollable
stress, with powerful, intracellular mechanisms that rapidly take the PFC “off-line.” High levels
of norepinephrine and dopamine released during stress engage α1-AR and D1R, which activate
feedforward calcium-cAMP signaling pathways that open nearby potassium channels to weaken
connectivity and reduce PFC cell firing. Sustained weakening with chronic stress leads to atrophy
of dendrites and spines. Understanding these signaling events helps to explain the increased
susceptibility of the PFC to stress pathology during adolescence, when dopamine expression is
increased in the PFC, and with advanced age, when the molecular “brakes” on stress signaling are
diminished by loss of phosphodiesterases. These mechanisms have also led to pharmacological
treatments for stress-related disorders, including guanfacine treatment of childhood trauma, and
prazosin treatment of veterans and civilians with post-traumatic stress disorder.
Keywords: prefrontal cortex; stress adolescence; aging; calcium; cAMP; dopamine; norepinephrine
1. Introduction
The prefrontal cortex (PFC) provides “top-down” control of behavior, thought, and emotion.
However, these newly evolved circuits are especially vulnerable to uncontrollable stress, with built-in
mechanisms to rapidly take the PFC “off-line” and switch the brain from a reflective to reflexive state.
The current review summarizes the role of PFC circuits in top-down control, the unique molecular
mechanisms governing PFC synapses that induce this rapid loss of function during stress exposure,
and, with repeated stress, the atrophy of dendrites and spines. Understanding the molecular events
that drive these powerful changes in brain state has direct relevance to the etiology of stress-related
disorders such as depression, post-traumatic stress disorder (PTSD), substance abuse, schizophrenia,
and late onset Alzheimer’s disease (LOAD). These molecular mechanisms also help to explain why
the PFC is so susceptible to stress pathology during adolescence (when catecholamine expression
is increased in the PFC), and with advanced age (when the molecular “brakes” on stress signaling
are diminished). Finally, understanding the molecular basis of the stress response in PFC has led to
pharmacological treatments that are in widespread clinical use, a rare instance of successful translation
from animals to humans.
2. The PFC Circuitry in Primates Serving Top-Down Control
The PFC provides top-down regulation of thought, action, and emotion [1], and has extensive
connections to either promote or inhibit these neural events [2–6]. The PFC expands greatly in primate
evolution, with the ventral and medial PFC (vmPFC) specialized for the regulation of emotion (internal
states), while the more dorsal and lateral regions of the PFC (dlPFC) mediate cognition (external
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states) [2–4,7]. The most rostral, frontal pole serves metacognition, e.g., insight about oneself and
others [8]. These regions all interconnect to provide a holistic mental state, where more newly evolved
rostral and dorsolateral regions can provide top-down regulation of more ancient, caudal structures.
Evidence of “top-down” regulation by rostral and dlPFC–physiological recordings from monkeys
have provided extensive evidence of “top-down” regulation by the dlPFC and rostral PFC circuits.
Early studies found that these areas have the ability to generate neural activity in the absence of
sensory stimulation, e.g., during a working memory task, the foundation of abstract thought [9,10].
This persistent firing during working memory could also be used to guide behavior, e.g., inhibiting
an inappropriate response [11], and to suppress responding to distractors [12]. More recent studies
have shown extensive roles in categorization and abstract rules, top-down control of attention, and
strategic decision-making, e.g., References [12–17]. Recordings from rostral medial PFC circuits have
revealed signatures of high order cognitive capabilities, including social aspects of decision-making
such as “theory of mind,” i.e., understanding the minds of others [18], as well as metacognitive
self-evaluation, i.e., insights about one’s own decisions, in the frontal pole (area 10) [19,20]. These
physiological recordings are consonant with studies of monkeys and patients with lesions to these
regions, which demonstrate deficits in the top-down control of social and emotional behavior (reviewed
in Reference [21]).
Ventral and medial PFC circuits regulate emotion. The ventral (orbital) and medial PFC provide
flexible evaluation of affective information such as reward and punishment [18,22–25]. Although these
regions are often referred to in a unitary fashion as simply “vmPFC,” a more careful examination of
the human imaging data, coupled with the known anatomical connections of this region in nonhuman
primates, indicates important differentiations which likely mediate distinct functional contributions.
The medial PFC includes the cingulate cortices: the anterior cingulate cortex, also known as Brodmann
Area (BA)24, and the cingulate cortex under the genu of the corpus callosum, often called the subgenual
cingulate, or BA25 (Figure 1; numbering scheme of Reference [26]). BA24 and BA25 as well as the
insular cortex are all key parts of a medial circuit that processes the emotional aspects of pain [27,28].
These structures are overactive in neuropathic pain [29], and have been surgically removed to treat
intractable pain [30]. The anterior cingulate also activates with cognitive conflict, e.g., mental errors [31],
emphasizing the mental nature of its function. The anterior cingulate projects to nearby premotor areas,
e.g., BA6d, to influence motor responses such as eye or hand movements (Figure 1). Information also
flows from BA24 and the insular cortex to BA25, which serves as the major visceromotor output for the
PFC (Figure 1). BA25 is of particular interest given its overactivity in depression, and is thus a focus of
deep brain stimulation treatment [32]. This area has extensive projections to limbic areas such as the
amygdala, ventral striatum, and hypothalamus to control emotion and visceral responses [3,33]. This
includes projections to hypothalamus and brainstem centers that coordinate the stress response [34],
consistent with its activity correlating with increased cortisol release in stressed human subjects (see
Table S2 in the Supplement of Reference [35]). BA25 also interconnects with the medial subthalamic
nucleus [36], which, if playing a role similar to that in motor circuits, may provide pervasive inhibition
relevant to symptoms of “mental paralysis,” a hypothesis supported by the antidepressant effects of
subthalamic deep brain stimulation [37].
Anatomical tracing studies in monkeys [38] indicate that dlPFC may be able to regulate BA25
through indirect connections via areas BA10m and BA32 (Figure 1A). Human imaging studies
suggest these connections may be important in regulating stress and depression, as dlPFC functional
connectivity correlates with that of vmPFC BA32 as subjects overcome their response to stress [35], and
as activity in this “medial corridor” is related to a sustained anti-depressant response to deep brain
stimulation [39]. Furthermore, the antidepressant effects of TMS to strengthen the left dlPFC have
been related to its ability to reduce the activity of BA25 [40], supporting the circuit model shown in
Figure 1. Conversely, dlPFC and medial PFC deactivate during uncontrollable stress (Figure 1B), as
described below. The loss of top-down control by the dlPFC and rostral circuits with stress has been of
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special interest, as these newly evolved circuits are especially vulnerable in neuropsychiatric disorders.
Thus, they have been a focus of neurobiological research.
Figure 1. Schematic diagram of prefrontal cortex (PFC) circuits providing top-down regulation of
emotion, and the effects of arousal state on connectivity. (Top): Under non-stress conditions, newly
evolved dorsolateral PFC (dlPFC) and rostral areas (e.g., BA10) project back to anterior (BA24) and
subgenual (BA25) cingulate via BA32 to regulate visceromotor output and emotional response. Note
that these cingulate areas are part of the pathway that mediates the emotional aspects of the pain
response. (Bottom): Under conditions of uncontrollable stress, the connectivity of dlPFC and the rostral
aspect of medial PFC are weakened, and the top-down suppression of BA25 is diminished, promoting
activation of subcortical structures such as the amygdala. Anatomical projections are based on tracing
studies in monkeys [38], but are portrayed on a Brodmann drawing of the human brain to facilitate
translation to human brain imaging results.
3. The Microcircuitry for Generating Top-Down Goals for Regulating Thought, Action,
and Emotion
The work of Goldman-Rakic [41] and of González-Burgos [42,43] has uncovered the microcircuitry
in deep layer III of dlPFC that allows the persistent representation of information in the absence of
sensory stimulation, the neural basis for top-down control. Tract tracing studies of primate dlPFC
in vivo [41] and in slices [42] have shown extensive horizontal connections in deep layer III, the
anatomical basis for extensive recurrent excitation. This research showed that the persistent firing
of neurons across the delay period in a working memory task arises from the recurrent excitation of
pyramidal cells with shared characteristics (Figure 2A). For example, a group of pyramidal cells will
continue to fire across the delay epoch after a spatial cue is presented at a location 90◦ from the fixation
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point, but not other locations. These neurons are able to continue firing without sensory stimulation
due to their recurrent excitatory network connections, as illustrated in Figure 2A. These pyramidal cells
excite each other through glutamatergic NMDAR synapses even after the cue has been extinguished,
thus maintaining the memory of 90◦ across the delay period. Conversely, the spatial tuning of neuronal
firing is refined by lateral inhibition from parvalbumin-containing GABA interneurons, reducing firing
for nonpreferred information [41]. This contrasts with classic circuits in the sensory cortex, where
feedforward inhibition rather than lateral inhibition is the rule. Studies of dlPFC slices were able to
identify GABAergic basket and chandelier cells inhibiting pyramidal cells to produce lateral inhibition,
consistent with the in vivo recordings [43]. These layer III microcircuits have expanded greatly in
primate brain evolution [44], and are the neurons most afflicted in schizophrenia, with loss of dendrites
and spines from pyramidal cells, and compensatory weakening of GABA interneurons [45]. These
pyramidal cells also fill with neurofibrillary tangles and degenerate in Alzheimer’s Disease [46]. It is
not known whether medial and rostral PFC regions also contain recurrent microcircuits, which would
be an important area for future research.
4. The Unique Neurotransmission and Neuromodulation of dlPFC Synapses
The recurrent excitatory synapses on pyramidal cell spines in deep layer III of dlPFC have
characteristics that render them especially vulnerable to stress and atrophy, including important roles of
calcium signaling (Figure 2B). These characteristics include unusual glutamate neurotransmission and
neuromodulatory actions, where cAMP-calcium signaling weakens rather than strengthens network
connectivity, e.g., during uncontrollable stress exposure.
Neurotransmission classic glutamatergic circuits, e.g., in V1, rely heavily on AMPA receptor
(AMPAR) stimulation, which provides the permissive excitation for NMDA receptor (NMDAR actions
during neuroplasticity [47]. These circuits have few NMDAR with NR2B subunits in the adult, although
they predominate early in development [48]. In contrast, dlPFC delay cells have only a minor reliance
on AMPAR, and are greatly reliant on NMDAR-NR2B, which are found exclusively in the post-synaptic
density and not at extra-synaptic locations [49], and are concentrated in pyramidal cell synapses [50].
Layer III reliance on NMDAR is also seen in human dlPFC, where pyramidal cells express a greater
NMDAR than AMPAR message, while the converse is true in layer V [51]. Layer III delay cells also do
not rely on AMPAR to permit NMDAR actions. Instead this permissive role is played by cholinergic
stimulation [52], which occurs during waking but not deep sleep, contributing to conscious cortical
activity. The reliance of layer III dlPFC circuits on NMDAR-NR2B is particularly interesting, as these
receptors close slowly and allow a large amount of calcium into the post-synaptic spine (schematically
shown in Figure 2B), and calcium plays a major neuromodulatory role in determining the strength of
these network connections through powerful neuromodulatory actions.
Neuromodulation layer III dlPFC pyramidal cells also have unique neuromodulatory influences,
where calcium-cAMP signaling weakens connections by opening potassium (K+) channels on spines.
We have proposed that calcium plays a critical, negative feedback role in these recurrent excitatory
circuits where there is little feedback inhibition, and thus may prevent excessive neuronal firing [6]. We
see evidence of feedforward calcium-cAMP signaling in spines near K+ channels that are regulated by
calcium itself (e.g., SK channels [53]), or by cAMP-PKA signaling (HCN and KCNQ channels) [6,54,55].
As schematized in Figure 2B, layer III dlPFC spines have extensive smooth endoplasmic reticulum
(SER), which stores and releases calcium into the cytosol (the SER is called the spine apparatus where it
extends and elaborates in the spine). In layer III of dlPFC, the spine apparatus is the focus of extensive
cAMP-signaling machinery [54,56–58], consistent with feedforward calcium-cAMP signaling. Thus,
calcium release can drive the production of cAMP, which activates PKA, which drives further calcium
release [55]. Feedforward signaling promotes a rapid build-up of calcium-cAMP-PKA activity to
open K+ channels and reduce firing. These detrimental actions are prevented under optimal arousal
conditions by NE stimulation of α2A-AR [54] and NAAG/glutamate stimulation of mGluR3 [59].
These receptors are concentrated on layer III dlPFC post-synaptic spines where they inhibit cAMP
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signaling, close K+ channels, and enhance firing. Under healthy conditions, PKA also activates the
phosphodiesterases (e.g., PDE4A) to catabolize cAMP and thus provide brakes on cAMP-calcium
signaling after it has been activated. However, this negative feedback is lost with age and with
inflammation, as described below.
Figure 2. Recurrent excitation in deep layer III of the dlPFC. (A) Schematic drawing of clusters of
pyramidal cells in deep layer III of dlPFC with shared characteristics that excite each other through
extensive recurrent excitatory glutamatergic connections to keep information “in mind” in the absence of
sensory stimulation. (B) A glutamate synapse on a pyramidal cell spine in deep layer III of dlPFC. These
synapses depend on NMDAR stimulation, and have extensive elaboration of the calcium-containing
smooth endoplasmic reticulum (SER) “spine apparatus” in the spine, where there is evidence of
feedforward calcium-cAMP signaling, which can open HCN and KCNQ channels to reduce firing. This
process is held in check by the phosphodiesterases (PDE4), which catabolize cAMP and are anchored to
the spine apparatus by DISC1 [56].
5. Stress Rapidly Takes PFC Circuits “Offline”
Even mild uncontrollable stress increases catecholamine release in the PFC to drive feedforward
calcium-cAMP-K+ signaling and rapidly take the PFC “off-line.” These effects were initially observed
in rodent medial PFC, but similar mechanisms have been documented in the primate dlPFC. Due to
the early work of Steven Maier, it has long been appreciated that it is the uncontrollable aspect of the
stressor that initiates the stress response and leads to cognitive deficits, e.g., Reference [60], and an
acute, uncontrollable stress can induce a distracted behavior profile [61]. In contrast, a controllable
stressor does not induce dopamine release in the PFC [62]. Biochemical studies documented increased
catecholamine release in the rat medial PFC in response to mild uncontrollable stress [63–65]. High
levels of dopamine (DA) D1R and norepinephrine (NE) α1-AR stimulation in the PFC impair working
memory performance by driving feedforward calcium-cAMP-K+ signaling [66–69], as schematically
illustrated in Figure 3. Both α1R (Figure 3A; [70]) and D1R [57,71] have been localized on dendritic
spines in layer III of primate dlPFC, and their activation drives feedforward calcium-cAMP signaling
(Figure 3B). Thus, stimulation of α1R or D1R reduces the task-related firing of dlPFC neurons in
monkeys performing a working memory task, while blockade or closure of HCN channels rescues
firing [68–70,72]. These stress signaling pathways may interact with neuroinflammation, which may
remove the brakes on the stress response by inhibiting PDE4s, as illustrated in Figure 3B. Specifically,
in vitro studies have shown that MK2 inflammatory signaling can inhibit PDE4 regulation of the stress
response by un-anchoring PDE4s from their correct location and preventing PKA activation of PDE4
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negative feedback on the cAMP-PKA response [73,74]. Similar actions in PFC pyramidal cells would
accelerate and prolong the response to uncontrollable stress.
Figure 3. Uncontrollable stress weakens PFC synaptic connectivity through α1-AR and D1R drive
of calcium-cAMP-K+ signaling. (A) DAB immunolabeling shows that α1-AR (red arrowheads) are
localized on dendritic spines in layer III dlPFC near the calcium-containing SER spine apparatus,
pseudocolored in pink. The synapse is indicated by black arrows. Sp = spine, Ax = axon terminal,
Mit =mitochondrion. Figure 3A adapted from Reference [70]. (B) Schematic drawing showing that
uncontrollable stress induces cortisol and catecholamine release; high levels of NE and DA activate
α1-AR and D1R, which drive feedforward, calcium-cAMP opening of HCN and KCNQ channels to
reduce cell firing. With sustained stress exposure, calcium overload of mitochondria may induce
inflammatory responses such as MK2 signaling, which inhibits PDE4 and thus removes the “brakes”
on stress signaling pathways, ultimately leading to spine loss.
In contrast to the PFC, high levels of catecholamine strengthen the emotional responses of the
amygdala and the habitual responding of the striatum [75–77], and can enhance the functioning of the
primary sensory cortex [78]. Thus, high levels of catecholamine released during uncontrollable stress
switch the brain from a slow, thoughtful, reflective PFC-regulated state to a more reactive, reflexive
state that may be advantageous during danger, but would be detrimental when more thoughtful
solutions are needed [79].
The detrimental effects of stress-induced catecholamine release are exacerbated by glucocorticoids
(cortisol in primates, corticosterone in rodents). Cortisol blocks extraneuronal catecholamine
transporters, and thus expands the effects of catecholamines [80]. Corticosterone has been shown to
exacerbate the catecholamine response in rat brain, both in impairing PFC working memory [81] and
in fortifying the amygdala’s enhanced consolidation of emotional memories [82].
Stress-induced PFC dysfunction has now been documented in rats, monkeys, and humans,
indicating that this is a highly conserved response. For example, exposure to violent images impairs
performance of a working memory task and reduces the activity of the dlPFC in humans [83], and
the degree of impairment is related to COMT genotype, with greater catecholamines associated with
greater dlPFC dysfunction [84]. Functional brain imaging has also been used to assess the dynamic
changes in PFC and cortisol release in response to viewing violent images. This study showed that
cortisol release correlated with activation of a caudal region that included BA25, while the suppression
of the cortisol response was related to activity in the vmPFC (e.g., BA32), which initially deactivated
with stress but reactivated in correlation with coping [35]. Importantly, the reactivation of BA32
correlated with its connectivity with dlPFC, indicating a network of PFC subregions regulating the
stress response in humans. It would be helpful to extend this approach to the nonhuman primate,
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for example to determine the molecular mechanisms governing medial PFC (BA32, BA24, BA25)
connectivity and neuronal firing.
6. Architectural Changes with Chronic Stress
Chronic stress exposure leads to additional architectural changes, including spine loss and
dendritic atrophy from the medial PFC in rodents, and PFC gray matter loss seen with structural
imaging in humans. Dendritic atrophy induced by chronic stress was originally observed in the
rat hippocampus [85], but has been found to be even more sensitive in the rat medial PFC [86–90].
Dendritic changes are circuit-specific, where PFC pyramidal cells projecting to entorhinal cortex
atrophy with chronic stress, while those projecting to and activating the basolateral amygdala show
dendritic expansion [89]. The dendrites of amygdala neurons also expand [91], thus strengthening more
primitive emotional circuits in concert with the loss of PFC cortical–cortical connections. Importantly,
the loss of spines and dendrites in medial PFC correlates with impaired PFC cognitive functioning
on working memory [92,93] and attention-shifting [87] tasks, demonstrating that these architectural
changes have great functional relevance. Dendritic integrity is restored with a prolonged period of
non-stress following the chronic stress, at least in young animals [94]. Antidepressant treatments also
induce spinogenesis in medial PFC [90], and longitudinal in vivo imaging has revealed the retraction
and subsequent recovery of spines with antidepressant treatment, (although the return of PFC spines
was needed for the long-term maintenance of antidepressant effects on motivated escape behavior but
not for their initial induction [95]).
Parallel findings have been seen in human subjects with brain imaging, where exposure to
repeated stressors is associated with reduced gray matter in the rostral PFC areas that provide
top-down control [96]. Sustained stress also has been shown to induce weaker functional connectivity
with the dlPFC that correlates with impaired set-shifting attentional regulation that returns to normal
after the stress is over [97]. Reduced functional connectivity with PFC is also seen in human subjects
with severe childhood abuse [98]. Thus, there are strong parallels between animal and human studies.
It is important to understand the molecular signaling events that cause loss of PFC connections so
that we can develop informed strategies for treatment. The loss of dendritic spines with chronic stress
can be prevented by daily treatment with agents such as guanfacine that inhibit PKA signaling [93], or
chelerythrine, which inhibits PKC signaling [92]. Sustained high levels of feedforward, calcium-PKC
cAMP-PKA signaling may cause dendritic atrophy through a variety of downstream mechanisms. For
example, excessive calcium leak from the SER can cause calcium overload of mitochondria, initiating
inflammatory cascades, and sustained high levels of PKC activity. High levels of PKC activity can
phosphorylate MARCKS (myristoylated alanine-rich C-kinase substrate), which detaches the actin
cytoskeleton from the plasma membrane, causing spine collapse [99]. It is also noteworthy that PKC
activates GSK3β signaling, and both PKC and GSK3β are inhibited by anti-manic medications that
rescue PFC gray matter in patients [100,101]. Interestingly, the rapidly-acting antidepressant, ketamine,
induces spine formation through activation of mTOR and inhibition of GSK3β signaling [102]. Thus,
this is an exciting arena of current research with immediate clinical relevance.
7. Females Have a Greater Stress Response Than Males
Understanding the molecular basis of the stress response in PFC may help to explain the
prominent sex differences in the stress response in animals and humans. Female rats with circulating
estrogen have a greater stress response, e.g., due to greater promotion of noradrenergic [103], and
dopaminergic [104] actions. A parallel relationship can be seen in humans, where women have
reduced expression of COMT [105], and thus less catabolism of catecholamines. Female rats with
circulating estrogen have greater stress-induced PFC dysfunction than males (but outperform males
when they are ovariectomized) [106,107]. Female rats with circulating estrogen also have a greater
architectural response to chronic stress, with increased dendritic expansion in PFC neurons projecting
to amygdala [108].
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These neurobiological findings may help to explain the increased prevalence of depression and
PTSD in women [109–112]. However, cultural factors also likely play an important role, as women are
often given less control in society, and are even encouraged to be helpless, factors that would increase
the stress response.
8. Increased Susceptibility to Stress-Induced PFC Dysfunction During Adolescence
The neurobiology of stress can also help to explain differences in top-down control over the
lifespan. Adolescence is a time of biological susceptibility, for example due to hormonal changes and
to pruning of dendritic spines in cortex [113]. Adolescents are especially vulnerable to emotional
stress [114,115], with an increased risk of issues such as addiction [116]. Adolescence is also a time of
increased DA signaling in the PFC. There is an increased DA innervation of layer III in the macaque
dlPFC during adolescence [117,118], and increased expression of D1R on rat prelimbic PFC neurons
that project to the nucleus accumbens [119]. Thus, the stress response in PFC may be magnified during
adolescence, and may lower the threshold for high-risk behaviors and poor decision-making under
emotionally stressful conditions.
9. Increased Vulnerability During Aging Loss of Brakes on Stress Signaling Pathways
The stress response is also magnified with advanced age, due, at least in part, to the loss of
regulation at the intracellular and circuit levels. The PFC atrophies with advancing age, with loss
of spines from the layer III microcircuits that generate working memory [120]. For example, cortisol
levels are higher in elderly individuals, especially in older women [121], and this may involve weaker
PFC inhibition of the HPA axis with age. Aging may also alter the stress response through molecular
changes. Although there is a decline in PFC DA with advancing age [122], there is also a loss of
PDE4 expression from spines, the enzymes that normally catabolize cAMP and hold stress signaling
events in check [58]. These data suggest that there may be a higher threshold to activate the stress
response in aged individuals, but that once stress signaling is initiated, it would be more prolonged.
Increased stress calcium-cAMP signaling in the association cortex may have many consequences that
would increase risk of pathology, including mitochondrial abnormalities [123,124], spine loss [120],
and phosphorylation of tau [58,125], all of which are seen in layer III of aged monkey dlPFC. Stress
is now recognized as a risk factor for late onset AD, with stressful events linked to higher disease
onset decades later [126–128]. Indeed, recent evidence shows that increased cortisol is a risk factor for
disease [129]. The more prominent stress response in women may also help to explain the increased
prevalence of late onset AD in women compared to men [130,131], especially as AD pathology begins
decades before disease onset, at a time when estrogen mechanisms could exacerbate the biological
response to stress.
10. Successful Translation to Clinical Treatments
Pharmacological manipulations can protect dlPFC connectivity by inhibiting stress-induced
calcium-cAMP-K+ signaling and maintaining synaptic efficacy. It is possible that treatments such
as GCPII inhibitors that enhance stimulation of mGluR3 may be helpful in the future. However,
two treatments that have been helpful in animals—the α2A-AR agonist guanfacine, and the α1-AR
antagonist prazosin—are now in widespread clinical use for treating stress-related disorders.
The α2A-AR agonist, guanfacine, prevents PFC dysfunction caused by either acute [132] or
chronic [93] stress, including rescuing spine loss from PFC neurons (Figure 4A). Studies in monkeys
have shown that guanfacine acts by inhibiting cAMP-opening of HCN channels on spines (Figure 4B),
strengthening connectivity, persistent firing, and working memory abilities [54]. α2A-AR stimulation
also has anti-inflammatory actions, e.g., deactivation of microglia [133]. Based on research in animals,
extended release guanfacine (Intuniv®, Shire Takada Pharmaceuticals) is now in widespread use
for treating ADHD, but is also being used to treat traumatized children [134], including those with
oppositional behaviors often arising from maltreatment [135].
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Figure 4. The α2A-AR agonist guanfacine can strengthen PFC connectivity and protect the PFC from
stress. (A) Chronic restraint stress causes loss of apical distal spines from layer II/III prelimbic PFC
pyramidal cells in rats. Daily pre-treatment with guanfacine prevents spine loss and protects working
memory function. CN = control, ST = chronic restraint stress, VEH = vehicle, GFC = guanfacine.
* or ** significantly different from vehicle control; † or †† significantly different from vehicle stress at
p < 0.05 or 0.01 levels, respectively. Figure 4A adapted from [93]. (B) Schematic diagram showing that
guanfacine stimulation of α2A-AR on spines strengthens connectivity and protects PFC from stress by
inhibiting cAMP-calcium-K+ channel signaling.
Theα1-AR antagonist prazosin is in widespread use for treating PTSD in adults [136]. As described
above, stimulation of α1-AR is a key part of stress-induced PFC dysfunction, and also contributes to
the strengthening of amygdala during conditions of high NE release. Prazosin has been found to be
helpful in treating combat-related PTSD, including daytime hyperarousal symptoms and improving
global clinical status [137]. It is noteworthy that the hyperarousal subscale used to rate PTSD symptoms
includes many PFC-related deficits (e.g., impaired concentration, impaired regulation of mood and
aggression), in addition to alterations in sleep–wakefulness. Another double-blind placebo-controlled
study of civilians addressed whether daytime-only prazosin treatment reduced PTSD symptoms
during a trauma-relevant stress paradigm that measured PFC-related executive function through use of
an emotional version of the Stroop interference task [138]. Prazosin simultaneously reduced subjective
stress and improved cognitive performance [138]. High doses of prazosin may also be helpful in the
treatment of daytime PTSD symptoms, when levels of NE release are higher [139]. Prazosin may
also be helpful in reducing substance abuse, which is common in PTSD. Initial trials suggest that
prazosin can reduce cravings for and use of alcohol in patients with PTSD [140], as well as reducing
stress-induced craving for alcohol in subjects without PTSD [141].
11. Outstanding Questions and Future Directions
Although there has been remarkable progress in this field, with many similarities bridging across
rodent and both nonhuman and human primate species, there are still many outstanding questions.
Greater understanding of circuit specific changes with stress exposure is an important arena for future
research, but challenging to extend from rodent to primate. The rodent medial PFC represents many
primordial features of the PFC, and projections are organized in gradients rather than in discrete
subregions [142]. The great expansion of the PFC in primates suggests that these processes elaborate
and differentiate in brain evolution, and yet we know very little about the molecular regulation of the
primate medial PFC, including the subgenual cingulate BA25 that is powerfully positioned to activate
the stress response. Future research may find distinct molecular regulation of PFC subcircuits that may
help us target therapies more effectively.
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Abstract: One of the most exciting translational prospects for brain imaging research is the potential
use of functional magnetic resonance imaging (fMRI) ‘biomarkers’ to predict an individual’s risk of
developing a neuropsychiatric disorder or the likelihood of responding to a particular intervention.
This proposal depends critically on reliable measurements at the level of the individual. Several
previous studies have reported relatively poor reliability of amygdala activation during emotional
face processing, a key putative fMRI ‘biomarker’. However, the reliability of amygdala connectivity
measures is much less well understood. Here, we assessed the reliability of task-modulated coupling
between three seed regions (left and right amygdala and the subgenual anterior cingulate cortex) and
the dorsomedial frontal/cingulate cortex (DMFC), measured using a psychophysiological interaction
analysis in 29 healthy individuals scanned approximately two weeks apart. We performed two runs on
each day of three different emotional face-processing tasks: emotion identification, emotion matching,
and gender classification. We tested both between-day reliability and within-day (between-run)
reliability. We found good-to-excellent within-subject reliability of amygdala–DMFC coupling,
both between days (in two tasks), and within day (in one task). This suggests that disorder-relevant
regional coupling may be sufficiently reliable to be used as a predictor of treatment response or
clinical risk in future clinical studies.
Keywords: reliability; functional magnetic resonance imaging (fMRI); connectivity; emotion
processing; amygdala; prefrontal cortex
1. Introduction
Measurement reliability is essential when translating research findings to clinical practice.
Any study that describes brain function associated with risk or resilience to developing a
neuropsychiatric disorder or with good or poor treatment outcome following treatment, rests on the
assumption that the measurement has adequate reliability. For example, if a study finds that depressed
patients who respond to fluoxetine have higher subgenual anterior cingulate cortex (sgACC) activation
than non-responders, assessed with functional magnetic resonance imaging (fMRI), this could only
be of clinical use if the measurement of each patient’s sgACC activation were reliable, such that the
clinical prognosis derived from the scan of an individual patient was consistent over time. Only then
could brain activation (in the sgACC in this example) be tested as a putative fMRI ‘biomarker’ to
predict clinical response.
Recently, we conducted a test–retest reliability analysis of activation for three commonly proposed
biomarkers for depression, the left and right amygdala and the sgACC, measuring fMRI activation
during three different emotional face paradigms [1]. Discouragingly, we found consistently poor
reliability across all three tasks, both across days (two weeks apart) and within the scan session (two
runs 15 minutes apart). This replicated some previous poor reliability findings in the amygdala [2],
although others have produced more optimistic estimates [3,4].
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Several recent studies have suggested various measures of functional connectivity—i.e.,
the covariation of fMRI signal between two or more brain regions over time—as putative ‘biomarkers’.
For example, studies have reported a relationship between functional connectivity and ketamine
response in depression [5], antipsychotic response in schizophrenia [6], response to brain stimulation
(repetitive transcranial magnetic stimulation, rTMS) in depression [7], and cognitive behavioural
therapy (CBT) response in anxiety [8]. However, the reliability of these connectivity measures has not
been comprehensively tested. In this paper, we therefore explore the reliability of a specific connectivity
measure in the same dataset we analysed previously.
The example we focus on in this manuscript is a cortical–subcortical circuit that may play an
important role in threat processing [9], a behaviour with transdiagnostic relevance across affective
and anxiety disorders [10]. This circuit involves a region that encompasses areas of the dorsomedial
frontal/cingulate (DMFC) cortex, which shows increased connectivity with the amygdala during both
induced and pathological anxiety [9,11]. A large body of evidence in humans and rodents implicates the
extended amygdala in aversive processing [12–15], a key cognitive mechanism in anxiety disorders [16].
However, the amygdala functions in concert with more frontal (‘higher-order’) neural regions. There is
substantial evidence suggesting that anxiety-related processes, in fact, reflect a bidirectional modulation
between amygdala and medial prefrontal circuitry, in particular the DMFC [16,17], which itself has
been shown to be overactive in pathological anxiety [18]. Nonhuman primate research has found that
amygdala–DMFC coupling is involved in fear learning and other anxiety-related behaviours [16,19,20].
Moreover, this coupling can be down-regulated by attentional instruction, suggesting that psychological
therapy might function via similar neural mechanisms [21]. Therefore, DMFC–amygdala coupling is a
crucial potential biomarker of anxiety and, potentially, also of therapeutic response [16,22].
We built on our previous work by examining the test–retest reliability of task-modulated covariation
of fMRI signal between our initial ‘biomarker’ regions (the left and right amygdala and the sgACC)
and the DMFC target region derived from a circuit implicated in anxiety [9]. Specifically, we tested
whether the psychophysiological interaction (PPI, i.e., the modulation of coupling by a psychological
factor, in this case, processing emotional faces) between the amygdalae and sgACC seed regions and
the DMFC target was reliable within an individual. We examined reliability across scan days two
weeks apart, as well as within the same scanning session across two runs of the task.
2. Materials and Methods
This re-analysis was performed on a previously acquired dataset; the initial fMRI analysis was
described in more detail in our earlier publication [1]. In summary, we extended the initial task-related
activation analysis to encompass connectivity. The key details are re-stated below for completeness.
2.1. Participants
We recruited healthy controls (N = 29, age range 18–40, mean age 26 (SD = 6.24), 10 male)
through the UCL Institute of Cognitive Neuroscience and Department of Psychology subject databases.
We included only right-handed fluent English speakers (meeting standard MRI safety criteria) without
a recent (six-week) history of illegal substance use or any history of neurological or psychiatric disorders
(the latter was screened by using the Mini International Neuropsychiatric Interview, version 5.0.0 [23]).
We initially recruited 35 participants: 4 of them did not attend their follow-up fMRI scan, and data loss
occurred for 2 of them.
The study was approved by the UCL Departmental Research Ethics Committee (ID: fMRI/2013/005).
The participants provided informed consent in accordance with the Helsinki Declaration and were
compensated £30 for taking part.
2.2. Protocol
Our experimental protocol involved three separate testing days. The participants first attended a
screening session at the UCL Institute of Cognitive Neuroscience to determine eligibility and complete
67
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practice versions of the fMRI tasks. The second and third sessions took place at the Birkbeck-UCL
Centre for Neuroimaging 9–21 days later (mean 14.33, SD = 2.10). On each of these scan sessions,
the participants performed three tasks twice in the scanner (order counterbalanced between participants,
with order kept constant within each participant), using an MR-compatible button box.
The tasks have been described in detail previously [1] (see Table 1 for summary). Briefly,
the emotional identification (EI) task involved explicitly judging the emotion (happy, fearful, or neutral)
of sixty face stimuli (task adapted from a separate study [11]). Two participants were excluded from
this task analysis because of a high proportion of non-responses (>20 trials). The face matching (FM)
task [24] consisted of 30 trials (split into five blocks) of either shape matching (18 trials, 3 blocks)
or face matching (12 trials, 2 blocks). In both cases, the participants were instructed to match a
centrally presented emotional face or centrally presented shape (both displayed for 5 s) with one of two
alternatives displayed at the bottom (two test faces or two test shapes). No participants were excluded
because of poor task performance. In the gender classification (GC) task [25], the participants were
instructed to classify the gender of emotional faces (displayed for 2 seconds, happy, fearful, or neutral
faces, separated into blocks; equal proportion of male and female faces, displayed in a random order).
Each emotion block occurred 4 times per run (12 blocks total, 8 stimuli per block). One participant
(with performance worse than chance) was excluded from this analysis.











Task duration 4:03 5:55 6:24
Task design Event-related Blocked Blocked
Regressors of interest Happy; fearful; neutral Faces; shapes Happy; fearful; neutral
Instruction Explicit (match emotion) Implicit (match face orshape to test stimuli) Implicit (classify gender of face)
Regressors of no interest 6 movement parameters 6 movement parameters 6 movement parameters
+ errors
Contrast Faces > fixation Faces > shapes Faces > fixation
Design and analysis characteristics of the three emotional processing tasks used.
2.3. Image Acquisition and Analysis
fMRI image acquisition has been described in detail previously [1]. Briefly, gradient-echo
T2*-weighted images were acquired using a Siemens Avanto 1.5 Tesla MRI scanner employing a
32-channel head coil (this head coil improves signal-to-noise ratio up to 3.5 times compared to standard
8- or 12-channel coils [26]). We collected 36 slices per volume, slice gap 1 mm (2 mm slices; 50% distance
factor) (see Table 1). The echo planar imaging (EPI) sequence was highly optimised to minimise ventral
prefrontal cortex dropout (for extensive sequence details, see previous work [1,25,27]): echo time
= 50 ms, repetition time/slice = 87 ms, slice thickness = 2 mm, in-plane resolution = 2 × 2 mm.
One fieldmap per participant per day was acquired using identical parameters to the EPI scans; for each
participant, we also acquired one magnetization-prepared rapid gradient-echo T1-weighted 1 mm
isotropic anatomical scan.
We used Statistical Parametric Mapping (SPM12; Wellcome Trust Centre for Neuroimaging,
London, UK, www.fil.ion.uck.ac.uk/spm) in Matlab R2015a (for the initial region-of-interest (ROI)-based
analyses) and Matlab R2018a (for the PPI analyses). All data were slice-time corrected to account for the
long repetition time (TR) (3.132 seconds). Preprocessing was identical to that described previously [1].
2.4. Psychophysiological Interaction Analysis
We used these data to conduct a PPI analysis, a functional connectivity method commonly
applied to task-based fMRI data. This analysis reveals how experimental task conditions modulate
the covariation in signal between a ‘seed’ region and the rest of the brain [28]. This is in contrast to
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the so-called “resting-state” functional connectivity, which examines such covariation independent of
any specific cognitive demands. Therefore, PPI analysis can reveal which voxels in the brain exhibit
different covariation with the seed region as a function of task condition [28] (in our study: for GC and
EI, faces > fixation cross; for FM, faces > shapes). Note that PPI analyses do not provide any inferences
about the directionality of this relationship or whether any connections are direct or indirect.
We followed the steps of a PPI analysis outlined by O’Reilly and colleagues [28]. We first
defined anatomical masks for our three seed regions (PickAtlas left and right amygdala masks and a
custom-made sgACC mask described previously [1]; note the sgACC mask was bilateral, to adhere with
typical practice in the field and maintain comparability between these and our previous results [1]) and
extracted representative time courses for each seed region. One subject did not show any suprathreshold
activation in the left amygdala seed on any of the tasks; for this subject, we analysed only the right
amygdala and the sgACC. Next, we computed the PPI time course (a single regressor describing
the interaction between the time course of each region and the time course of each task). Finally,
we entered this interaction regressor into a general linear model which included the physiological
and psychological time courses as covariates. All models also included six movement regressors of
no interest, and for the gender classification task, an error regressor only in those participants who
made errors. For each task, we constructed parameter estimate images for the primary contrast of
interest (for gender classification and emotion identification, faces > fixation cross, the implicit baseline;
for emotion matching, faces > shapes). The results (voxels where activation was significantly explained
by the interaction between seed and task time course) therefore describe only those voxels where
the variance explained was over and above (1) the physiological covariation between each voxel and
the seed region, and (2) the haemodynamic response function (HRF)-convolved time course of the
task [28].
We performed a PPI analysis for each region (N = 3) and each task (N = 3). We took an a priori
ROI approach to the analysis. Our a priori ROI was defined as the more rostral of two functionally
defined ROIs created from clusters emerging from a whole-brain threat-by-valence interaction during
a threat of shock task [11] and included, primarily, areas of DMFC (see Figure 1A; see Figure 1B,C for
amygdala and sgACC masks, respectively). Our ROI analysis approach proceeded in much the same
way as the ROI analyses in our previous paper, but now the extracted betas represented the modulation
of covariance between the ROI and the seed by the task, rather than activation within the ROI.
Across an average of all four runs of each task (two on each day), we conducted one-way t-tests to
verify there was a significant PPI effect between these regions. We then selected the regions showing a
significant effect to perform reliability testing. We also tested for effects of day, run, and the interaction
between day and run, using an analysis of variance on each ROI for each task.
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Figure 1. A priori ROIs and whole-brain PPI connectivity averaged across all runs and scan days.
Figure A depicts the DMFC ROI used as a target region in the PPI analysis (A). Figure B,C depict
the three seed regions: the left and right amygdala (B) and the subgenual anterior cingulate cortex
(C). D,H depict results from seed regions showing significant PPI effects in the DMFC cortex ROI.
Increases in whole-brain connectivity (positive PPI contrast) were observed during the EI task for the
left amygdala (D), right amygdala (E), and subgenual anterior cingulate cortex (F) seeds. Decreases in
whole-brain PPI connectivity (negative PPI contrast) were observed during the GC task for the left
amygdala (G) and right amygdala (H) seeds. For illustrative purposes only, images were thresholded
at p < 0.001 (uncorrected), and the colour bars indicate t-values. The inverse PPI contrast is displayed
for the GC task (G,H) because mean PPI connectivity with the DMFC ROI was significantly negative
(see Figure 2).
2.5. Reliability Testing
To quantify within-subject reliability, we performed intraclass correlation coefficient (ICC) analyses
on the PPI results, using the Statistical Package for the Social Sciences 22 (http://www.ibm.com/analytics/
us/en/technology/spss/). The ICC enabled us to quantify the stability of measurement across each fMRI
session [29] and is usually interpreted as a ratio of between-subjects to within-subjects variance [30]
(an ICC = 1.0 would indicate perfect agreement between test and retest fMRI sessions). For each seed
region (left and right amygdala; sgACC), we calculated five ICCs: three between-day ICCs (averaged
across both runs, as well as separately for the first and second runs) and two within-day ICCs (between
the two runs, separately for each day).
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We employed a two-way mixed effects ICC [31], defined as:
ICC(3,1) = BMS - EMS/BMS + (k - 1)*EMS
This form of the ICC has three important characteristics: it assumes the effect of measure (scanner)
to be fixed, the effect of participant to be random, and tests for “consistency” (rather than “absolute”
agreement) between sessions. We report average measures (rather than single measures) ICCs.
We adhered to a conventional interpretation of ICCs: ICC < 0.4 was interpreted as poor reliability;
ICC = 0.4–0.75 as moderate-to-good reliability; ICC > 0.75 as excellent reliability [2,32]. We also report
p-values and 95% confidence intervals obtained from an F-test against the null hypothesis.
2.6. Power Analysis
Our power analysis was computed for the original reliability dataset. To achieve 80% power to
detect a moderate-to-large effect size (correlation r = 0.5, which we chose as a clinically meaningful
degree of reliability) at our specified alpha (0.05, two-tailed), we required 26 participants [1].
3. Results
3.1. PPI Analysis
We first analysed the overall PPI effects (collapsing across day and run); we report average PPI
effect size (Cohen’s d, or standardised mean difference, averaged across all voxels within the DMFC
ROI) for each task and region. For the FM task [24], there was no significant (p < 0.05) PPI effect
between any of our seed regions and the DMFC ROI (all p > 0.2, Figure 2B; left amygdala: d = −0.233;
right amygdala: d = −0.088; sgACC: d = 0.162). Therefore, the FM task was not analysed further.
For the EI task, the average PPI effect for all three seed regions was significant (all p < 0.002,
Figure 2A; left amygdala: d = 0.966; right amygdala: d = 0.726; sgACC: d = 1.09). For the GC task,
the average PPI effect for the sgACC was non-significant (p > 0.1), and, therefore, this seed was not
analysed further. The GC task PPI effect for both left and right amygdala was significant (both p < 0.003)
(Figure 2C; left amygdala: d = −0.657; right amygdala: d = −0.624; sgACC: d = −0.162). It is notable
that one of the tasks (EI) evoked considerably more robust PPI effects, both within the DMFC ROI
(Figure 2) and across the entire brain (see Figure 1).
The participants showed very high accuracy in both of the tasks analysed: for the EI task, over 91%
of button presses were accurate (SD = 8.06); for the GC task, over 94% of button presses were accurate
(SD = 6.33). There was no association between PPI activation and accuracy on the EI (sgACC: r = 0.194,
p = 0.332; left amygdala: r = 0.247, p = 0.225; right amygdala: r = 0.249, p = 0.210) or GC task
(left amygdala: r = 0.172, p = 0.382; right amygdala: r = 0.291, p = 0.126).
For the seed regions resulting in a significant DMFC PPI effect, we conducted ANOVAs, testing
for effects of day, run, and the interaction between day and run. There were no significant main
effects of day or run for either task, nor any significant interaction between day and run in the EI task,
for either the amygdala or the sgACC. However, both regions tested for the GC task (left and right
amygdala) showed a day-by-run interaction (left amygdala: F(1,27) = 7.12, p = 0.013; right amygdala:
F(1,28) = 6.63, p = 0.016), such that activation decreased from run 1 to run 2 on day 1, but increased from
run 1 to run 2 on day 2 (see Figure 2C).
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Figure 2. Psychophysiological interaction (PPI) parameter estimates for each task between the seed
regions and the dorsomedial frontal/cingulate (DMFC) cortex region of interest. Data marked with
“x” (as opposed to those marked with a filled circle) indicate runs that were not significantly different
from zero (and therefore were not analysed further). Horizontal lines in the box plots indicate the
mean (darkest line), standard deviation, and 95% confidence interval. A: Emotion identification
(EI) task; B: Face matching (FM) task (not analysed further, as the average PPI parameter estimates
were not significantly different from zero); C: Gender classification (GC) task (the subgenual anterior
cingulate cortex (sgACC) seed was not analysed further, as the average PPI parameter estimate
was not significantly different from zero). ROI: region of interest; LAmyg: left amygdala; RAmyg:
right amygdala.
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3.2. Reliability
We performed ICC analyses to test the within-subject reliability of the PPI effect, across days
and runs (two-way fixed effects mixed ICCs; testing for consistency rather than absolute agreement).
Table 2 details all reliability statistics computed; scatter plots illustrating the average between-day
reliability for the amygdala seed regions are presented in Figure 3.
Table 2. Results from intraclass correlation coefficient (ICC) analysis of PPI for the EI and GC tasks,
extracted from the DMFC region of interest.
Task Reliability LAmyg ICC (95% CI) p-value RAmyg ICC (95% CI) p-value sgACC ICC (95% CI) p-value
EI Between-day (both runs) 0.704 (0.340 to 0.867)* 0.002 0.738 (0.427 to 0.881)* 0.001 0.121 (−0.928 to 0.600) 0.372
Between-day (run 1) 0.585 (0.074 to 0.814)* 0.016 0.765 (0.485 to 0.893)* <0.001 0.167 (−0.828 to 0.620) 0.323
Between-day (run 2) 0.573 (0.047 to 0.808) * 0.019 0.555 (0.008 to 0.801)* 0.024 0.017 (−1.158 to 0.552) 0.483
Within-day (day 1) 0.652 (0.224 to 0.844)* 0.005 0.832 (0.626 to 0.925)* <0.001 0.314 (−0.504 to 0.688) 0.171
Within-day (day 2) 0.768 (0.482 to 0.896)* <0.001 0.699 (0.339 to 0.863)* 0.002 0.408 (0.299 to 0.730)* 0.094
GC Between-day (both runs) 0.442 (−0.206 to 0.742)* 0.068 0.627 (0.206 to 0.825)* 0.006 Not analysed
Between-day (run 1) 0.071 (−1.01 to 0.570) 0.425 0.579 (0.103 to 0.802)* 0.013 Not analysed
Between-day (run 2) 0.493 (−0.095 to 0.765)* 0.042 0.326 (−0.435 to 0.684) 0.151 Not analysed
Within-day (day 1) 0.143 (−0.852 to 0.603) 0.346 0.146 (−0.818 to 0.599) 0.339 Not analysed
Within-day (day 2) 0.171 (−0.792 to 0.616) 0.315 −0.319 (−1.810 to0.381) 0.766 Not analysed
ICCs, their 95% confidence intervals (CI) and associated p-values are presented for each seed region analysed,
for each task; * indicates ICCs exceeding 0.4 (these ICCs are depicted in bold), the lower bound for moderate
reliability. EI=emotion identification; GC=gender classification; LAmyg=left amygdala; RAmyg=right amygdala;
sgACC=subgenual anterior cingulate cortex; DMFC=dorsomedial frontal cortex; CI=confidence interval.
Figure 3. Distribution of PPI effect averaged across days. The regions displayed exceeded our threshold
for reliability (ICC > 0.4, see Table 1 for full statistics). The sgACC in the EI task did not exceed our
threshold for reliability and is not displayed. EI=emotion identification; GC=gender classification;
LAmyg=left amygdala; RAmyg=right amygdala.
3.3. Emotion Identification
For the EI task, we found good-to-excellent reliability (all ICCs between 0.5 and 0.9) in all
between-day and within-day ICC analyses (see Table 1). Note the high between-day reliability
averaging across both runs in both left and right amygdala (left: ICC = 0.704 (95%CI = 0.340 to 0.867),
p = 0.002; right: ICC = 0.738 (95%CI = 0.427 to 0.881), p = 0.001), as well as excellent reliability between
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runs on day 1 for the right amygdala (ICC = 0.832 (95%CI = 0.626 to 0.925), p < 0.001) (the same
analysis for the left amygdala showed good reliability: ICC = 0.652 (95%CI = 0.224 to 0.844), p = 0.005;
similarly good reliability was obtained for both amygdalae on day 2). In contrast, the sgACC had only
one instance of moderate reliability across all analyses: the within-day reliability on the second day
(ICC = 0.408 (95%CI = 0.299 to 0.730), p = 0.094). See Figure 3 for average between-day reliability.
3.4. Gender Classification
For the GC task, reliability was more variable. There were two instances of moderate between-day
reliability, for the left amygdala (overall, between days, averaging across both runs: ICC = 0.442 (95%CI
= 0.206 to 0.742), p = 0.068; and between the second runs of both days (ICC = 0.493 (95%CI = 0.095
to 0.765), p = 0.042) and for the right amygdala (overall, between days, averaging across both runs:
ICC = 0.627 (95%CI = 0.206 to 0.825), p = 0.006; and between the first runs of both days (ICC = 0.579
(95%CI = 0.103 to 0.802), p = 0.013). However, there were no instances of moderate (or higher)
within-day reliability (see Table 2).
4. Discussion
We tested the reliability of amygdala–DMFC and sgACC–DMFC connectivity using a ROI-guided
PPI analysis of three emotion-processing tasks. Following initial analyses, only two tasks were analysed
for reliability, as one task (face matching) did not show a significant PPI effect using our specific
analytic approach. In contrast to our previous results, which showed poor within-subject reliability
across these tasks for evoked hemodynamic responses [1], we found good-to-excellent reliability in
every amygdala reliability analysis for the emotion identification task. We generally found poorer
reliability for sgACC–DMFC task-modulated coupling and mixed reliability for the amygdala–DMFC
PPI effect during the gender classification task.
These findings have particular implications for translational neuroimaging work in anxiety and
related disorders. Converging human and animal data have implicated coupling between the DMFC
and amygdala in both normal and pathological anxiety [9,16–20]. There are well-known contributions
of the amygdala to fear and aversive processing [12–15] and of the DMFC region in fear appraisal,
expression, and pathological anxiety [17,18]. However, there is substantial and bidirectional coupling
between the DMFC and the amygdala [19,20]; anxiety behaviours may emerge from changes in the
balance of (reciprocal) fronto–amygdala information flow [16]. This coupling has been suggested to
represent a common neurobiological phenotype underpinning affective and anxiety disorders (within
the ‘negative valence systems’ construct of the Research Domain Criteria) [16], making its investigation
as a putative biomarker essential.
Our target ROI was taken directly from the anxiety literature [11] (ROI available at https://figshare.
com/authors/Oliver_Robinson/568652). This enabled us to test whether task-related amygdala–DMFC
coupling was sufficiently reliable to justify its exploration as a biomarker of treatment response,
as previously suggested [9]. We provide support for the use of one of our tasks (emotion identification)
in this endeavour and weaker support for another (gender classification).
It is notable that one of the tasks (emotion identification) evoked very robust PPI effects, both in
the ROI (see Figure 2) and the brain as a whole (see Figure 1). One of the tasks (face matching) showed
no significant PPI effect in the DMFC ROI, and for the other (gender classification), the PPI effect
was more modest. The tasks differed in several key aspects which could have contributed to these
differences: the emotion identification task was the only one that required explicit emotional labelling;
one possibility is that such labelling evokes greater prefrontal–subcortical coupling than the incidental
processing of emotional faces. Indeed, somewhat surprisingly, while we identified a significant increase
in amygdala–DMFC covariation during the emotion identification task (relative to fixation baseline),
this covariation was significantly decreased during the gender classification task.
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Limitations and Future Directions
There are a number of important limitations to our findings. First, we conducted a very specific
type of connectivity analysis (PPI), so our cautiously optimistic finding of good within-subject reliability
for PPI with the amygdala, particularly in the emotion identification task, may not apply to data
analysed using a different method. Others have reported similarly high reliability estimates of so-called
“resting-state” connectivity measures, ranging from moderate to large [33–35], though these differ
widely depending on the methodology used and the measure tested [35]. It is also worth noting that at
least some resting-state reliability estimates may be artificially inflated because of the extremely high
reliability of physiological noise (cardiac and respiratory) [36], while this is much less of a concern
for our PPI analyses (as such, physiological noise is presumably similar between the task conditions).
Second, it will be essential to test the reliability of activation and PPI effects in clinical samples, who may
differ in relevant aspects from our sample of healthy controls. Finally, in larger samples than ours, it
will also be important to perform more exploratory analyses of PPI between these seed regions and
the rest of the brain. In this study, we restricted ourselves to a single DMFC ROI (and a single fMRI
contrast for each task, as in our previous work [1]). This allowed us to constrain our hypotheses to
avoid false positives, which could arise from a combination of multiple testing and low statistical
power (common in PPI) [28]; however, this approach precludes inference about other regions.
5. Conclusions
We report good within-subject reliability of amygdala–DMFC PPI using emotion-processing tasks,
both between days (in two tasks) and within-day (between runs, in one task). This suggests that PPI
may have more utility as a ‘biomarker’ to predict treatment outcome than task-related hemodynamic
responses, which (in this dataset at least), showed very poor within-subject reliability [1]. Functional
connectivity has been implicated as a possible ‘biomarker’ across a number of studies and treatment
modalities, including pharmacological [5,6,37], psychological [8,37], and brain stimulation [38]. It is
certainly a compelling suggestion that regional coupling implicated in a disorder could be tested as a
predictor of treatment response. Our finding of relatively good within-subject reliability tentatively
supports testing this ambitious proposal in future translational work.
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Abstract: Uncovering brain-behavior mechanisms is the ultimate goal of neuroscience. A formidable
amount of discoveries has been made in the past 50 years, but the very essence of brain-behavior
mechanisms still escapes us. The recent exploitation of machine learning (ML) tools in neuroscience
opens new avenues for illuminating these mechanisms. A key advantage of ML is to enable the
treatment of large data, combing highly complex processes. This essay provides a glimpse of how ML
tools could test a heuristic neural systems model of motivated behavior, the triadic neural systems
model, which was designed to understand behavioral transitions in adolescence. This essay previews
analytic strategies, using fictitious examples, to demonstrate the potential power of ML to decrypt the
neural networks of motivated behavior, generically and across development. Of note, our intent is
not to provide a tutorial for these analyses nor a pipeline. The ultimate objective is to relate, as simply
as possible, how complex neuroscience constructs can benefit from ML methods for validation and
further discovery. By extension, the present work provides a guide that can serve to query the
mechanisms underlying the contributions of prefrontal circuits to emotion regulation. The target
audience concerns mainly clinical neuroscientists. As a caveat, this broad approach leaves gaps,
for which references to comprehensive publications are provided.
Keywords: triadic neural systems model; development; adolescence; machine learning; networks
1. Introduction
Adolescence is a period during which individuals undergo irreversible transformations in
multiple physical, biological, cognitive, emotional, social, and behavioral domains. This implies
immense complexity in trying to capture the overall landscape of these mutations. This review
presents how the use of machine learning (ML) tools could test neural systems theories of motivated
behaviors, particularly across the developmental period of adolescence. This is not a tutorial nor a
pipeline, but rather an introduction to the growing possibilities that the combination of powerful ML
tools with large datasets opens up to probe brain-behavior questions. An effort was made to keep
this complex topic as straightforward as possible, at the expense of discussions of limitations and
constraints. However, readers are referred to publications that begin to address these gaps.
At present, only simple heuristic models of the ontogeny of neural systems have been proposed
to account for the behavioral changes occurring in adolescence (e.g., [1–3]). Among these models,
the triadic model [2] figures as the broadest theory that provides functional mechanisms underlying
motivated behaviors in general, and specifically across development. The triadic model is based on
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a functional balance across three neural systems dedicated to (1) approach behavior, (2) avoidance
behavior, and (3) control processing (Figure 1). The triadic model, as a whole, has not yet been
tested, although individual components have been validated, such as the developmental pattern of the
approach system across adolescence [4–6]. We believe that the introduction of machine learning (ML)
tools to brain-behavior analyses and the emerging availability of big developmental data can test the
entirety of the model. This review will illustrate how this could be achieved.
Figure 1. The triadic model. (A) This figure shows that at the most elementary level, behavioral
responses to a stimulus can take only two forms: approach or avoidance. The selection of the behavioral
response is monitored or adjudicated by a supervisory controller (control system). In yellow is the
stimulus (i.e., object, situation), purple is the approach response, red is the other possible avoidance
response, and green is the controller. (B) This represents the neural translation (nodes of the triadic
model) of the three behavioral entities described in (A). The term node is used here to refer to a
neural system whose core structure is unique. The ventral striatum is specific to the approach system,
the amygdala to the avoidance system, and the prefrontal cortex (PFC) to the control system. In addition,
these three systems establish a balance that is represented as a triangle in equilibrium. The adult
balance is used as the yardstick, to which the adolescent is being compared. In an approach context,
the adolescent balance is tilted towards the approach system, and away from the avoidance system,
in a way that translates the proclivity of adolescent behavior towards approach, including risk-taking.
In an avoidance context, the adolescent balance is tilted towards the avoidance system, and away from
the approach system, in a way that translates the proclivity of adolescent behavior towards emotional
intensity and lability, perhaps reflecting the peak onset of internalizing disorders in adolescence.
This chapter is divided in two main sections. The first section reviews the triadic neural systems
model [2,7]. The second section focuses on the ways to test this model, using a hypothetical study of
two large community samples, one of adults and the other of children tested repeatedly from childhood
into emerging adulthood. Of note, only functional magnetic resonance imaging (fMRI) data were used
to identify neural predictors. In addition, we will not provide details on how to acquire, preprocess,
and process the fMRI data. All the neural data used for the analyses were scalar variables of intrinsic
functional connectivity (iFC) of regions of interest extracted from resting state scans and regional activations
in task-related fMRI scans. The iFC values corresponded to Fisher-transformed Pearson correlations.
2. The Triadic Neural Systems Model
The three neural systems of the triadic model consist of an approach, avoidance, and control
module. At the most elementary level, motivated behaviors can be reduced to the generation of two
possible actions, approach or avoidance, and the decision to adopt one or the other action is ultimately
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regulated by the control system (Figure 1). The triadic model is a generic heuristic explanation of how
input information is processed at the brain neural–systems level to generate a motivated action output.
2.1. Conceptual Definition
We first address the approach and avoidance systems and then the control system.
A fundamental assumption of the model is that the approach and avoidance responses are encoded
by two separate, although overlapping, neural systems. The “approach system” is classically associated
with positive-value encoding, which underlies reward and motivation functions. The “avoidance
system” maps to negative-value encoding, which captures punishment and negative emotion
processing. These two “approach” and “avoidance” systems are not just the mirror of one another.
They have different properties and behave according to distinct rules. For example, punishments
weigh more than rewards. Indeed, economic tasks reveal that the subjective value of a $5.00 loss
equates to the subjective value of a $10.00 gain [8]. Another example of these loss/gain differences is
the impact of uncertainty onto behavior. Uncertainty, which carries a negative cost, increases avoidance
but decreases approach. However, this functional separation of the approach and avoidance systems is
far from absolute. Overlaps exist at both behavioral and neural levels.
Accordingly, motivation processing is common to both approach and avoidance systems. In other
words, motivation fuels approach and avoidance responses. In fact, “motivated avoidance” is another
conceptualization of “active avoidance”, a construct currently under investigation in the field of
defensive responses (e.g., anxiety, fear) [9–11]. Similarly, emotion takes both negative and positive
flavors. Taken together, the approach and avoidance systems bleed into one another, which is reflected
at the neural level.
The third component of the triadic model is the control system, which adjudicates courses of
action between the approach and avoidance systems. In the context of this chapter, “control” refers to
the formation of preference that is transferred to effector sites. Generally, control processes belong to
the cognitive domain. Theories on preference formation are still debated, with two main contenders:
(1) a feedforward competition of the representation of options and a resolution favoring the strongest
signal [12–15], and (2) an inhibitory feedback of one representation, leaving the other option to
prevail [16–19]. At this point, these potential mechanisms mediating control have not been considered
in the triadic model.
The triadic model is typically represented as a triangle whose angles denote each system,
and the sides denote the connections among the systems (Figure 1). Importantly, the triangle can
be tilted in various directions, as a function of the weight (i.e., activity) attached to each system.
Theoretically, the tilt could be measured by the location of the center of gravity of the triangle.
2.2. Neural Substrates
2.2.1. Approach System
The approach system is centered on the striatum, a relatively large multiplex structure,
whose components include the caudate nucleus, nucleus accumbens, putamen, and pallidum.
Broadly, the striatum is an essential contributor to the implementation of goals into actions and plays
this critical role through the processing of information along parallel striatal–thalamocortical–striatal
loops [20]. Although the bulk of research on the striatum has focused on reward function and
motivation [21–23], much work in the last two decades has been dedicated to the role of striatal
networks in aversive processes [24–28]. While both animal and human data clearly indicate
involvement of the striatal circuitry in the processing of aversive stimuli, for instance in active
avoidance, the exact mechanism is still unclear. However, it is also well-demonstrated that the
recruitment of the striatal circuitry predominates and is more consistent in the processing of appetitive
than aversive information [29–31].
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2.2.2. Avoidance System
This system is centered on the amygdala. The amygdala is composed of multiple nuclei with
distinct functions, which can be grouped into three compartments: (1) an input compartment,
carrying multimodal sensory information; (2) a processing compartment, which integrates and broadly
interprets the sensory information coming from the cortex and hippocampus; and finally (3) an output
compartment, which dispatches the processed signals to effector agents that code physiological and
motor responses. The amygdala input receiver is allocated to the lateral nucleus, and the output
dispatcher to the extended amygdala (central nucleus of the amygdala and the bed nucleus of
the stria terminalis). The information processing takes place in the basal/accessory basal nuclei.
This information processing center has not typically been considered an “output region”, but it
does have an important one-way projection to the striatum to inform complex motor programs.
The amygdala has raised considerable research aimed at understanding its function in the processing
of aversive stimuli, including aversive learning [32–34]. Similarly, its implication in reward learning
has been well established [33,35–39]. However, it is also important to point out that, like the biased
responsivity of the striatum towards appetitive stimuli, the amygdala responds prominently and more
consistently to aversive than appetitive stimuli [40,41].
2.2.3. Control System
The control system is centered in the prefrontal cortex (PFC). It falls under the umbrella term of
cognitive executive function, which is essential to self-directed behavior. Multiple models have been
proposed to describe the various components of executive function (e.g., working memory, inhibition,
set shifting), and to map these different components onto brain regions (e.g., [42]). The common
denominator across these models is the PFC. Regional specialization of the PFC has been parsed out in
various ways, depending on theoretical frameworks, such as, to cite just a few, inferior-lateral versus
mid-lateral PFC [43], anterior versus posterior PFC [44], or medial versus left lateral versus right lateral
PFC [45]. The triadic model does not specify the putative PFC organization to adjudicate on courses of
action. However, the framework most fit to accommodate the control of the direction of action (i.e.,
the decision proper) consists of a combination of regions that integrate the value and salience tagged
to the possible options to decide on, and regions that modulate the weight of these value options.
The former set of regions receives information (bottom-up process) and the latter apply the information
to direct the course of action (top-down). In other words, the first set of regions receives information
from the approach (striatum) and avoidance (amygdala) systems, which is sent then to the second
set. The second set of regions modulates the activity of the avoidance and/or approach systems,
which provides the signal that is dispatched to effectors which implement the action. This framework
has been applied to the pattern of the neural mechanisms involved in the expression of defensive
responses [46,47], which we generalize to motivated behaviors at large.
2.3. Triadic Model in Adolescence
The foundation of the triadic model is to explain how brain maturational changes underlie the
prototypical behavioral changes in adolescence.
At the behavior level, adolescence is characterized by unique patterns in three domains: peak
lifetime period of risk-taking, amplified and labile emotions, and highly context-dependent executive
control [48–50]. In addition, the adolescent world undergoes a dramatic social reorganization.
Accordingly, social processes should be considered as a fourth domain, but it is not yet integrated to
the triadic model. Finally, adolescence is a time of vulnerability for psychopathology, as evidenced by
a peak rise in the incidence of internalizing, addictive, and psychotic disorders.
The behavioral shifts across adolescence are modeled as a facilitation of approach behaviors,
serving an “exploratory purpose.” Indeed, adolescence refers to the transition period from childhood
into adulthood, when the individual moves away from the protective family nest and learns to
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independently navigate the world, which requires risk-taking and exploration. This behavioral pattern
can also reflect blindness or increased tolerance for possible failures.
According to the triadic neural systems model, the proclivity for exploratory behavior would
be supported by an increased reactivity of the approach neural system, which would peak in
mid-adolescence and taper down into adulthood. An opposite progression is described for the
avoidance neural system in the context of responses to reward, i.e., hypo-responsivity of the avoidance
system supposedly to protect exploration. Finally, the adjudication by the control neural system
between approach and avoidance is becoming progressively more refined and efficient with age.
This elementary description of the developmental dynamics of each unit of the triadic system accounts
for the most commonly described changes in the adolescent motivated behavior, i.e., risk-taking and
improved cognition [7,51].
Although generally less emphasized, the model also supports exacerbated emotions, positive
as well as negative. The avoidance neural system, which contributes most significantly to emotional
expression, has been shown to be hyper-responsive to aversive stimuli in adolescents compared to
adults (e.g., [52–54]). This finding suggests that, in a negative context, the adolescent may react more
emotionally than the adult. Therefore, the direction of the developmental trajectory depends on the
context in which these systems are called into play.
This cursory description of how the triadic model is instantiated in adolescence, in a way that
can explain typical adolescent behaviors, reveals obvious gaps. For example, it is unclear how the
approach (appetitive) system is uniquely affected in aversive contexts in adolescence. The neural
delineation of the circuits of each system is only partial. The amount and nature of overlaps among the
systems is also unclear, and how these overlaps change with age and with context (appetitive versus
aversive) has hardly been addressed. The next section explores how these limitations can be leveraged
by the combined use of large datasets and machine learning tools.
3. Testing the Triadic Neural Systems Model
3.1. Introduction to Machine Learning Tools
The potential benefits of machine learning (ML) tools to facilitate discoveries in neuroscience
research have generated huge hope and excitement (e.g., [55–58]). Indeed, these tools have gained
enormous popularity among neuroscientists, particularly clinical neuroimagers, at a time when large
datasets are becoming publicly available (e.g., [59–64]). Historically, ML tools have been developed to
pursue artificial intelligence. As a growing field, ML has diversified into branches within statistics,
computer science, and mathematics. The interdisciplinary nature of this field presents challenges when
applying ML tools to neuroscience questions, especially in the neuroimaging domain, as it requires
substantial expertise in a wide range of domains. For example, engineering, neuroscience, advanced
physics, and psychology are each deep and well-developed fields. Achieving mastery of each of them
is a daunting task. For this reason, collaborative approaches are highly recommended when applying
ML tools to neuroscience research, since it behooves a team to have expertise in each of the domains
involved in solving a problem.
Machine learning consists of algorithms that train computers to learn patterns from arrays of
variables. Computer science, statistics, and engineering research have been instrumental to the
development of these mathematical tools. Typically, nuanced solutions require large pools of data.
As the neuroscience concepts addressed by the triadic model are complex, large datasets will be needed
to apply ML tools to its testing. Machine learning consists of automated and iterative computations
that promote computer learning of patterns (i.e., models). These patterns can serve to classify data and
to provide predictive models. For example, ML is a critical tool in artificial intelligence, the science
that trains computers to reproduce human behavior. Deep learning is a sub-specialized area of ML
that uses multiple layers of learning, with successive layers using the output from previous layers
as the input (e.g., [65]). Deep-learning algorithms have reached new limits in accuracy compared
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to other methods, and they permit to learn more precise rules when other ML approaches reach a
plateau [66,67]. Deep learning typically requires substantially more data than simpler machine learning
models, and this presents a limitation of its use in neuroscience, since large neuroscience datasets are
rare for psychiatric disorders.
Finally, ML is divided into “supervised” and “unsupervised” algorithms (e.g., [68]).
Supervised ML assumes a ground truth (e.g., patient versus healthy groups; faces versus houses) and
trains the computer to use data that will best predict the ground truth. The power of these algorithms
lies in the fact that the patterns learned are generalizable to testing datasets (not used to train the
model). Some examples of supervised algorithms include multilayer perceptrons (MLP), decision
trees, and support vector machines (SVMs). In this manuscript we use decision trees. A more detailed
description of this algorithm is included later.
Unsupervised ML is not predicated on a ground truth. It provides training to find reliable patterns
in data that can inform the constituents of models. In other words, it attempts to group objects (e.g.,
brain activation maps) according to their intrinsic properties, as opposed to similarity with some
ground truth. These algorithms could also be used to identify important dimensions or components
of a dataset. Popular unsupervised algorithms including clustering algorithms such as k-means
clustering, hierarchical clustering, Gaussian mixture models (GMMs), and dimensionality reduction
tools such as principal component analysis (PCA), and independent component analysis (ICA).
Deep learning is particularly well-suited for these applications. In all cases, ML’s initial solutions,
computed in a first sample (training sample), must be tested in a new independent sample (test
sample) [69,70].
3.2. Overall Strategy for Testing the Triadic Neural Systems Model
The triadic neural–systems model can be tested in three sequential stages to address three main
aims (questions) that seek to delineate: (1) the functional architecture of each system: describe and
validate the brain mapping of each system (the approach, avoidance, and control system); (2) the
dynamic interaction among the three systems: describe and validate how these systems work together
to generate adaptive motivated actions; (3) the maturation of the triadic model: model how these
three systems and their interactions develop with age. The strategy to test the first two questions is
illustrated in Figure 2.
To accomplish these three aims, three types of data need to be collected in healthy individuals.
These types of data include measures of (1) functional neural architecture, (2) behavioral characteristics,
and (3) changes of neural and behavioral measures with maturation. Furthermore, each of these sets
of data should be acquired in three different contexts, an appetitive context for approach responses,
an aversive context for avoidance responses, and a cognitive context for control responses.
The first two questions do not require pediatric samples. Although it would be optimal for the
samples of Question 1 and Question 2 to be independent, it is not a requirement. The samples should
be large enough to apply machine learning analysis, allowing for a larger subsample of >150 subjects
to be used as a training sample to define the model, and a smaller subsample of >50 subjects to be
used as the testing sample to validate the model. For Question 3, an optimal design would be that
of a longitudinal study of a large community sample of children (e.g., n > 300). Research consortia
such as ABCD, NCANDA, IMAGEN, and connectome [59–62] are currently collecting longitudinal
behavioral and neuroimaging measures in large pediatric samples. Since these data are made available
to the public, the present discussion is highly propitious.
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Figure 2. Strategy for Questions 1 and 2 to test the triadic neural systems model. All the data presented
in this figure are totally fictitious. They only serve as concrete illustrations. The upper-panel addresses
Question 1. Two sequential analyses are presented. (A) The first analysis is a principal component
analysis (PCA is considered an unsupervised algorithm), which reduces and groups all behavioral
data (from questionnaires, physiological, task performance) into latent factors. These factors map
to the approach (aF), avoidance (vF), and cognitive (cF) domains. The second analysis applies a
supervised ML algorithm. This algorithm uses the latent behavioral factors (aF, vF, cF) provided
by the PCA as the predicted (output) data. The input data are all the significant regions of interest
identified in the neuroimaging scans (task-related activation: regions of interest (ROIs), and resting
state connectivity: intrinsic functional connectivity (iFCs)). In the present example, the input variables
are scalar variables. The solution of this algorithm reveals the brain regions (ROIs, iFCs) that best
predict the behavioral factors (aF, vF, cF). We consider these brain regions to represent the networks
underlying the coding for aF, vF, and cF. These networks consist of three regions for aF, A1–A3, four
regions for vF, V1–V4 for vF, and six regions for cF. These networks are drawn on the brain illustrations
for concrete illustration. However, their location is not to be interpreted, since they are arbitrary.
(B) The lower-panel delineates the analytic path to identify the relative contributions of the three
neural networks of approach, avoidance, and cognitive (provided by the solution of Question 1) to
individual behavioral propensity. This path rests on a supervised ML algorithm. The input variables
consist of all neural predictors isolated in Question 1, but extracted from the three task-related fMRI
scans, i.e., in the three behavioral contexts of interest. Therefore, 13 brain regions are extracted from
each of the reward, aversive, cognitive task-related scans, making up 39 input variables. X1 is the
extracted value of ROI1. There are 39 ROIs, and thus 39 X’s. The superscript i corresponds to the
subject i. The predicted variables (output variables) are the latent behavioral factors (aF, vF) calculated
in Question 1. The cognitive factor is not examined because, presently, the triadic model is specifically
focused on modeling approach and avoidance behaviors, and their relative dominance in the behavioral
patterns of individuals. The solution of the ML algorithm provides equations and trees. The equations
assign weight to each predictor (parameters that are unique to the equation predicting aF and those
predicting vF). The trees permit to assess how the different variables interact to predict the behavioral
factors (aF, vF).
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3.3. Question 1: Functional Architecture of Each System
Question 1 aims at defining the networks that are associated with the generation of three domains
of behavior: approach, avoidance, and cognitive control. Two types of data were used for this goal:
behavioral and neural measures. The strategy to test Question 1 progressed in two steps for data
organization and for the computation of the predictive model (Figure 2).
3.3.1. Data Organization/Reduction
The behavioral measures were expected to be numerous, including paper and pencil measures
(self-report, interviews), task performance in both clinic and MRI (cognitive, motivation, emotion tasks),
and physiological data (e.g., skin conductance, heart rate, EMG) (Figure 3). Therefore, a first step was to
organize and reduce these measures to isolate latent factors most representative of the three domains of
approach, avoidance, and control. In other words, rather than dictating which behaviors and questionnaires
are associated with any one of the triadic systems, a data-driven approach can yield more objective and
valid categorization of behavioral data. Principal component analysis (PCA) [71] is a reasonable approach
to map existing behavioral data to distinct functional domains. This way, many metrics (e.g., questionnaire
ratings, task performance, stress physiological responses) can be employed to reveal clusters (factors) of
behavioral items that best describe the three behavioral domains of approach, avoidance, and control.
Principal component analysis identifies the factors (eigen vectors) that best capture the variance in the
existing dataset. These factors can be arranged in the order of their importance as defined by their
corresponding eigen values. Ideally, a PCA approach would identify three principal factors that account
for almost all of the variance of the behavior-based dataset, and which would map to the approach (aF),
avoidance (vF), and cognitive control (cF) behavioral domains.
The results of the PCA might be more complex. This analysis could provide more than one factor
score for each of the three behavioral domains. In addition, other factors, not related to the triadic domains,
could emerge. Finally, the possibility for not being able to clearly identify an approach, avoidance or
cognitive factor also exists, although the nature of the inputted items, all related to the behaviors of interest,
make this possibility unlikely. For simplicity, only one behavioral factor for each domain will be used as
illustration, and each factor score can be used to define two groups, one with individuals scoring low on
the given behavioral factor, and the other group scoring high. Finally, additional unrelated factors, which
can also emerge from the PCA results, will not be discussed here. The next step was to identify which and
how neural measures predict each behavioral domain, respectively.
Figure 3. Principal component analysis (PCA) for behavioral data organization and reduction and for
addressing Question 1, step 1. This step pools together all behavioral variables that are entered into a
PCA. The PCA is aimed at grouping the behavioral variables into components (factors) based on their
intrinsic properties. Based on the nature of the input variables, it is most likely that the variables will be
groups into at least 3 factors, one capturing approach, another avoidance, and a third cognitive control.
Other factors may also emerge. But, for simplicity, we only consider the three factors of interest, aF, vF,
and cF for the approach, avoidant, and cognitive factors, respectively. Subjects can then be divided
by their score level, e.g., high-score group versus the low-score group. Of note, the number of groups
is arbitrary, since subjects could as well be separated into three groups, for example, based on low,
moderate, and high factor scores.
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3.3.2. The Predictive Model
This step identifies the activity patterns of the neural networks predicting each of the three
behavioral domains, quantified by the data reduction PCA step as factors: approach factor (aF),
avoidance factor (vF), and control factor (cF). These behavioral domains are examined separately,
but concurrently, using the same procedure. This step uses supervised ML tools. The ML algorithms
(such as support vector machine model or random forest model) implement iterative computations to
train the computer to recognize the neural patterns that optimally predict the behavioral factor scores
(aF, vF, and cF). In other words, the goal of these analyses is to produce the most efficient (low-cost,
low-noise) predictive model of a given behavior using neural activity patterns as predictors. The neural
inputs (i.e., predictors) to the model consist of resting state connectivity (iFC) measures, in the form
of weights between hubs (e.g., ventral striatum to ventromedial prefrontal cortex), and regional
blood-oxygen-level dependent (BOLD) activations during task-related fMRI (Figure 4). These input
data are scalar, since a single variable (beta for activation, or Fisher-transformed Pearson correlation for
connectivity) is extracted, and not the timeseries of BOLD activity/connectivity data. One advantage
of ML methods is that multiple neural variables can be examined as predictors of a given behavior in a
single model, without violating the assumptions of the statistical model (e.g., t-tests are conducted
with the assumption that the data is normally distributed). In Figure 4, we present three equations
for each behavioral domain (F, G, H). Each equation is unique to its behavioral domain in terms of
the parameters (computed by the ML algorithms) that weigh the neural predictors. A higher weight
signifies a more determinant role in predicting the behavior. The dominant predictors are those that
also appear most determinant in decision trees (see comment below describing decision trees in more
details), which maximize the output separation (subjects scoring high on the behavioral domain
versus those scoring low). Furthermore, many ML models, by default, test interactions. For example,
classification trees are a type of machine-learning model where the sample is partitioned in a sequence
of steps (e.g., two steps: tree sequentially split by gender and then by family history of substance use).
We provide for the reader a comment, which describes decision trees in more details. “A decision
tree is s supervised learning algorithm, which attempts to classify or regress a dataset in a hierarchical fashion.
As the name suggests, a decision tree has a tree-like architecture, with points (nodes) at which the tree splits
into branches (edges). The split in the tree depends on the dimension that best separates the data. The criterion
governing this split is defined by a cost function. The cost function computes the difference between the predefined
label/score assigned to the datapoint and the prediction based on the split. The dimension, along which the cost
function is minimized, becomes the node criterion. This process is then repeated in a recursive fashion, with the
ends of the new branches becoming new nodes. A popular algorithm used in decision trees is the Recursive Binary
splitting algorithm, where each node splits into 2 branches in a recursive fashion. An important consideration
while using decision trees is to know when to stop the tree from growing any further and which splits to remove.
A number of thumb rules can be used For example, one can predefine the maximum possible depth (length of the
longest path) of the tree; or pre-set the minimum number of datapoints required in a branch before a split can
occur; or get rid of the branches that do not impact the cost function too much.”
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Figure 4. Supervised machine-learning step. Supervised ML analysis to identify the networks
predicting the three PCA factors of interest (aF, vF, cF). This algorithm computes the predictive value of
the extracted neural measures. As such, it provides the components (nodes) of the neural networks
that predict the behavioral factors previously identified by PCA (Figure 3). The predictive model can
take the form of equations, F for aF, G for vF, and H for cF. The predictors are neuroimaging data.
More specifically, a (1) is the first extracted value of the resting state functional magnetic resonance
imaging (fMRI), up to a(20) which is the value of the last extracted measure that passes the significant
threshold set for the resting state study (this number is arbitrary). The variable x(1) is the extracted
value of the most significant regional activation of the approach-task-based fMRI, and (i) is the number
of regions extracted from the reward-task fMRI scans; y(1) corresponds to the avoidance domain with
(j) being the number of regional activations extracted from the avoidance-task based fMRI scans; and
z(1) corresponds to the control domain with (k) being the number of regional activations extracted
from the control-task fMRI scans. The brain illustrations on the right of the equations represent the
solution of the ML analysis, which identifies the nodes (neural predictors) that best predict aF, vF,
and cF, respectively (i.e., have the highest weight). The number of these regional activations (or nodes)
is arbitrarily set to three for the approach factor, four for the avoidance factor, and six for the control
factor. These nodes define the neural networks that best predict reactivity to the behavioral domains of
the triadic model.
We present two simple fictitious examples of classification tree results in Figure 5. The first example
(Figure 5A) uses demographic and clinical data to classify participants as high or low risk-takers. The model
places gender at the top of the tree, i.e., first key variable that splits the sample in function of the propensity
for risk-taking. It shows that males are more frequently high risk-takers than females. The second variable
emerging as the next strongest predictor is family history of substance use. A positive family history of
substance use strongly increases propensity for risk-taking in males, but less so in females. In other words,
a positive family history confers risk that differs between males and females.
The second example (Figure 5B), also totally fictitious, is closer to the thematic of this paper, i.e.,
identify neural predictors of behavior. In this made-up example, the classification tree analysis reveals
that approach behavior (e.g., aF) is most frequently (at the top of the tree) predicted by high ventral
striatal (VS) response to reward, but only if the circuit’s strength between VS and ventral medial PFC
(vmPFC) is low, and the dorsolateral PFC (DLPFC) response is high. Machine learning would be
able to identify this model, but linear models would not, unless the interaction term was specified
(known a priori). With many potential interactions, it would be challenging for human researchers
to consider all the possible interaction terms, but it is easy for a machine. Ultimately, a classification
tree analysis would delineate the brain regions that matter in the modulation of approach behavior.
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In the theoretical example of Figure 5B, the most powerful predictors are the VS, the vmPFC, and the
dorsolateral PFC (DLPFC) (all fictitious examples).
Figure 5. Two fictitious examples of solutions using classification tree algorithms. (A) Example
1 illustrates a ML classification of subjects into groups of high or low risk-takers (high versus low value
of the outcome measure), in function of sex and family history of substance use (fmhx-su). The sample
is composed of 120 males and 90 females. The modulation of risk-taking by fmhx-su is different in
males and females. Males with a positive fmhx-su are more prone to be high risk-takers (45 of 50,
90%) compared to males without fmhx-su (10 of 70, 14%). However, this factor does not seem to
be as determinant in females, 15 of 40 females (38%) compared to 5 of 45 (11%) without fmhx-su.
(B) Example 2 illustrates a ML classification of individuals as a function of high versus low propensity
for approach behavior (high aF versus low aF) using neural predictors. This tree shows that the ventral
striatum (VS) is the strongest predictor of high aF. All the individuals with low VS have a low aF scores.
In contrast, the association of high VS sensitivity with high aF is modulated by the connectivity of VS*
the medial prefrontal cortex (mPFC), and by the activity of the dorsolateral prefrontal cortex (DLPFC).
This tree clearly illustrates how such analysis can help clarify interactions among neural predictors of
specific behaviors. VS = ventral striatum activation, VS*mPFC = intrinsic connectivity between VS and
medial prefrontal cortex, DLPFC = dorsolateral prefrontal cortex.
3.3.3. Output of the Predictive Model of the Characterization of the Three Neural Systems
Taken together, the expected output of Question 1 is the delineation of the main nodes engaged
(via activation or connectivity) in each of the three functional domains. In addition to providing the
identity of these nodes, Question 1 also reveals patterns of interactions that predict the degree of behavioral
propensity towards either approach, avoidance or control. Here, these patterns of interactions are not
used in the subsequent analyses, although they are important to fully characterize the neural substrates
of each behavioral domain. Analyses for Question 2 will focus on the main nodes identified in Question
1. For illustration, we will arbitrary assign nodes to each neural system: approach system, A1, A2, A3,
avoidance system, V1, V2, V3, V4, and control system, C1, C2, C3, C4, C5, C6. In actuality, some nodes are
likely to be common to two or all three systems, but, for simplicity, this situation is not considered.
3.4. Question 2: Dynamic Interactions among the Three Systems
Question 2 concerns how the neural predictors of all three behavioral domains (i.e., approach
A1–A3, avoidance V1–V4, and control C1–C6) work together in each of the appetitive and aversive
contexts. Indeed, the triadic model predicts that, in an appetitive context, the approach system will be
active and more tightly intra-connected, whereas the avoidance system will tend to be silenced [7,72].
The opposite pattern would characterize the neural pattern in an aversive context (Figure 1). The control
network would manifest different couplings with the approach versus avoidance system as a function
of the appetitive versus aversive context. Clearly, the reality is more complex, particularly with
expected interactions among nodes of the different neural systems, which we anticipate being able to
characterize using ML strategies.
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3.4.1. Question 2, Step 1
The neural predictors identified in Question 1 provide the basis for the input variables of this analysis
(Figure 6). As a reminder, the fictitious results of Question 1 reveal three brain regions (A1–A3) that predict
approach, four brain regions (V1–V4) for avoidance, and six brain regions (C1–C6) for control. The strategy
to query Question 2 takes two steps: (1) the collection of all neural data from all three contexts (approach,
avoidance, control), and (2) a supervised ML “categorization” analysis (Figure 6).
Figure 6. Strategy for addressing Question 2, Steps 1–2. Extraction of neural predictors and supervised
ML to predict behavioral factors aF and vF. (A) Step 1: Neural data extraction. This step consists of
gathering all potential neural predictors of the behavioral factors identified in Question 1 (Figure 4).
These neural predictors (nodes) are now all extracted from every task-based fMRI scan (cognitive-task
fMRI, avoidance-task fMRI, and approach-task fMRI). The brain illustrations show the activation maps
of all the nodes of interest, the approach nodes (purple), the avoidance nodes (red), and the control
nodes (green), in each task-based fMRI scan. The extraction of the blood-oxygen-level dependent
(BOLD) signals for all regions of interest (ROIs) (13 per scan) are labelled X1 through X39. (B) Step 2:
Supervised ML analysis. The extracted 39 ROIs variables (X1–X39) are the predictors used in two
analyses, one for the approach domain and the other for the avoidance domain. Each analysis can
be performed using two supervised algorithms. The first algorithm uses a linear model to estimate
the strength of each neural predictor (theta weights). The second algorithm uses a decision tree to
provide a hierarchical structure that informs more directly the interactions among neural predictors.
The example shows the sample divided in two groups, one group with low aF scores, and the other
group with high vF scores. The tree depicts four ROI with significant weights in predicting the groups.
These ROI are ROI4, ROI15, ROI22, and ROI8, and their respective BOLD values are X4, X15, X22, and X8.
The first data collection step (Figure 6A) is a re-examination of the task-based fMRI scans, in order
to extract the values of the neural predictors of all three contexts pooled together. In other words,
the “approach” nodes (or regions of interest, ROI) A1–A4 are also extracted from the control- and
avoidance-related scans, the “avoidance” ROIs V1–V3 from the control- and approach-related scans,
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and the “control” ROIs C1–C5 from the avoidance- and approach-related scans. Therefore, the number
of potential neural predictors for Question 2 is tripled (3 approach + 4 avoidance + 6 control ROIs
= 13 ROIs, whose activity is extracted from the reward-task fMRI + the negative-task fMRI + the
cognitive-task fMRI, i.e., 13 × 3 = 39). Similar to Question 1, for simplicity, only scalar variables are
used as input data, not timeseries.
3.4.2. Question 2, Step 2
In the second step (Figure 6B), the input data (n = 39) are categorized based on their predictive
value of each behavioral domain. This analysis falls under the supervised ML approach, using learning
algorithms of support vector machines or decision trees, as described in Question 1. To avoid confusion,
the supervised ML algorithm, used in Question 1, identified the neural predictors from task-based and
resting-state scans of approach, avoidance or control propensity. In Question 2, this ML algorithm is
used to identify the neural predictors from the pooled neural predictors (n = 13 extracted from all three
contexts, n = 13 × 3) of the propensity for approach, avoidance, and control separately. The result of
this last analysis informs the patterns of interactions across the three neural systems that support the
behavioral domains of the triadic model. These results would represent a major advance in knowledge
of how brain systems work together to organize behavior.
Figure 6 illustrates two types of representations of the results. The equations provide measures
of the strength of each neural predictor (theta weights). The trees provide a representation of the
hierarchical power of the neural predictors to influence behavioral outcomes, informing more directly
interactions among neural predictors.
3.5. Question 3: Maturation of the Triadic Neural System Dynamics
The strategy for Question 3 is a simple replication of the steps described above, but at each follow-up
(e.g., 12 years old, 16 years old, and 20 years old). An example of a possible outcome is presented in
Figure 7, which clearly shows how this process could inform the developmental trajectories not only of the
triadic neural systems, but also of their interactions. We summarize the steps below:
(a) Step 1: Behavioral characterization. The predicted behavior outcome measures are computed as
in Question 1 by conducting a factor analysis of all available behavioral data, at each follow-up.
(b) Step 2: Brain-behavior classification: This step gives rise to two types of results: trees that depict
the hierarchical organization of predictors at each follow-up point and equations that quantify
the contribution of each cluster to a given behavioral domain, respectively.
Figure 7. Decision trees across development. Fictitious examples of developmental analysis of neural
predictors of behavior: examples of decision-trees at each follow-up. Changes in classification trees at
different age groups inform the evolution of mechanisms underlying motivated behaviors of approach
and avoidance.
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4. Conclusions
In this paper we offer a preview of the potential contribution of the latest, so far most powerful,
tools to help delineate how brain networks code motivated behaviors. This window into brain-behavior
causal mechanisms can have invaluable implications for understanding developmental changes in
health and diseases, and can provide critical guides for refining and extending research in this field.
Specifically, the present work provides a guide that can serve to query the mechanisms underlying
the contributions of prefrontal circuits to emotion regulation. Finally, findings that emerge from such
an analytical approach can raise key questions that, in turn, can be examined in focused studies,
or warrant a re-examination of previous data.
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Abstract: Williams Syndrome (WS) is a neurodevelopmental disorder caused by a deletion of
25–28 genes on chromosome 7 and characterized by a specific behavioral phenotype, which includes
hypersociability and anxiety. Here, we examined the density of neurons and glia in fourteen
human brains in Brodmann area 25 (BA 25), in the ventromedial prefrontal cortex (vmPFC),
using a postmortem sample of five adult and two infant WS brains and seven age-, sex- and
hemisphere-matched typically developing control (TD) brains. We found decreased neuron density,
which reached statistical significance in the supragranular layers, and increased glia density and
glia to neuron ratio, which reached statistical significance in both supra- and infragranular layers.
Combined with our previous findings in the amygdala, caudate nucleus and frontal pole (BA 10),
these results in the vmPFC suggest that abnormalities in frontostriatal and frontoamygdala circuitry
may contribute to the anxiety and atypical social behavior observed in WS.
Keywords: Williams Syndrome; neuron density; glia density; ventromedial prefrontal cortex
1. Introduction
Williams Syndrome (WS) is a rare (<1 in 7500) neurodevelopmental disorder resulting from a deletion
of approximately 25–28 genes on chromosome band 7q11.23 [1]. Individuals with WS have a specific and
well defined cognitive and behavioral phenotype. The cognitive profile of WS is characterized by deficits
in global IQ and spatial processing, and relatively preserved language and face processing. However,
even in these relatively spared skills, WS individuals demonstrate delayed and abnormal development,
along with atypical cognitive processing during some language and face tasks [2,3]. WS behavior is
marked by high levels of sociability and anxiety. WS individuals have a high drive to engage in social
interactions with others, and a tendency to approach even unfamiliar individuals to engage them in
conversation [4,5]. In striking contrast to this, Autism Spectrum Disorders (ASD) are characterized
often by social avoidance [6,7]. Unlike WS, ASD are genetically complex and heterogenous [6,7].
Interestingly, however, duplication of the WS gene deletion appears to cause ASD in a small subset
of cases, demonstrating the range of behavioral effects that alterations at this locus can cause [8].
Abnormalities in the structure and function of the prefrontal cortex (PFC) have been demonstrated
in imaging studies of WS. Overall cortical surface area, including surface area in two regions linked
to emotion processing and social behavior, the orbital and medial prefrontal cortices, is decreased
in WS. Cortical thickness, however, appears increased in these regions, and relative to brain size,
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total gray matter volume may also be increased in the orbital and medial prefrontal cortices in
WS [9–11]. Functional imaging studies (fMRI) provide evidence of deficits in behavioral inhibition in
WS. WS subjects had slower response times on an inhibition task than TD controls and displayed lower
levels of activation in the striatum and frontal cortex [12]. These abnormalities in fronto-striatal circuitry,
and deficits in behavioral inhibition may relate to WS hypersociability, which has been described as an
inability to inhibit the desire to approach and engage with others [13,14]. In a functional imaging study
examining response to threat, WS individuals displayed lower levels of activation in the amygdala and
ventromedial prefrontal cortex vmPFC while viewing threatening faces, but higher levels of activation in
these regions while viewing threatening scenes, compared to TD controls [15]. Atypical communication
between frontal and limbic regions has been suggested as a possible factor in the high anxiety seen in
WS [16]. At the cellular level, microstructural analyses of WS subjects demonstrated lower neuronal
density in the infragranular layers of the rostral orbitofrontal cortex [17]. An increase in the ratio of
glia to neurons, and in the density of oligodendrocytes in WS, has been found in the in the medial
caudate nucleus, a region that receives projections from the vmPFC [18,19]. In the amygdala of WS
subjects, neuron number was higher in the lateral nucleus [20]. Taken together, these findings suggest
that abnormalities in PFC cytoarchitecture, and altered prefrontal inhibitory control of the amygdala
and striatum, may be linked to the atypical anxiety and social behavior characteristic of WS.
Here, we examined one area of the vmPFC, Brodmann area 25 (BA 25), that is critically involved
in social behaviors and related functions of inhibition and decision making [21]. This area is heavily
connected to several subcortical structures, including the amygdala and striatum, both of which are
altered in WS, and in other disorders including autism [18,20,22–24]. Using postmortem tissue from
ten adult and four infant subjects, seven WS and seven age, sex, and hemisphere matched typically
developing (TD) controls, we measured the density of neurons and glia in the supragranular (II/III)
and infragranular (V/VI) layers of BA 25 in the vmPFC to test whether the previously observed
decreases in neuron density in WS are restricted to rostral orbitofrontal cortical areas, or if there are
widespread alterations to the frontal cortex in WS.
2. Materials and Methods
2.1. Brain Tissue
We examined cortical tissue from BA 25 in the vmPFC in a total of fourteen postmortem human
subjects, including five adult WS and five adult TD subjects, as well as two WS infant subjects and
two TD infant subjects (Table 1). TD subjects were matched with WS subjects for age (110/114 and
234/245 days for infants, 18–43 years for adults), sex, and hemisphere (right), to control for possible
cytoarchitectonic asymmetries and age and sex-related differences [25,26].
Table 1. Subject Information.
Subject Age at Death Sex Hemisphere PMI (h) Cause of Death
WS 7 114 days M R <30 Multiorgan failure
TD 5883 110 days M R 34 Sudden unexplained death in infancy
WS 2 245 days F R N/A Sudden infant death syndrome
TD 4392 234 days F R 13 Intussuseption of Meckel’s diverticulum
WS 10 18 years M R 24 Cardiac complications
TD 4916 19 years M R 5 Drowning
WS 15 24 years F R 20 Pneumonia, Sepsis
TD 5350 25 years F R 26 Sepsis
WS 1 31 years M R 26 Cardiac complications
TD 5539 31 years M R 24 Acute drug intoxication
WS 14 42 years F R 18 Cardiac complications
TD 5445 42 years F R 10 Pulmonary thromboembolism
WS 9 43 years F R 12 Cardiac complications
TD 4636 43 years F R 19 Pulmonary thromboembolism
WS: Williams Syndrome; TD: typically developing control; PMI: post mortem interval in hours.
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All subjects in the Bellugi Williams Syndrome Brain Collection are part of an ongoing
donation-based program now run by the Laboratory for Human Comparative Neuroanatomy at
UCSD (La Jolla, CA, USA).
2.2. Regions of Interest
The region of interest (ROI) was identified using anatomical landmarks and by the absence of any
visible border between cortical layers II and III and between layers V and VI. BA 25 occupies a portion
of the brain immediately caudal and ventral to genu of the corpus callosum. It is agranular, lacking a
visible layer IV, and poorly laminated compared to surrounding cortical areas [27,28]. Cortical layers
II/III and V/VI were analyzed as two distinct ROIs (Figure 1).
Figure 1. Microphotographs of Brodmann area 25 (BA 25) in adult and infant Williams Syndrome (WS)
and typically developing control (TD). Images taken at 2×.
2.3. Processing of Tissue
Blocks of tissue containing BA 25 were extracted and cryoprotected using a series of 10%, 20%, and
30% sucrose solutions with 0.1 M phosphate buffer until saturated. Frozen tissue was cut on a Leica
SM 2010R (Leica Biosystems, Wetzlar, Germany) sliding microtome into ten series of 40 micrometer
(μm) thick sections in adult subjects. Due to the fragility of infant tissue, infant subjects were cut into
five series of 80 μm thick sections. One series was rehydrated for 48 h in a neutral phosphate buffer,
then mounted on gelatin-coated slides. Mounted sections were dried for 48 h at room temperature,
then dehydrated in a 1:1 chloroform ethanol solution overnight. These sections were stained with a
0.25% thionine stain for Nissl substance to visualize cell bodies, rehydrated, submerged in xylenes or
citrisolv for 15 min after staining, and then cover-slipped with permount. The remaining series were
stored for use in later processing, including a variety of immunohistological staining experiments.
2.4. Unbiased, Design-Based Stereology
Data collection was performed using StereoInvestigator software (MBF Bioscience, Williston, VT,
USA) on a Dell workstation receiving live video feed from an Optronics MicroFire color video camera
(East Muskogee, OK, USA) attached to a Nikon Eclipse 80i microscope (Nikon Instruments, Melville,
NY, USA) equipped with a Ludl MAC5000 stage (Ludl, Hawthorn, NY, USA) and a Heidenhain z-axis
encoder (Heidenhain, Plymouth, MN, USA). To increase the accuracy and consistency of measurements
across all subjects, we report neuron and glia density rather than number, a standard practice for data
collection in the cortex [17,29–31].
All data were collected by a single rater (LW). Inter-rater reliability was ensured through repeated
neuron density estimations on a sample previously reported in the literature to 95% concordance [17].
Sections were coded before data collection to blind the rater to diagnosis. Six sections per subject,
spaced as equidistantly as allowed by individual section quality, were analyzed, representing the
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maximum extent of the area in the coronal plane. Neuron and glia densities in layers II/III and V/VI
were estimated using the Optical Fractionator probe in StereoInvestigator. Two regions of interest
per section, one bounding layers II/III and the other bounding layers V/VI, were drawn at a 1×
magnification, consistent with previous work on WS cortex [17]. BA 25 in adults has no visible layer
IV. Neurons and glia were counted using a 1.4 numerical aperture, 100× oil objective lens, with a grid
size of 300 × 300 microns, a dissector height of 9 microns, and a counting frame of 85 × 85 microns.
For infant subjects, a 50 × 50 micron counting frame was used. Within this frame, neurons and glia not
touching the line of exclusion were counted using different markers. Cells were distinguished based
on their morphology. Neurons were identified by the presence of a distinct nucleolus, and a lightly
stained nucleus surrounded by cytoplasm. Glia were identified by their smaller size and lightly or
darkly stained nucleus, with very little or no staining of the surrounding cytoplasm (Figure 2) [32].
For each ROI (layers II/III and layers V/VI, respectively), neuron and glia densities were calculated by
dividing population estimate of each cell type by the planimetric volume estimate from the Optical
Fractionator probe.
Figure 2. Microphotograph of BA 25 adult WS and TD. Neurons (black arrowheads) were distinguished
from glia (red arrows) by their large size and distinctly stained nucleolus. Images taken at 100×.
2.5. Statistical Analysis
Standard two-tailed t-tests (p < 0.05) were used to compare neuron density, glia density, and glia
to neuron ratio in WS and TD. Supragranular and infragranular layers were compared separately, as
well as the average density of these layers combined. Percent difference in WS compared to TD was
calculated as the difference in mean value of WS from TD, in relation to the mean TD value, for neuron
density, glia density, and glia to neuron ratio, in each ROI.
3. Results
3.1. Adult Neuron Density
Results are summarized in Table 2 and Figure 3. In supragranular layers, neuron density was
significantly decreased in WS compared to TD (p = 0.046, 17% decrease). Neuron density infragranular
layers were decreased in WS, but this was not statistically significant (p = 0.186, 9% decrease).
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Table 2. Mean Neuron Density (neurons/mm3) and Standard Deviation in BA 25.
Cortical Layers II/III V/VI
TD 30,882 ± 2537 36,506 ± 2567
WS 25,594 ± 4157 33,094 ± 4417
% Difference −17% −9%
Figure 3. Mean neuron density in adults. * Statistically significant results.
3.2. Adult Glia Density and Glia to Neuron Ratio
Results are summarized in Tables 3 and 4, and Figure 4. Mean glia density was significantly
increased in WS compared to TD, in both supragranular (83% increase, p = 0.00007) and infragranular
(116% increase, p = 0.000001) layers. Glia to neuron ratio was also increased in WS compared to TD in
supragranular (125% increase, p = 0.003) and infragranular (140%, p = 0.0003) layers.
Table 3. Mean Glia Density (glia/mm3) and Standard Deviation in BA 25.
Cortical Layers II/III V/VI
TD 18,756 ± 426 19,721 ± 465
WS 34,355 ± 2038 42,510 ± 1844
% Difference +83% +116%
Table 4. Glia to Neuron Ratio in BA 25.
Cortical Layers II/III V/VI
TD 0.61 0.54
WS 1.38 1.30
% Difference +125% +140%
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Figure 4. Mean glia density and glia to neuron ratio in adults. * Statistically significant results.
3.3. Infant Neuron Density, Glia Density, and Glia to Neuron Ratio
Results are summarized in Figure 5. In the 114 (WS) and 110 (TD) day-old subject pair, neuron
density, glia density, and glia to neuron ratio were quite similar between the TD and WS subject in the
supragranular layers (within 1%). In the infragranular layers, neuron density, glia density, and glia to
neuron ratio were lower in the WS subject (33% lower, 55% lower, and 16% lower respectively). In
the 234- and 245-day pair, across all layers, neuron density was lower (35% lower supragranular, 16%
lower infragranular), and glia density (5% higher supragranular, 16% higher infragranular) and glia to
neuron ratio (63% higher supragranular, 61% higher infragranular) were both higher in the WS subject.
Table 5 summarizes results for all ages.
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Figure 5. Neuron density, glia density, and glia to neuron ratio in infants.
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II/III No difference No difference
V/VI 33% Lower 16% Lower
8 months
II/III 35% Lower 5% Higher
V/VI 16% Lower 16% Higher
Adult
II/III 17% Lower * 83% Higher *
V/VI 9% Lower 116% Higher *
* Statistically significant results.
4. Discussion
Very few histological studies of BA 25 in TD adults have been conducted [27,33,34], and none on
infants. All data from these few adult studies are qualitative rather than quantitative. The present
study provides the first quantitative data for neuron and glia density in TD adult and infant BA 25.
Our findings demonstrate variation in cell density between cortical layers consistent with expected
patterns based on adult TD brains from the limited reports available. Qualitative description of human
BA 25, along with quantitative findings in macaques, show that caudal, agranular regions of the
vmPFC, such as BA 25, are characterized by higher neuron density in infragranular layers compared
to supragranular layers, and lower glia density than neuron density in all layers [27,28]. As expected,
neuron density is much higher in infants than adults [35]. This study builds on previous research on
the adult PFC in both TD and WS, a region implicated in the behavioral phenotype of the disorder,
and is the first to examine the PFC in WS infants [9,17,35].
Adults: A previous postmortem histological study of WS, which included three of the same adult
WS subjects utilized here, along with an additional three adult WS subjects and six adult TD controls,
found decreased neuron density in BA 10 and 11 of the prefrontal cortex (PFC), with the greatest
difference observed in the infragranular layers [17]. A study on the morphology of basal dendrites in
adult WS subjects found that dendritic length and branching were compromised in the supragranular
layers in BA 10 and 11, relative to more posterior areas of the cortex, BA 4, 3 and 18 [36]. Based on
the above study, we expected to find decreased neuron density in BA 25 in WS adults compared to
TD adults, which is consistent with our results. This difference was greater in supragranular layers
than in infragranular layers. In the present study, we additionally found significant increases in glia
density and glia to neuron ratio, in both supragranular and infragranular layers of BA 25 in WS adults.
An increase in glia was also observed in the caudate nucleus in WS, which seems to be driven by an
increase in oligodendrocytes [18].
Infants: As expected, in both the TD and WS infants, overall neuron density was lower in the
eight-month-old subjects than in the four-month-old subjects. In the TD infants, this difference was
greatest in infragranular layers, while in WS infants there was a greater decrease in supragranular
layers. Additionally, glia density increased with age in both the TD and WS infants, although this
increase was far greater in WS. In the older TD infant, both neuron density and glia density were
elevated compared to adult TD subjects, but glia to neuron ratio was very close to the adult mean.
In the older WS infant, neuron density was elevated compared to adult WS. However, overall glia
density in this subject was similar to the WS adult mean, and glia to neuron ratio was much lower.
In the youngest infant pair examined here (about four months old), differences in both neuron and
glia density between TD and WS appear almost exclusively in the infragranular layers. Additionally,
this was the only pair examined in which the WS subject had lower glia density than the TD subject.
In the older infant pair (about eight months old) examined here, differences in neuron and glia density
occurred in a similar pattern as was seen in adults. There was a greater difference in neuron density
in supragranular layers, and a greater difference in glia density in infragranular layers, suggesting
that this pattern is not present at birth, but is established in infancy. At both time points in the infants,
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overall neuron density was lower in WS than TD, as it is in adults, but the difference in neuron density
in the supragranular layers may develop postnatally, in infancy. In the four-month-old infant pair,
glia density was lower in WS than in TD, in contrast to all other pairs examined. Although these
results represent only two WS infants, one at each age point, this suggests there may be disruptions in
prenatal gliogenesis or glial migration in WS, followed by a significant increase in glial cells which
begins in infancy, and continues beyond the ages of the infants included in this study.
Here, we demonstrated decreased neuron density in WS compared to TD subjects starting in early
infancy; and increased in glia density in WS older infants and adults compared to TDs, but not in the
youngest infant pair examined. Although the exact mechanisms for the decrease in neuron density,
and the differences in glia development observed here in BA 25 in WS are unknown, they may be due
in part to the deletion of GTF2I, GTF2IRD1, and FZD9 genes crucially involved in neural development,
cell division, and cell fate and neuroinflammatory processes increasing glia and decreasing neuronal
survival [37–39]. Given that the decrease in neuron density in BA 25 is present even early in the first
year of life, it likely results from a combination of deficient neurogenesis prenatally and increased
apoptosis prenatally, possibly extending slightly into the postnatal period. WS neural progenitor cells
(NPCs), differentiated from WS induced pluripotent stem cells (iPSCs), were found to have increased
doubling time, resulting in a smaller population of NPCs, and increased levels of apoptosis compared
to TD NPCs. FZD9 appears to be critically involved in these processes in WS. By restoring FZD9, both
apoptosis and the doubling time of WS NPCs and apoptosis were reduced to a similar level as in TD
controls, creating the same number of NPCs as TD controls [37].
The increase in glia density in BA 25 in WS could be due to excess production of glial cells, deficits
in apoptosis, or disrupted migration. Glia have critical roles in neural development and neurological
functions, affecting neuronal survival, and synapse formation, elimination, and functioning [40–42].
Changes in glia cells, or in the ratio of glia to neurons, can alter the typical course of neurodevelopment
and the formation and functioning of neural circuits [43]. Abnormalities in glia cells have been linked
to many neurological or neurodevelopmental disorders, including major depressive disorder, ASD,
and schizophrenia [42–44]. Decreased glia density has been found in the orbitofrontal cortex of subjects
with major depressive disorder, and increased microglia density has been found in the prefrontal
cortex in both ASD and schizophrenia [45–47].
Deletion of FZD9 gene has been shown to affect neural progenitor cells through the canonical
Wnt pathway, a pathway necessary to inhibit the differentiation of oligodendrocyte progenitor cells
(OPCs) [37,38]. The proliferation of oligodendrocytes occurs in a series of successive waves, beginning
prenatally, with later generated cells replacing earlier derived populations [38,48,49]. OPCs continue to
proliferate while migrating to white matter until an appropriate density of OPCs has been reached [50].
OPCs remain proliferative in the subventricular zone throughout postnatal life, although cell turnover
is low in typically developing adults [38,50].
In typical development, neural stem cells switch from neurogenic to gliogenic, producing
astrocytes and then oligodendrocytes, in the prenatal period. The timing of this switch is critical.
If the switch happens too early, it can result in overproduction of astrocytes and deficits in some
neuronal populations. If it occurs too late, this can reduce the number of astrocytes produced, limiting
the signals they provide for axonal guidance, neuronal survival, and synaptogenesis [43,51–53].
Chronic neuroinflammation, which is found in many neurological disorders, could cause increased
density and activation of microglia, and potentially atrophy in astrocytes, leading to the excessive
pruning of synapse and neuronal death. This may result in underconnectivity in the brain and
contribute to the phenotypes of neurodevelopmental disorders [42,44,54]. Inflammation may also
alter synaptic transmission through changes to astrocyte function, further affecting cognition and
behavior [42].
In contrast to the findings in WS, increases in neuron number have been found in the PFC of
young subjects with ASD, age range 2–16 years, with no significant difference in glia number [55].
Impaired connectivity between regions critical to social cognition and emotional regulation may be
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a common factor underlying some of the social and emotional abnormalities seen in both ASD and
WS. In ASD, reduced fractional anisotropy was found in white matter adjacent to the vmPFC, and
in the temporal lobe approaching the amygdala, suggesting disrupted connections between frontal
and limbic brain regions [56]. Additionally, there is evidence of atypical activation of the vmPFC
while evaluating emotional faces, as well as altered functional connectivity in fronto-striatal and
fronto-amygdala circuits [57,58]. Although no differences were found in total glia number in the PFC,
increased density, along with increased activation, of microglia has been demonstrated in the PFC in
ASD [46]. The increased activation of microglia may reflect ongoing neuroinflammatory processes,
which may contribute to loss of synaptic connections and under-connectivity in ASD [46].
Neuroinflammatory mechanisms could account for the increased glia density in WS. Although
no studies have been conducted to examine microglia in WS specifically, chronic neuroinflammation
is common in many neurodevelopmental disorders, including ASD and schizophrenia, and is often
the cause of increased glia density [42,44,46,54]. The results from infant subjects suggest that the
increased glia density in WS may develop over the first year of life, but it does not appear to be
present before 4 months of age. It is not currently known if this increase is restricted to certain
types of glia and to frontal and striatal regions, or if it represents a systemic perturbation of glia.
Further investigation, utilizing immunohistochemical staining to determine what type of glia cells are
affected, and examination of more brain regions in WS could help elucidate this matter.
The results presented here, combined with prior findings of decreased neuron density in BA
10 and 11 in WS, suggest that neuronal abnormalities in WS may be a common feature across the
PFC [17]. Additionally, abnormalities have been reported in the striatum and the amygdala in WS,
two subcortical structures heavily connected to BA 25 [18,20]. Together, these findings suggest that
abnormalities in PFC cytoarchitecture, and altered prefrontal inhibitory control of the amygdala and
striatum, may be linked to the atypical anxiety and social behaviors characteristic of WS.
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Abstract: This perspective describes the contribution of the prefrontal cortex to the symptoms of
depression in adolescents and specifically the processing of positive and negative information. We also
discuss how the prefrontal cortex (PFC) activity and connectivity during tasks and at rest might
be a biomarker for risk for depression onset in adolescents. We include some of our recent work
examining not only the anticipation and consummation of positive and negative stimuli, but also
effort to gain positive and avoid negative stimuli in adolescents with depression. We find, using
region of interest analyses, that the PFC is blunted in those with depression compared to controls
across the different phases but in a larger sample the PFC is blunted in the anticipatory phase of the
study only. Taken together, in adolescents with depression there is evidence for dysfunctional PFC
activity across different studies and tasks. However, the data are limited with small sample sizes
and inconsistent findings. Larger longitudinal studies with more detailed assessments of symptoms
across the spectrum are needed to further evaluate the role of the PFC in adolescent depression.
Keywords: depression; adolescent; prefrontal cortex; neural; reward; positive and negative
1. Depression a Global Burden
Depression is currently reported as the most important cause of worldwide ill health. In the last
10 years, the depression rate has increased by more than 18% [1] and more than 300 million people
worldwide now suffer from depression [1]. Unfortunately, a completely effective treatment has not
been developed for individuals suffering from depression. Although current pharmacotherapy and
psychotherapy helps many patients, they have limited efficacy and significant adverse effects [2].
Depression differs from the emotional fluctuations shown in daily life events, and long-term
depression, in particular, can lead to serious health problems. It can prevent an individual from
fulfilling his/her potential in school, in society, in family, and in work life. There are also high rates of
depression in those that commit suicide and approximately 800,000 people die from suicide each year,
with suicide being the second leading cause of death among 15–29-year-olds [1].
2. Adolescent Depression
Adolescent depression is defined by the diagnostic statistical manual (DSM) as having five or
more symptoms present during a two week period; (1) depressed or irritable, cranky mood (outside
being frustrated) or (2) loss of interest or pleasure and any three of the following: Significant weight
loss or decrease in appetite (more than 5% of body weight in a month) or failure to meet expected
weight gains, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue or lack of energy,
feelings of worthlessness or guilt, decreased concentration or indecisiveness, or recurrent thoughts of
death or suicide [3].
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Early onset depression, in particular during the adolescence period, has a destructive effect that
predicts worse health outcomes in later life [2]. Therefore, understanding the underlying mechanisms
of depression in adolescence is needed if we are to improve treatment and initiate prevention [4].
Adolescents experience dynamic changes in their social relations, thus leading to a very complex
emotional life, while at the same time deal with hormonal and neural changes [5]. As adolescence is a
time of fluctuating positive and negative emotional experiences, it is a vulnerable time for depression.
However, as with adult depression described above, there is a heterogeneity in symptoms of adolescent
depression and it is not entirely clear how they map to neurobiology [6]. One reason for this has been
inconsistent use of questionnaires and assessments in research, which lack any specific detail about
mood change in depression [7]. Understanding adolescent depression could benefit from more detailed
measures of specific symptoms, e.g., anhedonia (the reduced experience of interest and pleasure),
which is currently usually only assessed via its presence or absence and not in any detail from the
adolescent experience [7]. In an attempt to do this, we recently collected information on the adolescent
experience of depression and anhedonia through qualitative interviews and found that a number of
adolescents described a blunting of all emotion (positive and negative) and not just positive emotion,
which may have been expected [8]. However, this fits with the view of a recent meta-analysis also
suggesting overall blunting in positive and negative emotions in depression [9]. Still yet, more needs
to be done to illuminate the adolescent depression experience perhaps using experiential sampling
methodology, which is the changes in symptoms during daily life, if we are to develop even more
efficacious personalised treatments.
Recent methodological developments have led to significant improvements in understanding the
neurobiological mechanisms of the emotional lives of adolescents [10,11]. Owing to these improvements,
it is reported that in the course of adolescence, neural networks are reconstructed with both increases
and decreases in white and grey matter, respectively [12,13]. These changes have been suggested as
underlying age differences in behaviour for e.g., it is thought that adolescents are more sensitive to
peer relationships than adults because they have more activation in areas involved in socialisation,
such as the medial prefrontal cortex (mPFC), compared to adults [12].
3. Neurobiology of Depression
At the biological level, depression can have wide spread effects on the brain [14]. Studies
old [15–17] and new [18–20] find that depression affects many brain regions. Prominent
brain regions with both functional and structural differences in depression are the frontolimbic
brain regions such as the amygdala, hypothalamus, and prefrontal cortex (PFC) [21,22]
(for review, see References [23,24]). Dysfunctional connectivity between these regions via
an amygdala–striatal–pallidial–thalamic–cingulate cortex circuit is also found dysfunctional in
depression [14,25]. Interestingly, a recent review of voxel-level resting state functional connectivity
(RSFC) suggests that the lateral orbitofrontal cortex, which projects to the ACC, has increased
sensitivity to non-rewards in depression whereas the more medial orbitofrontal cortex reward system
is underactive in depression [26]. Moreover, Rolls et al. in 2018 found that unmedicated patients
with depression primarily had increased RSFC between the subcallosal anterior cingulate with the
lateral orbitofrontal cortex, between the pregenual/supracallosal anterior cingulate and the medial
orbitofrontal cortex, and between parts of the anterior cingulate with the inferior frontal gyrus, superior
parietal lobule, and with early cortical visual areas. Further, this study reported that the RSFC was
reduced in depressed patients that were medicated [26]. Interestingly, a recent study has also found
that increased pretreatment pregenual anterior cingulate cortex activity to sad vs. happy faces was
observed in responders relative to nonresponders, and that anterior cingulate cortex activity was able
to predict response status at the level of the individual participant [27]. Given the importance of such
networks of activity in the pathophysiology of depression and its treatment, how they might also act
as predictors for adolescent depression could aid the identification of new targets for intervention
approaches. In this respect, studies have emphasized that the PFC is one of the most important cortical
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brain regions in a network of regions in depression and is therefore a possible target for treatment and
prevention in adolescents [28].
4. The Importance of the PFC
The role of the PFC in behaviours involving cognitive control and emotion processing has
been well documented in adults (for review, see Reference [29]) and adolescents [30]. In summary,
the dlPFC is mostly associated with cognitive processes such as target-oriented behaviours and attention
control [31,32] while the vlPFC has a significant role in complex processes such as the self-regulation of
emotion [19,33].The vmPFC, on the other hand, has been shown to play a role in the production of
negative emotions [34–37].
Interestingly, during adolescence, the structural maturation of the PFC is suggested to underlie the
maturation of emotion regulation strategies. Studies consistently find normative thinning of the grey
matter during adolescence which has been identified as an adaptive process in longitudinal studies
on cognition [38]. For example, Shaw et al. [39] found that adolescents that exhibited greater peak
thickness around puberty, followed by greater cortical thinning into adulthood had superior intellectual
abilities. Furthermore, greater cortical thinning of the left dlPFC and left vlPFC during adolescence has
been found to predict greater use of cognitive reappraisal, the ability to negotiate emotionally stressful
situations by being more optimistic, reinterpreting the stressful stimuli, and actively mending their
negative mood, in healthy females [38]. These findings suggest that cortical maturation may play a
role in the development of adaptive emotion regulation strategies during adolescence. Interestingly,
dysfunction, by way of decreased perfusion in the PFC, has been reported in patients who attempted
suicide. It is thought this PFC dysfunction might reduce problem-solving ability, increase negative
emotions, and, finally, aid suicidal behaviour especially given the role of the orbitofrontal cortex in
response inhibition [22,40].
5. The Role of the PFC in Depression and the Processing of Negative Stimuli
The mechanisms underpinning the processing of negative emotions have received attention,
as low mood and negative thinking are thought to be maintaining characteristics of depression [41].
Negative emotional stimuli activate a broad network of brain regions, including the medial prefrontal
(mPFC) and anterior cingulate (ACC) cortices and, although early reviews suggested a dorsal-caudal
cognitive and ventral-rostral affective subdivision [42], more recent work suggests both subdivisions
make key contributions to emotional processing. Specifically, dorsal-caudal regions of the ACC
and mPFC are thought to be involved in appraisal and expression of negative emotion, whereas
ventral-rostral portions of the ACC and mPFC seem to have a regulatory role with respect to limbic
regions involved in generating emotional responses [43]. Examining these systems in relation to low
mood, a study by Aoki and colleagues [44] using the neuroimaging tool optical topography, found
that adults experiencing higher levels of negative moods showed lower levels of PFC activity during
a verbal working memory task. This also replicated the results of their previous study based on an
independent sample [45]. In another study using near infrared spectroscopy (NIRS), participants were
asked to remember parts of their lives related to positive (happiness) and negative (anger) feelings, and
at the same time, heart rate changes were measured. The authors found that changes in oxyhemoglobin
in the bilateral PFC during silent recall of negative episodes were significantly larger than those during
silent recall of positive episodes. The authors concluded that their results were important in showing
that the PFC plays a key role in the cognitive control of particularly negative emotions [18].
As mentioned above, the dlPFC is thought to be involved in executive function and cognitive
control over behaviour and action [46]. It has been found, using EEG, to have functional and structural
asymmetry that correlates with depressive symptoms in healthy young adults, individuals with
subclinical depression, and patients with depression [47]. Previous studies report that the left dlPFC is
hypoactive for positive and the right dlPFC hyperactive for negative stimuli in depression [48] and
a study by Siegle et al. [49] detected that depressed participants showed reduced dlPFC activity to
110
Brain Sci. 2019, 9, 104
negative words. Furthermore, the lateral orbitofrontal cortex (lOFC), which connects to the dlPFC,
has been found to have a critical role in reversal learning and adapting behaviour based on the
most positive outcome [50]. Recently, it has been posited that dysfunction of the lOFC “non-reward”
circuit may lead to the generation of negative self-thoughts and reduced self-esteem apparent in
depression [50,51].
6. PFC Markers of Risk for Depression and Early Life Stress (ELS)
To date, it is difficult to ascertain neural markers of risk for depression, e.g., it is not known
which of the functional neuroanatomical differences seen in depressed patients predate and predict
depression onset [52,53]. By examining adolescents, neurobiological studies can begin to address this
issue, and studies have found heightened activity in the amygdala during facial-emotion recognition
tasks [54] and greater connectivity between the amygdala and part of the PFC the subgenual anterior
cingulate cortex [55]. Further, recent studies examining PFC connectivity and risk of depression by
virtue of early life stress (ELS) find that adolescent females exhibited a positive association between
ELS and ventrolateral prefrontal cortex (vlPFC) during implicit emotion regulation and both males
and females exhibited an association between ELS and increased negative connectivity between right
vlPFC and bilateral amygdala [56]. The authors suggest these results might reflect greater vlPFC
activation in an emotion regulation context in response to stress i.e., under the stress accelerated
hypothesis. This is where accelerated development of neural circuitry involved in emotion functioning
is caused by stress and is adaptive in the short term [57]. Further, there is evidence in animal models of
ELS-induced changes in mPFC function and developmental trajectory, which may be responsible for
the emergence of both early-onset (during childhood and adolescence) and adulthood-onset anxiety
and mood disorders [58,59]. In summary, studies find ELS, a risk factor for depression, affects PFC
function in early puberty, thus indicating the importance of this region as a potential target for early
intervention in those at risk.
7. PFC and Resting State Functional Connectivity (RSFC) in Adolescents with Depression
Studies have begun to examine RSFC in adolescents with depression and a recent study found
that depressed adolescents showed significantly greater RSFC to left amygdala, bilateral supragenual
ACC, but not with PFC. The results partially support the putative dual-system hypothesis believed
to underlie disorders such as major depression i.e., an imbalance between “hot” limbic activity and
“cold” PFC activity. The authors suggested that adolescents have aberrant, bottom-up processing in
hot limbic regions without the concomitant differences in cognitive control in cold prefrontal regions,
unlike in adults with depression. In addition, changes in functional connectivity were significantly
associated with changes in symptom severity after cognitive behavioural therapy. This indicates that
symptom recovery may be at least partially associated with normalization of RSFC in hot emotional
brain systems, and their restoration is critical for successful therapeutic interventions [60]. We have
also examined resting state functional connectivity (RSFC) in adolescents and the relationship between
PFC connectivity and depression symptoms. We found decreased RSFC between the amygdala and
the pgACC and hippocampus and precuneus in young people with depression symptoms. We also
found decreased RSFC in the young people with depression symptoms between the pgACC and
the putamen and between the dmPFC and the precuneus [61]. Further, the pgACC RSFC with
the insula/orbitofrontal cortex correlated inversely with the anticipation of pleasure in all subjects.
Increased RSFC was observed between the pgACC and the prefrontal cortex and the amygdala
and the temporal pole in the young people with depression symptoms compared to those with no
symptoms. As increased connectivity between the pgACC and the insula correlated with decreased
ability to anticipate pleasure, we suggest this might be a mechanism underlying the risk of experiencing
anhedonia, a suggested biomarker for depression [61]. In our more recent work, we also found that in
a large sample of young people with a range of depression scores, both anhedonia and depression
severity related to decreased dmPFC RSFC with the precuneus, a part of the default mode network.
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However, we also found that increased dmPFC connectivity with the ACC/paracingulate gyrus related
to anhedonia whereas increased RSFC with the frontal pole related to depression severity. This study
is important as it shows us how we can dissociate symptoms in adolescents based on PFC RSFC [62].
In adolescents with depression, medial prefrontal cortical connectivity with brain regions involved in
executive functioning, emotion regulation, and attention have been reported altered [28].
8. The Role of the PFC in Depression and the Processing of Positive Stimuli
In regard to positive processing specifically, studies have shown blunted neural responses
that relate to positive affect [63] and depression symptoms in adolescents [64,65] and even young
children [66]. Further, in relation to positive stimuli, studies of adolescents with depression report mostly
decreased responses to monetary reward in regions like the ventral striatum, caudate, the dorsolateral
and medial prefrontal cortex (PFC), orbitofrontal cortex (OFC), anterior cingulate cortex (ACC),
and amygdala [67,68]. However, most neurobiological tasks of positive emotion processing (reward) do
not examine the different phases of processing such as the anticipatory, motivational, and consummatory
aspects of reward. This has led to inconsistencies across studies on reward in depression [69].
We have been interested in examining how young people at risk of depression respond to positive
and negative stimuli both behaviourally and at the neural level. Furthermore, as recent behavioural
data find that depressed adults have reduced effort expenditure for reward compared to healthy
controls [70], we are also interested in how this is represented at the neural level. Therefore, to address
this, we have developed an experimental model that examines the anticipation of a food reward and a
consummatory phase where rewarding food is eaten. We have shown previously that those at risk of
depression have decreased responses to anticipation and consummation (sight and taste of chocolate
reward) in both ventral striatum and anterior cingulate cortex (ACC) [71]. We also showed that young
people (16–21 years) with a family history of depression but no personal experience of depression
had diminished neural responses in the orbitofrontal cortex (OFC) and the dorsal anterior cingulate
cortex (dACC) to rewarding stimuli, sight, and taste combined in the at-risk group [72]. More recently,
we have also shown that when examining neural activity between young people with depression
symptoms and controls, using a region of interest analysis, regions like the pregenual ACC and ventral
medial PFC were blunted across all positive and negative phases in adolescents with depression
symptoms. We also found that whole brain analysis revealed further blunted activity in the precuneus
and inferior frontal gyrus (during aversive anticipation) and hippocampus (during effort for reward)
and ACC/frontal pole (during aversive consummation) in young people with depression symptoms.
Further, we found a negative correlation between pgACC activity during reward consummation and
anhedonia in adolescents with depression symptoms [73]. Although this was a comparatively small
study, the results are in keeping with the meta-analysis and first quantitative review of emotional
reactivity in depression that found consistent reductions in both positive AND negative reactivity [9]
which supported our previous study [71]). This also fits with the recent hypothesis that as connectivity
of the ACC, a hub for integrating cognitive, affective, and social information to guide self-regulation
across domains, supports adaptive development of self-regulation during adolescence, disrupted
maturation of ACC connectivity could contribute to the development of depression [74].
In our follow-up, much larger study currently under review, we found participants with depression
symptoms invested less physical effort to gain the positive rewarding stimulus than controls and had
blunted neural anticipation of positive and negative stimuli in the precuneus, insula, and PFC (left
dlPFC and lOFC) and blunted neural effort for positive in the putamen [75]. As the dlPFC is involved in
cognitive control and in executive functions [47], we suggest dysfunction in this region might indicate
a mechanism by which reduced planning to gain positive and avoid negative stimuli might arise in
those with depression symptoms. As the lOFC connects to the dlPFC, insula, and premotor areas [76]
and has been found to have a critical role in reversal learning and adapting behaviour based on the
most rewarding outcome [76], reduced lOFC activity might disrupt ability to switch behaviour, which,
in those depressed, might affect preparation to gain reward or avoid aversion.
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9. Conclusions
Taken together, the literature on the neural activity related to positive and negative emotion
processing is limited in adolescent psychopathology [7,64]. Depression, notwithstanding decades of
studies, is a serious disorder with early onset in adolescence indicating worse long-term outcomes,
yet the neural basis of adolescent depression is not yet fully understood [7]. Although the PFC is a
key region implicated in the processing of positive and negative emotion, some inconsistencies in
direction of effects are present in the literature [23,77]. Therefore, in order to understand the role of
PFC in adolescent depression, further studies are needed that examine the processing of positive and
negative stimuli in a dimensional fashion across the spectrum, in line with an RDoC type approach.
Further, it would also be of interest to examine how adolescents regulate their emotion processing
in relation to PFC activity over time and depression onset [38]. Adolescence is an important time, in
which both physical and mental changes are experienced. Although studies have shown that the PFC
region is implicated in depression in adults, less is known about how the PFC impacts upon negative
and positive moods in the adolescent period. Knowing how the PFC is involved in major symptoms
like anhedonia could allow us to develop more targeted interventions for youth depression.
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Abstract: Emotion regulation skills develop substantially across adolescence, a period characterized
by emotional challenges and developing regulatory neural circuitry. Adolescence is also a risk period
for the new onset of anxiety and depressive disorders, psychopathologies which have long been
associated with disruptions in regulation of positive and negative emotions. This paper reviews
the current understanding of the role of disrupted emotion regulation in adolescent anxiety and
depression, describing findings from self-report, behavioral, peripheral psychophysiological, and
neural measures. Self-report studies robustly identified associations between emotion dysregulation
and adolescent anxiety and depression. Findings from behavioral and psychophysiological studies
are mixed, with some suggestion of specific impairments in reappraisal in anxiety. Results from
neuroimaging studies broadly implicate altered functioning of amygdala-prefrontal cortical circuitries,
although again, findings are mixed regarding specific patterns of altered neural functioning. Future
work may benefit from focusing on designs that contrast effects of specific regulatory strategies,
and isolate changes in emotional regulation from emotional reactivity. Approaches to improve
treatments based on empirical evidence of disrupted emotion regulation in adolescents are also
discussed. Future intervention studies might consider training and measurement of specific strategies
in adolescents to better understand the role of emotion regulation as a treatment mechanism.
Keywords: anxiety; depression; adolescence; emotion regulation; fMRI; psychophysiology;
psychological treatment
1. Introduction
Emotion regulation is defined broadly as the capacity to manage one’s own emotional responses.
This includes strategies to increase, maintain, or decrease the intensity, duration, and trajectory of
positive and negative emotions [1–3]. Learning to regulate emotions is a key socio-emotional skill that
allows flexibility in emotionally-evocative situations. There are clear developmental shifts in how
we manage emotional responses. In early childhood, emotions are frequently expressed and external
support is sought (e.g., from a caregiver [4]). In adolescence, there is typically a decreased reliance
on parental support and limited efficacy of adaptive internal emotion regulation [5]. As individuals
mature into adulthood, emotional experiences are increasingly effectively managed through internal
regulatory strategies [6]. Disruptions to emotion regulation capacities in adulthood are central to
theories of how anxiety and depressive disorders manifest and are maintained [7,8]. These theories
suggest that reduced capacities to downregulate heightened negative affect are common to both
anxiety and depression, whereas reduced ability to regulate positive affect may be more specific
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to depressive disorders [9]. Many psychological interventions for anxiety and depression include
cognitive or behavioral strategies that aim to improve abilities to regulate emotion [10,11].
Emotion regulation capacities develop substantially across adolescence. Studies of typically
developing individuals suggest limited efficacy of internal regulatory strategies in early adolescence,
shifting towards increased use of adaptive strategies and decreased use of maladaptive strategies
with age [5,12]. This development coincides with changes in social environment and brain structure.
Adolescence is a period of life with various emotional challenges, such as new academic or work-place
pressures, increasing importance of peer and romantic relationships, and reduced dependence
on family support [13]. Heightened emotional reactivity, increased risk-taking, and impulsive
behaviors are also characteristic of adolescence [14]. This is coupled with ongoing neurobiological
development among circuitries implicated in the management of emotional processes (for a review,
see [15]). Investigation of normative development is ongoing, but current theories focus around
maturation in activity and connectivity among the prefrontal cortex, striatum and amygdala across
adolescence [16,17]. These models propose that increasing prefrontal control over emotionally reactive
subcortical regions enhances capacities to regulate negative emotions (particularly fear) and manage
impulsive tendencies (reward and approach [15,16,18]).
Adolescence is a period of heightened risk for the onset of anxiety disorders and depression [19,20].
It is well-established that stressful life events and childhood adversity are substantial risk factors for
future psychopathology [21]. There is also evidence suggesting that the capacity to regulate emotional
reactions to these events may play a mediating role [22,23]. Given increased independence and novel
demands during adolescence relative to childhood, adolescents may have a particular need to regulate
their emotions in response to stressors. Failure to do so may confer risk for mental health problems.
Thus, emotion regulation may be one important piece of a complex puzzle in terms of risk for anxiety
and depression. The current paper addresses the evidence linking disrupted emotion regulation
to the development of anxiety and depression in adolescence. This question has been investigated
across different levels of analysis including self-report, behavioral, peripheral psychophysiological
and neural measures. Repeated observations across multiple levels of analysis increase the reliability
and validity of observed associations and may improve precision in understanding dysfunction and
disease course [24,25]. Here we review the consistency of evidence across multiple modalities and
highlight discrepancies and gaps in the literature.
A major challenge in the study of emotion regulation is definition and operationalization of
the construct. In this review, we focus on evidence from the most widely-used measures of emotion
regulation, rather than providing an exhaustive list of all possible measures. We begin with an overview
of methodological approaches to studying emotion regulation most frequently used in adolescents.
We then review evidence across levels of analysis supporting claims of a link between negative and
positive emotion regulation capacities with anxiety and depression (summarized in Table 1; note that
as a narrative rather than a systematic review, we provide a selection of findings of interest, rather
than an exhaustive list of all findings in this area). Next, we discuss how these findings have informed
current and emerging interventions targeting emotion regulation and their potential for adolescent
populations. Finally, we provide an overview of discrepancies and gaps in current research and
directions for future work that may enhance our understanding of the development of emotion
(dys)regulation among adolescents at risk for anxiety and depression.
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2. Overview of Measures of Emotion Regulation
Theoretical models of emotion regulation provide organizational frameworks within which to
assess different strategies for regulation. The most widely used framework is the ‘process model of
emotion regulation’ [2,11] which differentiates strategies along the timeline of a developing (negative)
emotional response. A basic distinction in this model is between: (1) antecedent-focused strategies that
manage the generation of an emotional reaction before it occurs, and (2) response-focused strategies
that are invoked during an ongoing emotional reaction. A common antecedent-focused strategy is
cognitive reappraisal, the process by which individuals consider a situation in a different way with
the goal of managing their response when faced with that situation (e.g., when waiting for a friend
to return a message, thinking ‘they are busy’ rather than thinking ‘they don’t like me’). Reappraisal
is considered an adaptive regulatory strategy. A common response-focused strategy is expressive
suppression, whereby individuals try to reduce or ‘suppress’ facial, vocal, or other expressions of the
emotions they are currently experiencing. Expressive suppression is considered to be a maladaptive
regulatory strategy. There are also numerous other strategies that impact the duration and intensity of
negative emotions, such as problem solving, acceptance (considered to be adaptive) and rumination
(maladaptive). Cognitive strategies for the regulation of positive emotions are not as widely discussed,
but some focus on ‘enhancing’ and ‘dampening’, often in the context of interpersonal regulation
between parents and children. Enhancing describes parental reactions of enthusiasm, encouragement
or validation, whereas dampening refers to a focus on potential negative aspects of a situation, raising
concerns and minimizing positive aspects [69].
3. Self-Report Measures of Emotion Regulation
A widely used self-report measure is the Emotion Regulation Questionnaire (ERQ) that follows
the organizational principles of the process model of emotion regulation and has subscales for
reappraisal and expressive suppression [70]. Other questionnaires assess different combinations
of emotion regulation strategies, such as the Difficulties in Emotion Regulation Scale (DERS; [71]),
the Cognitive Emotion Regulation Questionnaire (CERQ; [72]) and the Fragebogen zur Erhebung der
Emotionsregulation bei Kindern und Jugenlichen (FEEL-KJ [73]). The varying content of these widely
used self-report measures highlights inconsistencies with which the term ‘emotion regulation’ is
used and limits the extent to which data across studies can be combined (see Table 2 for subscale
comparison across measures). There are fewer standardized self-report measures available for positive
emotion regulation. One such measure is the ‘responses to positive affect’ scale, which consists of three
sub-scales: dampening, self-focused positive rumination and emotion-focused positive rumination [74].
Table 2. Overview of subscales across self-report measures of negative emotion regulation. Strategies
are informally categorized as ‘adaptive’, ‘maladaptive’ or ‘uncategorized’ (describing more general
emotion regulation behavior, rather than specific strategies). ERQ: Emotion Regulation Questionnaire;
DERS: Difficulties in Emotion Regulation Scale; CERQ: Cognitive Emotion Regulations Questionnaire;
FEEL-KJ: Fragebogen zur Ehrebung her Emotionsregulation bei Kindern und Jugenlichen.
ERQ DERS CERQ FEEL-KJ
Adaptive Strategies
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Table 2. Cont.
ERQ DERS CERQ FEEL-KJ
Maladaptive Strategies















Retrospective self-report questionnaires are criticized for the likelihood of over-generalized
responding, the assumption that people are conscious of how they regulate their emotions and bias in
memory effects (remembering most recent and/or salient experiences [75]; Table 3 lists methodological
limitations of techniques discussed). Overcoming limitations based on memory, experience sampling
methodologies aim to capture responses to experiences during, or close in time to, real life events
through high density self-reporting (multiple times per day). This approach offers richer data on
emotional experiences and often encompasses both positive and negative affect. Existing studies
using this approach assess emotion regulation through self-report of strategy use and duration of
emotional experiences (i.e., ‘emotional recovery’). However, ‘emotional recovery’ may be influenced
by factors other than regulation, including emotional intensity or situational changes. This type of
approach therefore prevents discrete measurement of emotional reactivity from emotional regulation
(for a theoretical discussion of this issue, see [76]).
Table 3. Comparison of the methodological limitations of different study designs used to assess emotion
























across measures x x
Limited assessment of
positive vs. negative affect x x x x x
Retrospective bias x
Socially desirable
responding x x x x x
Conflates emotional
reactivity and regulation x x x x
Assumes accurate insight
into regulatory strategy x x
Lacks ecological validity x x x
4. Behavioral Assessment of Emotion Regulation
Observational approaches can be used to examine responses, for example: during in vivo
stress inductions (e.g., Trier Social Stress Task [77] or mock job interviews [46,59]); between pairs
of individuals in spontaneous interactions; or during prescribed stress-inducing or rewarding
situations [65,66,78]. Participants’ behavioral and verbal responses are coded and classified according
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to regulatory strategy and subjective affect ratings can be collected to measure emotional recovery.
As with self-report measures, these approaches too may be influenced by socially desirable responding
and lack the capacity to separate reactivity from regulation.
Computer-based methods of assessing emotion regulation behaviors involve presenting
participants with affectively evocative images (such as from the International Affective Picture
System [79]) and asking them to rate the strength of their emotional reaction. In some variants,
participants passively view images to assess ‘automatic’ or ‘spontaneous’ regulation, other variants
aim to enhance ecological validity by swapping affective images for descriptions of ambiguous
situations (e.g., mother is late to come home [40]). While providing a degree of experimental control
unavailable in observational studies, these ‘spontaneous regulation’ paradigms still cannot dissociate
emotional reactivity from regulation, conflating assessment of the strength of an emotional response
with the ability to regulate this response. Stronger ‘deliberate regulation’ designs compare ratings
from passive ‘reactivity’ trials with active ‘regulatory’ trials in which participants are instructed to
down- or up-regulate their emotional response. This approach offers a within-subjects inspection of
the impact of deliberate emotion regulation using predetermined strategies. A potential drawback
of this approach, however, is response bias in affect ratings where individuals may report reduced
negative affect as a consequence of following task instructions rather than successful regulation per se.
In some studies participants are trained to use specific strategies (such as reappraisal, distancing or
suppression), although there is variability in the extensiveness of pre-task training and participant
proficiency in strategy usage across studies.
5. Peripheral Psychophysiological Indicators of Emotion Regulation
Peripheral psychophysiological studies of emotion regulation use similar designs to those
described above for behavioral assessments, so the limitations of those designs also apply to methods
described here. Investigation of peripheral psychophysiological correlates of emotion regulation
encompass a range of measures. Cardiac and respiratory measures include heart-rate variability and
respiratory sinus arrhythmia (RSA; variation in heart rate within a breath cycle). Greater variation in
heart rate and RSA are considered indicative of greater physiological adaptation to emotional stimuli
(i.e., more effective regulation [80]). Ocular measures include pupil dilation, a measure of arousal
or ‘cognitive effort’ [81], and visual fixation patterns, which demonstrate areas of attentional focus
(and have also been suggested to indicate prefrontal cortex activation [82]). Facial electromyography
(EMG) of the startle blink reflex and corrugator muscle activation are used as measures of negative
emotional arousal [83]. Skin conductance levels and responses are used as a measure of emotional
arousal at a chronic, or stimulus-evoked level, respectively [84]. These measures offer the potential for
objective, low-cost biological markers of emotion regulation. However, they largely suffer from a lack
of specificity in relation to psychological constructs, making the functional significance of differences
observed difficult to interpret [85].
6. Neural Measures of Emotion Regulation
Neuroimaging studies using functional Magnetic Resonance Imaging (fMRI) to investigate neural
correlates of emotion regulation have primarily used deliberate regulation paradigms. Across studies
to date, instructions for regulation vary from broad approaches (e.g., ‘decrease’) to specific strategies
(e.g., ‘distance’ or ‘reappraise’). One concern with fMRI designs is that due to timing constraints,
participants are often given a short period of time (approximately eight seconds) to implement
a strategy per image, raising potential concerns of ecological validity. A different approach used in
fMRI studies are measures of ‘incidental regulation’, such as affect labeling [86,87]. Unlike study
designs assuming ‘automatic’ regulation, studies of ‘incidental’ regulation investigate processes
wherein a specific task may lead to emotion regulation, without the deliberate intention of doing
so. For example, in the affect labeling task, participants view images of emotional facial expressions
and are asked to label the emotion they see. Affect labeling has been shown to decrease experienced
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negative emotions and is also common across forms of psychotherapy [86]. As many individuals
may be unaware of their emotion regulation strategies, the incidental nature of affect labeling may
be helpful in addressing/circumventing limitations of self-report methodologies. One criticism of
this approach, however, is that individuals do not intend to regulate when labeling (i.e., the goal is
implicit), so it may not be considered a true form of emotion regulation. Despite this concern, studies
using this task have demonstrated that affect labeling recruits neural circuitries implicated in emotion
regulation in healthy adults, such as reduced amygdala activation, and increased inverse ventrolateral
prefrontal cortex (vlPFC)–amygdala connectivity [86,87]. Because affect labeling robustly activates this
circuitry in healthy samples, it offers an objective comparison of potential biological differences in
psychopathology during incidental emotion regulation.
7. Relationships between Emotion Regulation Abilities and Symptoms of Anxiety and
Depression in Adolescents
7.1. Findings from Self-Report Studies
Analyses of self-reported data consistently identify associations between emotion regulation
abilities and symptoms of anxiety and depression in adolescents. For example, less use of cognitive
reappraisal and greater use of expressive suppression was associated with higher symptoms of
depression [46,48], and higher levels of rumination were associated with greater symptoms of
social anxiety [39]. This was recently confirmed in a meta-analysis of 35 studies in adolescents
(aged 13–18 years), demonstrating that compared to healthy individuals, those with anxiety and
depressive disorders engaged in less reappraisal, problem solving, and acceptance (adaptive regulatory
strategies) and more avoidance, suppression and rumination (maladaptive strategies [36]). Of these
associations, the strongest effects were observed for reduced acceptance and increased avoidance
and rumination across both anxiety and depression, with little evidence of specific disruptions linked
to either disorder. Other work has sought to investigate patterns of disrupted emotion regulation
specific to individual anxiety disorders. One study suggested greater deficits in emotional clarity
and non-acceptance of emotions in social anxiety disorder compared to generalized anxiety disorder
(using the DERS [38]). However, another found no differences between groups of adolescents with
different anxiety disorder diagnoses (using the FEEL-KJ [37]). While use of different questionnaires
across studies may explain differences in effects observed, there is no strong evidence of specific
deficits in emotion regulation resulting in specific symptom profiles within anxiety disorders.
Relatively few studies have examined the role of positive emotion regulation in relation to
symptoms of anxiety and depression. One study in which parents reported on adolescent affect
found that parents of depressed adolescents rated shorter durations of ‘happy’ affect in their children,
compared to parents of non-depressed adolescents [61]. However, this study did not investigate
strategies for maintaining or dampening positive affect, limiting the ability to differentiate disruptions
in regulation from reactivity. Other studies have focused on interpersonal aspects of emotion regulation,
showing that self-reported parental dampening, or a lack of parental enhancing of positive affect,
was related to prospective increases in adolescent depression, potentially via their own dampening
of positive affect [63,64]. The extent to which these findings are specific to symptoms of depression,
rather than more general psychopathology remains unexplored.
Studies using experience sampling methodologies are beginning to examine relationships between
daily experiences of emotion, regulation strategies and symptoms of anxiety and depression. One such
study in adolescents aged 13–16 years over a 21-day period showed that symptoms of depression
were related to reduced variance in reported emotional state (including happiness, depression, anger
and anxiety), an effect that was associated with the ‘acceptance’ subscale of the DERS [47]. A study
that collected data over two weekends using nine daily self-reports of emotional events and self-rated
emotion regulation in a sample of 12–17 year-olds found no association between momentary use of
emotion regulation strategies and depression in girls, but an inverse relationship between acceptance
and depression in boys [88]. These types of approach hold much promise for examining daily life
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experiences of emotion regulation, but further work is required to standardize analytic approaches
and investigate other factors that may influence these relationships potentially explaining the mixed
findings observed to date.
Beyond simple correlations of co-occurring emotion regulation deficits and symptoms of anxiety
and depression, it has been suggested that disrupted emotion regulation is a risk factor for the
development of psychopathology [89,90]. Confirming this effect, meta-analytic data suggests that
disrupted self-reported emotion regulation abilities predict subsequent diagnosis of anxiety or
depression [36]. Critically, the same analyses did not find that psychopathology predicted subsequent
disruptions to emotion regulation. This unidirectional relationship was also observed in a large
(N = 1065) study of adolescents aged 11–14 years [75]. Although this study showed that while a latent
construct of ‘emotion dysregulation’ (combining multiple subscales) predicted symptoms of anxiety,
aggression and disordered eating behaviors, depression was predicted only by rumination, expression
of anger and expression of sadness. While highlighting the differing effects that can be observed with
varying definitions of emotion regulation, this work does provide support for the notion that disrupted
emotion regulation is a risk factor for future psychopathology.
Emotion regulation has also been proposed as a mediating variable between a risk factor (e.g., early
life adversity) and the development of psychopathology. Mediator variables hold the potential to
identify factors that might be altered through intervention to reduce the risk of psychopathology.
Studies investigating the mediating role of emotion regulation in adolescents suggest that increased
use of maladaptive emotion regulation strategies may mediate the association between adversity and
psychopathology. These studies found: (1) an effect of self-blame, catastrophizing, and rumination
on the relationship between stressful life events and symptoms of depression [57]; and (2) a role
for rumination and impulsive responding on the relationship between childhood maltreatment and
symptoms of internalizing psychopathology [58]. What these studies do not indicate is whether higher
levels of adaptive strategies reduce the risk of psychopathology following early life adversity.
7.2. Findings from Behavioral Studies
Across studies using deliberate emotion regulation paradigms, there is some evidence suggesting
that anxiety is associated with reduced use of reappraisal, while findings for depression are mixed.
Considering first anxiety, anxious adolescents were shown to have heightened emotional reactivity to
negative images and impairments in generating reappraisals when cued [40,41]. However, in trials
where they did successfully generate reappraisals, anxious adolescents were able to effectively reduce
their negative affect to a similar degree as their non-anxious counterparts. Deficits in reappraisal
generation corresponded both with less frequent self-reported everyday use of reappraisal and lower
reappraisal self-efficacy (i.e., the belief that reappraisal would improve their feelings), suggesting
a combination of real and perceived deficits in adaptive emotion regulation. Classification of anxious
adolescents’ verbal responses to ambiguous situations according to regulatory strategy showed
reduced spontaneous use of reappraisal and problem solving and increased use avoidance and
help-seeking strategies with no differences in attentional deployment (distraction) or behavioral
response modulation (suppression) [40]. Together, these findings suggest that reappraisal may be an
effective yet underutilized strategy in adolescents with anxiety. Another study assessing abilities to
suppress or amplify expressive behaviors in response to positive and negative images found no effects
of anxiety or depression [42], suggesting impairments observed may be specific to reappraisal skills.
Studies investigating reappraisal ability have demonstrated mixed effects for adolescent
depression. All studies to date with behavioral affect rating data have used deliberate emotion
regulation paradigms while participants also underwent fMRI (neural results are discussed below).
Two studies found no difference in reappraisal success (difference in average affect ratings for ‘look’
minus ‘decrease’ trials in samples aged 13–17 [49] and aged 15 [50]), but a third study in a sample of
15–25 year-olds showed poorer reappraisal success in adolescents with depression compared to healthy
controls [51]. One difference between studies that may contribute to the discrepancy in findings is
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depression severity, with deficits in reappraisal observed in a sample with more severe depressive
symptoms (and an older age range). It is possible that depression severity impedes the effectiveness
of reappraisal, although it remains unclear whether this is due to deficits in reappraisal generation
or implementation. Future work directly comparing these processes in adolescents with anxiety,
depression and mixed diagnoses would be helpful to delineate the nature of any differences associated
with specific disorders.
Behavioral studies of interpersonal positive emotion regulation highlight an association between
depressive symptoms and shorter duration of positive affect. In one study, adolescents and their
parents completed a trivia game which was rigged to provide positive feedback, followed by a ‘conflict
task’ in which families discussed previously identified ‘family issues’ [65]. While there was no
association between depressive symptoms and observed positive affect during the reward task,
there was an association with the ‘persistence’ of positive affect, defined as the maintenance of
positive affect in a negative situation. Other findings suggest links between parental and adolescent
emotion regulation, with reduced maternal positivity and increased dampening related to reduced
maintenance of positive affect [66] and higher adolescent depressive symptomatology [67]. However,
these studies did not assess self-focused regulatory strategies that may contribute to positive affect
persistence, again impacting the ability to dissociate disruptions to emotion regulation from disrupted
emotional reactivity.
As suggested in the self-report literature, there is emerging behavioral evidence that
emotion regulation may impact the association between stressful experiences and psychopathology.
In one study examining this effect, adolescents completed a social stress task (a mock job interview),
provided distress ratings before and after the task, and completed self-report measures of cognitive
reappraisal (using the ERQ) and depressive symptoms. Among those reporting higher levels of
depressive symptoms, greater self-reported tendency to use cognitive reappraisal was associated with
faster ‘emotional recovery’ (difference in distress ratings from before to 30 min after the task [59]).
These findings indirectly suggest that the ability to use cognitive reappraisal in the face of social
stressors may buffer the impact of depressive symptoms on emotional reactivity and recovery.
However, it is important to note that in-vivo emotion regulation was not directly assessed during
the stress task. Findings from self-report studies suggest that emotion regulation following stressful
life events may impact the likelihood of developing psychopathology, while this study suggests
a relationship in the opposite direction, that self-reported general emotion regulation tendencies may
affect the impact of depression upon emotional reactivity/recovery. A variant on this paradigm in
which participants are instructed to use reappraisal or other specific strategies in different conditions
would allow a more direct investigation of the efficacy of each strategy. This would also help clarify
the direction of these relationships, which would be useful in improving understanding of the
developmental etiology of depression in adolescents (e.g., clarifying emotional reactivity or recovery
as a vulnerability factor or a symptom of depression).
7.3. Findings from Studies of Peripheral Psychophysiology
Studies of peripheral psychophysiological indicators of emotion regulation in adolescents have
sought to identify specific patterns of disruption linked to anxiety and depression. One small study in
anxious youth (N = 27, aged 8–17 years) demonstrated that the number of fixations during negatively
and positively valenced pictures (relative to neutral pictures) was greater among individuals with
anxiety disorders, compared to healthy individuals [43]. The authors suggest that as visual fixations
have been shown to correlate with activation of the prefrontal cortex [82], these findings may indicate
that anxious adolescents were trying to regulate their responses even in the absence of instructions to do
so. However, given that there were no differences in visual fixations when participants were instructed
to regulate, this interpretation seems unlikely. The same study also found greater pupil dilation during
negative compared to neutral pictures when instructed to ‘upregulate’ emotional responses in anxious,
but not healthy adolescents [43]. As pupil dilation is considered an index of arousal this might suggest
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anxious adolescents experience more intense emotions when deliberately upregulating. However,
the general nature of instructions prevents conclusions regarding the type of strategy employed,
or whether, for example, adolescents with anxiety engage maladaptive regulatory strategies more
readily than healthy adolescents. In addition, it is important to note that using psychophysiological
measures to make inferences about emotional states is a form of ‘reverse inference’, and the lack of
specificity between emotional experiences and peripheral psychophysiological markers caution against
this type of conclusion.
Whereas research in children suggests a predictive relationship between RSA and future anxiety
and depression (e.g., [54,91]), findings from studies in adolescents are mixed. A large study of
11-year-olds (N = 1653) found no correlation between RSA and concurrent or future depressive
symptoms assessed at age 13 [55]. The same study did, however, identify an interaction with life
stress such that among individuals who experienced higher levels of stressful life events, higher RSA
was associated with reduced self-reported anxiety [55]. Other work has suggested that atypical RSA
patterns (either higher or lower) are associated with maladaptive regulatory strategies, which in turn
are predictive of future depressive episodes in older adolescents with a history of depression (although
RSA did not directly predict depression recurrence [53]). In another study, change over time in RSA
predicted emotion regulation abilities in a sample of 8-12 year-olds with varying levels of depression
and conduct problems [52]. Improving physiological responses to emotional challenges over time,
i.e., increased RSA during a sad mood induction, was associated with fewer self-reported difficulties in
emotion regulation, particularly in relation to ‘accepting’, ‘impulse control’ and ‘ability to use emotion
regulation strategies’. RSA is often considered a specific measure of emotion regulation, yet it has
also been shown to vary according to individual differences in emotional reactivity [80] which limits
interpretations that can be made with this measure.
Investigating the effects of sustaining positive affect, a study of young adults (18–21 year-olds)
involved a reward task, followed by a mood induction film clip that was positive, negative or
neutral [92]. Reporting higher positive emotion during the reward task was associated with a faster
return to physiological baseline (based on heart rate measures) when subsequently viewing a neutral
film clip, but slower return to baseline when subsequently viewing a positive film clip. This study
suggests that individual differences in reactivity to reward are related to physiological differences in
adaptation to subsequent mood induction stimuli to maintain (positive clip) or reduce (neutral clip)
positive affective states. However, this study did not examine the impact of intentional regulation
of positive affect, which would be of much interest to investigate whether individuals can generate
a ‘sustained’ positive valence state, and how this relates to symptoms of psychopathology.
Overall, evidence from psychophysiological studies linking emotion dysregulation to anxiety and
depression is preliminary and highly varied in experimental methodology and sample characteristics,
making comparisons across studies difficult. Addressing some of these challenges, a recent study
concurrently used a range of measures to assess emotion reactivity and regulation during presentation
of valenced images [44]. In a sample of young adolescents, measures of corrugator and startle EMG and
skin conductance were assessed while participants were instructed to ‘maintain’ or ‘discontinue’ their
emotional responses. Corrugator EMG activity was sensitive to valence (positive vs. negative stimuli),
while startle EMG and skin conductance was sensitive to regulation instruction. This approach offers
promise for identifying reliable indicators of emotion regulation across development and how they
may be disrupted in adolescent anxiety and depression.
7.4. Findings from fMRI Studies
In normative adolescent neural development, the maturation of prefrontal regions supporting
emotion regulation lags behind limbic regions involved in emotion generation (for a review, see [15]).
Most studies observe linear decreases in amygdala reactivity to affective stimuli with age [30–32],
alongside linear increases in dorsomedial prefrontal cortex (dmPFC) recruitment [33]. Age-related
improvements in cognitive regulation of emotion are also associated with reduced amygdala
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activation [34,93] as well as increases in inverse coupling (i.e., negative correlation in functional
connectivity) between the PFC and amygdala [34]. A shift from positive to inverse amygdala–PFC
connectivity occurs from childhood to adolescence [30]. By mid-adolescence, most youth display
inverse amygdala–PFC connectivity, with stronger inverse connectivity corresponding to lower
symptoms of anxiety in a non-clinical sample [30,94]. Evidence across fMRI studies suggests that
disruptions in the same cortico-limbic circuitry during emotion regulation are implicated in anxiety
and depression in adolescents.
Studies reviewed above described mixed findings as to whether adolescents with depression
demonstrated disrupted abilities to reduce ratings of negative affect during instructed
reappraisal [49–51]. In contrast, functional MRI data from the same studies have consistently found
evidence of aberrant prefrontal activation and connectivity during deliberate emotion regulation.
However, the specific regions implicated and disruptions in connectivity observed vary across studies
(see Figure 1). Three out of four extant studies found evidence of heightened amygdala reactivity
or greater amygdala–PFC connectivity during regulation in adolescents with depression [50,51,56].
However, the study which did not observe these findings was the largest (with the greatest power to
detect effects) and did not find robust evidence of altered amygdala reactivity or connectivity, instead
demonstrating changes in connectivity between dorsal regions of prefrontal cortex and inferior frontal
regions [49]. Studies of depression in adults generally support a model of heightened activation
in cognitive control regions and impaired subcortical down-regulation [95–98], which has been
interpreted as an effortful yet ineffective attempt to regulate. In adolescents, connectivity between
subregions of PFC may also play a role. Further investigation of inconsistencies across studies,
perhaps by utilizing measures of emotion regulation from other levels of analysis, would be useful in
determining the role of regulatory circuitry in adolescent depression. Importantly, no studies have
investigated neural differences in up-regulation of positive emotions in adolescents with depression,
which is an important avenue for future research given the relevance of the positive affect system in
major depressive disorder.
 
Figure 1. Patterns of altered neural activation and connectivity during emotion regulation in adolescents
with depression. Overall, studies to date have demonstrated altered activation and connectivity in the
amygdala and across regions of prefrontal cortex. The directionality of effects (greater or lesser in depressed
compared to non-depressed participants), and the specific set of regions involved however varies across
studies. (PFC: prefrontal cortex, dm/dlPFC: dorsomedial/dorsolateral PFC).
fMRI investigations of emotion regulation in adolescents with anxiety have been more limited
than in depression, with no studies of deliberate reappraisal to date. However, activation across similar
circuitry during incidental emotion regulation may prospectively predict the development of anxiety
symptoms. For example, in a sample of ninth grade females (mean age 15), positive amygdala–vlPFC
connectivity during an incidental emotion regulation task (affect labeling [87]) predicted future
symptoms of anxiety in the following 9 months [45]. Interestingly, childhood negative emotionality
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(assessed by parent, teacher, and self-report from grades 2–7) related to positive amygdala–right
vlPFC connectivity in ninth grade, but only in girls with low levels of cognitive control (assessed by
Brief Rating Inventory of Executive Functioning reports from grades 5–7). The authors suggested
that individual differences in negative emotionality and cognitive control may be respective risk
or resilience factors for ‘less mature’ positive connectivity between the amygdala and PFC, and in
turn anxiety.
Similar to behavioral and self-reported findings, there is some evidence that neural measures
of emotion regulation ability (cortico-limbic functional connectivity) may influence the association
between stress and depression. After completing an incidental emotion regulation task [87], a sample
of adolescent females (mean age 15) underwent a social stress manipulation by completing the
Cyberball task [99] in which they were unknowingly excluded from a virtual game of catch.
Positive amygdala-vlPFC connectivity during incidental emotion regulation was associated with
greater self-reported ‘stress-reactive rumination’ (following the Cyberball task) and mediated the
relationship between self-reported rumination and depressive symptoms [60]. The retrospective
self-report of depression and lack of temporal precedence limits these findings from a developmental
psychopathology perspective, but highlights a potential mediating mechanism that could be
investigated longitudinally in future research.
Taken together, these studies suggest that adolescents with anxiety and depression exhibit
differences in neural functioning compared to non-depressed peers during deliberate emotion
regulation. Evidence to date suggests that some of these differences may be similar to disruptions
in emotion regulation neural circuitries observed in adults, although no studies have yet directly
compared samples of adolescents and adults with anxiety or depression. Existing models of emotion
regulation make inferences based on directional connectivity between prefrontal and subcortical brain
regions. However, as functional connectivity analyses are correlational, it is ultimately impossible
to interpret directionality (i.e., whether inverse connectivity indicates prefrontal down-regulation
of affective regions). A less common yet promising analytical approach is ‘effective connectivity’
(e.g., dynamic causal modeling or Granger causality), which can be used to determine effective
connectivity, or the directional influence of one region upon another. For example, one study using
this technique demonstrated that adults with social anxiety disorder display impaired bidirectional
amygdala–vmPFC effective connectivity while perceiving affective stimuli [100]. Use of this approach,
and other advanced analytic techniques, may allow more direct investigation of proposed models of
neural circuitry dysfunction during emotion regulation in adolescents with psychopathology.
8. Clinical Implications for Interventions in Adolescents
Understanding emotion regulation in adolescents with anxiety and depression is critical for
improving the efficacy of existing treatments and informing the development of novel interventions.
Promoting adaptive emotion regulation is a central component of most evidence-based psychotherapies
for adolescent anxiety and depression, although different skills are emphasized across modalities.
Cognitive Behavioral Therapy (CBT), emphasizes cognitive restructuring and promotes the use of
reappraisal, while ‘third wave’ psychotherapies (e.g., mindfulness-based cognitive therapy, dialectical
behavioral therapy [101]) focus on acceptance and decentering to regulate emotions. Most studies of
psychotherapy effectiveness include both children and adolescents in combined samples, with age
relating to better treatment outcomes [102]. Older adolescents may be better able to benefit from CBT
possibly due to more developed cognitive and social skills, consistent with age-related improvements
in emotion regulation ability in healthy adolescents [26,27]. It remains unknown whether emotion
regulation skills taught in mindfulness-based versus cognitive behavioral approaches are better suited
for certain individuals across development, highlighting the importance of age effects and treatment
matching in future research.
As intervention packages typically contain several elements, it can be difficult to tease apart the
‘active ingredients’ of treatments. In line with the National Institute of Mental Health’s (NIMH) shift in
128
Brain Sci. 2019, 9, 76
clinical trials to an experimental therapeutic paradigm [103], a priority for intervention research is to
test specific mechanisms of action that account for meaningful clinical change. Emotion regulation
is a prime candidate for such mechanistic studies. This has been the goal in more recent treatments
that specifically focus on enhancing emotion (e.g., Contextual Emotion Regulation Therapy [104],
Emotion Regulation Therapy [105]). Changes in decentering and reappraisal through Emotion
Regulation Therapy temporally preceded reductions in anxiety and depression in young adults,
suggesting a potential mechanism [106]. Future work should extend and tailor these treatments to
adolescent populations.
Other mechanistic work aiming to distil the effects of individual treatment components
has focused on briefer computerized trainings designed to change attentional or interpretational
biases believed to contribute to anxiety and depression [107]. In line with the process model of
emotion regulation [2], Cognitive Bias Modification aims to tap into antecedent-focused regulatory
processes such as attentional deployment (Attention Bias Modification) and interpretation/reappraisal
(Interpretation Bias Modification). Although these approaches have been shown to effectively retrain
biases, estimates of the effects on clinical outcomes in adults are modest [108]. Recent adaptations that
train attention toward positive stimuli show promise in reducing symptoms of anxiety and depression
in children [109,110]. As reviewed above, adolescents with anxiety and depression may have specific
deficits in the generation of reappraisals. More open-ended modifications of interpretation bias training
may therefore be helpful in improving this ability.
Few interventions target positive emotion regulation in adolescence and adults alike, mirroring the
relative dearth of research in this domain. Designed specifically to treat anhedonia in adults, Positive
Affect Treatment (PAT [111]) promotes positive emotion through a variety of behavioral, cognitive,
and experiential exercises. For example, rather than challenging negative thoughts as in traditional
CBT, PAT promotes identifying positive aspects of situations (i.e., finding the silver lining). Through
its treatment components, PAT likely both induces and augments positive affect, involving both
bottom-up and top-down processes (i.e., emotional reactivity and regulation). Future research might
adapt similar interventions for adolescents. Given the link between adolescent depressive symptoms
and reduced positive emotion persistence [65,66] novel interventions may focus on techniques that
sustain positive affect in the presence of stress and train recovery after stressful events.
Intervention studies also offer a powerful approach to investigating mechanisms of treatment
action. Increasingly, neuroimaging measures have been included in trials of psychological interventions,
with mounting evidence suggesting changes in functioning and connectivity in amygdala-prefrontal
circuitry following CBT [112,113]. To date, there have been no studies of interventions with adolescents
assessing neural mechanisms of interventions using emotion regulation tasks. Neuroscientific research
of treatment mechanisms has started to lead to the development of novel treatment approaches, such
as repeated transcranial magnetic stimulation (rTMS [114]) and neurofeedback [115,116], which hold
promise for altering activation of emotion regulation neural circuitries.
9. Summary and Directions for Future Research
From the literature reviewed above (summarized in Table 1), there is a consistent body of
evidence from self-report studies that disruptions to emotion regulation capacities are associated
with greater likelihood of experiencing anxiety and depression in adolescence. There is also evidence
suggesting that these disruptions to emotion regulation are predictive, rather than sequelae, of future
psychopathology. To date, there is no strong evidence relating specific regulatory strategies with
specific diagnoses or symptom profiles, suggesting that altered capacities in this domain confer a more
general risk for psychopathology.
In contrast, findings from behavioral studies suggest that anxiety in adolescence may be
specifically related to a reduced spontaneous use of reappraisal regulatory strategies. However,
given that there are far fewer behavioral than self-report studies in this domain and that behavioral
studies have less comprehensively assessed all forms of emotion regulation across different diagnoses,
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the specificity of this effect may not be as clear as it appears. There is no consensus from behavioral
research as to whether depression is linked to disruptions in regulation of negative affect, with
some studies showing reduced reappraisal efficacy and others not showing this effect. One finding
that does appear more consistent is the reduced duration of positive affect among adolescents with
depression, although the extent to which this is tied to deficits in cognitive regulatory strategies has
not been investigated.
Findings from peripheral psychophysiological measures are limited, and effects observed are also
mixed. There is some preliminary evidence from individual studies, but the variance in methods used
prevents commentary on consensus of findings in this area. There has been a relative proliferation
of functional MRI studies assessing disrupted emotion regulation neural circuitry. On the whole,
these studies have identified differences in activation and functional connectivity between amygdala
and prefrontal cortical brain regions in adolescents with depression. Studies of anxiety suggest that
disruptions in neural functioning may precede onset of symptomatology. Although overall findings
from neuroimaging studies point to disruptions in similar circuitries, individual studies show different
spatial patterns of effects. A challenge to future work in this area is to establish greater specificity in
models of emotion regulation neural circuitry, including tests of effective connectivity that can begin
to investigate probable direction of information flow.
Across studies of self-report, behavioral, and neural measures of emotion regulation reviewed,
there were findings indicating relationships between reactivity to stressful events, emotion
dysregulation and psychopathology. Findings from self-report studies suggest that emotion regulation
skills may mediate the effects between early life adversity and subsequent psychopathology, while
evidence from other levels of analysis present less clear directionality. It may be that disruptions
to emotion reactivity and regulation are vulnerability factors for the development of future
psychopathology, or that these problems arise as symptoms of specific disorders.
Future Directions
As demonstrated in Table 1, there are clear gaps in current research on associations between
emotion regulation and psychopathology in adolescents. One particular discrepancy is the greater focus
on regulation of negative emotions, compared to positive emotions. Both the theory and (self-report)
measurement tools available are more established for negative compared to positive regulation.
Approaches used to investigate regulatory skills in behavioral, psychophysiological and neural levels
of analysis however, may be just as appropriate for the study of positive emotion regulation. Some
of the studies reviewed used multiple techniques to investigate emotion regulation across different
levels of analysis. This should be encouraged in future work, particularly in the integration of newer
techniques, such as ecological momentary assessment, to allow investigation of how findings observed
in retrospective self-report or lab-based studies relate to daily life experiences.
As noted throughout, many of the studies reviewed also rely on indirect measures of emotion
regulation, wherein responses to emotional stimuli are measured and the magnitude or duration of
response is considered evidence of regulation. More stringent study designs use direct comparisons of
instructed strategies which can help to disentangle effects of emotional reactivity from regulation.
The instructions provided and regulatory strategies used in these studies is somewhat varied,
but overall has focused on reappraisal, with less research investigating other regulatory skills
(e.g., acceptance). Studies also vary in the use of emotional stimuli, but there has been a lack of
discussion of whether there may be some strategies that are more appropriate than others for certain
stimuli. For example, reappraisal may be an appropriate strategy for social stimuli, but less appropriate
when responding to a moral violation (e.g., [27]).
There are also some individual difference variables that may be of much value to understanding
the development of emotion regulation capacities. These include gender, pubertal status and cognitive
abilities. Each of these have been suggested to impact the relationship between emotion regulation
and psychopathology (e.g., [117–119]) and may be of interest in future work. Finally, further work
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investigating mechanisms of psychological interventions targeting emotion regulation abilities may
be a particularly promising approach. This would allow a well-controlled investigation of whether
training to enhance cognitive strategies for emotion regulation in adolescents mediates the impact of
psychological therapies on symptoms of anxiety and depression.
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Abstract: Anxiety disorders that develop in adolescence represent a significant burden and are
particularly challenging to treat, due in no small part to the high occurrence of relapse in this
age group following exposure therapy. This pattern of persistent fear is preserved across species;
relative to those younger and older, adolescents consistently show poorer extinction, a key process
underpinning exposure therapy. This suggests that the neural processes underlying fear extinction
are temporarily but profoundly compromised during adolescence. The formation, retrieval, and
modification of fear- and extinction-associated memories are regulated by a forebrain network
consisting of the prefrontal cortex (PFC), the amygdala, and the hippocampus. These regions undergo
robust maturational changes in early life, with unique alterations in structure and function occurring
throughout adolescence. In this review, we focus primarily on two of these regions—the PFC and
the amygdala—and discuss how changes in plasticity, synaptic transmission, inhibition/excitation,
and connectivity (including modulation by hippocampal afferents to the PFC) may contribute to
transient deficits in extinction retention. We end with a brief consideration of how exposure to stress
during this adolescent window of vulnerability can permanently disrupt neurodevelopment, leading
to lasting impairments in pathways of emotional regulation.
Keywords: fear extinction; adolescence; prefrontal cortex; amygdala
1. Introduction
Adolescence is a developmental period of “storm and stress,” characterised by a host of
physical, cognitive, and emotional changes that permit a shift towards achieving independence while
simultaneously opening a window of vulnerability to the damaging effects of external stressors [1–3].
Anxiety disorders that emerge during adolescence are a major concern, as they pose more societal
burden and treatment cost than those emerging in adulthood [4]. One factor contributing to this burden
is that, relative to adults, adolescents are far more prone to relapse following exposure therapy [5,6],
the gold standard for treatment for anxiety disorders [7]. Identifying the neurological underpinnings
that make adolescents particularly vulnerable to fear relapse will help to inform effective treatment
approaches specifically tailored to the developing brain [8]. To this end, characterising the ways in
which behaviour, learning, and memory are influenced by dynamic neurodevelopmental processes
occurring during adolescence has become a topic attracting burgeoning international interest in recent
years (e.g., a special issue devoted to Adolescence in Neuroscience and Biobehavioral Reviews in 2016 and
a collection on Adolescence in Nature in 2018).
Extinction training is commonly used in an experimental setting to model the process of exposure
therapy. Briefly, following Pavlovian conditioning, in which a neutral conditioned stimulus (CS; e.g.,
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a white noise) is paired with an aversive unconditioned stimulus (US; e.g., a mild foot shock), an
animal will exhibit fear responses to the CS alone. During extinction training, the CS–US contingency
is degraded by repeatedly presenting the CS in the absence of the US. Eventually, CS-elicited fear
is suppressed as the animal learns that it no longer predicts a threat. Some studies have shown
that adolescents (both rodent and human) are delayed in reducing fear during extinction training,
referred to as an impairment in within-session extinction [9,10]. Other studies have reported that
even when within-session extinction is preserved, adolescents are far more prone to fear relapse
than older or younger age groups when tested again at a later time point; that is, adolescents show
deficits in extinction retention [11–13], reflective of the increased risk of relapse following exposure
therapy. Discovering how the neural correlates underlying fear acquisition and extinction change over
the course of development is a promising approach to understanding the cognitive and behavioural
rigidity associated with aversive learning processes during adolescence.
The neurocircuitry underlying the acquisition and extinction of fear memories in adults has
been extensively studied (and reviewed in detail in [14–20]). Two regions of particular interest are
the prefrontal cortex (PFC), particularly the medial PFC (mPFC), and the amygdala. These highly
interconnected forebrain structures regulate the formation and modification of associative memories,
and their contributions to fear learning and extinction have been well established. Both structures
undergo significant structural and functional changes over the course of development [21–23] that have
the potential to fundamentally alter learning, memory, and behaviour. In this review, we summarise
recent research describing developmental changes in PFC and amygdala regional plasticity, synaptic
transmission, inhibition/excitation, and connectivity. We incorporate these findings into a structural
framework modelling the ways in which these concomitant changes may underlie adolescent-specific
deficits in extinction learning and retention, and discuss how behaviour can be impacted when the
standard developmental trajectory is disrupted by exposure to external stressors.
2. Plasticity—Dendritic Spines
Developmental changes in neuroplasticity have been well-established; broad convention states
that plasticity is highest in early life, when young animals need to quickly process large volumes of
information about their environment, and decreases over development until reaching stable levels
in adulthood [24]. However, different regions of the brain mature at different rates, meaning that
later-developing regions like the PFC [25,26] are still highly plastic when other regions have largely
stabilised. Understanding how neuroplasticity changes over development in the PFC and amygdala
could help to identify regional imbalances in learning-dependent processes and reveal mechanisms
underlying cognitive and behavioural rigidity in adolescence.
One increasingly common approach used to characterise changes in neuroplasticity involves
examining the density and stability of dendritic spines. Dendritic spines are the primary sites of
glutamatergic synapses on excitatory principal neurons [27], like the pyramidal neurons of the mPFC
and basolateral amygdala (BLA). These spines are highly dynamic, and their morphology, density, and
stability (i.e., rate of turnover) change rapidly in response to plasticity-inducing forms of stimulation,
including learning events. Although data concerning the relationship between learning and spine
dynamics is thus far largely correlational (for review see [28]), increases in spine proliferation and
reorganisation generally predict enhanced neuroplasticity, while spine elimination signals diminished
capacity for change.
2.1. Prefrontal Dendritic Spines
Postnatal development represents a particularly dynamic period of synapse and spine formation
and elimination in the cortex across species [29,30]. Post-mortem analyses in humans show that
following birth, spines and synapses on excitatory pyramidal neurons in the PFC massively proliferate
until levels peak in mid-late childhood. Adolescence represents a period of dendritic pruning as
neuronal processes are refined—during this period approximately half of all prefrontal spines and
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synapses are eliminated until adulthood, when levels stabilise and remain relatively constant [31,32].
This pattern of proliferation and pruning in the PFC is conserved across mammalian species, and
has been demonstrated in the mPFC and dorsolateral PFC (dlPFC) of non-human primates [33–35],
the mPFC (combined infralimbic [IL] and prelimbic [PL] subregions) of rats [23], and the PL and
orbitofrontal cortex (OFC) of mice [36–38]. Importantly, when the PL and IL (rodent homologues
of Brodmann Areas 32 and 25, respectively) are examined separately, it appears that the quadratic
curve of spine density in the developing mouse mPFC is driven nearly entirely by the PL, with the IL
showing little, if any, changes from early adolescence to adulthood [36]. Across regions, this means
that in early adolescence, dendritic spine density in the PL is significantly higher than in the IL,
whereas, in juveniles and adults, densities are comparable between regions. Given that the PL has been
associated with fear expression, while the IL has been implicated in extinction [18], this temporary
imbalance in plasticity and excitability between these two regions may help to explain the adolescent
deficit in extinction retention, a hypothesis discussed in more detail in Section 2.3.
The transition from adolescence to adulthood involves circuit-specific changes in spine dynamics
in the PFC which are concurrent with changes in afferent projections (discussed in detail in Section 5),
suggesting there may be a relationship between spine fluctuations and the maturation of specific inputs
to this region. This idea is supported by findings that transient increases in spine turnover in the PL
of early adolescent mice occur in pyramidal neurons located in the same cortical layers that receive
input from the ventral hippocampus and BLA (Layers II/III and V). Additionally, this adolescent
increase in PL spine density and formation coincides with a peak in PL afferents arising from the
ventral hippocampus and BLA [36]. It is likely that the observed reductions in spine plasticity and
density in the PL between adolescence and adulthood are influenced by a combination of local changes
in excitatory and inhibitory drive and circuit-specific reorganisation of connectivity. We discuss such
changes and their implications for fear inhibition in adolescence in more detail in Sections 4 and 5.
2.2. BLA Dendritic Spines
Development of dendritic spines in the amygdala has been studied less extensively than in the
PFC, but compelling data from rats suggest that the BLA shows a maturational pattern distinct from
the proliferation-pruning trajectory of prefrontal areas. While PFC spines are dramatically eliminated
during adolescence, spine density in the BLA shows a relatively linear increase from the juvenile
period (childhood) to adulthood [23]. This study also reported slightly different patterns in BLA spine
development between males and females; from adolescence to adulthood, there was a modest increase
in density in males and an equally modest decrease in females. Concurrent with these changes in BLA
spine density are fluctuations in amygdalar volume and the total number of cells within the amygdala.
The volume of the lateral, basal, and central nuclei of the amygdala increases from Postnatal Day (P)7
to 35 in rats [39,40] (see Appendix A for a guide to postnatal development in rodents in postnatal
days). Thereafter, amygdala volume decreases across adolescence to similar levels as in adulthood
by P45 [39]. The decrease in amygdala volume across adolescence is likely due to small decreases in
neuron number ([40] but see [39]) and reduced arborisation. It is interesting to note that volumetric
analyses of amygdala development in humans appear to parallel the pattern of increasing amygdala
volume from preadolescence to early adolescence reported in rats but not the later decreases across
adolescence. Instead, the subtle differences between females and males in the trajectory of spine
density changes across adolescence in rodents are reflected in the pattern of amygdala volume in
human adolescents, although such studies in humans have often lacked the power to detect small sex
differences. These studies show a linear increase in amygdala gray matter volume in boys between the
ages of 4–18 that begins to slow around age 12, and a subtle quadratic curve for girls, with volume
peaking at age 14 before slightly decreasing [41,42]. Results such as these highlight the need for
increased research in the area of sex differences in neurodevelopment; this is an understudied topic
that requires substantially more attention given the documented differences in prevalence of anxiety
between males and females, with women and teenage girls having higher rates of anxiety than men
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and teenage boys, respectively [43–46]. In addition to more detailed investigations of sex differences
in spine density and pruning in prefrontal-amygdala circuits across development (e.g., building on
work in adults [47]), future analyses exploring whether there are differential trajectories in distinct
populations of BLA neurons (e.g., “fear on” versus “fear off” neurons [48,49]) may provide additional
insight into how BLA plasticity impacts fear and extinction across development.
2.3. Implications for Fear Learning and Inhibition
In terms of fear regulation, dendritic spines in the PFC and the BLA show evidence of remodelling
following both fear conditioning and extinction in the adult brain [50,51]; however, the direction of
the effect (formation vs. elimination of spines) is dependent on the region. In the frontal association
cortex, fear conditioning induces spine elimination whereas extinction increases the rate of spine
formation [50]. In contrast, fear conditioning is associated with increased spine density in the BLA;
this effect is reversed if animals are given extinction training [51]. There may even be individual
differences in BLA spine elimination after extinction that reflect the degree of within-session extinction
by that animal, given reports that spine density in the BLA is positively correlated with fear expression
during extinction, with increased spine density predicting higher levels of fear [52]. Interestingly,
the correlation between fear expression and spine density in several brain regions appears to be
mediated by stress exposure. Within the amygdala, stress exposure seems to recapitulate the effects of
fear conditioning on dendritic spines, in that stressed animals (like fear-conditioned animals) show
increased spine density in the BLA [53]. Stress also appears to have a direct impact on the interaction
between fear expression and spine density in the mPFC. One study found that fear conditioning plus
extinction was associated with decreased spine density in the IL relative to home cage controls [54].
However, when the animals were exposed to acute stress prior to extinction, a protocol that impaired
both within-session extinction and extinction retrieval, fear expression during extinction retrieval
was negatively correlated with IL spine density [54]. This suggests that increased IL spine density
may be a mechanism of stress resilience. Notably, this correlation was not present in non-stressed
animals. Although the effects of fear learning and extinction in the PL have not to our knowledge
been explored, a similar interaction between dendritic spines and stress resilience is seen in this
region; following chronic social defeat, stress-susceptible animals exhibited decreased PL spine
density whereas stress-resilient animals showed no changes relative to non-stressed controls [55].
Taken together, it could be argued that spine hypertrophy in the BLA, and hypotrophy in the mPFC,
is associated with states of negative emotional valence (i.e., fear and/or stress). As spine density is
undergoing a period of growth and proliferation in the adolescent BLA and elimination in the PL (no
major changes are detected in the IL), it is possible that the adolescent brain is similar to the brains
of high-fear/stress-susceptible adults, rendering them more vulnerable to exaggerated spine loss in
the mPFC and excessive hypertrophy in the BLA following adverse experiences. This may bias this
age group towards a negatively-valenced state, making them more susceptible to pervasive, inflexible
fear memories and more resistant to fear extinction. A novel question for future research is whether
extinction in adolescent rats produces the same changes in spine density in the mPFC and BLA that are
induced by extinction in adults, and whether such structural changes can be induced in adolescents by
interventions that augment extinction retention. A summary of region-specific changes in dendritic
spines in response to the conditions described above is provided in Figure 1.
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Figure 1. Summary of directionality of regional dendritic spine changes in response to fear conditioning,
extinction, stress, and adolescence.
3. Plasticity—Learning-Dependent Changes in Neural Activity and Excitatory Transmission
Whereas changes in dendritic spine density and turnover in specific regions of the maturing brain
can help to explain why adolescents may be biased towards negatively-valenced emotional learning,
examination of immediate early genes and physiological indications of synaptic plasticity/long-term
potentiation (LTP) in developing animals around the time of a learning event (e.g., fear extinction training)
can help to identify discrete impairments in different components of memory acquisition, retrieval,
and modification. Evidence that the adolescent brain shows altered synaptic plasticity after extinction
has been clearly demonstrated by studies examining learning-induced immediate early gene induction
and upregulation of protein markers implicated in neuroplasticity. Fear extinction in adults and
pre-adolescents causes upregulation of learning-dependent markers of activity and plasticity, for
example, c-Fos and phosphorylated mitogen-activated protein kinase (pMAPK) in the mPFC and
BLA, that is not seen in adolescent animals [10,12,13]. Such findings indicate that adolescents may be
less efficient at recruiting PFC-amygdala pathways during extinction, which may contribute to the
extinction retention deficits seen in this age group.
Experience-dependent plasticity in excitatory pyramidal neurons of the PFC and the BLA
is widely considered critical for effective storage and expression of fear- and extinction-related
memories [56,57] and appears to be dramatically disrupted in adolescence. In juvenile and adult
animals, fear conditioning induces an increase in spontaneous excitatory postsynaptic currents (sEPSC)
amplitude, EPSC amplitude, c-Fos expression, and AMPA/NMDA ratio in the PL, while extinction
training produces the same effects in the IL; none of these patterns is observed in adolescents [10].
EPSC amplitude also appeared to be non-specifically increased in adolescents compared to other
age groups in both regions of the mPFC, irrespective of learning condition (i.e., fear conditioning,
extinction, or control), creating a ceiling effect that may ostensibly interfere with circuit-specific
activation and LTP. Interestingly, this adolescent increase in basal synaptic transmission appears to
be specific to the PFC—the same increased activity is not observed in the BLA [58]. However, like
the adolescent PFC, the adolescent BLA also fails to show learning-dependent synaptic potentiation
following fear conditioning, an effect seen in the juvenile and adult BLA [58]. This suggests that
mechanisms other than a ceiling-effect interference with LTP are contributing to adolescent suppression
of learning-dependent plasticity.
We have found that, in addition to extended extinction training, treatment with the partial
NMDA-agonist D-Cycloserine (DCS) immediately following extinction training can enhance extinction
retention in adolescents [11,59]. DCS-mediated improvements in extinction retention were also
associated with increased pMAPK in the PFC after extinction training and testing. Further,
adolescents also show improved extinction retention and increased pMAPK expression in the
mPFC when they receive twice the amount of extinction training [12], suggesting that the lack of
prefrontal recruitment during extinction training associated with extinction retention deficits can be
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overcome. This demonstrates that if an excitatory transmission is pushed above a certain threshold,
normal learning-dependent plasticity can be restored in adolescence. It is possible that prefrontal
learning-dependent plasticity could be modulated by developing BLA inputs that emerge during
adolescence. Evidence for this idea comes from studies in adults demonstrating that direct stimulation
of the BLA (or exposure to early life stress) immediately prior to a test of extinction retrieval blocks LTP
in the mPFC and causes an increased return of fear [60]. The same study also reported that treatment
with the NMDA receptor antagonist MK-801 recapitulated the effects of BLA stimulation/stress
exposure on mPFC LTP, while DCS rescued stress-induced impairments in mPFC LTP. Together, these
results suggest a model wherein a developmentally-driven increase in BLA→mPFC transmission
during adolescence (discussed further in Section 5.1) may disrupt extinction-dependent LTP in the
mPFC by dampening NMDA receptor responsivity in the same manner of direct BLA stimulation or
previous stress exposure.
4. Development of Inhibitory Networks
Deficits in extinction retention typical of adolescents may also be influenced by shifting excitability
and inhibition in fear-modulatory networks over development. Although inhibitory neurons in the
BLA and mPFC are composed of several different subpopulations, we will focus primarily on a class
of fast-spiking interneurons expressing the calcium-binding protein parvalbumin (PV). Inhibitory PV
interneurons are critical for shaping network activity underlying cognition and memory [61]; these
GABAergic cells target both pyramidal neurons and other inhibitory interneurons, enabling both direct
inhibition as well as disinhibition of excitatory principal neurons [61]. PV interneurons also have a
prominent role in generating neuronal oscillations by synchronising the firing patterns of excitatory
neurons; in the PL, this process drives fear expression [62], and in the BLA, different PV-coordinated
oscillation frequencies drive fear expression vs. fear extinction by changing functional connectivity
between the BLA and mPFC [63]. In this section, we review developmental changes in PV interneurons
and consider how these changes may impact fear processing in adolescence.
4.1. Prefrontal Inhibition
Levels of PV significantly increase in the mPFC during adolescence [64,65], reflecting a heightened
capacity for local inhibition. As the numbers of PV neurons in the PL and IL are similar in juveniles,
adolescents, and adults [66,67], this change appears to be driven by increased growth and proliferation
of PV cell neurites, meaning that existing interneurons are dramatically arborising and increasing their
capacity to integrate signals and regulate activity in pyramidal neurons during adolescence. At the
same time, excitatory drive onto this inhibitory population (in the form of both synaptic contacts and
glutamatergic transmission) effectively doubles [64,68]. While excitation of inhibitory interneurons
in the rat mPFC increases throughout development, it was recently demonstrated that excitatory
synapses on inhibitory interneurons in the monkey dlPFC are actually pruned over adolescence [69],
just as they are on excitatory pyramidal neurons (as discussed in Section 2.1). Though this pattern
could be a primate specialisation, it is also possible that development of inhibitory networks may
follow different trajectories in later developing prefrontal areas, in which case, one might expect to
see pruning of excitatory input to inhibitory neurons in the primate and rodent OFC, though to our
knowledge this has not been explored.
The increase in inhibitory tone over the course of adolescence in the mPFC coincides with
enhanced GABAergic control of local field potentials. Evidence suggests that relative to adulthood and
late adolescence, early adolescence is associated with reduced GABAergic inhibition of glutamatergic
pyramidal neurons in the mPFC [70]. This is observed as a failure in the suppression of prefrontal local
field potentials in response to high-frequency ventral hippocampal stimulation (20 and 40 Hz) in early
adolescence. Ventral hippocampal-mediated long-term depression only emerges in late adolescence,
suggesting delayed maturation of GABAergic interneuron function. Other studies have identified signs
of increased prefrontal activity in infant and juvenile animals relative to adults (although adolescents
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were not included) [71], suggesting a linear increase in GABAergic control of prefrontal excitability that
stabilises in late adolescence. Importantly, disrupting NMDA receptor-mediated transmission during
adolescence (via systemic administration of the antagonist MK-801) from P35–49, but not adulthood,
rendered this early adolescent profile of PFC disinhibition long-lasting, such that it was observed well
into adulthood [70]. This enduring effect in adult rats after peri-adolescent NMDA receptor disruption
was reversed by increasing local GABAergic transmission in the PFC with a single local infusion of the
GABAA positive allosteric modulator Indiplon. Evidence suggests that earlier disruption of NMDA
signalling (via ketamine or MK-801 during the second-third postnatal week) has similar long-term
effects in adulthood, reducing expression of PV, disrupting synaptic properties in interneurons, and
causing disinhibition of pyramidal cells [72,73]. Taken together, these findings demonstrate (1) that
GABAergic control of prefrontal excitability increases across development before reaching mature
functional capacity in late adolescence, and (2) that sustained NMDA receptor transmission is critical
for moderating the normal functional development of GABAergic inhibitory networks in the mPFC.
Behaviourally, this developmental trajectory of prefrontal inhibitory networks could significantly
affect how memories are acquired, stored, and retrieved at different ages. For instance, transgenic mice
bred with a mutation that causes loss of PV neurons in the PFC (but not amygdala or hippocampus)
show specific deficits in the extinction of cued fear, but not in its acquisition or expression [74].
Given that extinction retention is intact prior to adolescence when PV neurons are still highly immature,
it appears that the mechanisms underlying fear extinction may transition from a PV-independent
form in juveniles to a PV-dependent form in adolescence and adulthood, leaving adolescents in a
compromised transitional period characterised by impaired extinction processing.
4.2. BLA Inhibition
Although the developmental trajectory of interneuron function in the amygdala has been
studied less extensively than in the PFC, the available evidence suggests that PV expression in the
rodent basolateral amygdala complex undergoes dynamic changes in periadolescence, and that these
changes could have dramatic effects on fear regulation. Berdel and Moryś [75] found that within
the magnocellular part of the basal nucleus of the amygdala, the number of PV neurons rapidly
increased after P17 and peaked at P21. Density decreased between P21 and P30, and then remained
stable through adulthood (P90). In contrast, PV staining in the lateral nucleus of the amygdala was
not detected at all at P17 or P21 in this study; it became apparent only at P30 and remained at the
same level until P90. Within the basal nucleus, the distribution of PV neurons was largely restricted
to the magnocellular region at P17 and P21 and only spread to the parvicellular component at P30
(information about the number of PV neurons in the parvicellular component across development was
not provided). It should be noted that using a different antibody than Berdel and Moryś [75], our group
detected PV-immunoreactive neurons in the lateral nucleus of juveniles (P24), adolescents (P35–36),
and adults (P70), and did not observe changes in the number of labelled cells across development in
this region [66]. Within the entirety of the BLA complex (lateral+basal nuclei), we did observe a trend
(p = 0.052) towards a loss of PV neurons between juveniles and adolescents that appeared to be driven
largely by changes in the basal nucleus. Although we did not distinguish between the magnocellular
and parvicellular components of the basal nucleus in our study, our results may partially replicate the
reduction in PV staining from juvenility to adolescence in the magnocellular basal nucleus found by
Berdel and Moryś. It is important to note that the loss of PV staining could reflect a loss of neurons
and/or a reduction in PV protein expression. In terms of implications for fear regulation, the anterior
magnocellular part of the basal nucleus is connected more prominently to the PL, whereas the IL
interacts more with the posterior parvicellular component [49]; differential development of inhibitory
networks in these separate regions could therefore create a temporary imbalance between the strength
of fear and extinction pathways across development, as the PL-amygdala fear pathway may mature
earlier than the IL-amygdala extinction pathway.
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Functionally, recent evidence demonstrates that PV interneurons in the BLA have a critical role in
modulating relapse of extinguished fear. PV neurons in the BLA are strategically located to modulate
PFC activity via BLA to PFC projections. Davis et al. [63] silenced PV interneurons in the BLA using
a selective chemogenetic approach coupled with activity-based neuronal-ensemble labelling and
electrophysiology. This approach allowed the authors to tag neurons that were active during fear
conditioning and examine the effect of PV-silencing specifically on the activity of these identified
“fear” neurons. When PV neurons were silenced, BLA fear neurons were disinhibited; as a result,
there was also increased activation of neurons in the PL. This BLA-PL fear circuit appears to be
important for regulating freezing after extinction, as PL activity associated with BLA dis-inhibition
correlated with freezing after extinction (i.e., at an extinction retention test for contextual fear learning).
An opposite effect was found in IL, where activity was inhibited following silencing of BLA PV neurons.
These findings suggest that impairments in extinction retention could be driven by poor (or immature)
functioning of BLA PV neurons, which, in turn, results in disinhibited activation of BLA fear neurons,
robust activation of the BLA-PL “fear network”, and suppression of the BLA-IL “extinction network”.
Although this hypothesis (i.e., hypofunctioning of BLA PV neurons during development) has not
explicitly been tested, there are indications that inhibitory transmission in the BLA undergoes dramatic
changes in adolescence. The mechanisms underlying GABAergic transmission onto BLA pyramidal
neurons (i.e., GABA receptor subunit expression, rise/decay time of GABA currents, etc.) are mature in
the rat by P28 [76], just at the transition between the juvenile period and adolescence. However, changes
in spontaneous inhibitory transmission continue throughout adolescence, suggesting a protracted
developmental trajectory for amygdala interneurons. Within the basal nucleus, both spontaneous
inhibitory postsynaptic current (sIPSC) frequency and the sIPSC:sEPSC frequency ratio increase from
P10 to P30, and then gradually decline into adulthood [77]. In contrast, sEPSC frequency increases
sharply between P10 and P15, then remains relatively stable into adulthood. A different pattern is
observed in the lateral amygdala; in this nucleus, both sIPSC frequency and the sIPSC:sEPSC frequency
ratio increase linearly from infancy through adulthood [78]. As the basal nucleus is the target of
prefrontal innervation, it seems likely that some of this periadolescent fine-tuning may be influenced
by changing connectivity across development. To explore this possibility further and examine its
functional implications, we must consider the postnatal maturation of the robust reciprocal projections
between the prefrontal cortex and amygdala.
5. Connectivity
The PFC and the amygdala are strongly connected via robust reciprocal projections. These projections
undergo substantial anatomical and functional changes over development that have the potential
to dramatically impact the storage and retrieval of fear-related memories. Pyramidal BLA-mPFC
projection neurons target both excitatory principal neurons and inhibitory interneurons in the
opposite structure, creating complex postsynaptic events that change over the course of development.
A summary of pathways established in adult rodents is shown in Figure 2. In this section, we review
the anatomical and functional maturation of projections between the mPFC and the BLA, and discuss
regulation of this pathway by the ventral hippocampus.
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Figure 2. Pathways for Fear and Extinction. Projection neurons in the basolateral amygdala (BLA)
and ventral hippocampal (vHPC) target both excitatory neurons and inhibitory interneurons in the
medial prefrontal cortex (mPFC). The mPFC targets excitatory and inhibitory cells in the BLA, although
innervation of BLA parvalbumin (PV) interneurons comes more strongly from the infralimbic (IL) than
the prelimbic (PL). Red pathways represent proposed mechanisms for fear expression, whereas green
pathways would promote extinction.
5.1. BLA→mPFC
5.1.1. Anatomical
Infusions of retrograde tracers into the mPFC in developing mice reveal an increase in the density
of neurons projecting from the BLA to the PL from juvenility through early adolescence (i.e., from
P23 to P30) and a subsequent decrease (at P45) in late adolescence [36]. In the same study, no changes
in connectivity were identified between the BLA and IL (p = 0.056), albeit this study had a smaller
sample size, suggesting further investigation with larger sample sizes (i.e., >4 per group) might reveal
developmental changes in BLA to IL projections. Complementary experiments using anterograde
tracers in the BLA show that fibres from the amygdala develop a progressively clear bilaminar pattern
with age; fibre density increases in layers II and V of the IL and PL from birth through late adolescence,
levelling off in adulthood [79]. This suggests that even as the number of BLA neurons projecting to
the mPFC is pruned, the remaining connections continue to mature and strengthen. Cunningham et
al. [79] also demonstrated that the percentage of contacts between BLA fibres and the spines, dendrites,
and axons of PFC neurons increased linearly with age, while the percentage of fibres making no
contacts showed an equal and opposite decrease, providing further evidence that maturing BLA→PFC
projections increase in functional capacity with age. It is interesting to consider that while Cunningham
et al. [79] reported a linear increase in BLA→mPFC axospinous synapses (excitatory contacts between
BLA axon terminals and PFC dendritic spines) over development, synapses, and spines in the PFC
overall undergo massive pruning in adolescence, as discussed in Section 2.1. This may suggest that
synaptic pruning occurs only in select pathways, presenting opportunities for newly forming patterns
of innervation to emerge. As excitatory afferents from distal forebrain sites like the amygdala and
hippocampus are slow to arrive in the PFC, one might predict that much of the excitatory innervation of
the PFC prior to adolescence is derived from thalamocortical and local corticocortical connectivity, and
that these may be the synaptic connections that are more vulnerable to pruning during adolescence.
5.1.2. Functional
Activation of BLA→prefrontal projections induces long-term potentiation (LTP) in the mPFC.
This effect is functional by P30 but still maturing, evidenced by larger increases in mPFC local field
potentials following BLA stimulation in adults compared to adolescents [80]. This effect was not
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dependent on GABA, indicating that BLA facilitation of prefrontal LTP is driven by innervation
of pyramidal neurons in the mPFC and does not require recruitment of interneurons. It should
be noted that these findings do not imply that BLA innervation of prefrontal GABAergic neurons
is not biologically or behaviourally relevant; it is entirely possible that discrete activation of BLA
subpopulations during complex learning events could selectively stimulate prefrontal GABAergic
transmission. For instance, unlike BLA-evoked prefrontal LTP, ventral hippocampal (vHPC)
stimulation induces long-term depression (LTD) in the mPFC; this effect emerges later in development
(after P55), and is dependent on GABAergic transmission [80]. If inputs from the vHPC and the
BLA send axon collaterals to the same PV interneuron, stimulation of that interneuron could drive
feedback inhibition onto both inputs, ultimately synchronising the firing pattern of PFC-projecting
BLA and vHPFC neurons. Indeed, it has been shown that 1) hippocampal and amygdala afferents
converge on neurons in the IL and ventral PL, 2) excitatory responses of these neurons are significantly
amplified by simultaneous vHPC+BLA stimulation, and 3) staggered stimulation of BLA and vHPC
(separated by 20–40 ms) has an inhibitory effect on the postsynaptic neuron [81]. This suggests that
synchronisation of BLA and vHPC firing in the mPFC by PV-mediated feedback inhibition could
significantly drive activity and plasticity necessary for the complex integration of cues and context.
The fact that desynchronised activity can have inhibitory effects on postsynaptic neurons may also
explain the lack of learning-dependent plasticity observed in adolescents (see Section 3). As the PFC is
receiving growing input from different brain regions while PV interneurons are still underdeveloped,
disorganised excitatory input (while increasing basal synaptic transmission) could actually decrease
the probability of action potentials in PFC neurons and blunt learning-dependent changes.
5.2. mPFC→BLA
5.2.1. Anatomical
Neurons in the mPFC that project to the BLA are predominately located in the same layers that
receive innervation from the amygdala; BLA-projecting neurons are present in superficial layers II/III
and deep layer V across the mPFC [63,82–86]. These neurons receive excitatory inputs from the ventral
hippocampus and are subject to inhibitory regulation through local PV interneurons [87]. The number
of neurons projecting from the PL and IL appears to be relatively balanced in adults, as infusions
of the retrograde tracer CTB in the BLA typically labels similar numbers of neurons in the PL and
IL [63]. However, these subregions differ in terms of the types of cells in the BLA that they contact.
While projections from the PL and the IL both preferentially innervate the basal nucleus of the BLA,
the IL sends stronger inputs to the parvicellular aspects, while the PL more selectively innervates the
magnocellular population [49]. In addition, the IL sends more projections to PV BLA interneurons than
the PL [63]; given that PV interneurons in the parvicellular division are late to develop (see Section 4.2),
this suggests that IL-domination of PV inhibition in the amygdala may not be functionally mature
until relatively late in adolescence, and that earlier in development, the balance of control may be
tipped more towards the PL.
Unlike bottom-up BLA→mPFC connectivity, top-down projections from the mPFC to the BLA
undergo pruning of both fibres and the total number of projection neurons from adolescence through
adulthood. Retrograde tracing showed that the number of IL neurons that project to the BLA decreases
linearly from juvenility (P25) through adulthood while PL→BLA neurons show a delayed pruning
pattern, remaining stable from P25 to late adolescence (P45) before sharply decreasing in number
to reach adult levels at P90 [88]. The same study also used anterograde tracing to further examine
pathway development, and found that fibres in the BLA originating from the mPFC (PL+IL) maintain a
similar density from P25–P45 and are then pruned from late adolescence through adulthood. Another
study that examined a broader window of development (six time points from P10–P80) revealed
massive mPFC→BLA fibre proliferation between P10 and P30, and confirmed a modest decrease later
in adolescence between P45 and adulthood [77]. These results suggest an overall increase in mPFC
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innervation of the BLA with age, with a discrete period of pruning and reorganisation occurring in
late adolescence.
5.2.2. Functional
Stimulation of mPFC afferents in the amygdala coupled with single cell recordings of principal
neurons of the BLA (specifically, the basal nucleus) reveal a strengthening of glutamatergic
mPFC-amygdala synapses in early development that plateaus by P30 and remains stable through
adulthood [77]. However, the same study found that disynaptic inhibitory transmission (i.e., mPFC
pyramidal neuron → BLA interneuron → BLA pyramidal neuron) massively increased in amplitude
between P21 and P30, and subsided again at P45 and P60. This led to a temporary surge in the
IPSC:EPSC amplitude ratio in early adolescence that was more than double the values observed in
adulthood, indicating that the mPFC has the capacity to drive substantial GABAergic transmission
in the amygdala for a transient period at the onset of adolescence. While the mechanisms for this
robust inhibitory potential are as yet unclear, it is possible that the peak in mPFC innervation of the
BLA at P30 reflects increased prefrontal targeting of amygdala inhibitory interneurons, and that these
synapses are preferentially eliminated between adolescence and adulthood; this could account for the
observed reduction in fibre density during this period. Importantly, the findings of Arruda-Carvalho
et al. [77] using in vitro stimulation stand in stark contrast to the effects observed using an in vivo
stimulation approach. Selleck et al. [89] analysed local field potentials and single-unit recordings in
the BLA following electrical stimulation of the mPFC in anaesthetised rats [89]; the findings of this
study suggest that prefrontal modulation of amygdala activity is significantly blunted in adolescents
compared to adults, contrary to the increased inhibitory control reported by Arruda-Carvalho et
al. [77]. In this approach, mPFC stimulation at 10–20 Hz induced local field potential facilitation in
the basal nucleus of the BLA of adults, but was ineffective in adolescents (P39). Further analyses
showed that in both adolescents and adults, the majority of BLA neurons (~65%) showed an inhibitory
response to mPFC stimulation; however, BLA inhibition evoked by stimulation of both the PL and the
IL was weaker in adolescents than adults. This pattern of increasing prefrontal inhibitory control of
the amygdala from adolescence to adulthood has also been demonstrated in humans [90], and nicely
fits the model of compromised emotional regulation in adolescents. Unfortunately, as younger age
groups were not included in the in vivo analyses, it is unclear whether the observed impairment in
prefrontal regulation of amygdala activity is specific to adolescence or simply a reflection of immature
connectivity that would also be observed in juveniles.
Aside from different methodological approaches, what might explain the contradictory findings
of Selleck et al. [89] and Arruda-Carvalho et al. [77] concerning mPFC-evoked inhibitory drive in the
adolescent BLA? For one, stimulation of the entire mPFC (Selleck et al.) could have more complex
downstream effects than discretely driving mPFC terminals within the BLA (Arruda-Carvalho et al.).
The former approach would stimulate excitatory and inhibitory cell bodies, dendrites, and afferents
within the mPFC and would drive mPFC-BLA network activity in both direct and indirect (i.e.,
mediated by thalamic or hippocampal relay) pathways. This in vivo approach has obvious advantages
in that it reveals how the mPFC coordinates amygdala activity in an intact, biologically-relevant system
with information being integrated from multiple networks. However, by excluding all additional
activity and honing in on a precise synaptic event, the in vitro approach may reveal more about the
precise anatomical and functional development of mPFC-BLA pathways. In any case, when taken
together, the results of these two studies show that the mPFC does not effectively inhibit amygdala
activity in adolescents under normal conditions, but indicate that it nonetheless has the capacity to
induce massive inhibition at this developmental stage; this suggests that mPFC→BLA inhibitory
transmission is experiencing interference upstream of the BLA during adolescence. Disruption of
mPFC-BLA functional connectivity is likely a major contributor to adolescent impairments in extinction
retention and future work aimed at facilitating connectivity between these structures may lead to
innovative treatment approaches for adolescent-onset anxiety.
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5.3. Ventral Hippocampus→mPFC
The BLA-mPFC network obviously does not exist in isolation; as referenced in previous sections,
the ventral hippocampus (vHPC) is a critical third node in this fear-regulatory forebrain network. Like
the mPFC and the BLA, the vHPC undergoes substantial changes in connectivity across development
that critically impact fear- and extinction-related processes.
As previously discussed (Sections 4.1 and 5.1.2), vHPC and BLA inputs into the PFC functionally
mature over different developmental time windows (P30 for the BLA and ~P55 for the vHPC) and
recruit distinct forms of plasticity in the PFC (LTP for the BLA vs. LTD for the vHPC). The vHPC is a
powerful regulator of BLA-mPFC functional connectivity; in adults, stimulation of vHPC inputs with
high frequency exerts inhibitory control over BLA drive to the mPFC [91]. Given the late emergence
of vHPC-mPFC functional connectivity, this suggests that in early adolescence, the BLA projections
to the mPFC are not yet dampened by vHPC regulation; this may contribute to the mPFC being
over-responsive to BLA inputs at this age.
In the adult mouse, the vHPC innervates pyramidal neurons situated in both superficial layers
II/III and deeper layer V of the IL, but only layer V of the PL [92]. As previously discussed, BLA and
vHPC inputs predominantly converge in the IL and the ventral aspects PL. Projections between the
vHPC and the PL surge between P23 and P30, peaking in early adolescence before pruning in late
adolescence and adulthood [36]. This means that maturation of vHPC→mPFC anatomical connectivity
precedes the development of functional connectivity in the form of vHPC-evoked prefrontal LTD
and inhibitory control of BLA→mPFC inputs. Like the BLA, the vHPC targets both pyramidal
neurons and PV interneurons in the mPFC [87] (see Figure 2). It could be speculated that these
early-emerging projections from the vHPC primarily target pyramidal neurons in the PFC, with
innervation of interneurons developing later. A simpler (not mutually exclusive) explanation is that
prefrontal PV interneurons receive vHPC input in early adolescence but are not yet mature enough
to mediate inhibitory transmission at levels sufficient to induce effective vHPC-evoked LTD and
synaptic dampening.
vHPC-mediated control of the IL appears to be composed of two functionally disparate pathways:
a pro-extinction Brain-Derived Neurotrophic Factor (BDNF)-dependent excitatory pathway and a
pro-fear inhibitory pathway. In general, the inhibitory pathway appears to be the default; driving
activity in vHPC→IL projections induces PV-mediated feedforward inhibition onto IL pyramidal
neurons, and both broad activation of the vHPC and selective activation of vHPC→IL projections
results in increased recovery of fear [87]. In contrast, extinction training induces BDNF production in
the vHPC, which has been shown to increase the firing rates of IL (but not PL) neurons and facilitate
acquisition and retention of extinction [93,94]. Notably, Rosas-Vidal et al. [93] found that while most of
the neurons recorded in the PL showed no change in response to vHPC BDNF, approximately 30%
were inhibited (compared to the excitatory effect on IL neurons). However, recordings appear to have
been taken from both deep and superficial layers of the PL, with a slight bias towards superficial
layers II/III; if recordings were restricted to layer V (which receives the majority of vHPC inputs), it is
possible that a more consistent inhibitory response would have been observed in the PL. Inactivating
the vHPC prior to extinction has also been shown to impair extinction acquisition and retention [95].
This suggests that while inhibition may be the dominant force mediating vHPC-IL interactions,
during extinction learning hippocampal BDNF selectively facilitates activity in an excitatory vHPC-IL
pathway that is necessary for fear suppression. vHPC-mediated control of the PL is also prominently
regulated by BDNF. Inhibiting BDNF activity in the vHPC during adolescence both impairs extinction
learning and causes diminished vHPC innervation of the PL (but not the IL) in adulthood [96]. Taken
together, these findings demonstrate that the vHPC can differentially modulate activity in the mPFC
to either promote fear expression or facilitate extinction. Delayed functional development of the
pro-extinction BDNF-dependent pathways relative to the vHPC→IL pro-fear inhibitory pathway may
be a contributing factor driving increased fear relapse in adolescence, but this remains a question for
future research.
148
Brain Sci. 2019, 9, 65
6. Disruption by Chronic Stress
Considering the massive changes in brain structure and function discussed above, it is no great
surprise that adolescence represents a significant window of vulnerability that renders the developing
animal particularly sensitive to environmental insults. These potential insults are wide-ranging and
include poor diet, drugs of abuse, and many other damaging influences, but for the purposes of this
discussion we will focus on the effects of chronic stress. Here we focus on how exposure to external
stressors during adolescence disrupts the normative developmental trajectory and results in persistent
changes to behaviour such as fear regulation. However, neurodevelopment and emotional behaviour
are affected by adverse experiences throughout the lifespan, including prior to conception [97],
prenatal [98] and early postnatal periods [99], and so we direct the reader to excellent reviews on
those topics.
In terms of effects on fear extinction in adolescence, chronic stressor exposure by restraint or social
instability in adolescence impairs the acquisition or retention of extinction memories when tested
in adolescence relative to non-stressed controls [100–102]. Adolescence appears to be a particularly
stress-sensitive developmental period in terms of fear regulation because animals are more susceptible
to extinction deficits when stress occurs during adolescence compared to when it occurs in the juvenile
period [103] or adulthood [102,104]. Further, such deficits induced by adolescent stress are long-lasting,
persisting into adulthood [104]. The consequences of adolescent stress on fear extinction are important
clinically when considering strategies for chronically stressed youth presenting for treatment of anxiety
disorders. This is because chronic exposure to the stress hormone corticosterone in adolescence reduces
the benefit of two approaches that augment extinction retention in adolescent rats, namely extra
extinction training [103,104] and pharmacological augmentation by DCS [103]. Such results suggest
that a history of chronic stress could further reduce the efficacy of anxiety treatments in adolescents.
The enduring effects of adolescent stress may be caused by maladaptive developmental trajectories
of subcortical and cortical emotion regulation systems. In support of this claim, there is evidence that
human adolescents with traumatic stress exposure (in late childhood or adolescence) have weaker
PFC-amygdala connectivity (reviewed by [2]). Further, in rodents, chronic exogenous corticosterone
exposure in adolescence diminishes neuronal activity in the mPFC via a down-regulation of
glutamatergic receptors (e.g., NMDA receptors [105]), which are essential for extinction consolidation,
and induces structural changes by simplifying hippocampal dendritic structure and altering neuronal
spine density in the IL, OFC, hippocampus, and amygdala [106]. Specifically, adolescent corticosterone
exposure (for 20 days in mice aged between 5 and 7 weeks old) reduces spine density on pyramidal
neurons in the IL (in deep layers), OFC, and hippocampus but has the opposite effect in the
amygdala [106]. Although some of these changes were transient and recovered once stressor exposure
ended, others such as spine reductions in the OFC and dendritic arborisation in the CA1 were long-term
effects that persisted after the stressor had ended.
Earlier onset of chronic stress may induce more persistent, and opposite, effects on BLA spine
density. For example, one study reported both immediate and long-term reductions in spine density of
BLA pyramidal neurons following restraint stress during juvenility and early adolescence (i.e., 2 h daily
restraint from P21 to P35; [107]). The reduction in spinogenesis in the BLA from chronic stress in the
juvenile-adolescent period contrasts with reports of increased spinogenesis and dendritic hypertrophy
resulting from stress later in adolescent development (described above [106]) or adulthood [108].
Further, chronic restraint stressor exposure in adolescence can induce changes in dendritic morphology
in the dorsal mPFC that are layer specific [107], suggesting that synaptic communication of specific
afferents (e.g., from the BLA) could be impaired.
The transition from juvenility to adolescence is also a time of maturation of prefrontal and
amygdala perineuronal net (PNN) maturation around PV inhibitory interneurons [66] and so it is
not surprising that chronic stress occurring during this time reduces inhibitory neuron expression in
the PL [109] and alters PNN expression in the PFC (in the OFC) [110]. The stress-induced loss of PV
interneurons may reduce local inhibition of pyramidal neurons in the PL and shift this region towards
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a more “pro-fear” state. Other work links adolescent stress-induced deficits to impaired function of the
IL. For instance, chronic unpredictable and chronic restraint stress in adolescence impair fear extinction
in adulthood through reductions in basal levels of BDNF and activation of its principal receptor (i.e.,
pTrkB) and downstream pMAPK signalling in the IL [111]. These cellular mechanisms in the PL and
IL may therefore lead to increased fear despite extended extinction training in stress-exposed male
adolescent animals [104]. Taken together, the findings discussed in this section illustrate that chronic
stress in adolescence alters pyramidal cell and interneuron structure and function, developmental
trajectories of PNN maturation, and suggest potential mechanisms by which adolescent stress might
impair extinction. Future studies could further investigate the functional consequences of stress in
adolescence, such as whether there is reduced synaptic plasticity in reciprocal connections between the
BLA and PFC during extinction, and whether the neural and behavioural effects of adolescent stress
can be prevented or rescued.
7. Conclusions
In this review, we summarise developmental changes in neuroplasticity, inhibition, and
connectivity that occur within and between the mPFC and amygdala in adolescent animals, see
Figure 3. We suggest ways in which these changes may influence the characteristic deficits in extinction
retention displayed by adolescents, and consider how these delicately-modulated neural processes may
be influenced by exposure to stress. It should be noted that the developmental differences discussed
here are by no means comprehensive; many other variables, including (but not limited to) dopaminergic
infiltration of the PFC, exposure to sex hormones, and changing levels of neurotrophins/neurotrophin
receptors likely have dramatic impacts on fear learning and memory in adolescence. Creating a
comprehensive roadmap of the complex and dynamic mechanisms underlying emotional processing
in the adolescent brain continues to be a massive undertaking; however, increasing interest in the field
means that the body of knowledge in this area is swiftly proliferating. Thanks to valuable research
contributions like those described above, we are steadily advancing towards the development of
targeted treatment approaches designed to meet the storm and stress of adolescence head-on.
Figure 3. Summary of Neuroanatomical Changes Across Development. Blue bell curve represents fear
relapse following extinction. Key: PFC, prefrontal cortex; BLA, basolateral amygdala; LFPs, local field
potentials; I/EPSC, inhibitory/excitatory postsynaptic current.
150
Brain Sci. 2019, 9, 65
Funding: This research was funded by a Project Grant from the National Health and Medical Research Council to
R.R. and KB (NHMRC; APP1086855), an Australian Research Council Discovery Early Career Researcher Award
(DE170100392) to K.D.B., and a Sir Keith Murdoch Fellowship from the American Australian Association to K.S.Z.
Conflicts of Interest: The authors declare no conflict of interest. The funders had no role in the writing of
the manuscript.
Abbreviations
BDNF Brain-Derived Neurotrophic Factor
CS Conditioned stimulus




dlPFC Dorsolateral Prefrontal Cortex





(s)EPSC (spontaneous) Excitatory Postsynaptic Current
















*See [30,112]. Values are based on rat development, but a similar trajectory is observed in mice.
References
1. Malter Cohen, M.; Tottenham, N.; Casey, B.J. Translational developmental studies of stress on brain and
behavior: Implications for adolescent mental health and illness? Neuroscience 2013, 249, 53–62. [CrossRef]
[PubMed]
2. Tottenham, N.; Galvan, A. Stress and the adolescent brain: Amygdala-prefrontal cortex circuitry and ventral
striatum as developmental targets. Neurosci. Biobehav. Rev. 2016, 70, 217–227. [CrossRef] [PubMed]
3. Casey, B.J.; Duhoux, S.; Malter Cohen, M. Adolescence: What Do Transmission, Transition, and Translation
Have to Do with It? Neuron 2010, 67, 749–760. [CrossRef]
4. Lee, F.S.; Heimer, H.; Giedd, J.N.; Lein, E.S.; Šestan, N.; Weinberger, D.R.; Casey, B.J. Adolescent mental
health-Opportunity and obligation. Science 2014, 346, 547–549. [CrossRef]
5. DiMauro, J.; Domingues, J.; Fernandez, G.; Tolin, D.F. Long-term effectiveness of CBT for anxiety disorders
in an adult outpatient clinic sample: A follow-up study. Behav. Res. Ther. 2013, 51, 82–86. [CrossRef]
6. Ginsburg, G.S.; Becker, E.M.; Keeton, C.P.; Sakolsky, D.; Piacentini, J.; Albano, A.M.; Compton, S.N.;
Iyengar, S.; Sullivan, K.; Caporino, N.; et al. Naturalistic follow-up of youths treated for pediatric anxiety
disorders. JAMA Psychiatry 2014, 71, 310–318. [CrossRef] [PubMed]
151
Brain Sci. 2019, 9, 65
7. Craske, M.G.; Stein, M.B. Anxiety. Lancet 2016, 388, 3048–3059. [CrossRef]
8. Casey, B.J.; Glatt, C.E.; Lee, F.S. Treating the developing versus developed brain: Translating preclinical
mouse and human studies. Neuron 2015, 86, 1358–1368. [CrossRef]
9. Hefner, K.; Holmes, A. Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in
C57BL/6J mice. Behav. Brain Res. 2007, 176, 210–215. [CrossRef]
10. Pattwell, S.S.; Duhoux, S.; Hartley, C.A.; Johnson, D.C.; Jing, D.; Elliott, M.D.; Ruberry, E.J.; Powers, A.;
Mehta, N.; Yang, R.R.; et al. Altered fear learning across development in both mouse and human. Proc. Natl.
Acad. Sci. USA 2012, 109, 16318–16323. [CrossRef]
11. McCallum, J.; Kim, J.H.; Richardson, R. Impaired extinction retention in adolescent rats: Effects of
D-cycloserine. Neuropsychopharmacology 2010, 35, 2134–2142. [CrossRef] [PubMed]
12. Kim, J.H.; Li, S.; Richardson, R. Immunohistochemical analyses of long-term extinction of conditioned fear
in adolescent rats. Cereb. Cortex 2011, 21, 530–538. [CrossRef] [PubMed]
13. Baker, K.D.; Richardson, R. Forming competing fear learning and extinction memories in adolescence makes
fear difficult to inhibit. Learn. Mem. 2015, 22, 537–543. [CrossRef]
14. Sevenster, D.; Visser, R.M.; D’Hooge, R. A translational perspective on neural circuits of fear extinction:
Current promises and challenges. Neurobiol. Learn. Mem. 2018, 155, 113–126. [CrossRef] [PubMed]
15. Orsini, C.A.; Maren, S. Neural and cellular mechanisms of fear and extinction memory formation.
Neurosci. Biobehav. Rev. 2012, 36, 1773–1802. [CrossRef] [PubMed]
16. Maren, S. Out with the old and in with the new: Synaptic mechanisms of extinction in the amygdala.
Brain Res. 2015, 1621, 231–238. [CrossRef] [PubMed]
17. Marek, R.; Sun, Y.; Sah, P. Neural circuits for a top-down control of fear and extinction. Psychopharmacology
2018. [CrossRef] [PubMed]
18. Milad, M.R.; Quirk, G.J. Fear extinction as a model for translational neuroscience: Ten years of progress.
Annu. Rev. Psychol. 2012, 63, 129–151. [CrossRef]
19. Arruda-Carvalho, M.; Clem, R.L. Prefrontal-amygdala fear networks come into focus. Front. Syst. Neurosci.
2015, 9, 145. [CrossRef]
20. Krabbe, S.; Grundemann, J.; Luthi, A. Amygdala Inhibitory Circuits Regulate Associative Fear Conditioning.
Biol. Psychiatry 2017. [CrossRef] [PubMed]
21. Caballero, A.; Granberg, R.; Tseng, K.Y. Mechanisms contributing to prefrontal cortex maturation during
adolescence. Neurosci. Biobehav. Rev. 2016, 70, 4–12. [CrossRef]
22. Jalbrzikowski, M.; Larsen, B.; Hallquist, M.N.; Foran, W.; Calabro, F.; Luna, B. Development of White Matter
Microstructure and Intrinsic Functional Connectivity Between the Amygdala and Ventromedial Prefrontal
Cortex: Associations With Anxiety and Depression. Biol. Psychiatry 2017, 82, 511–521. [CrossRef] [PubMed]
23. Koss, W.A.; Belden, C.E.; Hristov, A.D.; Juraska, J.M. Dendritic remodeling in the adolescent medial prefrontal
cortex and the basolateral amygdala of male and female rats. Synapse 2014, 68, 61–72. [CrossRef]
24. Oberman, L.; Pascual-Leone, A. Changes in plasticity across the lifespan: Cause of disease and target for
intervention. Prog. Brain Res. 2013, 207, 91–120. [CrossRef]
25. Gogtay, N.; Giedd, J.N.; Lusk, L.; Hayashi, K.M.; Greenstein, D.; Vaituzis, A.C.; Nugent, T.F.; Herman, D.H.;
Clasen, L.S.; Toga, A.W.; et al. Dynamic mapping of human cortical development during childhood through
early adulthood. Proc. Natl. Acad. Sci. USA 2004, 101, 8174–8179. [CrossRef]
26. Giedd, J.N.; Raznahan, A.; Alexander-Bloch, A.; Schmitt, E.; Gogtay, N.; Rapoport, J.L. Child Psychiatry
Branch of the National Institute of Mental Health Longitudinal Structural Magnetic Resonance Imaging
Study of Human Brain Development. Neuropsychopharmacology 2015, 40, 43–49. [CrossRef]
27. Alvarez, V.A.; Sabatini, B.L. Anatomical and physiological plasticity of dendritic spines. Annu. Rev. Neurosci.
2007, 30, 79–97. [CrossRef] [PubMed]
28. Segal, M. Dendritic spines: Morphological building blocks of memory. Neurobiol. Learn. Mem. 2017, 138, 3–9.
[CrossRef] [PubMed]
29. Moyer, C.E.; Zuo, Y. Cortical dendritic spine development and plasticity: Insights from in vivo imaging.
Curr. Opin. Neurobiol. 2018, 53, 76–82. [CrossRef]
30. Spear, L.P. The adolescent brain and age-related behavioral manifestations. Neurosci. Biobehav. Rev. 2000,
24, 417–463. [CrossRef]
31. Huttenlocher, P.R. Synaptic density in human frontal cortex — Developmental changes and effects of aging.
Brain Res. 1979, 163, 195–205. [CrossRef]
152
Brain Sci. 2019, 9, 65
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Abstract: Adolescence is a developmental phase characterized by emotional turmoil and coincides
with the emergence of affective disorders. Inherited serotonin transporter (5-HTT) downregulation in
humans increases sensitivity to these disorders. To reveal whether and how 5-HTT gene variance
affects fear-driven behavior in adolescence, we tested wildtype and serotonin transporter knockout
(5-HTT−/−) rats of preadolescent, adolescent, and adult age for cued fear extinction and extinction
recall. To analyze neural circuit function, we quantified inhibitory synaptic contacts and, through
RT-PCR, the expression of c-Fos, brain-derived neurotrophic factor (BDNF), and NDMA receptor
subunits, in the medial prefrontal cortex (mPFC) and amygdala. Remarkably, the impaired recall of
conditioned fear that characterizes preadolescent and adult 5-HTT−/− rats was transiently normalized
during adolescence. This did not relate to altered inhibitory neurotransmission, since mPFC inhibitory
immunoreactivity was reduced in 5-HTT−/− rats across all ages and unaffected in the amygdala.
Rather, since mPFC (but not amygdala) c-Fos expression and NMDA receptor subunit 1 expression
were reduced in 5-HTT−/− rats during adolescence, and since PFC c-Fos correlated negatively with
fear extinction recall, the temporary normalization of fear extinction during adolescence could relate
to altered plasticity in the developing mPFC.
Keywords: serotonin transporter; rat; fear extinction; medial prefrontal cortex; NMDA; BDNF;
adolescence; age
1. Introduction
Adolescence is a period of physical and brain maturation that is characterized by emotional
turmoil and an increase in pervasive fears, and coincides with the emergence of anxiety and other
affective disorders [1–7]. Recent data implicates organizational changes of the cognitive control circuitry
regulating emotional behavior in this vulnerability during adolescence. More specifically, there is
evidence for relative immaturity of the medial prefrontal cortex (mPFC) and its top-down control
over subcortical areas mediating emotion and motivation such as the amygdala, whose development
precedes that of the PFC [3]. According to the developmental mismatch hypothesis, the delayed
maturation of the PFC in comparison to the amygdala results in a temporary imbalance between
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emotion and its regulatory processes [8]. However, there are substantial individual differences [9] in
this transient “imbalance” during adolescence, and the underlying mechanisms and factors influencing
the maturation process are not yet clear. As the PFC-amygdala circuit is dysfunctional in anxiety
disorders [10] that frequently emerge during adolescence and often persist into adulthood [11],
the understanding of the maturation of the PFC-amygdala circuit in healthy subjects is expected to
inform the pathophysiology of stress-related neuropsychiatric disorders.
Appropriate PFC-amygdala circuit balance is critical for adequate extinction of fear. Previous
research demonstrated that fear extinction is diminished in pre-adolescents and adolescents compared to
adults, in both humans and animals [12–14]. This phenomenon only applies to fear that is cue-dependent
and thus involving the PFC, whose activity—as assessed by c-Fos immunoreactivity—has been found to
be reduced during adolescence compared to preadolescence and adulthood [12]. In contrast, improved
extinction of contextual fear, as mediated by the hippocampus, is observed in adolescence compared to
preadolescence and adulthood [15].
GABAergic inhibitory signaling plays an important role in this regulation of fear. The excitability
of the basolateral amygdala (BLA), the amygdalar subnucleus responsible for maintaining the learned
fear-association [16], is regulated by inhibitory signaling of local GABAergic interneurons [17],
a mechanism by which fear and anxiety are attenuated [18]. Similarly, top-down control as mediated
by the infralimbic cortex (IL) is modulated by GABAergic inhibition. The infralimbic cortex (IL)
contributes to the inhibition of the fear response in the central amygdala (CeA) after successful fear
extinction via its glutamatergic excitatory projections to the intercalated cells of the amygdala. IL
function is regulated by excitatory inputs from several regions, including the BLA [19–21]. Although
these projections are glutamatergic, their stimulation in vivo primarily inhibits neural activity in
the PFC [22,23], which has been suggested to be caused by robust feedforward inhibition mediated
by GABAergic interneurons [23,24]. Similar to the amygdala, some hippocampal projections may
preferentially target IL interneurons, inhibiting IL output to downstream targets [25]. Besides this
local inhibition, the IL also receives inhibitory innervations from the dorsal raphe nucleus (DRN) [26]
as well as the basal forebrain [27]. Patients suffering from post-traumatic stress disorder, a disorder
of aberrant fear extinction, are characterized by abnormalities in GABAergic signaling within the
prefrontal cortex [28], implicating this local inhibitory circuit in its pathology. However, as of yet,
the exact contribution of these inhibitory circuits to the impaired fear extinction in adolescents remains
to be investigated.
Glutamate receptors represent another signaling system critical for the consolidation of extinction
memories. Previous studies have demonstrated that the partial NMDA receptor agonist D-cycloserine
(DCS) improves extinction retention in adolescent rats [13,29]. This implies that besides alterations in
GABAergic signaling, a failure to recruit N-methyl-D-aspartate (NMDA) receptors may contribute to
the impaired fear extinction during adolescence as well [12].
Brain-derived neurotrophic factor (BDNF) has also been implicated in fear circuitry maturation [30].
BDNF levels in the hippocampus peak during adolescence, suggesting that BDNF plays a key role
in the maturation of subcortical regions. Furthermore, developmental studies utilizing a genetic
BDNF single nucleotide polymorphism (Val66Met) knock-in mouse indicate that BDNFMet/Met mice
tested in preadolescence and early adolescence do not differ from wild-type controls regarding fear
extinction, but show an impairment during adulthood. These results indicate that the impairment
in cued fear extinction in BDNFMet/Met mice emerges in a time frame corresponding to the transition
from adolescence to adulthood and that BDNF may thus be critical in this developmental stage for
appropriate circuit development.
Interestingly, the adolescent behavioral and supposed neural phenotype shows striking similarities
to those seen in carriers of the low activity variant short (s) allele of the serotonin transporter linked
polymorphic region (5-HTTLPR) in humans. Adult s-allele carriers, which presumably display
increased extracellular serotonin levels, show increased acquisition [31] and reduced extinction [32]
of conditioned fear, together with amygdala hyper-reactivity [33] and attenuated anatomical and
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functional coupling between the mPFC and amygdala [34,35]. Thus, the behavioral and brain
phenotypes seen in adult carriers of the s-allele of the 5-HTTLPR may also imply a cortical-subcortical
functional imbalance. Serotonin acts as a neurotrophic factor during development, and variations
in serotonin availability occurring due to a limited availability of 5-HTT are thought to affect the
development of circuits involved in the regulation of emotional behavior [36–38]. This poses the
hypothesis that 5-HTTLPR may affect the development of the cortical-subcortical circuit, such that
the transitions from preadolescence to adolescence, and from adolescence to adulthood are altered in
5-HTTLPR s-allele carriers.
Serotonin transporter knockout (5-HTT−/−) rats are used as a model organism for the 5-HTTLPR
s-allele in humans and show many phenotypical similarities, both adaptive and maladaptive,
to s-allele carriers [39]. Similar to humans and rodents during adolescence, as well as adult
5-HTTLPR s-allele carriers, 5-HTT−/− rodents display impaired fear extinction (recall) [40–46]. Since
5-HTT−/− rats display decreased inhibitory GABAergic control over excitatory neurons in the cortex
during preadolescence [47], reduced expression of BDNF and GABA system components across
development [48], altered NMDA receptor subunit expression in the PFC at adulthood [49], and an
association with impaired fear extinction-reduced c-Fos expression in the IL [46], it is possible that the
5-HTT genotype affects the development of the PFC–amygdala circuitry and thereby fear extinction
recall across developmental stages.
Here, we employed a cued fear extinction paradigm to evaluate how differential 5-HTT expression
affects the development of fear extinction learning and recall across adolescence using homozygous
(5-HTT−/−) and heterozygous (5-HTT+/−) serotonin transporter knockout rats and compared them
to wildtype animals (5-HTT+/+). We assessed the population of inhibitory cells in the IL and BLA
by measuring the number of synaptic contacts expressing the inhibitory markers glutamic acid
decarboxylase 65 and 67 (GAD65/67). Additionally, we assessed expression levels of BDNF, NMDA
receptor subunits, and c-Fos in the PFC and amygdala at baseline and after fear extinction and fear
extinction recall across ages in 5-HTT+/+ and 5-HTT−/− rats.
2. Materials and Methods
2.1. Animals
All experiments were approved by the Committee for Animal Experiments of the Radboud
University Nijmegen Medical Centre, Nijmegen, the Netherlands, and all efforts were made to
minimize animal suffering and to reduce the number of animals used. Serotonin transporter knockout
rats (Slc6a41Hubr) were generated on a Wistar background by N-ethyl-N-nitrosurea (ENU)-induced
mutagenesis [50]. Experimental animals were derived from crossing heterozygous 5-HT transporter
knockout (5-HTT+/−) rats that were outcrossed for at least 12 generations with wildtype Wistar rats
obtained from Harlan Laboratories (Horst, the Netherlands). Ear punches were taken at the age of 21
days for genotyping, which was done by Kbiosciences (Hoddesdon, United Kingdom. Male adult
5-HTT−/−, 5-HTT+/−, and wildtype (5-HTT+/+) rats entered the experiment at p24 (preadolescent),
p35 (adolescent), or p70 (adult). The adult animals were housed in pairs, while the adolescent and
preadolescent animals were housed three per cage, in open cages. All animals had ad libitum access to
food and water. A 12 h light–dark cycle was maintained, with lights on at 8:00 a.m. All behavioral
experiments were performed between 8:00 a.m. and 6:00 p.m.
2.2. Apparatus
A 30.5 × 24.1 × 21 cm operant conditioning chamber (Model VFC-008, Med Associates) was used
for fear conditioning and sham conditioning. The box was housed within a sound-attenuating cubicle
and contained a white LED stimulus light, a white and near infrared house light, as well as a speaker
capable of producing an 85 dB 2.8 kHz tone. The metal grid floor of the apparatus was connected to
a scrambled shock generator (model ENV-412, Med Associates) configured to deliver shocks at 0.6
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mA intensity. Fear extinction and extinction recall were tested in a novel context, in a novel room.
The novel context consisted of a 25 × 25 × 30 cm Plexiglas cage, the bottom of which was covered with
a +/− 0.5-cm-thick layer of black bedding. In this context, 85 dB (measured at the center of the floor)
2.8 kHz auditory stimuli were delivered through a set of external speakers.
2.3. Procedure
In total, 329 rats were exposed to behavioral testing. As genotypes of the animals at some ages were
only known after completion of the protocol, relatively more 5-HTT+/− animals were tested compared to
5-HTT+/+ and 5-HTT−/− rats (n5-HTT+/+-p24 = 26, n5-HTT+/+-p35 = 30, n5-HTT+/+-p70 = 35, n5-HTT+/−-p24 = 51,
n5-HTT+/−-p35 = 79, n5-HTT+/−-p70 = 32, n5-HTT−/−-p24 = 25, n5-HTT−/−-p35 = 21, n5-HTT−/−-p70 = 30). On
the day on which the animals entered the experiment (p24 for the preadolescent group, p35 for the
adolescent group, and p70 for the adult group), the animals were habituated to the conditioning context
for 10 minutes. Twenty-four hours after habituation, animals were given a cued fear conditioning
session. Fear conditioning began with a 2-minute habituation period, followed by 5 instances of a
30-second 85 dB 2.8 kHz auditory stimulus co-terminating with a 1-second 0.6 mA foot shock, followed
by a 1-minute inter-trial interval. Twenty-four, 48, and 72 hours after conditioning, fear extinction and
two sessions of extinction recall were given, respectively. Thus, extinction learning and extinction recall
(2×) were assessed on three consecutive days. In each of these sessions, rats were exposed to a 2-minute
habituation period, after which 24 20-second presentations of the auditory stimulus were given, with
an inter-trial interval of 5 seconds. Sessions were recorded, and freezing was automatically assessed by
a software program (see below). For the conditioning and the habituation to the fear conditioning
chamber, the apparatus was cleaned before and after each animal using a tissue slightly dampened
with 70% EtOH. Water was used for cleaning in between the extinction and extinction recall sessions.
2.4. Assessment of Behavior
Time spent freezing during the conditioning session was not assessed, as previous work as
indicated no differences between genotypes in the acquisition of fear memory [46]. For assessing
the time spent freezing during extinction learning and both extinction recall sessions, we used
the Ethovision 9.0 behavioral software package (Noldus Information Technology B.V., Wageningen,
the Netherlands). Freezing was determined using the Activity Monitor feature of the software package.
The threshold for pixel change between frames was set between 0.05 and 0.09% (depending on the
specific camera in use, but not different between groups). Automatic assessment was compared to
manually scored samples in in total 696 samples of 20 seconds, derived from 29 extinction sessions by
two different observers blind to the genotype of the animal, and proved to be a reliable assessment of
freezing behavior (correlation between manual and automatic outcomes: r = 0.7397). To analyze fear
extinction learning, extinction sessions were divided into 6 blocks representing the average freezing
responses to 4 auditory cue presentations each. Average freezing to all auditory cue presentations
during the recall sessions was used as index for fear extinction recall.
Since 5-HTT+/− and 5-HTT+/+ showed a comparable behavioral profile, we focused on 5-HTT−/−
and 5-HTT+/+ rats during subsequent histological and molecular studies aiming to understand the
mechanisms underlying the genotype × age effects.
2.5. GAD65/67 Immunostaining
The immunostaining procedure was adopted from Olivier et al. (2008) and Nonkes et al.
(2010) [51,52]. Ninety minutes following either the extinction learning session or the second extinction
recall session, a subset of the rats (n = 5, randomly selected) were anesthetized and perfused
transcardially with 0.1 mol/L PBS, pH 7.3, followed by 4% paraformaldehyde dissolved in 0.1 mol/L
phosphate buffer (PB), pH 7.2. The pressure of the perfusion was reduced for the preadolescent
rats. Perfusion continued until signs of successful perfusion were observed (shaking limbs, stiff
cheeks, etc.). Subsequently, the brains were removed from the skull and post-fixed overnight in 4%
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paraformaldehyde at 4 ◦C. Before sectioning, the brains were cryoprotected with 30% sucrose in 0.1
mol/L PB. Forty-micrometer-thick brain sections were cut on a freezing microtome and collected in
six parallel series in 0.1 mol/L PBS containing 0.1% sodium azide. One series from each rat was used
for every staining. The free-floating sections were washed three times in PBS and preincubated with
0.3% perhydrol (30% H2O2, Merck, Darmstadt, Germany) for 30 min. After washing three times
in PBS, the sections were presoaked for 30 min in an incubation medium consisting of PBS with
0.1% bovine serum albumin and 0.5% Triton X-100. The sections were then incubated with goat
anti-GAD65/67, 1:2000 (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA), overnight on a shaker,
at room temperature, and consecutively incubated for 90 min at room temperature with biotinylated
donkey-anti-goat (Jackson Immuno Research Laboratories, West Grove, PA, USA) diluted 1:1500 in
incubation medium and for 90 min at room temperature with ABC-elite, diluted 1:800 in PB (Vector
Laboratories, Burlingame, CA, USA). Between incubations, sections were rinsed three times with
PBS. The GAD65/67–antibody peroxidase complex was made visible using 3,3-diaminobenzidine
tetrahydrochloride staining. Sections were incubated for 10 min in a chromogen solution consisting of
0.02% 3,3-diaminobenzidine tetrahydrochloride and 0.03% nickel–ammonium sulfate in 0.05 mol/L
Tris-buffer (pH 7.6) and subsequently for 10 min in chromogen solution containing 0.006% hydrogen
peroxide. This resulted in a blue–black staining. The sections were then rinsed three times in PBS and
mounted on gelatin chrome alum-coated glass slides, dried overnight in a stove at 37 ◦C, dehydrated in
an increased series of ethanol, cleared in xylene, embedded with Entellan (Merck), and coverslipped.
2.6. Quantification
Numbers of GAD65/67-immunopositive granules, representing inhibitory synaptic contacts,
were quantified using the software program Fiji ImageJ, a public domain image-processing program
(http://rsb.info.nih.gov/ij/) [53]. Granules were counted in the IL in equally framed sections across groups
at 2.20 from Bregma at ×40 magnification using an Axio Imager.A2 microscope (Zeiss, Oberkochen,
Germany). BLA GAD65/67 immunoreactivity was measured in sections at −1.88 mm from Bregma at
×40 magnification. The results for each subject are expressed as the total amount of immunopositive
granules counted in a standardized sample area measuring 281.6 × 211.2 um within each section.
2.7. Gene Expression Analyses
The remaining animals were sacrificed by rapid decapitation at 90 minutes following either the
extinction learning session or the second extinction recall session. Brains were rapidly removed from
the skull and quick-frozen on dry ice and stored at −80 °C until further processing.
Brains from WT and 5-HTT−/− rats were sectioned into 220 μm coronal slices on a Leica CM3050
S Research Cryostat (Leica Biosystems, Amsterdam, the Netherlands), with a chamber temperature
of −12 ◦C and an object temperature of −10 ◦C, after which regions of interest were punched out.
To be able to relate gene expression profiles following extinction (recall) to basal gene expression
patterns, additional naïve control WT and 5-HTT-/- brains were obtained and processed in a similar
fashion (n5-HTT+/+-p24 = 6, n5-HTT+/+-p35 = 7, n5-HTT+/+-p70 = 7, n5-HTT−/−-p24 = 7, n5-HTT−/−-p35 = 7,
n5-HTT−/−-p70 = 6). Medial prefrontal cortex punches were taken bilaterally with a 1.0 mm diameter
hollow needle from 8 subsequent slices (Bregma ≈ 3.70:2.20 mm), for a total of 32 punches (prelimbic
and infralimbic cortex were punched bilaterally and punches combined to obtain sufficient amounts of
material for gene expression analyses). Likewise, 8–10 1.0 mm diameter punches were taken from the
bilateral amygdala (Bregma ≈ −2.30: −3.30 mm).
Total RNA was isolated by a single step of guanidinium isothiocyanate/phenol extraction
using PureZol RNA isolation reagent (Bio-Rad Laboratories, Italy) according to the manufacturer’s
instructions and quantified by spectrophotometric analysis. Following total RNA extraction,
the samples were processed for real-time polymerase chain reaction (RT-PCR) to assess total BDNF,
NR1, NR2A, and c-Fos mRNA expression. An aliquot of each sample was treated with DNase to avoid
DNA contamination. RNA was analyzed by TaqMan qRT-PCR instrument (CFX384 real time system,
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Bio-Rad Laboratories, Segrate, Italy) using the iScriptTM one-step RT-PCR kit for probes (Bio-Rad
Laboratories, Segrate, Italy). Samples were run in 384 well formats in triplicate as multiplexed reactions
with a normalizing internal control (β-actin). Primers sequences (Table 1) used were purchased from
Eurofins MWG-Operon.
Table 1. Sequences of forward and reverse primers and probes used in real-time PCR analyses and
purchased from Eurofins MWG-Operon.
Gene Forward Primer Reverse Primer Probe
BDNF tot AAGTCTGCATTACATTCCTCGA GTTTTCTGAAAGAGGGACAGTTTAT TGTGGTTTGTTGCCGTTGCCAAG
NR1 TCATCTCTAGCCAGGTCTACG CAGAGTAGATGGACATTCGGG TGGGAGTGAAGTGGTCGTTGGG
NR2A GCACCAGTACATGACCAGATTC ACCAGTTTACAGCCTTCATCC CGTCCAACTTCCCGGTTTTCAAGC
c-Fos TCCTTACGGACTCCCCAC CTCCGTTTCTCTTCCTCTTCAG TGCTCTACTTTGCCCCTTCTGCC
β-actin CACTTTCTACAATGAGCTGCG CTGGATGGCTACGTACATGG TCTGGGTCATCTTTTCACGGTTGGC
Thermal cycling was initiated with an incubation at 50 ◦C for 10 min (RNA retrotranscription) and
then at 95 ◦C for 5 min (TaqMan polymerase activation). After this initial step, 39 cycles of PCR were
performed. Each PCR cycle consisted of heating the samples at 95 ◦C for 10 s to enable the melting
process and then for 30 s at 60 ◦C for the annealing and extension reactions. A comparative cycle
threshold method was used to calculate the relative target gene expression [54]
2.8. Statistics
All statistical analyses were performed using SPSS Statistics version 24.0 (SPSS Inc., IBM, Armonk,
NY, USA). Data are presented as mean ± standard error of the mean (SEM). Behavioral data were
analyzed using a repeated measures analysis of variance (ANOVA), whereas the immunohistochemical
and gene expression were analyzed using a 2-way ANOVA, with genotype and age (preadolescent,
adolescent, adult) as between-subject factors. Statistical testing on the latter was performed on obtained
deltaCT values, whereas data are plotted as fold-change expression levels relative to the preadolescent
5-HTT+/+ group. For Pearson correlation analyses between freezing and neural measures, we averaged
freezing rates observed during all cue presentations to a single measure. Probability p-values of less
than 0.05 were considered significant. Bonferroni correction was applied to correct for multiple testing
in post hoc tests.
3. Results
3.1. Freezing Behavior
Baseline freezing. To measure baseline freezing, we assessed freezing during the 2-minute stimulus
free period preceding the first extinction session. Freezing in response to the novel context was
significantly affected by age (F(2,319) = 41.016, p < 0.001), but not genotype (F(2,319) = 1.745, p = 0.176),
and no significant genotype × age interaction was found (F(4,319) < 1) (Figure 1). Bonferroni post hoc
analysis revealed that adolescent animals froze more upon novel context exposure than adult animals
(p < 0.001), while preadolescent animals froze more than adolescent and adult animals (both p < 0.001).
Fear extinction learning. In the extinction learning session, freezing during the cue presentations
reduced over blocks (F(5,324) = 145.945, p < 0.001), and this reduction (i.e. The speed of extinction
learning) was dependent on both age (block × age interaction; F(10,650) = 3.607, p < 0.001) and genotype
(block × genotype interaction; F(20,650) = 3.458, p < 0.001), but not on a genotype × age interaction
(F(20,1308) < 1) (Figure 1). Exploration of the genotype effect through post hoc tests revealed that
5-HTT−/− rats showed slower extinction learning than both 5-HTT+/− and 5-HTT+/+ rats (both p< 0.001),
whereas 5-HTT+/− and 5-HTT+/+ animals showed similar extinction rates (p = 0.653). Exploration of the
age effect revealed significant differences in extinction learning curves between all three ages, which
seemed to be driven by slower extinction in pre-adolescent compared to adolescent rats (p = 0.006) and
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lower initial freezing (in block 1) of adult rats compared to preadolescent rats (p = 0.008). There were
no age effects within the genotypes (p > 0.1).
First fear extinction recall. Total freezing during the first extinction recall session was used as a
behavioral indicator of the recall of the extinction memory acquired during the first fear extinction
learning session. We observed a main effect of genotype (F(2,144) = 4.051, p = 0.019), a trend-level
significant main effect of age (F(2,144) = 2.910, p = 0.058) and a genotype × age interaction for this
parameter (F(4,144) = 2.747, p = 0.031) (Figure 1). The latter appeared to be driven by a significant
effect of genotype in the preadolescent (F(2,46) = 6.016, p = 0.005), but not the adolescent (F(2,52) = 1.401,
p = 0.255) and adult animals (F(2,46) = 2.254, p = 0.116). The genotype effect in the preadolescent
group was driven by 5-HTT−/− rats, which froze significantly more than 5-HTT+/− (p = 0.012) and
5-HTT+/+ (p = 0.007) animals, while freezing was not different between 5-HTT+/− and 5-HTT+/+ animals
(p = 1.000). When comparing age effects in genotype groups we observed that fear extinction recall was
significantly affected by age in 5-HTT−/− rats (F(2,35) = 60.527, p = 0.004), but not 5-HTT+/+ (F(2,35) < 1)
and 5-HTT+/− (F(2,74) < 1 rats. The age effect in 5-HTT−/− rats was attributed to improved recall during
adolescence compared to preadolescence (p = 0.004) and adulthood (p = 0.049), in the absence of a
difference between the latter two groups (p = 0.471).
Second fear extinction recall. We found a main effect of genotype (F(2,142) = 8.601, p < 0.001), age
(F(2,142) = 10.756, p < 0.001), and genotype × age interaction (F(4,142) = 2.921, p = 0.023) in freezing
behavior during the second extinction recall session (Figure 1). Here, we found a significant effect of
genotype in the preadolescent (F(2,44) = 7.334, p = 0.002) and the adult group (F(2,46) = 6.115, p = 0.004),
but again not in the adolescent animals (F(2,52) < 1). 5-HTT−/− rats froze more than 5-HTT+/− and
5-HTT+/+ animals in both the preadolescent (p = 0.001 and p = 0.016, respectively) and the adult
(p = 0.005 and p = 0.057 respectively) age groups, while freezing between 5-HTT+/− and wildtype
animals was not different in either age group (both p-values = 1.000). When comparing age effects in
genotype groups, we observed that fear extinction recall was significantly affected by age in 5-HTT−/−
rats (F(2,35) = 75.819, p = 0.002), but not 5-HTT+/+ rats (F(2,35) = 1.286, p = 0.289). In 5-HTT−/− rats,
reduced freezing was observed during adolescence as compared to preadolescence (p = 0.002), but not
adulthood (p = 0.125), whereas freezing at these latter two ages did not differ significantly (p = 0.125).
In 5-HTT+/− rats, a significant effect of age was found (F(2,72) = 20.583, p = 0.037), caused by improved
fear extinction with age (resulting in a significant difference in freezing during recall in preadolescence
vs. adulthood (p = 0.036), whereas the other comparisons were non-significant (all p-values > 0.27)).
As all significant genotype effects were driven by aberrant behavior of the 5-HTT−/− rats, further neural
analyses focused on the comparison of these genotypes with their 5-HTT+/+ counterparts.
In Figure S1, the freezing per genotype across the three ages is depicted, and Figure S2 depicts the
freezing across blocks during the recall sessions.
3.2. GAD65/67 Immunoreactivity
Infralimbic cortex. The number of GAD65/67 immunopositive granules in the IL was significantly
affected by genotype (F(1,24) = 14.326, p = 0.001), but not age (F(2,24) = 2.110, p = 0.143), and no genotype
× age interaction could be detected (F(2,24) = 1.222, p = 0.312, Figure 2). The number of granules
expressing GAD65/67 was significantly reduced in 5-HTT−/− animals compared to 5-HTT+/+ animals
(p = 0.001). Although the effect of genotype did not significantly differ between age groups, post hoc
testing revealed the most prominent effects of genotype in preadolescent rats (p < 0.001), whereas
adolescent and adult rats did not display significant differences between genotypes (p-values > 0.3).
Basolateral amygdala. No effects of genotype (F(1,24) < 1) or age (F(1,24) < 1), nor a genotype ×
age interaction (F(2,24) = 1.583, p = 0.226), were found in the number of GAD65/67 immuno-positive
granules in the BLA (Figure 2).
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Figure 1. Fear conditioning behavioral data across extinction learning and the two extinction recall sessions.
Freezing during the 2-minute stimulus free baseline period preceding extinction learning decreased across
age in all genotypes. Fear extinction learning is impaired in preadolescent 5-HTT−/− rats, normalized in
this genotype during adolescence, and impaired again in adulthood. Fear extinction recall is impaired
in preadolescent 5-HTT−/− rats, normalized in this genotype during adolescence, and impaired again
in adulthood. Data are expressed as the mean % of time spent freezing during stimulus presentations
± standard error of the mean. #: a significant effect of genotype (p < 0.05); $: a significant effect of age
(p < 0.05); ¥: a significant age × genotype interaction (p < 0.05); *: a significant post hoc difference between
5-HTT−/− vs. 5-HTT+/− and/or 5-HTT+/+ rats (p < 0.05); **: a significant post hoc difference between
5-HTT−/− vs. 5-HTT+/− and/or 5-HTT+/+ rats (p < 0.05); & a significant effect of extinction block (p < 0.05);
@ a significant age × block interaction (p < 0.05); % a significant genotype × block interaction (p < 0.05).
3.3. Gene Expression Levels Neuronal Plasticity and Activity Genes
Basal expression. mPFC. In the mPFC of naive control animals (Figure 3, upper panel), c-Fos
expression was affected by genotype (F(1,32) = 16.321, p < 0.001) and age (F(2,32) = 3.502, p = 0.042),
but not by a genotype × age interaction (F(2,32) = 1.828, p = 0.177). These effects appeared to be driven by
significantly lower c-Fos expression levels in 5-HTT−/− compared to 5-HTT+/+ rats (p < 0.001), whereas
adolescent animals tended to display increased expression compared to pre-adolescent (p = 0.036),
but not adult (p = 0.236) rats. BDNF expression was also dependent on genotype (F(1,33) = 29.072,
p < 0.001) and age (F(2,33) = 27.108, p < 0.001), without displaying a genotype × age interaction
(F(2,33) < 1). Additionally, BDNF levels were significantly lower in 5-HTT−/− compared to 5-HTT+/+ rats
(p < 0.001), whereas adolescent rats displayed the highest expression (both p-values < 0.001), whereas
adult rats displayed higher levels than preadolescent rats (p = 0.007). NR1 levels only depended on the
age of the rat (F(2,33) = 71.644, p< 0.001), with again the adolescent rats displaying the highest expression
164
Brain Sci. 2019, 9, 118
(both p-values < 0.001), and adult rats displaying higher levels than preadolescent rats (p = 0.020).
NR2A levels were characterized by a main effect of age (F(2,32) = 113.835, p < 0.001) and a genotype
× age interaction (F(2,32) = 8.020, p = 0.002). Similarly to NR1 and BDNF, NR2A expression levels
were highest in adolescence (both p-values < 0.001), and adult rats showed higher NR2A expression
than pre-adolescent rats (p = 0.001). Moreover, in adolescence, 5-HTT−/− rats displayed significantly
higher NR2A expression levels compared to 5-HTT+/+ rats (p < 0.001), whereas no differences between
genotypes were observed at preadolescence (p = 0.165) and adulthood (p = 0.666).
Figure 2. GAD65/67 immunoreactivity in the infralimbic cortex (IL) and basolateral amygdala (BLA)
of preadolescent (p24), adolescent (p35), and adult (p70) 5-HTT−/− and 5-HTT+/+ rats. GAD 65/67
immunoreactivity is significantly reduced in preadolescent, adolescent, and adult 5-HTT−/− animals in
the IL, but not BLA. #: a significant effect of genotype (p < 0.05).
Figure 3. Relative expression levels of c-Fos, BDNF, NR1, and NR2A in the medial prefrontal cortex
(mPFC) and amygdala of naive preadolescent (p24), adolescent (p35), and adult (p70) 5-HTT−/− and
5-HTT+/+ rats. #: a significant effect of genotype (p < 0.05); $: a significant effect of age (p < 0.05); ¥: a
significant age × genotype interaction (p < 0.05); *: a significant post hoc difference between 5-HTT−/−
vs. age-matched 5-HTT+/+ rats (* p < 0.05; *** p < 0.001).
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Amygdala. In the amygdala (Figure 3, lower panel), c-Fos expression was modulated by age
(F(2,34) = 7.090, p = 0.003), but not genotype (F(1,34) < 1) nor a genotype × age interaction (F(2,34) = 1.171,
p = 0.322). This age effect was driven by a significantly higher expression in adolescent compared to
preadolescent (p = 0.005) and adult rats (p = 0.011), whereas no differences between these latter age
groups were found (p = 1.000). BDNF expression in the amygdala was modulated by a genotype ×
age interaction (F(2,32) = 6.067, p = 0.006), but no main effects (both p-values > 0.2). Further testing
suggested that this interaction was driven by lower amygdala BDNF expression in pre-adolescent
and adolescent 5-HTT−/− rats compared to WTs (p = 0.041 and p = 0.046 respectively), whereas
adult 5-HTT−/− rats tended to display increased amygdala BDNF expression (p = 0.069). Amygdala
NR1 expression was not modulated by genotype, age (both F-values < 1), or a genotype × age
interaction (F(2,32) = 1.059, p = 0.359), whereas NR2A expression was different for the distinct age
groups (F(2,32) = 11.156, p < 0.001), without a significant effect of genotype (F(1,32) < 1) or genotype ×
age interaction (F(2,32) = 2.371. p = 0.110). Further testing revealed that pre-adolescent rats displayed
lower amygdala NR2A expression compared to adolescent and adult rats (both p-values = 0.001),
whereas the latter two age groups were not different (p = 1.000).
3.4. Gene Expression following Fear Extinction Learning
mPFC. Levels of c-Fos expression in the mPFC following extinction learning (Figure 4, upper panel)
were dependent on the rats’ age (F(2,36) = 6.182, p = 0.005), but not on genotype (F(1,36) = 1.032, p = 0.317)
or on the genotype× age interaction (F(2,36) < 1). Preadolescent rats showed lower c-Fos expression than
adolescent (p = 0.014) and adult (p = 0.002) animals, whereas adolescent and adult animals displayed
similar levels (p = 0.850). mPFC BDNF expression following extinction was also dependent on age
(F(2,39) = 7.507, p = 0.002) and showed a trend towards an effect of genotype (F(1,39) = 3.107, p = 0.086),
without displaying a genotype × age interaction (F(2,39) = 1.185, p = 0.316). Similar to naïve animals,
BDNF levels were highest in adolescent rats (p < 0.001 and p = 0.003 compared to preadolescent and
adult rats, respectively), whereas no differences were observed between adult and preadolescent rats
(p = 0.502). Adolescent 5-HTT−/− rats showed lower mPFC BDNF expression than 5-HTT+/+ rats
(p = 0.014), while no significant differences were observed at the other ages (both p-values > 0.5). NR1
levels only depended on the age of the rat (F(2,40) = 30.131, p < 0.001), with again the adolescent rats
displaying the highest expression (both p-values < 0.001), and levels in preadolescent and adult rats
not differing (p = 0.206). Similarly, mPFC NR2A expression following extinction was characterized by
a main effect of age (F(2,39) = 36.840, p < 0.001), but no effect of genotype or genotype × age interaction
(both F-values < 1). Again, expression levels were highest in adolescence (both p-values < 0.001),
and adult rats showed higher NR2A expression than pre-adolescent rats (p = 0.031). No correlations
were observed between basal or cue-induced freezing and mPFC expression levels.
Amygdala. In the amygdala (Figure 4, lower panel), c-Fos expression following extinction learning
was modulated by age (F(2,40) = 5.918, p = 0.006) and a genotype × age interaction (F(2,40) = 3.870,
p = 0.029), whereas the main effect of genotype did not reach significance (F(1,40) = 3.092, p = 0.086). This
age effect was driven by a higher expression in the adolescent compared to preadolescent amygdala
(p = 0.017), whereas neither age group significantly differed from adults (p = 0.547 and p = 0.379
respectively). The interaction was driven by a significant genotype effect in preadolescent rats, with
WTs showing lower expression (p = 0.047), whereas no differences were observed at the other ages (both
p-values > 0.22). Amygdala BDNF expression was also dependent on age (F(2,37) = 5.158, p = 0.011),
without the effect of genotype nor the interaction (both F-values < 1). BDNF levels were higher in the
adult compared to the preadolescent (p = 0.053) and adolescent (p = 0.006) amygdala, whereas the
latter were not different from each other (p = 1.000). Similarly, amygdala NR1 expression following
extinction depended on age (F(2,40) = 4.992, p = 0.012), but not genotype or a genotype × age interaction
(both F-values < 1), with adult rats displaying the same expression levels as the preadolescent rats
(p = 0.149) but higher levels compared to adolescent rats (p = 0.007). These groups did not differ
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from each other (p = 0.927)). Amygdala NR2A expression was not affected by age, genotype, or their
interaction (all F-values < 1).
Correlational analyses across all ages and genotypes related both amygdala BDNF and NR1 levels
to basal anxiety, with lower expression levels following testing being related to higher freezing during
the habituation period (BDNF: r(43) = 0.307, p = 0.045; NR1: r(46) = 0.310, p = 0.036) (Figure S3).
Moreover, amygdala BDNF was negatively related to cue-induced freezing during the extinction
session (r(43) = 0.440, p = 0.003) (Figure S3).
Figure 4. Relative expression levels of c-Fos, BDNF, NR1, and NR2A in the medial prefrontal cortex
(mPFC) and amygdala of 5-HTT−/− and 5-HTT+/+ rats following fear extinction learning during
preadolescence (p24), adolescence (p35), and adulthood (p70). #: a significant effect of genotype
(p < 0.05); ~: a trend-level significant effect of genotype (p = 0.086); $: a significant effect of age (p < 0.05);
¥: a significant age × genotype interaction (p < 0.05); *: a significant post hoc difference between
5-HTT−/− vs. age-matched 5-HTT+/+ rats (p < 0.05).
3.5. Gene Expression following Fear Extinction Recall
mPFC. Following the last fear extinction recall session, expression levels of c-Fos in the mPFC
(Figure 5, upper panel) were modulated by the rats’ age (F(2,25) = 4.993, p = 0.015), genotype
(F(1,25) = 13.612, p = 0.001), and a genotype × age interaction (F(2,25) = 4.046, p = 0.030). Further
testing revealed that WT rats showed highest expression levels in adolescence (p < 0.001 and p = 0.001
compared to preadolescent and adult animals, respectively) and higher levels in adult compared to
preadolescent rats (p = 0.043). No such effect of age was observed in 5-HTT−/− rats (all p-values = 1.000),
resulting in significantly higher mPFC c-Fos expression in WT compared to 5-HTT−/− rats during
adolescence (p = 0.013), but not preadolescence (p = 0.778) or adulthood (p = 0.075). mPFC BDNF
expression following extinction recall was modulated by a genotype × age interaction (F(2,28) = 5.397,
p = 0.010), without the main effects of age (F < 1) or genotype (F(1,28) = 1.084, p = 0.307). This interaction
was caused by a significant effect of age in 5-HTT+/+ rats (F(2,13) = 6.174, p = 0.013) that was absent in
5-HTT−/− rats (F(2,15) = 1.672, p = 0.221), resulting in a significant effect of genotype only at adult age
(p = 0.005, other p-values > 0.2), with 5-HTT+/+ rats displaying lower BDNF expression. Additionally,
mPFC NR1 levels following extinction recall were modulated in a genotype× age manner (F(2,28) = 4.034,
p = 0.029), without main effects of age or genotype (both F-values < 1). Preadolescents (p = 0.960)
of both genotypes showed similar NR1 expression. Adolescent 5-HTT−/− rats were characterized by
lower NR1 expression compared to their 5-HTT+/+ counterparts (p = 0.048), whereas adult 5-HTT−/−
rats tended to show higher expression (p = 0.081). NR2A expression levels were characterized by a
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genotype × age interaction as well (F(2,28) = 4.080, p = 0.028), without significant effects of age (F < 1) or
genotype (F(1,28) = 1.920, p= 0.177). Post hoc testing only revealed a significant effect of genotype during
adulthood, when mPFC NR2A expression in response to extinction recall was significantly increased
in 5-HTT−/− compared to 5-HTT+/+ rats (p = 0.034). No significant differences were found during
preadolescence and adolescence between 5-HTT−/− compared to WT rats (p = 0.106 and p = 0.137,
respectively).
Figure 5. Relative expression levels of c-Fos, BDNF, NR1, and NR2A in the medial prefrontal cortex
(mPFC) and amygdala of 5-HTT−/− and 5-HTT+/+ rats following the second session of fear extinction
recall during preadolescence (p24), adolescence (p35), and adulthood (p70). #: a significant effect of
genotype (p < 0.05); $: a significant effect of age (p < 0.05); ¥: a significant age × genotype interaction
(p < 0.05); ~: a trend-level significant age × genotype interaction (p = 0.054); *: a significant post hoc
difference between 5-HTT−/− vs. age-matched 5-HTT+/+ rats (* p < 0.05; ** p < 0.01).
Correlational analyses across all ages and genotypes revealed that mPFC c-Fos expression was
significantly related to the amount of cue-induced freezing during this last extinction recall session
(r(31) = 0.366, p = 0.043), with reduced c-Fos levels relating to increased freezing, reflecting impaired
extinction recall (Figure S3).
Amygdala. In the amygdala (Figure 5, lower panel), c-Fos expression following extinction recall was
not modulated by age, genotype, or a genotype × age interaction (all F-values < 1). Amygdala BDNF
expression revealed a trend towards an age × genotype interaction (F(2,28) = 3.242, p = 0.054), without a
main effect of genotype (F(1,28) = 1.111, p = 0.301) or age (F(2,28) = 2.450, p = 0.105). Exploratory post hoc
tests revealed a significant reduction in amygdala BDNF expression during preadolescence in 5-HTT−/−
compared to 5-HTT+/+ rats (p = 0.017) that was not observed at other ages (p-values > 0.6). Amygdala
NR1 expression following extinction recall only revealed a significant effect of age (F(2,28) = 5.178,
p = 0.012), but not of genotype (F(1,28) = 1.106, p = 0.302) or of their interaction (F(2,28) = 1.403,
p = 0.262), with adult rats displaying higher expression levels compared to preadolescent (p = 0.035)
and adolescent rats (p = 0.015), whereas these latter groups did not differ from each other (p = 1.000).
Amygdala NR2A expression only revealed trends for a reduced expression in 5-HTT−/− rats across
ages (F(1,28) = 3.871, p = 0.056) and an increase with age (F(2,28) = 2.662, p = 0.087), without interaction
(F < 1). No significant correlations between amygdala gene expression levels and freezing during
extinction recall were observed.
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4. Discussion
Here, we confirm that fear extinction recall is impaired in 5-HTT−/− rats, an established and often
replicated phenomenon [44,45,55,56], as is extinction learning in rats of this genotype [46]. Strikingly,
an effect of age on fear extinction recall was seen only in 5-HTT−/− rats, which enjoyed a transient
normalization (i.e. improvement) of fear extinction recall during adolescence. Whereas augmented
fear extinction learning seems to be responsible for the improved fear extinction recall observed in
5-HTT−/− rats during adolescence, age × genotype effects on learning rates failed to reach significance.
The number of GAD65/67 positive synaptic contacts, indicative of inhibitory regulation, was decreased
in the IL of 5-HTT−/− rats, regardless of age, and no clear effect of age or genotype were seen on
the number of GAD65/67 positive synaptic contacts in the BLA. In naïve rats, we observed increases
in BDNF, NR1, and NR2A expression levels in the mPFC, and in c-Fos in the mPFC and amygdala,
during adolescence. Furthermore, BDNF levels were reduced in 5-HTT−/− rats across all ages. While
no genotype × age interactions were observed following fear extinction learning, fear extinction recall
was associated with a genotype × age interaction for NR1, NR2A, and c-Fos in the mPFC. These data
suggest that specifically (glutamatergic) plasticity changes in the mPFC contribute to the temporary
normalization of fear extinction recall in 5-HTT−/− rats during adolescence.
A number of developmental abnormalities arising from 5-HTT abolishment have been described
in the literature. The development of several motor and sensory functions, namely reflexes, motor
coordination and olfactory discrimination, is delayed in 5-HTT−/− rats but normalized upon reaching
adulthood [57]. Remarkably, other deficiencies seen in adult 5-HTT−/− animals, i.e. impaired object
recognition, object directed behavior, and sensorimotor gating, do not arise until after adolescence [57].
The present results suggest that the abnormal emotional profile seen in 5-HTT−/− rats is subject to
a nonlinear developmental trajectory as well, implying that 5-HTT abolishment influences neural
maturation depending on the developmental phase and locus. The finding of the transiently alleviated
recall of fear extinction during adolescence in 5-HTT−/− rats suggests that the pacing of development
of cortical and subcortical regions may be altered in these rats. Congruent with our findings, a study in
5-HTT−/− mice has demonstrated that increased anxiety, another hallmark trait of the 5-HTT−/− rodent
phenotype, is not present during adolescence [58].
This study does not replicate findings from other studies that suggest fear extinction recall deficits
in adolescent animals and humans with normal 5-HTT expression [12,13], as our results indicate that,
in 5-HTT+/+ animals, fear extinction recall is not significantly affected by age. We corroborate findings
of another study, in which extinction learning was found to be similar between adolescent and adult
C57BL/6J mice [59]. Differences in the details of the experimental procedures may crucially determine
whether an effect of age presents itself. For instance, the experiments may differ in the degree to which
contextual cues from the conditioning session are present during the extinction, which determines the
additional involvement of the hippocampus on fear expression and extinction [60]. This variability
in the reported findings necessitates additional investigation towards the exact circumstances under
which adolescent fear extinction (recall) is impaired.
The inhibitory immunoreactivity in the IL as assessed by immunohistochemistry is reduced in
5-HTT−/− rats across all age groups. This finding is in line with previous observations of reduced
inhibitory synapses onto cortical excitatory neurons in preadolescent 5-HTT−/− rats [47]. Previous
work has, however, associated increased inhibitory synaptic transmission onto IL projection neurons
with impaired retrieval of extinction memory by inhibiting the consolidation of extinction [61], which
contrasts our observation of reduced inhibition in the genotype group with poorest extinction recall.
Yet, here we did not determine the class of neurons targeted by these inhibitory contacts, leaving the
possibility of reduced inhibition of local interneurons in 5-HTT−/− rats open. In any case, the observed
reduction in inhibitory synapses appears to remain stable across the development from preadolescence
to adulthood, making it unlikely that altered development of prefrontal inhibition contributing to the
remarkable development of fear extinction behavior seen in these animals.
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Under basal conditions, in naive rats, c-Fos, BDNF, NR1, and NR2A gene expression levels in
the mPFC were highest during adolescence, indicating that adolescence is indeed a critical period of
mPFC development. For NR2A, we additionally observed that levels were highest during adolescence
in 5-HTT−/− rats. The peak in NMDA receptor expression may relate to pruning (removal of synapses),
known to occur during adolescence and to be NMDA-receptor-dependent [62]. Increased c-Fos
expression levels in the PFC during adolescence may reflect a compensatory attempt of the mPFC to
retain control over the amygdala, while the lower c-Fos expression levels in 5-HTT−/− rats across ages
may correspond to the reduced prefrontal cortical top-down control over the amygdala as reported for
human 5-HTTLPR s-allele carriers [34]. The peak in BDNF levels during adolescence is in line with
previous observations [30]. We also replicated previous observations of reduced BDNF expression
in the PFC of 5-HTT−/− regardless of age [48,63,64]. In the amygdala, c-Fos levels were found to
peak during adolescence, which potentially reflects the increased activity of this area due to reduced
prefrontal top-down control [4]. However, c-Fos remained high during adulthood, which might reflect
the completion of amygdala maturation during adolescence. Amygdala BDNF levels were reduced in
5-HTT−/− rats during preadolescence and adolescence, in line with the overall decreased BDNF levels
in these rats found previously [48,63,64], but BDNF levels tended to be increased in 5-HTT−/− rats
during adulthood. For NR1, no genotype and age effects were observed, and for NR2A there was a
decrease in expression in preadolescent rats. These data show that the mPFC and amygdala mature at
different paces and through different plasticity routes.
BDNF, NR1, and NR2A expression levels in the mPFC after fear extinction learning largely
recapitulated the baseline findings in naive rats, suggesting that extinction learning does not change the
expression of these plasticity factors. During the recall test, however, we observed that (over all animals
and ages combined) c-Fos expression in the mPFC was negatively correlated with cue-induced freezing.
This implies that impaired extinction recall is associated with reduced prefrontal cortex activity and
thereby cognitive control over the emotional response. This finding is in line with the study of Patwell
et al. [12] reporting a link between impaired extinction recall and reduced c-Fos expression in the IL
in adolescent animals. Nonetheless, the increased mPFC c-Fos expression in 5-HTT+/+ adolescents
is quite remarkable. It is important to note that we combined IL and PrL tissue for gene expression
analyses, raising the possibility that the increase in c-Fos expression in adolescent 5-HTT+/+ rats is due
to increased c-Fos expression in the PrL. The function of this is open to speculation. As this observation
does not result in lower freezing levels in adolescent 5-HTT−/− rats, other neuroplasticity changes in the
mPFC or amygdala might counteract this effect. BDNF and NR2A were increased in adult 5-HTT−/−
rats specifically, which thereby seem to be unrelated to the temporary improvement in fear extinction
in adolescent 5-HTT−/− rats. We furthermore observed that adolescent 5-HTT−/− rats display lower
levels of NR1 in the mPFC. The essential NR1 subunit of the NMDA receptor expressed in excitatory
prefrontal cortical neurons has been shown to decrease fear generalization [65]. If NMDAR-dependent
neural signaling in the mPFC is a component of a neural mechanism for disambiguating the meaning
of fear signals, our finding may point towards a temporary improvement in the interpretation of the
fear-predicting cue during adolescence in 5-HTT−/− rats, allowing the animals to discriminate the
fear and safety better. We did not explicitly assess fear generalization in this study, but the measure
that comes closest is baseline freezing observed prior to the tone presentations in the extinction recall
sessions. Interestingly, baseline freezing prior to extinction recall was modulated by genotype, with
5-HTT−/− rats displaying higher freezing than the other groups (Figure S2). Thus, 5-HTT−/− rats showed
higher baseline freezing levels as well as reduced mPFC NR1 expression in adulthood. However, these
measures did not significantly correlate (p > 0.15), leaving our interpretation still speculative. In the
amygdala, c-Fos expression tended to peak in adolescence independently of genotype, which thereby
follows the pattern observed in the mPFC. None of the other genes assessed displayed an expression
pattern that followed the age- and genotype-dependent changes in freezing during extinction learning.
This implies that the amygdala does not play a key role in the temporary disappearance of genotype
effects on freezing during extinction learning in adolescence. We did observe that BDNF and NR1
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expression significantly correlated with baseline freezing behavior. Specifically, lower expression
of both NR1 and BDNF in the amygdala was associated with more freezing during the habituation
period. Furthermore, amygdala BDNF was negatively related to cue-induced freezing during the
extinction session. Amygdala BDNF has been demonstrated to facilitate fear learning [66], which
appears incongruent with our observation. Potentially, lower BDNF levels in the amygdala mediated
unconditioned fear in this study. Overall, our data suggest that the temporary normalization of
fear extinction recall in 5-HTT−/− rats during adolescence relates to neuroplasticity changes in the
mPFC, whereas the amygdala seems to exert more generalized (genotype-independent) effects on the
freezing response.
Some limitations of the study require attention. The quantified granules in the IL are hypothesized
to represent synaptic contacts. However, without performing a functional tracer study, it is not possible
to determine the source of the GABAergic inputs. In addition, it is not certain that these synaptic
terminals interface with neurons that are functional within the circuitry driving fear expression and
extinction. In addition, animals that had undergone one and three days of fear extinction were pooled
to determine GAD65/67 immunoreactivity in the IL and BLA to obtain sufficient statistical power for
a comparison. Since GAD65/67 expression is influenced by recent fear conditioning, it is possible
that levels of expression were affected by this variation in time between conditioning and sacrifice
of the animal. However, all GAD65/67 positive synaptic contacts were included in the assessment
regardless of expression level; given the high signal to the background ratio of the DAB-Ni, variations
in expression due to the varying regimes of fear conditioning is unlikely to have affected the findings.
Furthermore, because CT values were too different between the obtained from the naïve, extinction
learning, and extinction recall group, we did not express the gene expression changes after extinction
as the percentage of baseline gene expression in the naïve animals. For RT-PCR, we punched the
whole mPFC, while we studied the IL part of the mPFC in the immunohistochemical study. This
was necessary to obtain a sufficient amount of tissue for the PCRs and to reduce gene expression
variance due to variations in the precise positioning of the punch needle. As a consequence, it is
possible that differential gene expression in the IL and PrL diluted the effects we observed for the
whole mPFC. Another limitation is that we did not measure freezing during conditioning during
acquisition. We previously observed no genotype differences during fear conditioning in adults [46].
However, we do not know whether genotype differences are also absent during preadolescence and
adulthood. Since freezing during Blocks 1–4 was not different between genotypes during the fear
memory recall/extinction session, it is not likely there were genotype differences in freezing during
conditioning. As yet another limitation, visual observation of Figure 1 implies that the increased
freezing during Session 2 and 3 is due to an extinction learning deficit during Session 1. However,
the observed age × genotype effects as observed during the extinction recall sessions seemed to result
from altered recall of extinction. Nonetheless, additional differences in extinction learning between
genotypes and ages cannot be ruled out. Finally, housing conditions varied between the age groups;
although no animals were kept in isolation, preadolescent and adolescent animals were housed with
more cage mates than adults for practical and ethical reasons. Although this aspect is often overlooked
in animal research concerning stress and psychiatric illness, social elements in housing conditions
have been shown to influence emotional behavior [67] and are known to be especially influential and
instrumental to psychiatric wellbeing during adolescence [68].
5. Conclusions
In conclusion, the present findings show that the influence of genetic reduction of 5-HTT expression
on the development of fear extinction recall manifests in a non-linear pattern, temporarily normalizing
during adolescence, to become deficient again at adulthood. This discovery raises as many questions
as it answers; delayed or aberrant maturation of cortical or subcortical regions or interconnecting tracts
is a likely cause but exploiting this finding for therapeutic benefit will require further specification of
their nature and functional implications. The anatomical and functional development of excitatory
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neurons in the IL projecting to the amygdala are of particular interest for future study. An in vivo
electrophysiology or calcium imaging study in which single neurons or populations of neurons
are followed across the different stages from fear conditioning to extinction and extinction recall
would be enlightening. As it stands, the data suggest that reduced inhibitory signaling within the IL
and temporary altered excitatory signaling in the mPFC represent potential causes for the impaired
control over the amygdala seen in individuals with reduced expression of 5-HTT and its temporary
normalization during adolescence.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3425/9/5/118/s1,
Figure S1: Fear conditioning behavioral data across extinction learning and the two extinction recall sessions,
sorted on genotype, Figure S2: Fear conditioning behavioral data across extinction learning and the two extinction
recall sessions, including baseline, Figure S3: Correlational plots showing associations between brain gene
expression levels and behavioral freezing.
Author Contributions: Conceptualization: P.S., J.R.H., and M.J.A.G.H.; methodology: P.S., J.R.H., M.J.A.G.H.,
and F.C.; validation: P.S., P.B., D.d.L., L.M., B.A., F.R., and M.M.M.V.; formal analysis: P.S. and M.J.A.G.H.;
writing—original draft preparation: P.S., M.J.A.G.H., and J.R.H.; writing—review and editing: P.S., M.M.M.V.,
T.K., M.A.R., F.C., M.J.A.G.H., and J.R.H.; visualization: M.J.A.G.H.; supervision: M.J.A.G.H. and J.R.H.; funding
acquisition: M.J.A.G.H. and J.R.H.
Funding: M.J.A.G.H. is the recipient of VENI grant 863.15.008. This work was supported by Era-Net NEURON
grant “RESPOND” and VIDI grant 864.10.003 awarded to J.R.H. Funding organizations had no further role in the
design of the study or in the collection, analysis, and interpretation of data.
Acknowledgments: We thank Anthonieke Middelman for the breeding and genotyping of the animals, and Jana
van Luttikhuizen and Jos Dederen for their assistance with the immunostainings.
Conflicts of Interest: There are no conflicts of interest.
References
1. Somerville, L.H.; Kelley, W.M.; Heatherton, T.F. Self-esteem Modulates Medial Prefrontal Cortical Responses
to Evaluative Social Feedback. Cereb. Cortex 2010, 20, 3005–3013. [CrossRef] [PubMed]
2. Pine, D.S.; Coplan, J.D.; Papp, L.A.; Klein, R.G.; Martinez, J.M.; Kovalenko, P.; Tancer, N.; Moreau, D.;
Dummit, E.S.; Shaffer, D.; et al. Ventilatory Physiology of Children and Adolescents With Anxiety Disorders.
Arch. Gen. Psychiatry 1998, 55, 123–129. [CrossRef] [PubMed]
3. Somerville, L.H.; Casey, B. Developmental neurobiology of cognitive control and motivational systems.
Curr. Opin. Neurobiol. 2010, 20, 236–241.
4. Somerville, L.H.; Jones, R.M.; Casey, B.J. A time of change: Behavioral and neural correlates of adolescent
sensitivity to appetitive and aversive environmental cues. Brain Cogn. 2010, 72, 124–133. [CrossRef]
5. Dahl, R.E. Adolescent brain development: A period of vulnerabilities and opportunities. Keynote address.
Ann. N. Y. Acad. Sci. 2004, 1021, 1–22. [CrossRef]
6. Steinberg, L. Cognitive and affective development in adolescence. Trends Cogn. Sci. 2005, 9, 69–74. [CrossRef]
7. Britton, J.C.; Lissek, S.; Grillon, C.; Norcross, M.A.; Pine, D.S. Development of anxiety: The role of threat
appraisal and fear learning. Depress. Anxiety 2011, 28, 5–17. [CrossRef]
8. Heller, A.S.; Cohen, A.O.; Dreyfuss, M.F.W.; Casey, B.J. Changes in cortico-subcortical and subcortico-subcortical
connectivity impact cognitive control to emotional cues across development. Soc. Cogn. Affect. Neurosci. 2016,
11, 1910–1918. [CrossRef] [PubMed]
9. Hare, T.A.; Tottenham, N.; Galvan, A.; Voss, H.U.; Glover, G.H.; Casey, B. Biological substrates of emotional
reactivity and regulation in adolescence during an emotional go-nogo task. Biol. Psychiatry 2008, 63, 927–934.
[CrossRef]
10. Shin, L.M.; Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology
2010, 35, 169–191. [CrossRef]
11. Kim-Cohen, J.; Caspi, A.; Moffitt, T.E.; Harrington, H.; Milne, B.J.; Poulton, R. Prior juvenile diagnoses in adults
with mental disorder: Developmental follow-back of a prospective-longitudinal cohort. Arch. Gen. Psychiatry 2003,
60, 709–717. [CrossRef]
172
Brain Sci. 2019, 9, 118
12. Pattwell, S.S.; Duhoux, S.; Hartley, C.A.; Johnson, D.C.; Jing, D.; Elliott, M.D.; Ruberry, E.J.; Powers, A.;
Mehta, N.; Yang, R.R.; et al. Altered fear learning across development in both mouse and human. Proc. Natl.
Acad. Sci. USA 2012, 109, 16318–16323. [CrossRef] [PubMed]
13. McCallum, J.; Kim, J.H.; Richardson, R. Impaired Extinction Retention in Adolescent Rats: Effects of
D-Cycloserine. Neuropsychopharmacology 2010, 35, 2134–2142. [CrossRef] [PubMed]
14. Baker, K.D.; Bisby, M.A.; Richardson, R. Impaired fear extinction in adolescent rodents: Behavioural and
neural analyses. Neurosci. Biobehav. Rev. 2016, 70, 59–73. [CrossRef]
15. Pattwell, S.S.; Bath, K.G.; Casey, B.J.; Ninan, I.; Leea, F.S. Selective early-acquired fear memories undergo
temporary suppression during adolescence. Proc. Natl. Acad. Sci. USA 2011, 108, 1182–1187. [CrossRef]
16. LeDoux, J.; Cicchetti, P.; Xagoraris, A.; Romanski, L. The lateral amygdaloid nucleus: Sensory interface of the
amygdala in fear conditioning. J. Neurosci. 1990, 10, 1062–1069. [CrossRef]
17. Saffari, R.; Teng, Z.; Zhang, M.; Kravchenko, M.; Hohoff, C.; Ambrée, O.; Zhang, W. NPY+−, but not PV+−
GABAergic neurons mediated long-range inhibition from infra- to prelimbic cortex. Transl. Psychiatry 2016,
6, e736. [CrossRef]
18. Ehrlich, I.; Humeau, Y.; Grenier, F.; Ciocchi, S.; Herry, C.; Lüthi, A. Amygdala Inhibitory Circuits and the
Control of Fear Memory. Neuron 2009, 62, 757–771. [CrossRef]
19. Krettek, J.E.; Price, J.L. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the
rat and cat. J. Comp. Neurol. 1977, 172, 687–722. [CrossRef] [PubMed]
20. Little, J.P.; Carter, A.G. Synaptic Mechanisms Underlying Strong Reciprocal Connectivity between the Medial
Prefrontal Cortex and Basolateral Amygdala. J. Neurosci. 2013, 33, 15333–15342. [CrossRef]
21. Little, J.P.; Carter, A.G. Subcellular Synaptic Connectivity of Layer 2 Pyramidal Neurons in the Medial
Prefrontal Cortex. J. Neurosci. 2012, 32, 12808–12819.
22. Floresco, S.B.; Tse, M.T. Dopaminergic Regulation of Inhibitory and Excitatory Transmission in the Basolateral
Amygdala-Prefrontal Cortical Pathway. J. Neurosci. 2007, 27, 2045–2057.
23. Dilgen, J.; Tejeda, H.A.; O’Donnell, P. Amygdala inputs drive feedforward inhibition in the medial prefrontal
cortex. J. Neurophysiol. 2013, 110, 221–229.
24. McGarry, L.M.; Carter, A.G. Inhibitory Gating of Basolateral Amygdala Inputs to the Prefrontal Cortex.
J. Neurosci. 2016, 36, 9391–9406.
25. Sotres-Bayon, F.; Sierra-Mercado, D.; Pardilla-Delgado, E.; Quirk, G.J. Gating of fear in prelimbic cortex by
hippocampal and amygdala inputs. Neuron 2012, 76, 804–812. [CrossRef]
26. Bang, S.J.; Commons, K.G. Forebrain GABAergic Projections From the Dorsal Raphe Nucleus Identified by
Using GAD67–GFP Knock-In Mice. J. Comp. Neurol. 2012, 520, 4157–4167. [CrossRef]
27. Henny, P.; Jones, B.E. Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic
and glutamatergic inputs to pyramidal cells or interneurons. Eur. J. Neurosci. 2008, 27, 654–670.
28. Michels, L.; Schulte-Vels, T.; Schick, M.; O’Gorman, R.L.; Zeffiro, T.; Hasler, G.; Mueller-Pfeiffer, C. Prefrontal GABA
and glutathione imbalance in posttraumatic stress disorder: Preliminary findings. Psychiatry Res. Neuroimaging 2014,
224, 288–295. [CrossRef]
29. Baker, K.D.; Richardson, R. Pharmacological evidence that a failure to recruit NMDA receptors contributes
to impaired fear extinction retention in adolescent rats. Neurobiol. Learn Mem. 2017, 143, 18–26. [CrossRef]
30. Dincheva, I.; Lynch, N.B.; Lee, F.S. The Role of BDNF in the development of fear learning. Depress. Anxiety
2016, 33, 907–916. [CrossRef]
31. Garpenstrand, H.; Annas, P.; Ekblom, J.; Oreland, L.; Fredrikson, M. Human fear conditioning is related to
dopaminergic and serotonergic biological markers. Behav. Neurosci. 2001, 115, 358–364. [CrossRef] [PubMed]
32. Klucken, T.; Alexander, N.; Schweckendiek, J.; Merz, C.J.; Kagerer, S.; Osinsky, R.; Walter, B.; Vaitl, D.;
Hennig, J.; Stark, R. Individual differences in neural correlates of fear conditioning as a function of 5-HTTLPR
and stressful life events. Soc. Cogn. Affect. Neurosci. 2013, 8, 318–325. [CrossRef]
33. Hariri, A.R.; Mattay, V.S.; Tessitore, A.; Kolachana, B.; Fera, F.; Goldman, D.; Egan, M.F.; Weinberger, D.R.
Serotonin transporter genetic variation and the response of the human amygdala. Science 2002, 297, 400–403.
[CrossRef]
34. Pezawas, L.; Meyer-Lindenberg, A.; Drabant, E.M.; A Verchinski, B.; E Munoz, K.; Kolachana, B.S.; Egan, M.F.;
Mattay, V.S.; Hariri, A.R.; Weinberger, D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala
interactions: A genetic susceptibility mechanism for depression. Nat. Neurosci. 2005, 8, 828–834. [CrossRef]
173
Brain Sci. 2019, 9, 118
35. Pacheco, J.; Beevers, C.G.; Benavides, C.; McGeary, J.; Stice, E.; Schnyer, D.M. Frontal-Limbic White Matter
Pathway Associations with the Serotonin Transporter Gene Promoter Region (5-HTTLPR) Polymorphism.
J. Neurosci. 2009, 29, 6229–6233. [CrossRef]
36. Witteveen, J.S.; Middelman, A.; Van Hulten, J.A.; Martens, G.J.M.; Homberg, J.R.; Kolk, S.M.; Martens, G.J.M.
Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation.
Front. Cell. Neurosci. 2013, 7, 143. [CrossRef]
37. Gaspar, P.; Cases, O.; Maroteaux, L. The developmental role of serotonin: news from mouse molecular
genetics. Nat. Rev. Neurosci. 2003, 4, 1002–1012. [CrossRef]
38. Homberg, J.R.; Schubert, D.; Gaspar, P. New perspectives on the neurodevelopmental effects of SSRIs. Trends
Pharmacol. Sci. 2010, 31, 60–65. [CrossRef]
39. Homberg, J.R.; Lesch, K.-P. Looking on the Bright Side of Serotonin Transporter Gene Variation. Biol.
Psychiatry 2011, 69, 513–519. [CrossRef]
40. Narayanan, V.; Heiming, R.S.; Jansen, F.; Lesting, J.; Sachser, N.; Pape, H.-C.; Seidenbecher, T. Social Defeat:
Impact on Fear Extinction and Amygdala-Prefrontal Cortical Theta Synchrony in 5-HTT Deficient Mice.
PLoS ONE 2011, 6, e22600. [CrossRef] [PubMed]
41. Pang, R.D.; Wang, Z.; Klosinski, L.P.; Guo, Y.; Herman, D.H.; Celikel, T.; Dong, H.W.; Holschneider, D.P.
Mapping Functional Brain Activation Using [14C]-Iodoantipyrine in Male Serotonin Transporter Knockout
Mice. PLoS ONE 2011, 6, e23869. [CrossRef]
42. Hartley, C.A.; McKenna, M.C.; Salman, R.; Holmes, A.; Casey, B.J.; Phelps, E.A.; Glatt, C.E. Serotonin
transporter polyadenylation polymorphism modulates the retention of fear extinction memory. Proc. Natl.
Acad. Sci. USA 2012, 109, 5493–5498. [CrossRef]
43. Wellman, C.L.; Izquierdo, A.; Garrett, J.E.; Martin, K.P.; Carroll, J.; Millstein, R.; Lesch, K.-P.; Murphy, D.L.;
Holmes, A. Impaired Stress-Coping and Fear Extinction and Abnormal Corticolimbic Morphology in
Serotonin Transporter Knock-Out Mice. J. Neurosci. 2007, 27, 684–691. [CrossRef]
44. Shan, L.; Schipper, P.; Nonkes, L.J.P.; Homberg, J.R. Impaired Fear Extinction as Displayed by Serotonin Transporter
Knockout Rats Housed in Open Cages Is Disrupted by IVC Cage Housing. PLoS ONE 2014, 9, e91472. [CrossRef]
45. Nonkes, L.J.; De Pooter, M.; Homberg, J.R. Behavioural therapy based on distraction alleviates impaired fear
extinction in male serotonin transporter knockout rats. J. Psychiatry Neurosci. 2012, 37, 224–230. [CrossRef]
46. Shan, L.; Guo, H.-Y.; Heuvel, C.N.A.M.V.D.; Van Heerikhuize, J.; Homberg, J.R. Impaired fear extinction in
serotonin transporter knockout rats is associated with increased 5-hydroxymethylcytosine in the amygdala.
CNS Neurosci. Ther. 2018, 24, 810–819. [CrossRef]
47. Miceli, S.; Kasri, N.N.; Joosten, J.; Huang, C.; Kepser, L.; Proville, R.; Selten, M.M.; Van Eijs, F.; Azarfar, A.;
Homberg, J.R.; et al. Reduced Inhibition within Layer IV of Sert Knockout Rat Barrel Cortex is Associated
with Faster Sensory Integration. Cereb. Cortex 2017, 27, 933–949. [CrossRef]
48. Calabrese, F.; Guidotti, G.; Middelman, A.; Racagni, G.; Homberg, J.; Riva, M.A. Lack of Serotonin Transporter Alters
BDNF Expression in the Rat Brain During Early Postnatal Development. Mol. Neurobiol. 2013, 48, 244–256. [CrossRef]
49. Karel, P.; Calabrese, F.; Riva, M.; Brivio, P.; van der Veen, B.; Reneman, L.; Verheij, M.; Homberg, J.
d-Cycloserine enhanced extinction of cocaine-induced conditioned place preference is attenuated in serotonin
transporter knockout rats. Addict. Biol. 2018, 23, 120–129. [CrossRef]
50. Smits, B.M.G.; Mudde, J.B.; Van De Belt, J.; Verheul, M.; Olivier, J.; Homberg, J.; Guryev, V.; Cools, A.R.; A
Ellenbroek, B.; A Plasterk, R.H.; et al. Generation of gene knockouts and mutant models in the laboratory rat
by ENU-driven target-selected mutagenesis. Pharmacogenetics Genom. 2006, 16, 159–169.
51. Olivier, J.; Van Der Hart, M.; Van Swelm, R.; Dederen, P.; Homberg, J.; Cremers, T.; Deen, P.; Cuppen, E.;
Cools, A.; Ellenbroek, B. A study in male and female 5-HT transporter knockout rats: An animal model for
anxiety and depression disorders. Neuroscience 2008, 152, 573–584. [CrossRef]
52. Nonkes, L.J.; Tomson, K.; Mærtin, A.; Dederen, J.; Maes, J.R.; Homberg, J. Orbitofrontal cortex and amygdalar
over-activity is associated with an inability to use the value of expected outcomes to guide behaviour in
serotonin transporter knockout rats. Neurobiol. Learn. Mem. 2010, 94, 65–72. [CrossRef]
53. Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch, T.; Preibisch, S.; Rueden, C.;
Saalfeld, S.; Schmid, B.; et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 2012,
9, 676–682. [CrossRef]
54. Livak, K.J.; Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods 2001, 25, 402–408. [CrossRef]
174
Brain Sci. 2019, 9, 118
55. Schipper, P.; Kiliaan, A.J.; Homberg, J.R. A mixed polyunsaturated fatty acid diet normalizes hippocampal
neurogenesis and reduces anxiety in serotonin transporter knockout rats. Behav. Pharmacol. 2011, 22, 324–334.
[CrossRef]
56. Schipper, P.; Nonkes, L.J.; Karel, P.; Kiliaan, A.J.; Homberg, J.R. Serotonin transporter genotype x construction
stress interaction in rats. Behav. Brain 2011, 223, 169–175. [CrossRef]
57. Kroeze, Y.; Dirven, B.; Janssen, S.; Kröhnke, M.; Barte, R.M.; Middelman, A.; Van Bokhoven, H.; Zhou, H.;
Homberg, J.R. Perinatal reduction of functional serotonin transporters results in developmental delay.
Neuropharmacology 2016, 109, 96–111. [CrossRef]
58. Sakakibara, Y.; Kasahara, Y.; Hall, F.S.; Lesch, K.-P.; Murphy, D.L.; Uhl, G.R.; Sora, I. Developmental alterations
in anxiety and cognitive behavior in serotonin transporter mutant mice. Psychopharmacology 2014, 231, 4119–4133.
[CrossRef]
59. Hefner, K.; Holmes, A. Ontogeny of fear-, anxiety- and depression-related behavior across adolescence in
C57BL/6J mice. Behav. Brain Res. 2007, 176, 210–215. [CrossRef]
60. Maren, S.; Phan, K.L.; Liberzon, I. The contextual brain: Implications for fear conditioning, extinction and
psychopathology. Nat. Rev. Neurosci. 2013, 14, 417–428. [CrossRef]
61. Vollmer, L.L.; Schmeltzer, S.; Schurdak, J.; Ahlbrand, R.; Rush, J.; Dolgas, C.M.; Baccei, M.L.; Sah, R.
Neuropeptide Y Impairs Retrieval of Extinguished Fear and Modulates Excitability of Neurons in the
Infralimbic Prefrontal Cortex. J. Neurosci. 2016, 36, 1306–1315. [CrossRef]
62. Henson, M.A.; Tucker, C.J.; Zhao, M.; Dudek, S.M. Long-term depression-associated signaling is required for
an in vitro model of NMDA receptor-dependent synapse pruning. Neurobiol. Learn Mem. 2017, 138, 39–53.
[CrossRef]
63. Molteni, R.; Cattaneo, A.; Calabrese, F.; Macchi, F.; Olivier, J.D.; Racagni, G.; Ellenbroek, B.A.; Gennarelli, M.;
Riva, M.A. Reduced function of the serotonin transporter is associated with decreased expression of BDNF
in rodents as well as in humans. Neurobiol. Dis. 2010, 37, 747–755. [CrossRef]
64. Guidotti, G.; Calabrese, F.; Auletta, F.; Olivier, J.; Racagni, G.; Homberg, J.; Riva, M.A. Developmental
influence of the serotonin transporter on the expression of npas4 and GABAergic markers: Modulation by
antidepressant treatment. Neuropsychopharmacology 2012, 37, 746–758. [CrossRef]
65. Vieira, P.A.; Corches, A.; Lovelace, J.W.; Westbrook, K.B.; Mendoza, M.; Korzus, E. Prefrontal NMDA receptors
expressed in excitatory neurons control fear discrimination and fear extinction. Neurobiol. Learn. Mem. 2015,
119, 52–62. [CrossRef]
66. Endres, T.; Lessmann, V. Age-dependent deficits in fear learning in heterozygous BDNF knock-out mice.
Learn. Mem. 2012, 19, 561–570. [CrossRef]
67. Hunter, A.S. The effects of social housing on extinction of fear conditioning in rapid eye movement
sleep-deprived rats. Exp. Brain 2014, 232, 1459–1467. [CrossRef]
68. Crone, E.A.; Dahl, R.E. Understanding adolescence as a period of social–affective engagement and goal
flexibility. Nat. Rev. Neurosci. 2012, 13, 636–650. [CrossRef]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution







Tel. +41 61 683 77 34






St. Alban-Anlage 66 
4052 Basel 
Switzerland
Tel: +41 61 683 77 34 
Fax: +41 61 302 89 18
www.mdpi.com ISBN 978-3-03921-703-8
